Sample,Block,Barcode ID,Barcode,Condition,Input Conc.,Input Hyb Conc.,Diagnosis,Notes/Other,Sequencing Run,SeqL,CL,Area,Bait,Area_id,NA_id,dept_number,specimen,dx_text,site_code,icd9,note,micro,pat_age,p_stage,thickness,subtype,prim,mitoses,gender,pat_id
1,12-6261A,1,AACGTGAT,None,512,,Melanocytic Nevus,Cheek,HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-6261A_Tumor,NA_12-6261A_Tumor,12-6261,A,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS,173304,216.3,,"Sections show a domed segment of skin, with nests, cords and strands of small round melanocytes in the dermis.",35,,,,,,M,1092077
2,12-6261B,2,AAACATCG,None,210,,Melanocytic Nevus,Neck,HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-6261B_Tumor,NA_12-6261B_Tumor,12-6261,B,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS,173403,216.4,,"Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine.",35,,,,,,M,1092077
6,12-12366,3,ATGCCTAA,None,1000,,SCC,"Associated with Solar Keratosis, rt cheek",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-12366_Tumor,NA_12-12366_Tumor,12-12366,A,FIBROEPITHELIAL POLYP,139522,214.9,,Sections show a polypoid skin segment with a core composed of loose fibrous connective tissue.,35,,,,,,M,1098182
7,12-12467,4,AGTGGTCA,Hybridization Input DNA Manipulation,1000,,Melanocytic Nevus,"Predominately intradermal, rt breast",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-12467_Tumor,NA_12-12467_Tumor,12-12467,A,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS,173505,216.5,,Sections show a predominantly intradermal proliferation of small melanocytes with round to oval nuclei that mature (diminish in size) with descent in the dermis.  The overlying epidermis shows elongated rete that intertwine.,31,,,,,,F,1098283
11,12-12470D,8,CATCAAGT,None,480,,BCC,"Nodular/Infiltrative, upper anterior forearm",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-12470D_Tumor,NA_12-12470D_Tumor,12-12470,D,NODULAR/INFILTRATIVE BASAL CELL CARCINOMA,423654,173.61,The neoplasm extends to the edges of the specimen.,"Sections show nodular aggregations of atypical, peripherally palisaded basaloid cells. In some areas, angulate aggregations of similar cells are apparent in infiltrative array. There is enveloping cellular stroma. There is crush artifact.",98,,,,,,M,192328
13,12-562,10,ACAAGCTA,None,1000,,,,HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-562_Tumor,NA_12-562_Tumor,12-562,A,"PRURIGO NODULARIS, CRUSTED",173340,698.3,,"There is the surface of a dome shaped segment of skin with psoriasiform epidermal hyperplasia, a thick granular layer and compact hyperkeratosis that contains neutrophils.",59,,,,,,M,1042076
15,12-12647,12,AGTACAAG,None,330,,Melanocytic Nevus,"Intradermal, right breast",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-12647_Tumor,NA_12-12647_Tumor,12-12647,A,"BASAL CELL CARCINOMA, SUPERFICIAL AND NODULAR PATTERNS, EXTENDING TO THE DEEP MARGIN",333504,173.51,,"Sections show a neoplastic proliferation of atypical, peripherally palisaded basaloid cells arranged as aggregations attached to the undersurface of the epidermis and as nodules within the dermis.",52,,,,,,M,858006
20,12-12626,13,AACAACCA,Hybridization Input DNA Manipulation,1000,,Cellular Dermatofibroma ,Right Arm,HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-12626_Tumor,NA_12-12626_Tumor,12-12626,A,CELLULAR DERMATOFIBROMA,173602,216.6,,"Sections show a cellular proliferation of spindled and stellate cells, arranged amongst thickened collagen bundles in some areas. The overlying epidermis is acanthotic.",28,,,,,,F,1098442
23,12-13587B2,14,AACCGAGA,None,1000,,SCC,"Ext deep margins, leg",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-13587B2_Tumor,NA_12-13587B2_Tumor,12-13587,B,"SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP MARGIN",173740,173.72,"While there are some features of keratoacanthoma, the preponderance of atypical keratinocytes and broad zones of squamous cell carcinoma in situ involving the flanking epidermis rules out this possibility.","There is an exo-endophytic proliferation of keratinocytes.  Some areas have lobules composed of cells with abundant pale cytoplasm and central foci of abrupt keratinization, while others are composed of cells with a high nuclear to cytoplasmic ratio, and atypical nuclei. The flanking epidermis shows atypical keratinocytes that in several areas involve the entire thickness of the epithelium.",84,,,,,,F,502329
24,12-18438A,15,AACGCTTA,None,400,,"SCC, in situ",,HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-18438A_Tumor,NA_12-18438A_Tumor,12-18438,A,SQUAMOUS CELL CARCINOMA IN SITU (BOWEN'S DISEASE),102538,232.5,The neoplasm extends to the edge of the specimen.,"The epidermis is thickened, with widened rete ridges and keratinocytes that confluently have large, atypical nuclei.  Keratinocytes in the basal layer have smaller nuclei than do the cells above them in some areas.  There are patchy infiltrates of lymphocytes.",81,,,,,,M,1104255
27,12-13152,17,AAGGTACA,Hybridization Input DNA Manipulation,554,,Melanocytic Nevus,"Compound, Clarks or Dysplastic type, back",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-13152_Tumor,NA_12-13152_Tumor,12-13152,A,"COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE",273588,216.5,The neoplasm extends to the base of the specimen in one small focus but is widely excised towards the periphery. The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.,"Sections show a broad compound proliferation of melanocytes, with a junctional component composed of nested and single melanocytes that extend lateral to an underlying papillary dermal component of similar cells.  The papillary dermis shows fibrosis, some in a lamellar configuration.",71,,,,,,M,1098968
28,12-12750B,18,ACACAGAA,None,1000,,SCC,Forehead,HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-12750B_Tumor,NA_12-12750B_Tumor,12-12750,B,"SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP BIOPSY MARGIN",123398,173.32,,"Sections show a proliferation composed of atypical keratinocytes, arrayed as irregular nests that infiltrate the dermis.  There are keratotic whorls and pale keratinocytes. The mitotic rate is high.",91,,,,,,M,114451
29,12-19596,19,ACAGCAGA,None,1000,,"SCC, in situ","Bowen's Disease, pagetoid",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-19596_Tumor,NA_12-19596_Tumor,12-19596,A,"SQUAMOUS CELL CARCINOMA IN SITU (BOWEN'S DISEASE), PAGETOID PATTERN, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN",173610,232.6,,Sections show a proliferation of atypical keratinocytes in confluent array within the surface epithelium.  Some of the atypical keratinocytes have pallid cytoplasm and are scattered within the epidermis in pagetoid fashion.,89,,,,,,F,1105413
31,12-19187A,20,ACCTCCAA,None,1000,,Dermatofibroma,Shin,HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-19187A_Tumor,NA_12-19187A_Tumor,12-19187,A,DERMATOFIBROMA,187724,216.7,,"There is a dermal proliferation of spindled cells, arranged as interconnecting fascicles. These are more compactly arranged in the center of the lesion than at its periphery, where these cells progressively are interspersed between reticular dermal collagen bundles. The overlying epidermis is thickened.",48,,,,,,F,1105004
35,12-22172,22,ACGTATCA, Normal Tumor Pair,371,,"SCC, in situ","Bowen's Disease,Left lateral back",HiSeq1_BB2,BB2_SeqL,BB2_CL,Normal,Agilent?,12-22172_Normal,NA_12-22172_Normal,12-22172,A,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS,123122,216.1,,Sections show a predominantly dermal proliferation of melanocytes without pronounced nuclear variability.,29,,,,,,F,1107990
36,12-22172,23,ACTATGCA,Normal Tumor Pair,1000,,"SCC, in situ","Bowen's Disease, Lateral left back",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-22172_Tumor,NA_12-22172_Tumor,12-22172,A,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS,123122,216.1,,Sections show a predominantly dermal proliferation of melanocytes without pronounced nuclear variability.,29,,,,,,F,1107990
38,12-21726A,24,AGAGTCAA,None,157,,Dermatofibroma,"A Melan-A stain (-), leg",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-21726A_Tumor,NA_12-21726A_Tumor,12-21726,A,CELLULAR DERMATOFIBROMA,173740,216.7,A Melan-A stain is negative.,"Sections show a dome shaped, cellular proliferation of spindled and stellate cells, arranged amongst thickened collagen bundles in some areas. The overlying epidermis is acanthotic.",29,,,,,,F,1107544
39,12-22901A,25,AGATCGCA,Normal Tumor Pair,497,,Melanocytic Nevus,"Intradermal, forehead",HiSeq1_BB2,BB2_SeqL,BB2_CL,Normal,Agilent?,12-22901A_Normal,NA_12-22901A_Normal,12-22901,A,"PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)",123398,216.3,,Sections show a predominantly dermal proliferation of melanocytes without pronounced nuclear variability.,67,,,,,,M,1108719
40,12-22901A,26,AGCAGGAA,Normal Tumor Pair,1000,,Melanocytic Nevus,"Intradermal, forehead",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-22901A_Tumor,NA_12-22901A_Tumor,12-22901,A,"PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)",123398,216.3,,Sections show a predominantly dermal proliferation of melanocytes without pronounced nuclear variability.,67,,,,,,M,1108719
41,12-22776B5,27,AGTCACTA,None,1000,,"Melanoma, Acral","Biopsy site w/residual Acral,Toe web",HiSeq1_BB2,BB2_SeqL,BB2_CL,Normal,Agilent?,12-22776B5_Normal,NA_12-22776B5_Normal,12-22776,B,"BIOPSY SITE WITH RESIDUAL ACRAL MELANOMA, 1.5 MM IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)",666955,172.9,We do not have a record of a prior biopsy on this site. Can you please forward a copy of the previous pathology report to our office. Histopathologic features of possible prognostic importance include:  Level: IV Vascular or lymphatic invasion: absent Dermal mitotic rate: rare mitotic figures Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: not detected Stage: pT2a,"Sections show a biopsy site on acral skin with an adjacent, broad proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells extending broadly into the dermis. There is a dense lichenoid lymphocytic infiltrate. In some areas melanocytes are present in pagetoid array within the epidermis.",36,T2a,1.5,,Primary,,M,1096148
43,BuffyCoat,28,ATCCTGTA,Buffy Coat Derived DNA,1000,,,,HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,BuffyCoat_Tumor,NA_BuffyCoat_Tumor,,,,,,,,,,,,,,,
44,12-13587B2,29,ATTGAGGA,Diluted Input Library DNA,750,,SCC,"Ext deep margins, leg",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-13587B2_Tumor,NA_12-13587B2_Tumor,12-13587,B,"SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP MARGIN",173740,173.72,"While there are some features of keratoacanthoma, the preponderance of atypical keratinocytes and broad zones of squamous cell carcinoma in situ involving the flanking epidermis rules out this possibility.","There is an exo-endophytic proliferation of keratinocytes.  Some areas have lobules composed of cells with abundant pale cytoplasm and central foci of abrupt keratinization, while others are composed of cells with a high nuclear to cytoplasmic ratio, and atypical nuclei. The flanking epidermis shows atypical keratinocytes that in several areas involve the entire thickness of the epithelium.",84,,,,,,F,502329
45,12-13587B2,30,CAACCACA,Diluted Input Library DNA,500,,SCC,"Ext deep margins, leg",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-13587B2_Tumor,NA_12-13587B2_Tumor,12-13587,B,"SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP MARGIN",173740,173.72,"While there are some features of keratoacanthoma, the preponderance of atypical keratinocytes and broad zones of squamous cell carcinoma in situ involving the flanking epidermis rules out this possibility.","There is an exo-endophytic proliferation of keratinocytes.  Some areas have lobules composed of cells with abundant pale cytoplasm and central foci of abrupt keratinization, while others are composed of cells with a high nuclear to cytoplasmic ratio, and atypical nuclei. The flanking epidermis shows atypical keratinocytes that in several areas involve the entire thickness of the epithelium.",84,,,,,,F,502329
46,12-13587B2,31,CAAGACTA,Diluted Input Library DNA,250,,SCC,"Ext deep margins, leg",HiSeq1_BB2,BB2_SeqL,BB2_CL,Tumor,Agilent?,12-13587B2_Tumor,NA_12-13587B2_Tumor,12-13587,B,"SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP MARGIN",173740,173.72,"While there are some features of keratoacanthoma, the preponderance of atypical keratinocytes and broad zones of squamous cell carcinoma in situ involving the flanking epidermis rules out this possibility.","There is an exo-endophytic proliferation of keratinocytes.  Some areas have lobules composed of cells with abundant pale cytoplasm and central foci of abrupt keratinization, while others are composed of cells with a high nuclear to cytoplasmic ratio, and atypical nuclei. The flanking epidermis shows atypical keratinocytes that in several areas involve the entire thickness of the epithelium.",84,,,,,,F,502329
43,BuffyCoa,28,ATCCTGTA,Buffy Coat Derived DNA,1000,,Family History (9 members) have melanoma,Collaborated with Robert Nussbaum to get this blood,HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,BuffyCoa_Tumor,NA_BuffyCoa_Tumor,,,,,,,,,,,,,,,
47,12-22775,32,CAATGGAA,,1000,,SCC,"Crateriform, chest",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22775_Tumor,NA_12-22775_Tumor,12-22775,A,"CRATERIFORM SQUAMOUS CELL CARCINOMA, EXTENDING TO THE BASE OF THE SPECIMEN",173527,173.52,,Sections show a papillated to crateriform proliferation of atypical keratinocytes with central and overlying ortho- and parakeratosis. Keratinocytes with atypical nuclei are scattered throughout the proliferation.,69,,,,,,M,249102
48,12-22794A,33,CACTTCGA,,1000,,Melanoma,"Level III, right shoulder",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22794A_Tumor,NA_12-22794A_Tumor,12-22794,A,"MELANOMA, 0.80 MM IN THICKNESS, EXTENDING TO THE PERIPHERY OF THE BIOPSY",173620,172.6,Histopathologic features of possible prognostic importance include: Level:III Tumor infiltrating lymphocytes: absent Vascular or lymphatic invasion: not detected Dermal mitotic rate: 1/ HPF Perineural invasion: not detected Ulceration: not detected Regression: not detected Microsatellite metastasis: not detected Solar elastosis: moderate Stage: pT1b,"Sections show an asymmetrical proliferation of nested and solitary melanocytes with atypical nuclear features, and dusty cytoplasms. They are arrayed irregularly within the epidermis, with foci of suprabasal scatter of cells.  Larger clusters of similar melanocytes are present in the dermis.",49,T1b,0.80,,Primary,,M,454633
49,12-22573,34,CAGCGTTA,,1000,,Melanocytic Nevus,"Intradermal, breast",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22573_Tumor,NA_12-22573_Tumor,12-22573,A,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS,192588,216.5,,"Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine. There are numerous horn pseudocysts.",23,,,,,,F,1108391
51,12-22582A,36,CCAGTTCA,,444,,Melanocytic Nevus,"Compound,  Neck",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22582A_Tumor,NA_12-22582A_Tumor,12-22582,A,COMPOUND MELANOCYTIC NEVUS,173441,216.4,,"Sections show a proliferation of melanocytes arrayed singly and as nests along the epidermal-dermal junction, with clusters and strands of similar cells in the underlying dermis.  In some areas within dermal clusters, melanocytes are separated by clefts, in a pattern that resembles vascular channels.",16,,,,,,F,1108400
55,12-22587,40,CGAACTTA,,773,,Melanocytic Nevus,"Compound, hyperpigmented melanocytes,neck",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22587_Tumor,NA_12-22587_Tumor,12-22587,A,"COMPOUND MELANOCYTIC NEVUS, WITH HYPERPIGMENTED MELANOCYTES",173477,216.4,,"Sections show a melanocytic proliferation composed of nests of melanocytes along the junction, with clusters of similar cells in the subjacent dermis.  Many superficial melanocytes have pigmented cytoplasm, and there are also surrounding melanophages.",12,,,,,,F,1108405
56,12-22592,41,CGACTGGA,,670,,"Keratosis,Atrophic Solar ",Scalp,HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22592_Tumor,NA_12-22592_Tumor,12-22592,A,ATROPHIC SOLAR KERATOSIS,429444,702.0,,The epidermis has a thinned appearance.  Keratinocytes with enlarged nuclei focally replace the basal layer and are focally separated by clefts from the overlying epidermis.  The dermis is altered by severe solar elastosis.,75,,,,,,M,559886
58,12-22597,43,CTCAATGA,Undiluted lib for comparison,1000,,BCC,"Micronodular, neck",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22597_Tumor,NA_12-22597_Tumor,12-22597,A,"BASAL CELL CARCINOMA, MICRONODULAR PATTERN, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN",173450,173.41,,Sections show a proliferation of small nodular collections of basaloid keratinocytes in poorly-circumscribed array.,87,,,,,,M,575947
59,12-22602A,44,CTGAGCCA,,1000,,Melanocytic Nevus,"Intradermal, anterolateral neck",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22602A_Tumor,NA_12-22602A_Tumor,12-22602,A,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS,123455,216.4,,Sections show a predominantly intradermal proliferation of small melanocytes with round to oval nuclei that mature (diminish in size) with descent in the dermis.  The overlying epidermis shows elongated rete that intertwine.,37,,,,,,F,1081809
60,12-22602B,45,CTGGCATA,,1000,,Melanocytic Nevus,"Intradermal,posteriolateral neck",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22602B_Tumor,NA_12-22602B_Tumor,12-22602,B,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS,173477,216.4,,"Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine.",37,,,,,,F,1081809
61,12-22603,46,GAATCTGA,,1000,,"Pilomatricoma, cystic",Forehead,HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22603_Tumor,NA_12-22603_Tumor,12-22603,A,CYSTIC PILOMATRICOMA,123398,216.3,,"There is a cystic space lined in part by matrical (basaloid) cells, and shadow cells are also apparent.",69,,,,,,F,1108421
62,12-22604,47,GACTAGTA,,278,,BCC,"Infiltrative, Keloidal stroma, nasal bridge",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22604_Tumor,NA_12-22604_Tumor,12-22604,A,"INFILTRATIVE BASAL CELL CARCINOMA, WITH KELOIDAL STROMA, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN",103341,173.31,,"Sections show a neoplastic proliferation of atypical basaloid keratinocytes arrayed as jagged aggregates in infiltrative array, and the surrounding stroma displays evidence of coarse fibrosis in the form of thickened (keloidal) collagen bundles.",83,,,,,,M,1108422
64,12-22720A1,49,GATAGACA,,370,,Leiomyoma,Upper back,HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22720A1_Tumor,NA_12-22720A1_Tumor,12-22720,A,"LEIOMYOMA, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)",174533,216.5,,Sections show a fascicled dermal proliferation of spindled cells with blunt-ended nuclei and eosinophilic cytoplasm situated in the superficial reticular dermis.  Mitotic figures are inconspicuous.,46,,,,,,F,118827
65,12-22868,50,GCCACATA,,1000,,Melanocytic Nevus,"Intradermal, back",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22868_Tumor,NA_12-22868_Tumor,12-22868,A,"PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)",173532,216.5,,"Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine.",11,,,,,,F,1108686
66,12-22884C,51,GCGAGTAA,,1000,,Melanocytic Nevus,"Intradermal, congenital pattern, back",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22884C_Tumor,NA_12-22884C_Tumor,12-22884,C,"PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, CONGENITAL PATTERN",173502,216.5,,Sections show a predominantly dermal proliferation of melanocytes that diminish in size with descent in the dermis.  Mitotic figures are inconspicuous.  Some small melanocytes are situated between reticular dermal collagen bundles.,55,,,,,,F,1108702
67,12-22884D,52,GCTAACGA,,208,,Melanocytic Nevus,"Intradermal, left lower lip",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22884D_Tumor,NA_12-22884D_Tumor,12-22884,D,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS,201098,216.0,,"Sections show a domed segment of skin, with nests, cords and strands of small round melanocytes in the dermis.",55,,,,,,F,1108702
68,12-22886,53,GCTCGGTA,,1000,,Melanocytic Nevus,"Lipoid Metaplasia, right neck",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22886_Tumor,NA_12-22886_Tumor,12-22886,A,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH LIPOID METAPLASIA (A SENESCENT CHANGE),173405,216.4,,"Sections show nests, cords and strands of small round melanocytes in the dermis.  These cells mature with descent.  There are admixed adipocytes.",35,,,,,,F,337537
70,12-22894B,55,GGTGCGAA,,303,,Melanocytic Nevus,"Compound, congenital pattern, neck",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22894B_Tumor,NA_12-22894B_Tumor,12-22894,B,"COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)",173450,216.4,,"Sections show clusters of cytologically bland melanocytes, both at the dermal-epidermal junction and in the reticular dermis, where melanocytes lie between reticular dermal collagen bundles.",32,,,,,,M,1108712
71,12-22898,56,GTACGCAA,,981,,Melanocytic Nevus,"Intradermal, rt upper arm",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22898_Tumor,NA_12-22898_Tumor,12-22898,A,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS,173688,216.6,,Sections show a predominantly intradermal proliferation of small melanocytes with round to oval nuclei that mature (diminish in size) with descent in the dermis.  The overlying epidermis shows elongated rete that intertwine.,35,,,,,,F,445158
72,12-22900,57,GTCGTAGA,,604,,SCC,Eybrow,HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22900_Tumor,NA_12-22900_Tumor,12-22900,A,"SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP BIOPSY MARGIN",102345,173.32,,"Sections show a proliferation composed of atypical keratinocytes, arrayed as irregular nests that infiltrate the dermis.  Foci of keratinization are apparent.",59,,,,,,M,2427054
73,12-22597,58,GTCTGTCA,Diluted Input Library DNA,700,,BCC,"Micronodular, neck",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22597_Tumor,NA_12-22597_Tumor,12-22597,A,"BASAL CELL CARCINOMA, MICRONODULAR PATTERN, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN",173450,173.41,,Sections show a proliferation of small nodular collections of basaloid keratinocytes in poorly-circumscribed array.,87,,,,,,M,575947
74,12-22597,59,GTGTTCTA,Diluted Input Library DNA,500,,BCC,"Micronodular, neck",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22597_Tumor,NA_12-22597_Tumor,12-22597,A,"BASAL CELL CARCINOMA, MICRONODULAR PATTERN, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN",173450,173.41,,Sections show a proliferation of small nodular collections of basaloid keratinocytes in poorly-circumscribed array.,87,,,,,,M,575947
75,12-22597,60,TAGGATGA,Diluted Input Library DNA,250,,BCC,"Micronodular, neck",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22597_Tumor,NA_12-22597_Tumor,12-22597,A,"BASAL CELL CARCINOMA, MICRONODULAR PATTERN, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN",173450,173.41,,Sections show a proliferation of small nodular collections of basaloid keratinocytes in poorly-circumscribed array.,87,,,,,,M,575947
76,12-22597,61,TATCAGCA,Diluted Input Library DNA,100,,BCC,"Micronodular, neck",HiSeq2_BB3,BB3_SeqL,BB3_CL,Tumor,Agilent?,12-22597_Tumor,NA_12-22597_Tumor,12-22597,A,"BASAL CELL CARCINOMA, MICRONODULAR PATTERN, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN",173450,173.41,,Sections show a proliferation of small nodular collections of basaloid keratinocytes in poorly-circumscribed array.,87,,,,,,M,575947
WP_11,WP11,L2DR01,AAGGGA,,100,,Iwei Autopsy,,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,WP11_Tumor,NA_WP11_Tumor,,,,,,,,,,,,,,,
WP_23,WP23,L2DR02,CCTTCA,,100,,Iwei Autopsy,,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,WP23_Tumor,NA_WP23_Tumor,,,,,,,,,,,,,,,
WP_29,WP29,L2DR03,GGACCC,,100,,Iwei Autopsy,,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,WP29_Tumor,NA_WP29_Tumor,,,,,,,,,,,,,,,
PG_8,PG8,L2DR04,TTCAGC,,100,,Iwei Autopsy,,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,PG8_Tumor,NA_PG8_Tumor,,,,,,,,,,,,,,,
Kit_37_Acral_NRAS,KIT37,L2DR05,AAGACG,,100,,Known Mutations,_Acral_NRAS,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,KIT37_Tumor,NA_KIT37_Tumor,,,,,,,,,,,,,,,
Kit_62__Acral_NRAS,KIT62,L2DR06,CCTCGG,,50,,Known Mutations,__Acral_NRAS,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,KIT62_Tumor,NA_KIT62_Tumor,,,,,,,,,,,,,,,
Kit_118_Muc_NRAS,KIT118,L2DR07,GGATGT,,100,,Known Mutations,_Muc_NRAS,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,KIT118_Tumor,NA_KIT118_Tumor,,,,,,,,,,,,,,,
Kit_181_Muc_BRAF,KIT181,L2DR08,TTCGCT,,100,,Known Mutations,_Muc_BRAF,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,KIT181_Tumor,NA_KIT181_Tumor,,,,,,,,,,,,,,,
Kit_227_Acral_WT,KIT227,L2DR09,ACACGA,,100,,Known Mutations,_Acral_WT,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,KIT227_Tumor,NA_KIT227_Tumor,,,,,,,,,,,,,,,
Kit_275_Muc_BRAF,KIT275,L2DR10,CACACA,,100,,Known Mutations,_Muc_BRAF,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,KIT275_Tumor,NA_KIT275_Tumor,,,,,,,,,,,,,,,
Bivona_L_1,Bivona-L1,L2DR11,GTGTTA,,100,,Lung Cells,,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,Bivona-L1_Tumor,NA_Bivona-L1_Tumor,,,,,,,,,,,,,,,
Bivona_L2,Bivona-L2,L2DR12,TGTGAA,,100,,Lung Cells,,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,Bivona-L2_Tumor,NA_Bivona-L2_Tumor,,,,,,,,,,,,,,,
Bivona_L3,Bivona-L3,L2DR13,ACAAAC,,100,,Lung Cells,,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,Bivona-L3_Tumor,NA_Bivona-L3_Tumor,,,,,,,,,,,,,,,
Bivona_L4,Bivona-L4,L2DR14,CACCTC,,100,,Lung Cells,,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,Bivona-L4_Tumor,NA_Bivona-L4_Tumor,,,,,,,,,,,,,,,
Bivona_L5,Bivona-L5,L2DR15,GTGGCC,,100,,Lung Cells,,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,Bivona-L5_Tumor,NA_Bivona-L5_Tumor,,,,,,,,,,,,,,,
Bivona_L6,Bivona-L6,L2DR16,TGTTGC,,100,,Lung Cells,,Nimblegen1_BB4,BB4_SeqL,BB4_CL,Tumor,NimV1,Bivona-L6_Tumor,NA_Bivona-L6_Tumor,,,,,,,,,,,,,,,
21-1,10-41439,L2DR01,AAGGGA,100,62.5,,RIGHT MID UPPER BACK," MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Melanoma,NimV1,10-41439_Melanoma,NA_10-41439_Melanoma,10-41439,A,"MELANOMA, 0.65 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",139524,172.5,"The nevus has a congenital pattern. The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, but has a mitotic figures in its dermal component. Therefore it should be classified as T1b per the 2009 revision of the AJCC staging system for melanoma. A superficial scar is also present. If this area was previously biopsied (we do not know of any in our files), the slides from it should be reviewed to make sure that the prognostic information above is correct.","Sections show a proliferation of melanocytes involving the epidermis, papillary and superficial reticular dermis. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, forming confluent nests, with no maturation and a mitotic figure among the dermal melanocytes.  Beneath this is a zone of paucicellular fibrosis, with horizontally oriented, closely apposed collagen bundles. Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis, in part around epithelial adnexal structures.",67,T1b,0.65,,Primary,,M,936014
21-2,10-41439,L2DR02,CCTTCA,100,62.5,,RIGHT MID UPPER BACK," MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Melanoma,NimV1,10-41439_Melanoma,NA_10-41439_Melanoma,10-41439,A,"MELANOMA, 0.65 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",139524,172.5,"The nevus has a congenital pattern. The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, but has a mitotic figures in its dermal component. Therefore it should be classified as T1b per the 2009 revision of the AJCC staging system for melanoma. A superficial scar is also present. If this area was previously biopsied (we do not know of any in our files), the slides from it should be reviewed to make sure that the prognostic information above is correct.","Sections show a proliferation of melanocytes involving the epidermis, papillary and superficial reticular dermis. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, forming confluent nests, with no maturation and a mitotic figure among the dermal melanocytes.  Beneath this is a zone of paucicellular fibrosis, with horizontally oriented, closely apposed collagen bundles. Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis, in part around epithelial adnexal structures.",67,T1b,0.65,,Primary,,M,936014
21-3,10-41439,L2DR03,GGACCC,100,62.5,,RIGHT MID UPPER BACK," MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Nevus,NimV1,10-41439_Nevus,NA_10-41439_Nevus,10-41439,A,"MELANOMA, 0.65 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",139524,172.5,"The nevus has a congenital pattern. The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, but has a mitotic figures in its dermal component. Therefore it should be classified as T1b per the 2009 revision of the AJCC staging system for melanoma. A superficial scar is also present. If this area was previously biopsied (we do not know of any in our files), the slides from it should be reviewed to make sure that the prognostic information above is correct.","Sections show a proliferation of melanocytes involving the epidermis, papillary and superficial reticular dermis. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, forming confluent nests, with no maturation and a mitotic figure among the dermal melanocytes.  Beneath this is a zone of paucicellular fibrosis, with horizontally oriented, closely apposed collagen bundles. Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis, in part around epithelial adnexal structures.",67,T1b,0.65,,Primary,,M,936014
21-4,10-41439,L2DR04,TTCAGC,100,62.5,,RIGHT MID UPPER BACK," MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Nevus,NimV1,10-41439_Nevus,NA_10-41439_Nevus,10-41439,A,"MELANOMA, 0.65 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",139524,172.5,"The nevus has a congenital pattern. The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, but has a mitotic figures in its dermal component. Therefore it should be classified as T1b per the 2009 revision of the AJCC staging system for melanoma. A superficial scar is also present. If this area was previously biopsied (we do not know of any in our files), the slides from it should be reviewed to make sure that the prognostic information above is correct.","Sections show a proliferation of melanocytes involving the epidermis, papillary and superficial reticular dermis. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, forming confluent nests, with no maturation and a mitotic figure among the dermal melanocytes.  Beneath this is a zone of paucicellular fibrosis, with horizontally oriented, closely apposed collagen bundles. Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis, in part around epithelial adnexal structures.",67,T1b,0.65,,Primary,,M,936014
21-5,10-41439,L2DR05,AAGACG,15.6,44.8,,RIGHT MID UPPER BACK," MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Normal,NimV1,10-41439_Normal,NA_10-41439_Normal,10-41439,A,"MELANOMA, 0.65 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",139524,172.5,"The nevus has a congenital pattern. The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, but has a mitotic figures in its dermal component. Therefore it should be classified as T1b per the 2009 revision of the AJCC staging system for melanoma. A superficial scar is also present. If this area was previously biopsied (we do not know of any in our files), the slides from it should be reviewed to make sure that the prognostic information above is correct.","Sections show a proliferation of melanocytes involving the epidermis, papillary and superficial reticular dermis. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, forming confluent nests, with no maturation and a mitotic figure among the dermal melanocytes.  Beneath this is a zone of paucicellular fibrosis, with horizontally oriented, closely apposed collagen bundles. Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis, in part around epithelial adnexal structures.",67,T1b,0.65,,Primary,,M,936014
24-1,11-23681,L2DR06,CCTCGG,100,62.5,,RIGHT GLUTEUS," MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Melanoma,NimV1,11-23681_Melanoma,NA_11-23681_Melanoma,11-23681,A,"MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",132590,172.5,"Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.","Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",58,T4b,5.5,,Primary,3,F,1013119
24-2,11-23681,L2DR07,GGATGT,100,62.5,,RIGHT GLUTEUS," MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Melanoma,NimV1,11-23681_Melanoma,NA_11-23681_Melanoma,11-23681,A,"MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",132590,172.5,"Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.","Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",58,T4b,5.5,,Primary,3,F,1013119
24-3,11-23681,L2DR08,TTCGCT,100,62.5,,RIGHT GLUTEUS," MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Nevus,NimV1,11-23681_Nevus,NA_11-23681_Nevus,11-23681,A,"MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",132590,172.5,"Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.","Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",58,T4b,5.5,,Primary,3,F,1013119
24-4,11-23681,L2DR09,ACACGA,100,62.5,,RIGHT GLUTEUS," MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Nevus,NimV1,11-23681_Nevus,NA_11-23681_Nevus,11-23681,A,"MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",132590,172.5,"Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.","Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",58,T4b,5.5,,Primary,3,F,1013119
24-5,11-23681,L2DR10,CACACA,12,33.04,,RIGHT GLUTEUS," MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Normal,NimV1,11-23681_Normal,NA_11-23681_Normal,11-23681,A,"MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",132590,172.5,"Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.","Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",58,T4b,5.5,,Primary,3,F,1013119
28-1,11-37533,L2DR11,GTGTTA,100,33.88,,LEFT POPLITEAL FOSSA," RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Melanoma,NimV1,11-37533_Melanoma,NA_11-37533_Melanoma,11-37533,A,"RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN",897777,172.7,"The residual neoplasm contains diagnostic areas of melanoma, including some smaller cells in a nevoid melanoma pattern, as well as a pre-existent nevus. Histopathologic features of possible prognostic importance include the following. The thickness of the tumor in the re-excision is greater than that in the original biopsy. Dermal mitotic rate has supplanted Clark's levels with respect to staging of melanoma less than 1 mm in thickness in the current AJCC classification. Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: not evident AJCC stage: T1a","Sections show a zone of fibrosis and inflammation consistent with prior biopsy and a residual compound proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly and in poorly circumscribed fashion within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the fibrotic superficial dermis, along with some smaller but still atypical melanocytes.  Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis. There is a focal epidermal defect and subjacent fibrosis consistent with prior biopsy.",74,T1a,0.75,,Primary,,F,1021763
28-2,11-37533,L2DR12,TGTGAA,100,62.5,,LEFT POPLITEAL FOSSA," RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Melanoma,NimV1,11-37533_Melanoma,NA_11-37533_Melanoma,11-37533,A,"RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN",897777,172.7,"The residual neoplasm contains diagnostic areas of melanoma, including some smaller cells in a nevoid melanoma pattern, as well as a pre-existent nevus. Histopathologic features of possible prognostic importance include the following. The thickness of the tumor in the re-excision is greater than that in the original biopsy. Dermal mitotic rate has supplanted Clark's levels with respect to staging of melanoma less than 1 mm in thickness in the current AJCC classification. Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: not evident AJCC stage: T1a","Sections show a zone of fibrosis and inflammation consistent with prior biopsy and a residual compound proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly and in poorly circumscribed fashion within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the fibrotic superficial dermis, along with some smaller but still atypical melanocytes.  Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis. There is a focal epidermal defect and subjacent fibrosis consistent with prior biopsy.",74,T1a,0.75,,Primary,,F,1021763
28-3,11-37533,L2DR13,ACAAAC,36.96,62.5,,LEFT POPLITEAL FOSSA," RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Nevus,NimV1,11-37533_Nevus,NA_11-37533_Nevus,11-37533,A,"RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN",897777,172.7,"The residual neoplasm contains diagnostic areas of melanoma, including some smaller cells in a nevoid melanoma pattern, as well as a pre-existent nevus. Histopathologic features of possible prognostic importance include the following. The thickness of the tumor in the re-excision is greater than that in the original biopsy. Dermal mitotic rate has supplanted Clark's levels with respect to staging of melanoma less than 1 mm in thickness in the current AJCC classification. Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: not evident AJCC stage: T1a","Sections show a zone of fibrosis and inflammation consistent with prior biopsy and a residual compound proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly and in poorly circumscribed fashion within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the fibrotic superficial dermis, along with some smaller but still atypical melanocytes.  Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis. There is a focal epidermal defect and subjacent fibrosis consistent with prior biopsy.",74,T1a,0.75,,Primary,,F,1021763
28-4,11-37533,L2DR14,CACCTC,100,62.5,,LEFT POPLITEAL FOSSA," RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Nevus,NimV1,11-37533_Nevus,NA_11-37533_Nevus,11-37533,A,"RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN",897777,172.7,"The residual neoplasm contains diagnostic areas of melanoma, including some smaller cells in a nevoid melanoma pattern, as well as a pre-existent nevus. Histopathologic features of possible prognostic importance include the following. The thickness of the tumor in the re-excision is greater than that in the original biopsy. Dermal mitotic rate has supplanted Clark's levels with respect to staging of melanoma less than 1 mm in thickness in the current AJCC classification. Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: not evident AJCC stage: T1a","Sections show a zone of fibrosis and inflammation consistent with prior biopsy and a residual compound proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly and in poorly circumscribed fashion within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the fibrotic superficial dermis, along with some smaller but still atypical melanocytes.  Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis. There is a focal epidermal defect and subjacent fibrosis consistent with prior biopsy.",74,T1a,0.75,,Primary,,F,1021763
28-5,11-37533,L2DR15,GTGGCC,100,62.5,,LEFT POPLITEAL FOSSA," RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN",Nimblegen2_BB5,BB5_SeqL,BB5_CL,Normal,NimV1,11-37533_Normal,NA_11-37533_Normal,11-37533,A,"RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN",897777,172.7,"The residual neoplasm contains diagnostic areas of melanoma, including some smaller cells in a nevoid melanoma pattern, as well as a pre-existent nevus. Histopathologic features of possible prognostic importance include the following. The thickness of the tumor in the re-excision is greater than that in the original biopsy. Dermal mitotic rate has supplanted Clark's levels with respect to staging of melanoma less than 1 mm in thickness in the current AJCC classification. Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: not evident AJCC stage: T1a","Sections show a zone of fibrosis and inflammation consistent with prior biopsy and a residual compound proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly and in poorly circumscribed fashion within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the fibrotic superficial dermis, along with some smaller but still atypical melanocytes.  Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis. There is a focal epidermal defect and subjacent fibrosis consistent with prior biopsy.",74,T1a,0.75,,Primary,,F,1021763
Kit 262,KIT262,L2DR16,TGTTGC,100,62.5,,Rectal,,Nimblegen2_BB5,BB5_SeqL,BB5_CL,Tumor,NimV1,KIT262_Tumor,NA_KIT262_Tumor,,,,,,,,,,,,,,,
N3_1,Dog12,L2DR01,AAGGGA,Low Hyb. Input DNA,45,,"Ivanka, Dog Melanoma| mucosal melanoma +EIN",sp-12-3436|mucosal melanoma +EIN,Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,Dog12_Tumor,NA_Dog12_Tumor,,,,,,,,,,,,,,,
N3_2,Dog24,L2DR02,CCTTCA,,62.5,,"Ivanka, Dog Melanoma| mucosal melanomas-non-pigmented",sp-07-8373|mucosal melanomas-non-pigmented,Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,Dog24_Tumor,NA_Dog24_Tumor,,,,,,,,,,,,,,,
N3_3,Dog43,L2DR03,GGACCC,,62.5,,"Ivanka, Dog Melanoma| melanocytoma",2990543-1|melanocytoma,Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,Dog43_Tumor,NA_Dog43_Tumor,,,,,,,,,,,,,,,
N3_4,Dog55,L2DR04,TTCAGC,,62.5,,"Ivanka, Dog Melanoma| acral melanoma",3146318-1|acral melanoma,Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,Dog55_Tumor,NA_Dog55_Tumor,,,,,,,,,,,,,,,
N3_5,HW3,L2DR05,AAGACG,,62.5,,"Hong Wu, Melanaoma| TUMOR Mucosal Melanoma, nasal sinus","73001, 73002|TUMOR Mucosal Melanoma, nasal sinus",Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,HW3_Tumor,NA_HW3_Tumor,,,,,,,,,,,,,,,
N3_6,HW3,L2DR06,CCTCGG,,62.5,,"Hong Wu, Melanaoma| Normal Melanoma, Mucosal nasal sinus","73003|Normal Melanoma, Mucosal nasal sinus",Nimblegen3_BB6,BB6_SeqL,BB6_CL,Normal,NimV1,HW3_Normal,NA_HW3_Normal,,,,,,,,,,,,,,,
N3_7,HW4,L2DR07,GGATGT,,62.5,,"Hong Wu, Melanaoma| TUMOR Melanoma, Mucosal nasal sinus","73004|TUMOR Melanoma, Mucosal nasal sinus",Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,HW4_Tumor,NA_HW4_Tumor,,,,,,,,,,,,,,,
N3_8,HW4,L2DR08,TTCGCT,,62.5,,"Hong Wu, Melanaoma| Normal Melanoma, Mucosal nasal sinus","73005|Normal Melanoma, Mucosal nasal sinus",Nimblegen3_BB6,BB6_SeqL,BB6_CL,Normal,NimV1,HW4_Normal,NA_HW4_Normal,,,,,,,,,,,,,,,
N3_9,HW6,L2DR09,ACACGA,,62.5,,"Hong Wu, Melanaoma| Tumor Melanoma, Mucosal vulva","73010|Tumor Melanoma, Mucosal vulva",Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,HW6_Tumor,NA_HW6_Tumor,,,,,,,,,,,,,,,
N3_10,HW6,L2DR10,CACACA,,62.5,,"Hong Wu, Melanaoma| Normal Melanoma, Mucosal vulva","73010|Normal Melanoma, Mucosal vulva",Nimblegen3_BB6,BB6_SeqL,BB6_CL,Normal,NimV1,HW6_Normal,NA_HW6_Normal,,,,,,,,,,,,,,,
N3_11,10-86469,L2DR11,GTGTTA,,62.5,,"Iwei, CGH Array run| NTRK3 Translocation case",CGH11-029 Need to Get diagnosis from Iwei|NTRK3 Translocation case,Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,10-86469_Tumor,NA_10-86469_Tumor,10-86469,A,"ULCERATED COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, INVOLVING THE DEEP EDGE OF THE BIOPSY",173701,238.2,"This proliferation shows conflicting criteria, including some attributes (large confluent nests, a high proliferation index, easily-identifiable dermal mitotic figures, a thinned epidermis, and focal ulceration) that raised the possibility of spitzoid melanoma as a potential consideration in the differential diagnosis. The differential diagnosis also includes a traumatized cellular Spitz nevus. We received the tissue block and utilized it to pursue array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, aCGH analysis did not reveal any chromosomal gains or losses. As you probably know, genomic gains and losses can be identified in the vast majority of melanomas, including proliferations within the spectrum of so-called childhood-type spitzoid melanoma. In short, the lack of demonstrable genomic anomalies in this specimen does not provide direct support for a diagnosis of spitzoid melanoma. I recommend complete excision of this site in follow-up. If the resultant reexcision specimen does not contain any residuum, then I view a traumatized hypercellular Spitz nevus as the most likely diagnostic possibility. If a nodular residuum is found below the site of the present biopsy, then it should be reassessed jointly with this specimen.","Sections show an ulcerated proliferation of large oval and fusiform melanocytes with a domed surface. The epidermis is irregularly hyperplastic in some areas, and relatively thinned in others. There are large, confluent nests of cells with abundant amphophilic cytoplasm and large, vesicular nuclei superficially, with smaller aggregations of somewhat smaller cells toward the base of the lesion. Scattered mitotic figures are present. The enclosed immunoperoxidase-stained sections show retention of p16 staining by most of the nuclei, and a relatively high proliferation rate.",16,,,,,,M,981048
N3_12,11-12273,L2DR12,TGTGAA,,62.5,,"Iwei, CGH Array run| ROS1 Translocation case",CGH11-045 Need to Get diagnosis from Iwei|ROS1 Translocation case,Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,11-12273_Tumor,NA_11-12273_Tumor,11-12273,A,CHILDHOOD-TYPE SPITZOID MELANOMA OF 2.9 MM IN THICKNESS,102270,172.2,"Our differential diagnosis included childhood-type spitzoid melanoma on one hand and a peculiar cellular Spitz nevus on the other. To address this differential, we completed array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosome 1q and loss of chromosome 6q. The identification of multiple chromosomal gains and losses is not known to occur in Spitz nevi and favors instead the above interpretation. The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination.  This proliferation has not been adequately excised. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show a cellular, exophytic, polypoid compound proliferation of melanocytes. Within the background epidermis, which is thin, there are single melanocytes and nests distributed erratically, and cells above the junction can be found. The dermis below this contains large and irregular nests of similar melanocytes that lack maturation with descent in the dermis. An increase in dermal vascularity is appreciable. Dermal melanocytes in mitosis are easily found.",2,,2.9,,,,M,1001710
N3_13,11-23710,L2DR13,ACAAAC,,62.5,,"Iwei, CGH Array run| ROS1 Translocation case",CGH11-092 Need to Get diagnosis from Iwei|ROS1 Translocation case,Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,11-23710_Tumor,NA_11-23710_Tumor,11-23710,A,"SPITZOID MELANOMA, CHILDHOOD TYPE",173307,172.3,"As you note in your correspondence regarding this case, this proliferation does not represent a conventional Spitz nevus. The lesion is ulcerated, has a high overall cellularity and has a nodular component in the subcutis. Comparative genomic hybridization shows loss of chromosome 6q, an aberration that is common in melanoma. There is also a gain of a small area in the distal part of 5q. Given these findings, I believe that this is best assessed as a spitzoid melanoma of childhood. I use this term for an emerging class of lesions that usually lack b-raf mutations (which are present in most melanomas) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma.  While the thickness is approximately 4.5 mm., it would be a mistake to use prognostic data from adult melanoma cases in this setting. The prognosis is far better. As the lesion extends to a dermal margins, a narrow re-excision is reasonable. Lesions of this type are usually well circumscribed, and I have not seen regrowth when narrow but clear margins have been obtained. The role of sentinel lymph nodes is debatable, as sentinel lymph node involvement is common, but distant metastasis is rare.","Sections show enlarged spindled and fusiform melanocytes arrayed in nests and fascicles in compound fashion. Large nests and fascicles are apparent at the junction in concert with acanthosis (and also central erosion), and many coalescing fascicles reside in the dermis and upper subcutis below that in concert with a lymphohistiocytic infiltrate. There is only partial maturation with descent. Dermal melanocytes in mitosis can be found, especially in the upper half of the proliferation.",9,,,,,,F,1013148
N3_14,11-30426,L2DR14,CACCTC,,62.5,,"Iwei, CGH Array run| NTRK3 Translocation case",CGH11-125 Need to Get diagnosis from Iwei|NTRK3 Translocation case,Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,11-30426_Tumor,NA_11-30426_Tumor,11-30426,A,"MELANOMA, 2.3 MM. IN THICKNESS",173727,172.7,"Comparative genomic hybridization shows losses involving 6p and 16q. 6p gain is common in melanoma, but 6p loss is unusual. 16q loss is infrequent, but a repeatable event in melanoma. Given the combination of these features and the findings in the hematoxylin and eosin-stained sections, I believe that melanoma is the most appropriate diagnosis here. The base of the specimen is focally involved. The final thickness measurement should be made after complete excision.","There is a proliferation of large melanocytes with a domed surface and a wedge-shaped base. Large nests predominate superficially, and are composed of cells with abundant pale vacuolated cytoplasm and dusty melanin, and large pleomorphic vesicular nuclei. The sizes of the aggregations and of the cells that comprise them diminish with descent, and the cytoplasm in the underlying dermis is less vacuolated and less pigmented.",18,,2.3,,,,F,1019864
N3_15,11-31904,L2DR15,GTGGCC,,62.5,,"Iwei, CGH Array run| BRAF Translocation case",CGH11-194 Need to Get diagnosis from Iwei|BRAF Translocation case,Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,11-31904_Tumor,NA_11-31904_Tumor,11-31904,A,"MELANOMA, 2.65 MM. IN THICKNESS",139522,172.5,"While the pattern at scanning magnification suggested a Spitz's nevus, there were several worrisome morphologic features, including striking confluence of junctional nests, some pagetoid scatter and a so-called marginal mitosis (see microscopic description below). We therefore performed comparative genomic hybridization. This shows a gain involving a discrete area of 7p near its terminal end, a loss involving part of 7q and a gain involving the terminal end of 7q. Gains and losses within the same chromosome reflect severe genetic damage, and in this context favor melanoma. Furthermore, gains involving all, or part of chromosome 7 are common in melanoma.  Given the lack of ulceration, this is a T3a primary lesion in the 2009 AJCC staging schema for melanoma.","There is a broad-based  proliferation of melanocytes involving the epidermis and papillary dermis. There is irregular epidermal hyperplasia with a thick granular and a compact cornified layer. Situated along the junction are confluent nests of large oval melanocytes with pleomorphic, vesicular nuclei. Some pagetoid scatter is present, largely in the center of the lesion. Smaller aggregates of smaller cells are evident in the subjacent dermis. There are rare mitotic figures, one in a melanocyte at the lower edge of the lesion (a so-called marginal mitosis). There are focally dense lymphocytic infiltrates.",39,T3a,2.65,,Primary,,F,1021342
N3_16,11-47644,L2DR16,TGTTGC,Low Hyb. Input DNA,60,,"Iwei, CGH Array run| BRAF Translocation case",CGH11-201 Need to Get diagnosis from Iwei|BRAF Translocation case,Nimblegen3_BB6,BB6_SeqL,BB6_CL,Tumor,NimV1,11-47644_Tumor,NA_11-47644_Tumor,11-47644,A,"MELANOMA OF 1.3 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION",373719,172.7,"This atypical melanocytic proliferation does not represent a conventional Spitz nevus. Rather, our differential diagnosis included an atypical Spitz nevus on one hand and melanoma on the other. To more fully assess this differential, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosomes 2, 7q, 11q, 12, 13, 15, and 19. A segmental gain in chromosome 11p was also documented. As you probably know, the identification of multiple chromosomal gains or losses can be documented in most melanomas. In contrast, chromosomal gain/loss is not known to occur in melanocytic nevi. In summary, the combination of results derived from conventional microscopy coupled with aCGH points clearly to a diagnosis of melanoma. With respect to staging, this melanoma is non-ulcerated and shows Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.  Based upon the above clinical synopsis, we presume that a prior biopsy from this site was obtained. We have not reviewed that earlier specimen.","Sections show a compound proliferation of enlarged epithelioid and spindled melanocytes with finely yet heavily pigmented cytoplasm. Single melanocytes and nests are distributed relatively confluently along the junction, and in some areas the background epithelium is slightly thinned. Limited scatter of melanocytes above the junction can be seen. In fibrotic perijunctional dermis below this, non-maturing or partially-maturing nests, fascicles, and cords of similar melanocytes can be seen. A patchy associated infiltrate of lymphocytes and melanophages is also noted.",13,,1.3,,,,F,1037083
MB_161_Tumor,MB_161,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,100,,"UC Denver, Frozen Tissue",,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Tumor,NimV1,MB_161_Tumor,NA_MB_161_Tumor,,,,,,,,,,,,,,,
MB_161_Normal,MB_161,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,100,,"UC Denver, FFPE",,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Normal,NimV1,MB_161_Normal,NA_MB_161_Normal,,,,,,,,,,,,,,,
MB_327_Tumor,MB_327,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,100,,"UC Denver, Frozen Tissue",,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Tumor,NimV1,MB_327_Tumor,NA_MB_327_Tumor,,,,,,,,,,,,,,,
MB_1454_Normal,MB_1454,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,100,,"UC Denver, Frozen Tissue",,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Normal,NimV1,MB_1454_Normal,NA_MB_1454_Normal,,,,,,,,,,,,,,,
MB_760_Tumor,MB_760,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,100,,"UC Denver, Frozen Tissue",,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Tumor,NimV1,MB_760_Tumor,NA_MB_760_Tumor,,,,,,,,,,,,,,,
MB_1418_Normal,MB_1418,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,100,,"UC Denver, Frozen Tissue",,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Normal,NimV1,MB_1418_Normal,NA_MB_1418_Normal,,,,,,,,,,,,,,,
MB_1029_Tumor,MB_1029,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,100,,"UC Denver, Frozen Tissue",,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Tumor,NimV1,MB_1029_Tumor,NA_MB_1029_Tumor,,,,,,,,,,,,,,,
MB_1028_Normal,MB_1028,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,100,,"UC Denver, Frozen Tissue",,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Normal,NimV1,MB_1028_Normal,NA_MB_1028_Normal,,,,,,,,,,,,,,,
MB_1046_Tumor,MB_1046,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,100,,"UC Denver,Frozen Tissue",,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Tumor,NimV1,MB_1046_Tumor,NA_MB_1046_Tumor,,,,,,,,,,,,,,,
MB_1036_Normal,MB_1036,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,100,,"UC Denver, Frozen Tissue",,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Normal,NimV1,MB_1036_Normal,NA_MB_1036_Normal,,,,,,,,,,,,,,,
Bivona__L_17,Bivona-L17,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,100,, Patient Treated with EGFR TK1,,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Tumor,NimV1,Bivona-L17_Tumor,NA_Bivona-L17_Tumor,,,,,,,,,,,,,,,
Bivona_L_18,Bivona-L18,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,62.72,, Patient Treated with EGFR TK1,,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Tumor,NimV1,Bivona-L18_Tumor,NA_Bivona-L18_Tumor,,,,,,,,,,,,,,,
Bivona_L_19,Bivona-L19,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,9.12,, Patient Treated with EGFR TK1,,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Tumor,NimV1,Bivona-L19_Tumor,NA_Bivona-L19_Tumor,,,,,,,,,,,,,,,
Kit_227_Acral_WT,KIT227,L2DR14,CACCTC,"13 Cycle Post Hybridization LM-PCR, run to run variation observance",100,,"Melanoma, vulva",_Acral_WT,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Tumor,NimV1,KIT227_Tumor,NA_KIT227_Tumor,,,,,,,,,,,,,,,
Kit_53_Acral_NRAS,KIT53,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,100,,"Melanoma, Heel",_Acral_NRAS,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Tumor,NimV1,KIT53_Tumor,NA_KIT53_Tumor,,,,,,,,,,,,,,,
Kit_313_Mucosal,KIT313,L2DR16,TGTTGC,13 Cycle Post Hybridization LM-PCR,100,,"Melanoma, Rectum",_Mucosal,Nimblegen4_BB7,BB7_SeqL,BB7_CL,Tumor,NimV1,KIT313_Tumor,NA_KIT313_Tumor,,,,,,,,,,,,,,,
BB008_HW2NC,HW2,L2DR01,AAGGGA,16 Cycle Post Hybridization LM-PCR,100,,"Mucosal Melanoma, vulva, Hong Wu", FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis),Nimblegen5_BB8,BB8_SeqL,BB8_CL,Normal,NimV1,HW2_Normal,NA_HW2_Normal,,,,,,,,,,,,,,,
BB008_HW2TC,HW2,L2DR02,CCTTCA,16 Cycle Post Hybridization LM-PCR,100,,"Mucosal Melanoma, vulva, Hong Wu", FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis),Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,HW2_Tumor,NA_HW2_Tumor,,,,,,,,,,,,,,,
BB008_HW8NC,HW8,L2DR03,GGACCC,"16 Cycle Post Hybridization LM-PCR, low hybridization input DNA",100,,"Mucosal Melanoma, Urethra, Hong Wu", FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis),Nimblegen5_BB8,BB8_SeqL,BB8_CL,Normal,NimV1,HW8_Normal,NA_HW8_Normal,,,,,,,,,,,,,,,
BB008_HW8TC,HW8,L2DR04,TTCAGC,16 Cycle Post Hybridization LM-PCR,100,,"Mucosal Melanoma, Urethra, Hong Wu", FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis),Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,HW8_Tumor,NA_HW8_Tumor,,,,,,,,,,,,,,,
BB008_HW9-NB,HW9,L2DR05,AAGACG,16 Cycle Post Hybridization LM-PCR,100,,"Mucosal Melanoma, Blood, Hong Wu", FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis),Nimblegen5_BB8,BB8_SeqL,BB8_CL,Normal,NimV1,HW9_Normal,NA_HW9_Normal,,,,,,,,,,,,,,,
BB008_HW9TC,HW9,L2DR06,CCTCGG,16 Cycle Post Hybridization LM-PCR,100,,"Mucosla Melanoma, vulva, Hong Wu", FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis),Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,HW9_Tumor,NA_HW9_Tumor,,,,,,,,,,,,,,,
BB008_CGH12-047,12-6981,L2DR07,GGATGT,16 Cycle Post Hybridization LM-PCR,100,,"NTRK3, Iwei Translocations",CGH12-047 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array,Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,12-6981_Tumor,NA_12-6981_Tumor,12-6981,A,"COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES",17733,238.2,"I agree with the considerations in Dr. Gottlieb's report. Comparative genomic hybridization did not show chromosomal gains or losses, a finding that is strongly against melanoma and favors a unusual Spitz's nevus. Any lesion this controversial and needed molecular testing for diagnosis should be fully excised, but the findings do not support additional measures beyond that.",Sections show a compound proliferation of melanocytes with features as noted in Dr. Gottlieb's consultation report.,63,,,,,,F,1092797
BB008_CGH10-013,10-55707,L2DR08,TTCGCT,16 Cycle Post Hybridization LM-PCR,100,,"ALK, Iwei Translocations",CGH10-013 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array,Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,10-55707_Tumor,NA_10-55707_Tumor,10-55707,A,CHILDHOOD-TYPE SPITZOID MELANOMA OF 2.9 MM IN THICKNESS,173300,172.3,"ADDENDUM, November 10, 2010: Per a clinical request, we completed comparative genomic hybridization (CGH) analysis of this tumor. Genomic analysis revealed loss in chromosomes 2p, 6q, 8p, and 12q, and loss of the entirety of chromosome 18 is also apparent. The presence of multiple genomic anomalies points to spitzoid melanoma as the best interpretation. Please note that childhood-type spitzoid melanoma represents an emerging entity that we believe is distinct from conventional adult melanoma. Cases reported in the literature as malignant Spitz nevus probably represent the same entity. With respect to clinical behavior, there is a risk for extension to regional lymph nodes, but our experience to date suggests that the risk for seeding of widespread metastatic disease is low. This proliferation is narrowly excised in the available sections. Further excision remains warranted to ensure that local eradication has been accomplished.  As we reported previously, our differential diagnosis included a cellular epithelioid Spitz nevus on one hand and so-called childhood-type spitzoid melanoma on the other. The latter has now been proven as the diagnosis for this case based upon the results of aCGH analysis. We also completed immunoperoxidase staining utilizing a two-color development system (with MART-1 labeled red and Ki-67 labeled brown) was included in our evaluation. By this staining method, we found diffuse MART-1 reactivity. Although the overall labeling index is modest, the MART-positive cells show focally increased nuclear expression of Ki-67, especially in the upper half of the proliferation, thus implying that cellular proliferation is focally elevated. This staining result is diagnostically inconclusive.","Sections show a domed, cellular, laterally demarcated compound proliferation of enlarged epithelioid melanocytes. The background epidermis is acanthotic but is also focally thinned. Within the epidermis and along the junction, there are single melanocytes and nests distributed relatively densely, and some of the junctional nests are sizable. In the dermis below this, nests and cords of coalescing and partially-maturing melanocytes extend relatively deeply, where a flanking lymphohistiocytic infiltrate can also be seen.",21,,2.9,,,,F,950283
BB008_CGH11-153,11-34950,L2DR09,ACACGA,16 Cycle Post Hybridization LM-PCR,100,,"ALK, Iwei Translocations",CGH11-153 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array,Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,11-34950_Tumor,NA_11-34950_Tumor,11-34950,A,"DESMOPLASTIC COMPOUND SPITZOID NEOPLASM, CONSISTENT WITH A DESMOPLASTIC COMPOUND SPITZ NEVUS",173625,238.2,"I believe this proliferation represents an unusual compound desmoplastic Spitz nevus. To further assess spitzoid melanoma as a potential consideration in the differential diagnosis, we pursued array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis did not reveal any chromosomal gains or losses. As you probably know, the identification of genomic gain or loss is common to the vast majority of melanomas. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as a desmoplastic Spitz nevus rather than melanoma. This proliferation is focally present at the periphery of this biopsy. Further excision can be considered to ensure that local eradication has been accomplished and that persistence does not ensue.","Sections show a domed compound proliferation of enlarged slightly spindled melanocytes that is somewhat asymmetrical. The background epidermis is acanthotic and hyperkeratotic, and a rare large nest can be found at the junction. In fibrotic dermis below this, there are nests, cords, and fascicles of similar melanocytes that mature with descent in the dermis. One peripheral edge of the specimen lacks clears circumscription, and an increase in vasculature can be found around the proliferation as well. Rare superficial dermal melanocytes in mitosis can be seen. There is also a juxtaposed patchy lymphocytic infiltrate.",35,,,,,,F,1024388
BB008_CGH11-036,11-8228,L2DR10,CACACA,16 Cycle Post Hybridization LM-PCR,100,,"ALK, Iwei Translocations",CGH11-036 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array,Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,11-8228_Tumor,NA_11-8228_Tumor,11-8228,A,ULCERATED COMPOUND PROLIFERATION OF STRIKINGLY HYPERPIGMENTED/SPINDLED MELANOCYTES,173417,238.2,"Our differential diagnosis included an unusual hypermelanotic spindled melanocytic nevus on one hand and childhood-type melanoma on the other. To more fully assess this differential, array-based comparative genomic hybridization (aCGH) was utilized to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis did not demonstrate chromosomal gains or losses. GNAQ and GNA11 gene sequencing was also completed, and GNAQ exon 5 and GNA11 exon 5 were both found to be wild-type (non-mutated). Based upon the results derived from conventional microscopy and molecular assessment, I offer the following conclusions:  1. The lack of genomic aberrations, as demonstrated by aCGH analysis, speaks against melanoma as a possibility and favors interpretation as a peculiar melanocytic nevus. I do not believe this lesion should be interpreted as a pigmented epithelioid melanocytoma (with respect to that diagnostic term, this proliferation is composed of melanocytes that have distinctly spindled cytomorphology).  2. The lack of mutation in GNAQ or GNA11 suggests that this proliferation fits better on the spectrum of pigmented spindle cell nevus or plexiform spindle cell nevus rather than blue nevus.  3. The proliferation is unusual and involves the deep edge of this biopsy. Further excision is thus warranted to ensure that local eradication has been accomplished and that persistence cannot ensue.","Sections show an asymmetrical and focally ulcerated compound proliferation of slender spindled melanocytes with heavily melanized cytoplasm. There is a small junctional component jointly with marked acanthosis, and below this coalescing fascicles of non-maturing melanocytes reside in the dermis, where many interstitial melanophages are apparent.",4,,,,,,M,997665
BB008_CGH11-386,11-84681,L2DR11,GTGTTA,16 Cycle Post Hybridization LM-PCR,100,,"ROS1, Iwei Translocations",CGH11-386 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array,Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,11-84681_Tumor,NA_11-84681_Tumor,11-84681,A,MELANOMA WITH SPITZOID FEATURES,987777,173.7,"Comparative genomic hybridization shows losses involving chromosomes 6q, 10q and 12q. Loss of 6q and involving chromosome 10 are among the most common aberrations in melanoma. The final thickness measurement should be made after complete excision. The portion of the lesion seen in these sections is just over 1 mm in thickness, but not ulcerated. The final thickness measurement should be made after complete excision. In determining re-excision margins, please keep in mind that most spitzoid melanomas in children are well circumscribed and recurrence at the biopsy site due to residual neoplastic melanocytes is rare, regardless of thickness, even with very narrow (e.g. 5 mm) margins. Also, involvement of sentinel lymph nodes is more common than in adult melanoma, but distant metastasis is much less frequent. Therefore, the role of sentinel lymph node biopsy is questionable.","There is a broad-based, dome-surfaced proliferation of large oval melanocytes coupled with irregular epidermal hyperplasia, compact hyperkeratosis and a proliferation of melanocytes that is broadly transected at the base of the specimen in the superficial reticular dermis. The lesional cells are large, fusiform or polygonal, and have large, pleomorphic heterochromatic nuclei, some with prominent intranuclear inclusions.",9,,,,,,F,1074129
BB008_Kit 227 Acral WT,KIT227,L2DR12,TGTGAA,"16 Cycle Post Hybridization LM-PCR, Library to Library variation using the same template",100,,"Used in Library BB007 & BB004, Melanoma Vulva","Alyssa Kit mutations.  Same template was used to go into BB007, BB004. Understanding run to run variation.  Influence of LM-PCR cycle reduction  Acral WT",Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,KIT227_Tumor,NA_KIT227_Tumor,,,,,,,,,,,,,,,
BB008_WM3211,WM3211,L2DR13,ACAAAC,16 Cycle Post Hybridization LM-PCR,100,,"Wistar Cell Lines, passage 61, wt/wt","Cell Line DNA received from Patricia Brafford, Wistar Institute",Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,WM3211_Tumor,NA_WM3211_Tumor,,,,,,,,,,,,,,,
BB008_NB2107,NB2107,L2DR14,CACCTC,16 Cycle Post Hybridization LM-PCR,100,,"Wistar Cell Lines, passage 5, wt/wt","Cell Line DNA received from Patricia Brafford, Wistar Institute",Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,NB2107_Tumor,NA_NB2107_Tumor,,,,,,,,,,,,,,,
BB008_LAL-L1,London-L1,L2DR15,GTGGCC,16 Cycle Post Hybridization LM-PCR,100,,Thomas ,N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes,Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,London-L1_Tumor,NA_London-L1_Tumor,,,,,,,,,,,,,,,
BB008_LAL-L2,London-L2,L2DR16,TGTTGC,16 Cycle Post Hybridization LM-PCR,100,,Thomas ,N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes,Nimblegen5_BB8,BB8_SeqL,BB8_CL,Tumor,NimV1,London-L2_Tumor,NA_London-L2_Tumor,,,,,,,,,,,,,,,
BB09_Bivona_L7,Bivona-L7,L2DR01,AAGGGA,13 cycle LM PCR Post Hybridization,,,Bivona Lung Cell Line,N/A|Bivona Lung Cell Line,Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,Bivona-L7_Tumor,NA_Bivona-L7_Tumor,,,,,,,,,,,,,,,
BB09_Bivona_L8,Bivona-L8,L2DR02,CCTTCA,13 cycle LM PCR Post Hybridization,,,Bivona Lung Cell Line,N/A|Bivona Lung Cell Line,Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,Bivona-L8_Tumor,NA_Bivona-L8_Tumor,,,,,,,,,,,,,,,
BB09_Bivona_L9,Bivona-L9,L2DR03,GGACCC,13 cycle LM PCR Post Hybridization,,,Bivona Lung Cell Line,N/A|Bivona Lung Cell Line,Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,Bivona-L9_Tumor,NA_Bivona-L9_Tumor,,,,,,,,,,,,,,,
BB09_Bivona_L10,Bivona-L10,L2DR04,TTCAGC,13 cycle LM PCR Post Hybridization,,,Bivona Lung Cell Line,N/A|Bivona Lung Cell Line,Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,Bivona-L10_Tumor,NA_Bivona-L10_Tumor,,,,,,,,,,,,,,,
BB09_HW3_T,HW3,L2DR05,AAGACG,13 cycle LM PCR Post Hybridization,,,"TUMOR Mucosal Melanoma, nasal sinus","73001, 73002|Hong Wu, Melanaoma",Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,HW3_Tumor,NA_HW3_Tumor,,,,,,,,,,,,,,,
BB09_HW3_N,HW3,L2DR06,CCTCGG,13 cycle LM PCR Post Hybridization,,,"Normal Melanoma, Mucosal nasal sinus","73003|Hong Wu, Melanaoma",Nimblegen6_BB9,BB9_SeqL,BB9_CL,Normal,NimV1,HW3_Normal,NA_HW3_Normal,,,,,,,,,,,,,,,
BB09_HW4_T,HW4,L2DR07,GGATGT,13 cycle LM PCR Post Hybridization,,,"TUMOR Melanoma, Mucosal nasal sinus","73004|Hong Wu, Melanaoma",Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,HW4_Tumor,NA_HW4_Tumor,,,,,,,,,,,,,,,
BB09_HW4_N,HW4,L2DR08,TTCGCT,13 cycle LM PCR Post Hybridization,,,"Normal Melanoma, Mucosal nasal sinus","73005|Hong Wu, Melanaoma",Nimblegen6_BB9,BB9_SeqL,BB9_CL,Normal,NimV1,HW4_Normal,NA_HW4_Normal,,,,,,,,,,,,,,,
BB09_HW6_TD,HW6,L2DR09,ACACGA,13 cycle LM PCR Post Hybridization,,,"Tumor Melanoma, Mucosal vulva","73010|Hong Wu, Melanaoma",Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,HW6_Tumor,NA_HW6_Tumor,,,,,,,,,,,,,,,
BB09_HW6_ND,HW6,L2DR10,CACACA,13 cycle LM PCR Post Hybridization,,,"Normal Melanoma, Mucosal vulva","73010|Hong Wu, Melanaoma",Nimblegen6_BB9,BB9_SeqL,BB9_CL,Normal,NimV1,HW6_Normal,NA_HW6_Normal,,,,,,,,,,,,,,,
BB09_CGH11_029,10-86469,L2DR11,GTGTTA,13 cycle LM PCR Post Hybridization,,,NTRK3 Translocation case,"CGH11-029 N/A|Iwei, CGH Array run",Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,10-86469_Tumor,NA_10-86469_Tumor,10-86469,A,"ULCERATED COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, INVOLVING THE DEEP EDGE OF THE BIOPSY",173701,238.2,"This proliferation shows conflicting criteria, including some attributes (large confluent nests, a high proliferation index, easily-identifiable dermal mitotic figures, a thinned epidermis, and focal ulceration) that raised the possibility of spitzoid melanoma as a potential consideration in the differential diagnosis. The differential diagnosis also includes a traumatized cellular Spitz nevus. We received the tissue block and utilized it to pursue array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, aCGH analysis did not reveal any chromosomal gains or losses. As you probably know, genomic gains and losses can be identified in the vast majority of melanomas, including proliferations within the spectrum of so-called childhood-type spitzoid melanoma. In short, the lack of demonstrable genomic anomalies in this specimen does not provide direct support for a diagnosis of spitzoid melanoma. I recommend complete excision of this site in follow-up. If the resultant reexcision specimen does not contain any residuum, then I view a traumatized hypercellular Spitz nevus as the most likely diagnostic possibility. If a nodular residuum is found below the site of the present biopsy, then it should be reassessed jointly with this specimen.","Sections show an ulcerated proliferation of large oval and fusiform melanocytes with a domed surface. The epidermis is irregularly hyperplastic in some areas, and relatively thinned in others. There are large, confluent nests of cells with abundant amphophilic cytoplasm and large, vesicular nuclei superficially, with smaller aggregations of somewhat smaller cells toward the base of the lesion. Scattered mitotic figures are present. The enclosed immunoperoxidase-stained sections show retention of p16 staining by most of the nuclei, and a relatively high proliferation rate.",16,,,,,,M,981048
BB09_CGH11_045,11-12273,L2DR12,TGTGAA,13 cycle LM PCR Post Hybridization,,,ROS1 Translocation case,"CGH11-045 N/A|Iwei, CGH Array run",Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,11-12273_Tumor,NA_11-12273_Tumor,11-12273,A,CHILDHOOD-TYPE SPITZOID MELANOMA OF 2.9 MM IN THICKNESS,102270,172.2,"Our differential diagnosis included childhood-type spitzoid melanoma on one hand and a peculiar cellular Spitz nevus on the other. To address this differential, we completed array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosome 1q and loss of chromosome 6q. The identification of multiple chromosomal gains and losses is not known to occur in Spitz nevi and favors instead the above interpretation. The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination.  This proliferation has not been adequately excised. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show a cellular, exophytic, polypoid compound proliferation of melanocytes. Within the background epidermis, which is thin, there are single melanocytes and nests distributed erratically, and cells above the junction can be found. The dermis below this contains large and irregular nests of similar melanocytes that lack maturation with descent in the dermis. An increase in dermal vascularity is appreciable. Dermal melanocytes in mitosis are easily found.",2,,2.9,,,,M,1001710
BB09_CGH11_092,11-23710,L2DR13,ACAAAC,13 cycle LM PCR Post Hybridization,,,ROS1 Translocation case,"CGH11-092 N/A|Iwei, CGH Array run",Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,11-23710_Tumor,NA_11-23710_Tumor,11-23710,A,"SPITZOID MELANOMA, CHILDHOOD TYPE",173307,172.3,"As you note in your correspondence regarding this case, this proliferation does not represent a conventional Spitz nevus. The lesion is ulcerated, has a high overall cellularity and has a nodular component in the subcutis. Comparative genomic hybridization shows loss of chromosome 6q, an aberration that is common in melanoma. There is also a gain of a small area in the distal part of 5q. Given these findings, I believe that this is best assessed as a spitzoid melanoma of childhood. I use this term for an emerging class of lesions that usually lack b-raf mutations (which are present in most melanomas) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma.  While the thickness is approximately 4.5 mm., it would be a mistake to use prognostic data from adult melanoma cases in this setting. The prognosis is far better. As the lesion extends to a dermal margins, a narrow re-excision is reasonable. Lesions of this type are usually well circumscribed, and I have not seen regrowth when narrow but clear margins have been obtained. The role of sentinel lymph nodes is debatable, as sentinel lymph node involvement is common, but distant metastasis is rare.","Sections show enlarged spindled and fusiform melanocytes arrayed in nests and fascicles in compound fashion. Large nests and fascicles are apparent at the junction in concert with acanthosis (and also central erosion), and many coalescing fascicles reside in the dermis and upper subcutis below that in concert with a lymphohistiocytic infiltrate. There is only partial maturation with descent. Dermal melanocytes in mitosis can be found, especially in the upper half of the proliferation.",9,,,,,,F,1013148
BB09_CGH11_125,11-30426,L2DR14,CACCTC,13 cycle LM PCR Post Hybridization,,,NTRK3 Translocation case,"CGH11-125 N/A|Iwei, CGH Array run",Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,11-30426_Tumor,NA_11-30426_Tumor,11-30426,A,"MELANOMA, 2.3 MM. IN THICKNESS",173727,172.7,"Comparative genomic hybridization shows losses involving 6p and 16q. 6p gain is common in melanoma, but 6p loss is unusual. 16q loss is infrequent, but a repeatable event in melanoma. Given the combination of these features and the findings in the hematoxylin and eosin-stained sections, I believe that melanoma is the most appropriate diagnosis here. The base of the specimen is focally involved. The final thickness measurement should be made after complete excision.","There is a proliferation of large melanocytes with a domed surface and a wedge-shaped base. Large nests predominate superficially, and are composed of cells with abundant pale vacuolated cytoplasm and dusty melanin, and large pleomorphic vesicular nuclei. The sizes of the aggregations and of the cells that comprise them diminish with descent, and the cytoplasm in the underlying dermis is less vacuolated and less pigmented.",18,,2.3,,,,F,1019864
BB09_CGH11_194,11-31904,L2DR15,GTGGCC,13 cycle LM PCR Post Hybridization,,,BRAF Translocation case,"CGH11-194 N/A|Iwei, CGH Array run",Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,11-31904_Tumor,NA_11-31904_Tumor,11-31904,A,"MELANOMA, 2.65 MM. IN THICKNESS",139522,172.5,"While the pattern at scanning magnification suggested a Spitz's nevus, there were several worrisome morphologic features, including striking confluence of junctional nests, some pagetoid scatter and a so-called marginal mitosis (see microscopic description below). We therefore performed comparative genomic hybridization. This shows a gain involving a discrete area of 7p near its terminal end, a loss involving part of 7q and a gain involving the terminal end of 7q. Gains and losses within the same chromosome reflect severe genetic damage, and in this context favor melanoma. Furthermore, gains involving all, or part of chromosome 7 are common in melanoma.  Given the lack of ulceration, this is a T3a primary lesion in the 2009 AJCC staging schema for melanoma.","There is a broad-based  proliferation of melanocytes involving the epidermis and papillary dermis. There is irregular epidermal hyperplasia with a thick granular and a compact cornified layer. Situated along the junction are confluent nests of large oval melanocytes with pleomorphic, vesicular nuclei. Some pagetoid scatter is present, largely in the center of the lesion. Smaller aggregates of smaller cells are evident in the subjacent dermis. There are rare mitotic figures, one in a melanocyte at the lower edge of the lesion (a so-called marginal mitosis). There are focally dense lymphocytic infiltrates.",39,T3a,2.65,,Primary,,F,1021342
BB09_Bivona_L11,Bivona-L11,L2DR16,TGTTGC,13 cycle LM PCR Post Hybridization,,,Bivona Lung Cell Line,N/A|Bivona Lung Cell Line,Nimblegen6_BB9,BB9_SeqL,BB9_CL,Tumor,NimV1,Bivona-L11_Tumor,NA_Bivona-L11_Tumor,,,,,,,,,,,,,,,
HW_A1_Tumor,HWA1,L2DR01,AAGGGA,,100,,"Acral Melanoma, FFPE Curls",Hong Wu,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Tumor,NimV1,HWA1_Tumor,NA_HWA1_Tumor,,,,,,,,,,,,,,,
HW_A1_Cntl,HWA1,L2DR02,CCTTCA,"Low Post-Shear/Ampure Bead purified DNA, requirement of 100ng for End Repair",34.3,,"Acral Melanoma, FFPE Curls",Hong Wu,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Normal,NimV1,HWA1_Normal,NA_HWA1_Normal,,,,,,,,,,,,,,,
HW_A2_Tumor,HWA2,L2DR03,GGACCC,,100,,"Acral Melanoma, FFPE Curls",Hong Wu,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Tumor,NimV1,HWA2_Tumor,NA_HWA2_Tumor,,,,,,,,,,,,,,,
HW_A2_Cntl,HWA2,L2DR04,TTCAGC,"Low Post-Shear/Ampure Bead purified DNA, requirement of 100ng for End Repair",95.8,,"Acral Melanoma, FFPE Curls",Hong Wu,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Normal,NimV1,HWA2_Normal,NA_HWA2_Normal,,,,,,,,,,,,,,,
HW_A3_Tumor,HWA3,L2DR05,AAGACG,,100,,"Acral Melanoma, FFPE Curls",Hong Wu,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Tumor,NimV1,HWA3_Tumor,NA_HWA3_Tumor,,,,,,,,,,,,,,,
HW_A3_Cntl,HWA3,L2DR06,CCTCGG,"Low Post-Shear/Ampure Bead purified DNA, requirement of 100ng for End Repair",67,,"Acral Melanoma, FFPE Curls",Hong Wu,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Normal,NimV1,HWA3_Normal,NA_HWA3_Normal,,,,,,,,,,,,,,,
HW_A4_Tumor,HWA4,L2DR07,GGATGT,,100,," Acral Melanoma, FFPE Curls",Hong Wu,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Tumor,NimV1,HWA4_Tumor,NA_HWA4_Tumor,,,,,,,,,,,,,,,
HW_A4_Cntl,HWA4,L2DR08,TTCGCT,"Low Post-Shear/Ampure Bead purified DNA, requirement of 100ng for End Repair",84.4,," Acral Melanoma, FFPE Curls",Hong Wu,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Normal,NimV1,HWA4_Normal,NA_HWA4_Normal,,,,,,,,,,,,,,,
CGH11_035,11-5482,L2DR09,ACACGA,,100,,MET,CGH11-035 Iwei Translocation Case,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Tumor,NimV1,11-5482_Tumor,NA_11-5482_Tumor,11-5482,A,"CHILDHOOD-TYPE SPITZOID MELANOMA OF AT LEAST 4.0 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY",192799,172.7,"I believe this proliferation represents childhood-type spitzoid melanoma not a peculiar or atypical Spitz nevus. To further substantiate this interpretation, we completed comparative genomic hybridization via array methodology (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis revealed gain in chromosomes 7q and 12p. The presence of multiple chromosomal gains is not known to occur in Spitz nevi and favors instead the above interpretation. The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination.  This tumor is transected at the deep edge of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show an exophytic, eroded compound proliferation of enlarged spindled and epithelioid melanocytes. Intraepidermally, these cells are distributed in concert with marked epidermal hyperplasia. At the junction, there are cellular nests and fascicles of melanocytes that often hold a vertical orientation, and some large nests show central necrosis en masse within them. There are cellular fascicles, cords, and nests of cytologically similar melanocytes that descend into the dermis below this, where partial maturation with descent is appreciable. Dermal melanocytes in mitosis or single necrotic melanocytes are easily found. A juxtaposed sparse lymphohistiocytic infiltrate is apparent within fibrotic peritumoral dermis.",15,,4.0,,,,F,994919
CGH11_343,11-79158,L2DR10,CACACA,,100,,NTRK3,CGH11-343 Iwei Translocation Case,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Tumor,NimV1,11-79158_Tumor,NA_11-79158_Tumor,11-79158,A,NODULAR COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES,173676,238.2,"The differential diagnosis includes an unconventional deep penetrating nevus or combined melanocytic nevus as well as low-grade melanoma. To further address this differential, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies, as per your request. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in distal chromosome 1q as well as focal gain and focal loss in distal chromosome 15q. This represents an ambiguous aCGH result. We have observed 15q gain in association with Spitz nevi, but the fact that multiple chromosomal gains and losses have been identified indicates that the interpretation is less than straightforward. In summary, the combination of results derived from conventional microscopy coupled with aCGH has yielded an ambiguous result. Based solely upon conventional microscopy, I favor a peculiar melanocytic nevus as most likely. The proliferation extends quite close to the inked margins of excision. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show enlarged epithelioid and slightly spindled melanocytes arrayed asymmetrically in epidermis and dermis. Within the epidermis, there are single melanocytes and nests distributed centrally, and thinning of the epidermis is noted. In the dermis, there are nests, fascicles, syncytia, and sheets of melanocytes, and encompassing sclerosis is focally apparent. There is a deep nodular focus in which a bulbous extension of melanocytes extends through most of the reticular dermis.",17,,,,,,M,1068606
DP12_200,DP12-200,L2DR11,GTGTTA,,100,,"RT, Upper Arm, Polypoid Pyogenic Granuloma (Lobular Capillary Hemangioma)",Dr. Lutzky's Case,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Tumor,NimV1,DP12-200_Tumor,NA_DP12-200_Tumor,,,,,,,,,,,,,,,
ALK_Cntl,TissueCoreALKControl,L2DR12,TGTGAA,,100,,"Tissue Core ALK positive Control, FFPE derived",Tissue Core ALK | Barcode mismatch comment in note,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Normal,NimV1,TissueCoreALKControl_Normal,NA_TissueCoreALKControl_Normal,,,,,,,,,,,,,,,
CGH10_16,10-59344,L2DR13,ACAAAC,"Low Post-Shear/Ampure Bead purified DNA, requirement of 100ng for End Repair",74.3,,PDGFRB,CGH10-016 Iwei Translocation Case | Barcode mismatch comment in note,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Tumor,NimV1,10-59344_Tumor,NA_10-59344_Tumor,10-59344,A,COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES,173304,238.2,"This lesion has some features that make a conventional Spitz's nevus unlikely, including a thinned epidermis, the extent of confluence of nests and the number of mitotic figures, some of them in the lower half of the lesion. The more striking cytologic atypia seen in the lesions that I term spitzoid melanoma of childhood is not evident. Similar lesions to this one have been reported under a variety of names, including atypical Spitz tumor. They tend to involve local (and sentinel) lymph nodes at a relatively high rate, but distant metastasis is unlikely. Given the sharp circumscription of the lesion, one could consider a re-excision of this site, but I have not seen lesions of this type recur when excised by even a few millimeters. With regard to sentinel lymph node biopsy, there is little prognostic information as there is such a disparity between a percent of patients with nodal involvement and distant metastases. Comparative genomic hybridization does not show clear-cut evidence of chromosomal gains or losses. Because deflections were present in the plotted CGH data, we consulted with our former colleague, Dr. Boris Bastian (now chairman of Pathology at Memorial Sloan-Kettering Medical Center, New York) who agrees that no definite aberrations are present. The lack of aberrations does not exclude the possibility of melanoma, but makes it less likely (aberrations, especially multiple ones in loci characteristic of conventional melanomas would have resulted in an outright diagnosis of melanoma in this case). If one is looking for a more specific name for a lesion like this one, atypical Spitz tumor may be apt.  Please note that a margin of about a millimeter or so is present between the neoplasm and the peripheral margin. Lesions of this type are usually well circumscribed, and do not recur even with narrow excision margins, if the excision margins are histopathologically proven. Hence, I believe that this site could be treated with a reexcision of only a few more millimeters.","There is a proliferation of melanocytes with a domed surface and a wedge-shaped base. The overlying epidermis is alternatively thinned and irregularly thickened. There are large, confluent nests of cells with relatively monomorphous oval vesicular nuclei and abundant pale amphophilic cytoplasm. Many mitotic figures are present both in the upper and lower parts of the lesion. Both maturation, and dispersion to smaller aggregations toward the inferior edge of the specimen is evident.",9,,,,,,F,953920
CGH11_60,11-16253,L2DR14,CACCTC,"Low Post-Shear/Ampure Bead purified DNA, requirement of 100ng for End Repair",34,,BRAF/ME,CGH11-060 Iwei Translocation Case,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Tumor,NimV1,11-16253_Tumor,NA_11-16253_Tumor,11-16253,A,"CELLULAR COMPOUND SPITZOID NEOPLASM, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION",173508,238.2,"This proliferation does not represent a conventional Spitz nevus. Rather, our differential diagnosis included a hypercellular Spitz nevus on one hand and so-called childhood-type spitzoid melanoma on the other. To further address this differential, we pursued array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated loss of a small segment of distal chromosome 7q and gain in the proximal portion of chromosome 11p. Chromosome 11p gain can be seen in association with Spitz nevi, especially, large and cellular Spitz nevi, and this molecular aberration is not common to melanoma. The segment of chromosomal loss in 7q is quite small and is not believed to be diagnostically significant. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as a cellular Spitz nevus. We have not demonstrated molecular anomalies via aCGH that are supportive of a diagnosis of childhood-type spitzoid melanoma. This proliferation has been fully excised by means of this specimen, and I do not believe that further surgery at this site is indicated.","Sections show a sessile, exophytic, compound proliferation of enlarged melanocytes. Within the epidermis, which is acanthotic and hyperkeratotic, there are single melanocytes and nests and fascicles of melanocytes distributed somewhat unevenly. Some collections of melanocytes extend above the junction. In dermis below this, there are nests and fascicles of melanocytes that are encompassed by fibrotic dermis. Very large and coalescing fascicles are present in the subjunctional zone, but maturation into smaller nests, cords, and fascicles is apparent more deeply. Part of the proliferation encompasses a folliculosebaceous unit. Dermal melanocytes in mitosis can be found but are uncommon.",4,,,,,,F,1005690
CGH11_252,11-61046,L2DR15,GTGGCC,,100,,NTRK3,CGH11-252 Iwei Translocation Case,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Tumor,NimV1,11-61046_Tumor,NA_11-61046_Tumor,11-61046,A,INTRADERMAL PROLIFERATION OF ENLARGED SPINDLED MELANOCYTES,173439,238.2,"We believe this proliferation falls on the spectrum of a pigmented spindle cell nevus (or plexiform spindle cell nevus). To further assess its nature, we completed immunoperoxidase staining. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show low nuclear expression of Ki-67, thus implying that cellular proliferation is very low, which is reassuring but not definitive. There is also general preservation of p16 expression, which also lends support to a benign interpretation. To definitively assess the nature of this tumor, we also completed array-based comparative genomic hybridization (aCGH), with your approval. This approach was utilized to screen this tumor tissue for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a small segmental loss of chromosome 15q and a small segmental gain in chromosome 19p. Neither of these small aberrations is known to be associated with melanoma. Most melanomas demonstrate multiple chromosomal copy number gains and losses when assessed via aCGH, and this was not apparent in this instance.  In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as an unconventional pigmented spindle cell nevus. This is a most unusual melanocytic proliferation, and we utilized sophisticated techniques to evaluate its nature. Further excision is recommended ensure that local eradication has been accomplished and that persistence cannot ensue.","Sections show a proliferation of large spindled melanocytes arrayed in the dermis as coalescing fascicles that form a larger sessile nodule. There is partial maturation with descent. Many of the constituent melanocytes have finely melanized cytoplasm. Superficially, there is perijunctional fibrosis. The superjacent epidermis is thinned. There are melanophages scattered in the upper dermis as well.",16,,,,,,F,1050489
CGH10_17,10-56047,L2DR16,TGTTGC,,100,,PDGFRB,CGH10-017 Iwei Translocation Case,Nimblegen7_BB10,BB10_SeqL,BB10_CL,Tumor,NimV1,10-56047_Tumor,NA_10-56047_Tumor,10-56047,A,"MELANOMA, 1.7 MM IN THICKNESS",173508,172.5,"The enclosed Ki-67 stain is difficult to interpret, as many lymphocytes are present. A few mitotic figures are present, including one in the lower half of the lesion. Immunoperoxidase staining performed in our laboratory using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) to more specifically evaluate the proliferation rate in melanocytes shows a very low labeling rate, although a few positive nuclei are present near the base of the lesion. A p16 stain labels only rare cells (less than 5%). My initial assessment of this lesion was that it is not a conventional Spitz's nevus, but a lesion with low metastatic potential (referred to as atypical Spitz tumor in some studies). However, comparative genomic hybridization shows a loss of chromosome 9, and a gain involving most of chromosome 7. The chromosome 9 loss corroborates the near-total absence of staining for p16, as the gene is located on 9p. Gains involving chromosome 7 and losses involving chromosome 9 are common aberrations in melanoma.  Hence, I believe an outright diagnosis of melanoma is more apt.  The lesion appears to have been narrowly excised.","Sections show a moderately narrow, relatively symmetrical proliferation of large oval melanocytes involving the superficial dermis. The lesional cells have abundant amphophilic cytoplasm and moderately pleomorphic, vesicular nuclei. Relatively small nests are present, with even smaller aggregations toward the base of the lesion. A sparse lymphocytic infiltrate is present.",49,,1.7,,,,F,950623
D12_67298_Tumor,12-67298,L2DR01,AAGGGA,,100,,"lft, Lateral Ankle, Malignant S-100 positive spindle cell Neloplasm, Braf15 V600E mutation",,Nimblegen8_BB11,BB11_SeqL,BB11_CL,Tumor,NimV1,12-67298_Tumor,NA_12-67298_Tumor,12-67298,A,"MALIGNANT S-100 POSITIVE SPINDLE CELL NEOPLASM, BRAF V600E MUTATION DETECTED",100711,238.2,The histopathological diagnosis was established by our previous pathology report DT12-55826. Sanger sequencing of exon 15 of BRAF revealed a V600E mutation.,,75,,,,,,F,960004
D12_67298_Norm,12-67298,L2DR02,CCTTCA,,78.2,,"lft, Lateral Ankle, Malignant S-100 positive spindle cell Neloplasm, Braf15 V600E mutation",Less than 100 ng input for End Repair,Nimblegen8_BB11,BB11_SeqL,BB11_CL,Normal,NimV1,12-67298_Normal,NA_12-67298_Normal,12-67298,A,"MALIGNANT S-100 POSITIVE SPINDLE CELL NEOPLASM, BRAF V600E MUTATION DETECTED",100711,238.2,The histopathological diagnosis was established by our previous pathology report DT12-55826. Sanger sequencing of exon 15 of BRAF revealed a V600E mutation.,,75,,,,,,F,960004
S12_20321_A2_Tumor,12-20321,L2DR03,GGACCC,,100,,"Brain, right frontal, biopsy: Glioblastoma, WHO Grade IV ",,Nimblegen8_BB11,BB11_SeqL,BB11_CL,Tumor,NimV1,12-20321_Tumor,NA_12-20321_Tumor,12-20321,A,POLYPOID SEBORRHEIC KERATOSIS,173404,702.19,,"Sections show a polypoid segment of skin with a papillated surface, and the epidermis is expanded by a proliferation of keratinocytes arrayed as interanastomosing rete.",58,,,,,,M,1102231
L11_96096_A2_Norm,11-96096,L2DR04,TTCAGC,,100,,"Metastatic Melanoma, Lymph Node, sentinel. Capsular nevus is present",,Nimblegen8_BB11,BB11_SeqL,BB11_CL,Normal,NimV1,11-96096_Normal,NA_11-96096_Normal,11-96096,A,"METASTATIC MELANOMA, PRESENT IN LYMPH NODE",222922,198.2,"In addition to rare melanoma cells (in areas less than 0.1 mm in diameter), a capsular nevus is present. The cells of the nevus greatly outnumber those of the melanoma.","Sections show a lymph node with reactive changes and small nests, cords and strands of melanocytes with cytologically bland small round nuclei and scant cytoplasm nuclei within its capsule and trabeculae (best seen in the MART-1 stained sections). In addition, there is a focus in which pigmented histiocytes are present within the nodal parenchyma. Accompanying these are rare cells with abundant homogeneous-appearing eosinophilic cytoplasm and strikingly enlarged nuclei.",55,,,,,,F,1085544
MB1242_Tumor,MB1242,L2DR05,AAGACG,,100,,"Acral Tumor, Frozen Tissue DNA Extracted by Denver","UC Denver, Bill Robinson Study",Nimblegen8_BB11,BB11_SeqL,BB11_CL,Tumor,NimV1,MB1242_Tumor,NA_MB1242_Tumor,,,,,,,,,,,,,,,
MB1241_Norm,MB1241,L2DR06,CCTCGG,,100,,"Acral Normal, Frozen Tissue DNA  Extracted by Denver","UC Denver, Bill Robinson Study",Nimblegen8_BB11,BB11_SeqL,BB11_CL,Normal,NimV1,MB1241_Normal,NA_MB1241_Normal,,,,,,,,,,,,,,,
MB1423_Tumor,MB1423,L2DR07,GGATGT,,100,,"Acral Tumor, Heel, Frozen Tissue DNA Extracted by Denver","UC Denver, Bill Robinson Study",Nimblegen8_BB11,BB11_SeqL,BB11_CL,Tumor,NimV1,MB1423_Tumor,NA_MB1423_Tumor,,,,,,,,,,,,,,,
MB1423_Norm,MB1423,L2DR08,TTCGCT,,100,,"Acral Normal Heel, FFPE Extracted DNA by Denver","UC Denver, Bill Robinson Study",Nimblegen8_BB11,BB11_SeqL,BB11_CL,Normal,NimV1,MB1423_Normal,NA_MB1423_Normal,,,,,,,,,,,,,,,
MB1424 _Tumor,MB1424_,L2DR09,ACACGA,,100,,"Acral Tumor, Thumb, Frozen Tissue DNA extracted by Denver","UC Denver, Bill Robinson Study",Nimblegen8_BB11,BB11_SeqL,BB11_CL,Tumor,NimV1,MB1424__Tumor,NA_MB1424__Tumor,,,,,,,,,,,,,,,
MB1421_Norm,MB1421,L2DR10,CACACA,,100,,"Acral Normal, Thumb, Frozen Tissue DNA extracted by Denver","UC Denver, Bill Robinson Study",Nimblegen8_BB11,BB11_SeqL,BB11_CL,Normal,NimV1,MB1421_Normal,NA_MB1421_Normal,,,,,,,,,,,,,,,
MB1429_Tumor,MB1429,L2DR11,GTGTTA,,100,,"Acral Tumor, Heel, Frozen Tissue DNA Extracted by Denver","UC Denver, Bill Robinson Study",Nimblegen8_BB11,BB11_SeqL,BB11_CL,Tumor,NimV1,MB1429_Tumor,NA_MB1429_Tumor,,,,,,,,,,,,,,,
MB1428_Norm,MB1428,L2DR13,ACAAAC,,100,,"Acral Normal, Heel Frozen Tissue DNA Extracted by Denver | Barcode mismatch comment in note","UC Denver, Bill Robinson Study",Nimblegen8_BB11,BB11_SeqL,BB11_CL,Normal,NimV1,MB1428_Normal,NA_MB1428_Normal,,,,,,,,,,,,,,,
CGH12_317,12-71679,L2DR12,TGTGAA,,100,,NTRK3 | Barcode mismatch comment in note,CGH12-317 ,Nimblegen8_BB11,BB11_SeqL,BB11_CL,Tumor,NimV1,12-71679_Tumor,NA_12-71679_Tumor,12-71679,A,COMPOUND PROLIFERATION OF LARGE SOMEWHAT SPITZOID MELANOCYTES,105536,238.2,"Comparative genomic hybridization has been performed, and while not technically optimal, shows no chromosomal aberrations. Especially given this result, I favor an unusual nevus in the Spitz/pigmented spindle cell nevus spectrum. As the junctional nests are closely apposed, resulting in a hypercellular appearance, a spitzoid melanoma is also in the differential diagnosis, albeit less likely. In any case that is at this level of difficulty, a narrow reexcision is appropriate.","There is a broad-based compound proliferation of melanocytes in which the junctional component outflanks the centrally positioned intradermal one. There are closely apposed nests of moderately enlarged fusiform melanocytes with monomorphous oval nuclei and pale, lightly pigmented cytoplasm at the junction, extending into the upper portions of folliculosebaceous units. A few incipient Kamino bodies are present. There is a central focus in which nests of progressively smaller cells are embedded within fibrotic stroma. I did not detect mitotic figures in the dermal component. The enclosed two-color immunoperoxidase-stained sections show a moderate proliferation rate in melanocytes in the papillary dermis, with considerably less staining toward the base of the lesion.",41,,,,,,F,1157496
CGH12_343,12-80985B,L2DR14,CACCTC,,74.55,,NTRK3,CGH12-343 Less than 100 ng input for End Repair,Nimblegen8_BB11,BB11_SeqL,BB11_CL,Tumor,NimV1,12-80985B_Tumor,NA_12-80985B_Tumor,12-80985,B,"RESIDUAL ATYPICAL COMPOUND SPITZOID NEOPLASM, EXCISED IN THE AVAILABLE PLANES OF SECTION",173305,238.2,"Our differential diagnosis included both an unconventional Spitz nevus on one hand and childhood-type spitzoid melanoma on the other. Per your request, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen in association with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 8p as well as segmental loss of chromosome 12q and loss of distal chromosome 15q. The identification of multiple chromosomal copy number abnormalities provides confirmation that this tumor does not represent a conventional Spitz nevus. However, the several small segmental genomic aberrations we have identified are not specifically diagnostic of melanoma, either. Thus, this tumor can be considered an example of 'atypical Spitz tumor or 'Spitz tumor of ambiguous potential'. Dr. Boris Bastian has reviewed the molecular results and is in agreement with this interpretation.  The small residuum seen here is non-ulcerated and appears excised in the available planes of section.","Sections show a residual dermal proliferation of enlarged fusiform melanocytes arrayed as a wedge-shaped nodule of coalescing fascicles in the reticular dermis. There is a juxtaposed sparse permeative lymphohistiocytic infiltrate, and a swath of post-procedural fibrosing inflammatory alterations sits above this. There is no ulceration. Combining both specimens, a tumor thickness of 1.4 mm is appreciable.",7,,,,,,M,1166802
CGH12_135,12-31996,L2DR15,GTGGCC,,100,,NTRK1,CGH12-135 ,Nimblegen8_BB11,BB11_SeqL,BB11_CL,Tumor,NimV1,12-31996_Tumor,NA_12-31996_Tumor,12-31996,A,"ATYPICAL COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, WITH LOSS OF CHROMOSOME 9 DEMONSTRATED BY MOLECULAR ASSESSMENT",173507,238.2,"ADDENDUM, June 7, 2012: Our differential diagnosis included an unconventional Spitz nevus on one hand and so-called childhood-type spitzoid melanoma. Thank you for arranging for p16 immunostaining to be completed in your laboratory; relatively avid expression of p16 was documented. We also received a clinical request for us to complete array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 9 with no other chromosomal gains or losses. Loss in chromosome 9 represents a relatively common aberration in childhood spitzoid melanoma, but we do not consider it sufficient to be fully decisive from a diagnostic standpoint (most melanomas have multiple genomic aberrations). In summary, the combination of results derived from conventional microscopy coupled with aCGH raises childhood-type spitzoid melanoma as a possibility, but these molecular findings are not decisively diagnostic. This atypical melanocytic proliferation is 2.1 mm in thickness and involves the deep edge of the current specimen. Complete reexcision of this site is warranted in follow-up. My personal opinion is that nodal assessment is not beneficial in this context, as any results found do not correlate with prognosis, in contrast to experience with adult melanoma.","Sections show a domed compound proliferation of enlarged melanocytes, and the epidermis above these cells is thinned. There are very large nests and fascicles of melanocytes just below the junction, and a few central nests are noted above this. In dermis below this, partially-maturing nests, fascicles, and cords of similar melanocytes can be seen, and a number of dermal melanocytes in mitosis can be identified.",8,,,,,,F,1148421
CGH12_161,12-39632,L2DR16,TGTTGC,,30.3,,NTRK1,CGH12-161 Less than 100 ng input for End Repair,Nimblegen8_BB11,BB11_SeqL,BB11_CL,Tumor,NimV1,12-39632_Tumor,NA_12-39632_Tumor,12-39632,A,"COMPOUND PROLIFERATION OF LARGE SPINDLED AND EPITHELIOID MELANOCYTES, PROBABLY AN UNUSUAL SPITZ'S NEVUS, EXTENDING TO THE EDGE OF THE SPECIMEN",173508,238.2,"ADDENDUM, June 29, 2012: While there are features in common with a Spitz's nevus, there are also unusual features, including deep adnexal extension, marked thinning of the epidermis over some junctional nests, and a lack of complete maturation of the dermal component. We were interested in performing comparative genomic hybridization. This is a molecular technique that uses lesional tissue from the paraffin block. It is based on the presence of chromosomal gains and losses in about 95% of melanomas, but with the exception of a gain of 11p, a lack of them in Spitz's nevi. A reference on this technique and its applicability to this differential diagnosis is listed below. Thank you for informing us that we could proceed with this testing. This shows no significant loss or gain of chromosomal material. This favors a benign interpretation. About 95% of conventional melanomas show detectable losses or gains with this technique. Because of the unusual findings noted, however, complete re-excision of this site is of course warranted.  Reference:  Bastian BC, Wassermann U, Pinkel D, LeBoit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999 Dec;113(6):1065-9.","Sections show a compound proliferation of large spindled and epithelioid melanocytes, the junctional component of which is arrayed with the lowermost sections of an epithelium that is acanthotic and hyperkeratotic, with thinning of the epidermis over some large nests. Some single melanocytes are scattered above the basal layer. Rare small Kamino bodies are present. In the dermis, melanocytes are arrayed as nests and syncytia. There is some maturation, but some larger melanocytes persist at the base. There is deep adnexal extension. The stroma is focally myxoid.",5,,,,,,F,1125450
HW_A5_Tumor,HWA5,L2DR01,AAGGGA,,100,,"Acral Melanoma, Dissect","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Tumor,NimV1,HWA5_Tumor,NA_HWA5_Tumor,,,,,,,,,,,,,,,
HW_A5_Cntl,HWA5,L2DR02,CCTTCA,,82.6,,"Acral Melanoma, Dissect","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Normal,NimV1,HWA5_Normal,NA_HWA5_Normal,,,,,,,,,,,,,,,
HW_A6_Tumor,HWA6,L2DR03,GGACCC,,100,,"Acral Melanoma, All","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Tumor,NimV1,HWA6_Tumor,NA_HWA6_Tumor,,,,,,,,,,,,,,,
HW_A6_Cntl,HWA6,L2DR04,TTCAGC,,68.3,,"Acral Melanoma, All","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Normal,NimV1,HWA6_Normal,NA_HWA6_Normal,,,,,,,,,,,,,,,
HW_A7_Tumor,HWA7,L2DR05,AAGACG,,86.5,,"Acral Melanoma, Dissect","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Tumor,NimV1,HWA7_Tumor,NA_HWA7_Tumor,,,,,,,,,,,,,,,
HW_A7 Cntl,HWA7,L2DR06,CCTCGG,,100,,"Acral Melanoma, All","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Normal,NimV1,HWA7_Normal,NA_HWA7_Normal,,,,,,,,,,,,,,,
HW_A8_Tumor,HWA8,L2DR07,GGATGT,,100,,"Acral Melanoma, Dissect","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Tumor,NimV1,HWA8_Tumor,NA_HWA8_Tumor,,,,,,,,,,,,,,,
HW_A8_Cntl,HWA8,L2DR08,TTCGCT,,100,,"Acral Melanoma, All","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Normal,NimV1,HWA8_Normal,NA_HWA8_Normal,,,,,,,,,,,,,,,
HW_A9_Tumor,HWA9,L2DR09,ACACGA,,100,,"Acral Melanoma, Dissect","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Tumor,NimV1,HWA9_Tumor,NA_HWA9_Tumor,,,,,,,,,,,,,,,
HW_A9_Cntl,HWA9,L2DR10,CACACA,,100,,"Acral Melanoma, All","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Normal,NimV1,HWA9_Normal,NA_HWA9_Normal,,,,,,,,,,,,,,,
HW_A10_Tumor,HWA10,L2DR11,GTGTTA,,100,,"Acral Melanoma, Dissect","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Tumor,NimV1,HWA10_Tumor,NA_HWA10_Tumor,,,,,,,,,,,,,,,
HW_A10_Cntl,HWA10,L2DR12,TGTGAA,,97.4,,"Acral Melanoma, Dissect | Barcode mismatch comment in note","Hong Wu, FCCC, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Normal,NimV1,HWA10_Normal,NA_HWA10_Normal,,,,,,,,,,,,,,,
MB1617_Tumor,MB1617,L2DR13,ACAAAC,,100,,Acral Melanoma | Barcode mismatch comment in note,"UC Denver, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Tumor,NimV1,MB1617_Tumor,NA_MB1617_Tumor,,,,,,,,,,,,,,,
MB_1609_Normal,MB1609,L2DR14,CACCTC,,32.1,,Acral Melanoma,"UC Denver, FFPE",Nimblegen9_BB12,BB12_SeqL,BB12_CL,Normal,NimV1,MB1609_Normal,NA_MB1609_Normal,,,,,,,,,,,,,,,
WM51,WM51,L2DR15,GTGGCC,,100,,wt/wt Cell Line DNA,Wistar,Nimblegen9_BB12,BB12_SeqL,BB12_CL,Tumor,NimV1,WM51_Tumor,NA_WM51_Tumor,,,,,,,,,,,,,,,
WM3918,wm3918,L2DR16,TGTTGC,,100,,wt/wt Cell Line DNA,Wistar,Nimblegen9_BB12,BB12_SeqL,BB12_CL,Tumor,NimV1,wm3918_Tumor,NA_wm3918_Tumor,,,,,,,,,,,,,,,
DM1_Normal,DM1,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,34.3,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Normal,NimV2mix1,DM1_Normal,NA_DM1_Normal,,,,,,,,,,,,,,,
DM1_Tumor,DM1,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,100,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Tumor,NimV2mix1,DM1_Tumor,NA_DM1_Tumor,,,,,,,,,,,,,,,
DM2_Normal,DM2,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,89.9,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Normal,NimV2mix1,DM2_Normal,NA_DM2_Normal,,,,,,,,,,,,,,,
DM2_Tumor,DM2,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,100,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Tumor,NimV2mix1,DM2_Tumor,NA_DM2_Tumor,,,,,,,,,,,,,,,
DM5_Normal,DM5,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,32.6,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Normal,NimV2mix1,DM5_Normal,NA_DM5_Normal,,,,,,,,,,,,,,,
DM5 _Tumor,DM5,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,38.3,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Tumor,NimV2mix1,DM5_Tumor,NA_DM5_Tumor,,,,,,,,,,,,,,,
DM7_Normal,DM7,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,51.5,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Normal,NimV2mix1,DM7_Normal,NA_DM7_Normal,,,,,,,,,,,,,,,
DM7_Tumor,DM7,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,100,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Tumor,NimV2mix1,DM7_Tumor,NA_DM7_Tumor,,,,,,,,,,,,,,,
DM12_Normal,DM12,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,100,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Normal,NimV2mix1,DM12_Normal,NA_DM12_Normal,,,,,,,,,,,,,,,
DM12_Tumor,DM12,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,100,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Tumor,NimV2mix1,DM12_Tumor,NA_DM12_Tumor,,,,,,,,,,,,,,,
DM13_Normal,DM13,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,67.5,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Normal,NimV2mix1,DM13_Normal,NA_DM13_Normal,,,,,,,,,,,,,,,
DM13_Tumor,DM13,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,100,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Tumor,NimV2mix1,DM13_Tumor,NA_DM13_Tumor,,,,,,,,,,,,,,,
DM21_Normal,DM21,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,39.6,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Normal,NimV2mix1,DM21_Normal,NA_DM21_Normal,,,,,,,,,,,,,,,
DM21_Tumor,DM21,L2DR14,CACCTC,13 Cycle Post Hybridization LM-PCR,16.4,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Tumor,NimV2mix1,DM21_Tumor,NA_DM21_Tumor,,,,,,,,,,,,,,,
DM93_Normal,DM93,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,100,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Normal,NimV2mix1,DM93_Normal,NA_DM93_Normal,,,,,,,,,,,,,,,
DM93_CGN,DM93,L2DR16,TGTTGC,13 Cycle Post Hybridization LM-PCR,45.7,,Desmoplastic Melanoma,,Nimblegen10_BB13,BB13_SeqL,BB13_CL,Tumor,NimV2mix1,DM93_Tumor,NA_DM93_Tumor,,,,,,,,,,,,,,,
CGH11_078,11-20375,L2DR01,AAGGGA,,,,NTRK1,CGH11-078 Iwei Translocation Cases,Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,11-20375_Tumor,NA_11-20375_Tumor,11-20375,A,"BIPHASIC COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, INCLUDING A NODULAR POPULATION OF ATYPICAL MELANOCYTES WITH CHROMOSOME 1p LOSS",101624,238.2,"Based upon conventional microscopy, the dominant nodule within this specimen shows a configuration that is worrisome for childhood-type spitzoid melanoma. This nodular proliferation developed secondarily within a preexistent Spitz nevus. I also understand that an adjacent congenital melanocytic nevus was noted clinically. To further assess the nature of this proliferation, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, completion of aCGH analysis demonstrated loss in chromosomal 1p with no other associated chromosomal gains or losses. We have observed anomalies involving chromosome 1 in other examples of spitzoid melanoma. In summary, my interpretation of the the combination of results derived from conventional microscopy coupled with aCGH analysis is that a nodule of childhood-type spitzoid melanoma has developed secondarily within a preexistent Spitz nevus. The nodular population of melanocytes within this specimen is 1.6 mm in thickness. Please note that the negative prior analysis via fluorescence in situ hybridization (FISH) is unsurprising, as FISH testing only evaluates loci on chromosomes 6 and 11. To state it differently, the chromosomal anomaly that we have detected could not be identified via FISH.  The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination. The proliferation in this specimen involves the deep edge of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show a compound proliferation of melanocytes that assumes a domed profile. In some areas, the background epidermis is acanthotic, and in other areas the background epithelium is thinned. In areas where the epithelium is expanded, there are single melanocytes and nests distributed within the epidermis at all levels, and large and well-formed pink globules (Kamino bodies) can be found above dermal papillae. Below this, there are nests and cords of melanocytes that in some areas mature with descent. In areas where the epithelium is thin, a nodular array of non-maturing melanocytes is appreciable. These cells are slightly spindled and epithelioid in morphology and have amphophilic or finely melanized cytoplasm. Within these nodules, melanocytes in mitosis are relatively easily found. A juxtaposed sparse infiltrate of lymphocytes is apparent as well.",2,,,,,,F,1009813
CGH11_080,11-21491,L2DR02,CCTTCA,,,,NTRK1,CGH11-080 Iwei Translocation Cases,Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,11-21491_Tumor,NA_11-21491_Tumor,11-21491,A,"HYPERCELLULAR COMPOUND PROLIFERATION OF MELANOCYTES, CONSISTENT WITH A HYPERCELLULAR SPITZ NEVUS",173502,238.2,"The cellularity of this process raised concern for the possibility of childhood-type spitzoid melanoma as a potential alternative i the differential diagnosis. The best means to assess or refute this possibility is to complete array-based comparative genomic hybridization (aCGH) analysis, which we pursued. After extraction of tumoral DNA from the tissue block, aCGH analysis did not reveal any chromosomal gains or losses. As you know, the vast majority of melanomas, including childhood-type melanomas, harbor various genomic anomalies. In summary, the combination of results derived from conventional microscopy coupled with aCGH does not provide support for a diagnosis of melanoma. I believe this unusual proliferation represents a hypercellular Spitz nevus. The process appears excised in the available planes of section.","Sections show enlarged melanocytes arrayed as gargantuan nests and fascicles in compound fashion in concert with acanthosis in a sessile polypoid skin segment. The acanthotic epidermis is focally eroded. In the dermis, non-maturing and coalescing fascicles of melanocytes are coupled with a sparse encompassing lymphohistiocytic infiltrate, and cells in mitosis are relatively easily found.",14,,,,,,M,1010929
CGH11_281,11-65778,L2DR03,GGACCC,,,,BRAF,CGH11-281 Iwei Translocation Cases,Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,11-65778_Tumor,NA_11-65778_Tumor,11-65778,A,"COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, FOCALLY ABUTTING THE INKED SPECIMEN PERIPHERY",333504,238.2,"Our differential diagnosis for this spitzoid tumor included an unconventional Spitz nevus on one hand and spitzoid melanoma on the other. To further assess this differential via molecular means, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss of chromosome 7p as well as focal gain in chromosome 7q. No other chromosomal copy number aberrations were identified. As background, please note that chromosomal copy number aberrations involving multiple chromosomes can be identified in the vast majority of melanomas evaluated via aCGH, while most melanocytic nevi lack such aberrations. A subset of Spitz nevi demonstrate aberrations involving a single chromosome, including chromosomes 7, 11, and 15. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced clear support for a diagnosis of melanoma. Rather, I believe this proliferation represents an unconventional Spitz nevus with associated gain in chromosome 7q. My colleague, Dr. Boris Bastian, reviewed the aCGH tracing for this case and is in agreement with my diagnostic interpretation.  We recommend complete reexcision of this site in follow-up to be certain there is not possibility of local persistence.","Sections show a compound, wedge-shaped, slightly asymmetrical proliferation of spindled and epithelioid melanocytes arrayed as nests and fascicles which are vertically oriented in the dermis and focally along the junction of an epidermis that is acanthotic. Within the dermis, similar melanocytes are present in clusters, fascicles, and interstitially. Mitotic figures are evident very focally within the dermal component, including within deeper aspects of it. There is a patchy juxtaposed lymphocytic infiltrate.",22,,,,,,F,1055221
CGH10_058,10-88482,L2DR04,TTCAGC,,,,NTRK3,CGH10-058 Iwei Translocation Cases,Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,10-88482_Tumor,NA_10-88482_Tumor,10-88482,A,"DESMOPLASTIC MELANOMA, 3.8 MM. IN THICKNESS",173610,238.2,"There are conflicting findings, as noted in your cover letter. The architectural features of the lesion could well be those of a Spitz's nevus, but the setting, in an older patient, in severely sun-damaged skin with, and presence of deep mitotic figures is worrisome. A p16 stain is positive in about 30% of lesional nuclei. Testing with comparative genomic hybridization shows a gain involving much of the long arm of chromosome 15 (15q), and one involving 22q. Although these are not among the very most commonly affected loci in melanoma, gains in both of these areas are seen in a proportion of typical melanomas.  The lesion extends to within 1 mm of the margin in the reticular dermis. It is not ulcerated, and hence is a T3a primary melanoma in the 2009 AJCC staging schema for melanoma.","Sections show markedly sun-damaged skin with a well-circumscribed, wedge-shaped to somewhat rectangular proliferation of melanocytes that mostly involves the dermis. Most of the proliferation is embedded in markedly fibrotic stroma, which displaces the elastotic material. There are large nests of large oval melanocytes superficially. These cells have pale amphophilic cytoplasm with large, relatively monomorphous vesicular nuclei. The aggregates, the cells themselves and the sizes of their nuclei diminish with descent. Although the enclosed Ki-67 double-stained sections show a very low proliferative rate, a mitotic figure is present within a high power field of the base of the specimen.",74,,,,,,M,983061
CGH11_283,11-63178,L2DR05,AAGACG,,,,NTRK3,CGH11-283 Iwei Translocation Cases,Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,11-63178_Tumor,NA_11-63178_Tumor,11-63178,A,LENTIGINOUS COMPOUND MELANOCYTIC NEVUS,133232,216.2,,"Sections show a small compound proliferation of melanocytes with a junctional component comprised of single cells and small pigmented nests arrayed along the sides and bases of rete ridges. Small collections of similar melanocytes are positioned in the subjacent superficial dermis, where scattered melanophages are also evident.",41,,,,,,F,1052621
CGH10_020,10-71761,L2DR06,CCTCGG,,,,NTRK1,CGH10-020 Iwei Translocation Cases,Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,10-71761_Tumor,NA_10-71761_Tumor,10-71761,A,"ULCERATED PROLIFERATION OF LARGE, SOMEWHAT SPITZOID MELANOCYTES",173531,238.2,"Several findings are against the diagnosis of a conventional Spitz's nevus, including a thinned epidermis with apposed aggregates of melanocytes (consumption of the epidermis), focal ulceration, and a high mitotic rate that is still evident toward the base of the lesion. Given these findings, I was concerned that this is a spitzoid melanoma and not Spitz's nevus. Comparative genomic hybridization shows no loss or gain of chromosomal material. This favors a benign interpretation, or a low grade neoplasm with limited metastatic potential (what some call atypical Spitz tumors). About 95% of conventional melanomas show detectable losses or gains with this technique. However, given the limited nuclear atypia and negative comparative genomic hybridization results, I cannot make a diagnosis of spitzoid melanoma. A narrow re-excision of this site is advisable.","There is a dome-surfaced, focally ulcerated proliferation of moderately enlarged oval melanocytes with pale cytoplasm and monomorphous vesicular nuclei that have small nucleoli. These cells are arranged as discrete nests at the junction, and as confluent nests and sheets in the dermis. A high mitotic rate is present, with many mitotic figures present within one high power field of the deep margin. The lesion is partially encompassed by epithelial collarettes.",33,,,,,,F,966340
CGH10_049,10-84478,L2DR07,GGATGT,,,,NTRK1,CGH10-049 Iwei Translocation Cases,Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,10-84478_Tumor,NA_10-84478_Tumor,10-84478,A,"COMPOUND SPITZOID NEOPLASM, FOCALLY ABUTTING THE PERIPHERY OF THE BIOPSY",173649,238.2,"ADDENDUM, January 14, 2011: As noted previously, my differential diagnosis includes a hypercellular Spitz nevus on one hand and childhood-type spitzoid melanoma on the other, and I favor the former possibility as most likely. As this differential diagnosis is best addressed by inclusion of the results of molecular analysis, we pursued comparative genomic hybridization analysis via tissue array methodology (aCGH). After extraction of tumoral DNA, aCGH assessment demonstrated gain in chromosome 7q and no other genomic aberrations. Chromosome 7q gain as a monoaberration does not presently have defined significance. We have observed it in melanocytic tumors interpreted ambiguously. A monoaberration in chromosome 7q is not sufficient to warrant interpretation as childhood-type spitzoid melanoma. In summary, based upon the combination of conventional microscopy coupled with aCGH results, I continue to favor a hypercellular Spitz nevus as most likely. As this interpretation is not unequivocal, further excision of this site is warranted to ensure that local eradication has been accomplished and that persistence cannot ensue.","Sections show a domed, cellular and somewhat asymmetrical compound proliferation of enlarged spindled and epithelioid melanocytes. Within the epidermis, which is markedly acanthotic, there are strikingly enlarged nests and fascicles of melanocytes distributed somewhat unevenly, and centrally an area of erosion is capped by neutrophilic exudate. There are large nests and fascicles of similar melanocytes in the underlying dermis, and partial maturation with descent in the dermis is appreciable. In the deepest extent of the lesion, the lesional melanocytes extend amongst adnexal structures. A patchy dermal lymphocytic infiltrate is present concurrently. A number of dermal melanocytes in mitosis can be found.",16,,,,,,F,979057
CGH11_020,10-88475,L2DR08,TTCGCT,,,,NTRK1,CGH11-020 Iwei Translocation Cases,Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,10-88475_Tumor,NA_10-88475_Tumor,10-88475,A,"COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES",173727,238.2,"ADDENDUM, February 14, 2011: The following note has been modified from that in the original report, a copy of which is on file as .pdfs in our computer system: While the architectural features of this lesion favor a Spitz's nevus, some of the cytologic features are of concern (many cells have less cytoplasm than classic Spitz cells typically do), and many more mitotic figures are present than in most Spitz nevi. Additionally, the striking confluence of junctional nests is of concern.  Comparative genomic hybridization shows no chromosomal gains or losses. Given these findings, I am unable to render a diagnosis of spitzoid melanoma, and favor a unusual Spitz's nevus. The lesion appears to have been removed with a margin of about 3 mm on one side. It is very well circumscribed, and lesions of this type seldom recur in the scar from the previous biopsy. Also, it is very common for spitzoid lesions of all types (including benign Spitz nevi) to have small clusters of spitzoid melanocytes in a sentinel lymph node. The predictive value of this finding is very low, and I, for this reason, would not endorse this approach.","There is a well-circumscribed, dome-surfaced proliferation of melanocytes involving the junctional zone and superficial dermis. The base of the lesion is relatively flat, except in a central area where melanocytes extend along the access of an eccrine duct. The overlying epidermis is irregularly hyperplastic, with jagged rete ridges and a thick spinous layer. There are large, confluent nests of large oval melanocytes along the junction. These cells have monomorphous oval vesicular nuclei, small nucleoli and abundant pale eosinophilic cytoplasm. Many mitotic figures are present, both in the superficial and deep portions of the lesion. There is some maturation with descent, and in the central, peri-adnexal area, some myxoid stroma is present.",28,,,,,,F,983054
D12_54296_Norm,12-54296,L2DR09,ACACGA,,,,"Melanoma, Rt Inguinal Lymph node & Rt. Vulva","Swapna DNA, screened",Nimblegen11_BB14,BB14_SeqL,BB14_CL,Normal,NimV2mix1,12-54296_Normal,NA_12-54296_Normal,12-54296,A,"METASTATIC MELANOMA, KIT V654A MUTATIONS DETECTED",222922,198.2,"The histopathological diagnosis was established by UCSF Surgical Pathology report S12-9606. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 9, 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, detected a V654A mutation in KIT. This is an established, recurring mutation in KIT. The mutant to normal allele ratios indicate amplification of the mutant allele. This findings indicate that the tumor may respond to KIT inhibitors.",,71,,,,,,F,1140109
D12_54296_Tumor,12-54296,L2DR10,CACACA,,,,"Melanoma, Rt Inguinal Lymph node & Rt. Vulva","Swapna DNA, screened",Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,12-54296_Tumor,NA_12-54296_Tumor,12-54296,A,"METASTATIC MELANOMA, KIT V654A MUTATIONS DETECTED",222922,198.2,"The histopathological diagnosis was established by UCSF Surgical Pathology report S12-9606. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 9, 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, detected a V654A mutation in KIT. This is an established, recurring mutation in KIT. The mutant to normal allele ratios indicate amplification of the mutant allele. This findings indicate that the tumor may respond to KIT inhibitors.",,71,,,,,,F,1140109
D12_54992_Norm,12-54992,L2DR11,GTGTTA,,,,"Melanoma, Lt groin sentinel lymph nodes","Swapna DNA, screened",Nimblegen11_BB14,BB14_SeqL,BB14_CL,Normal,NimV2mix1,12-54992_Normal,NA_12-54992_Normal,12-54992,A,"METASTATIC MELANOMA, PENDING MUTATIONAL ANALYSIS",222922,198.2,"The histopathological diagnosis was established by pathology report S12-4130 of San Francisco General Hospital. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 9, 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, was completed using this tissue. The following results were obtained: BRAF exon 15: wild-type (non-mutated). NRAS exons 1 and 2: wild-type (non-mutated). KIT exons 9, 11, 13, 17 and 18: all wild-type (non-mutated).",,44,,,,,,F,1140805
D12_54992_Tumor,12-54992,L2DR13,ACAAAC,,,,"Melanoma, Lt groin sentinel lymph nodes","Swapna DNA, screened",Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,12-54992_Tumor,NA_12-54992_Tumor,12-54992,A,"METASTATIC MELANOMA, PENDING MUTATIONAL ANALYSIS",222922,198.2,"The histopathological diagnosis was established by pathology report S12-4130 of San Francisco General Hospital. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 9, 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, was completed using this tissue. The following results were obtained: BRAF exon 15: wild-type (non-mutated). NRAS exons 1 and 2: wild-type (non-mutated). KIT exons 9, 11, 13, 17 and 18: all wild-type (non-mutated).",,44,,,,,,F,1140805
WM3622,WM3622,L2DR12,TGTGAA,,,,wt/wt,"Wistar, Fusion Project, Cell Line DNA",Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,WM3622_Tumor,NA_WM3622_Tumor,,,,,,,,,,,,,,,
WM1963,WM1963,L2DR14,CACCTC,,,,wt/wt,"Wistar, Fusion Project, Cell Line DNA",Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,WM1963_Tumor,NA_WM1963_Tumor,,,,,,,,,,,,,,,
WM8,WM8,L2DR15,GTGGCC,,,,wt/wt,"Wistar, Fusion Project, Cell Line DNA",Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,WM8_Tumor,NA_WM8_Tumor,,,,,,,,,,,,,,,
WM3912,WM3912,L2DR16,TGTTGC,,,,wt/wt,"Wistar, Fusion Project, Cell Line DNA",Nimblegen11_BB14,BB14_SeqL,BB14_CL,Tumor,NimV2mix1,WM3912_Tumor,NA_WM3912_Tumor,,,,,,,,,,,,,,,
DM11_Tumor,DM11,L2DR01,AAGGGA,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Tumor,NimV2mix1,DM11_Tumor,NA_DM11_Tumor,,,,,,,,,,,,,,,
DM11_Normal,DM11,L2DR02,CCTTCA,,,,"Hunter, Desmoplastic Melanoma",Less than the optimal 100 ng input conc. For End Repair,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Normal,NimV2mix1,DM11_Normal,NA_DM11_Normal,,,,,,,,,,,,,,,
DM14_Tumor,DM14,L2DR03,GGACCC,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Tumor,NimV2mix1,DM14_Tumor,NA_DM14_Tumor,,,,,,,,,,,,,,,
DM14_Normal,DM14,L2DR04,TTCAGC,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Normal,NimV2mix1,DM14_Normal,NA_DM14_Normal,,,,,,,,,,,,,,,
DM26_Tumor,DM26,L2DR05,AAGACG,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Tumor,NimV2mix1,DM26_Tumor,NA_DM26_Tumor,,,,,,,,,,,,,,,
DM26_Normal,DM26,L2DR06,CCTCGG,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Normal,NimV2mix1,DM26_Normal,NA_DM26_Normal,,,,,,,,,,,,,,,
DM28_Tumor,DM28,L2DR07,GGATGT,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Tumor,NimV2mix1,DM28_Tumor,NA_DM28_Tumor,,,,,,,,,,,,,,,
DM28_Normal,DM28,L2DR08,TTCGCT,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Normal,NimV2mix1,DM28_Normal,NA_DM28_Normal,,,,,,,,,,,,,,,
DM29_2_Tumor,DM29,L2DR09,ACACGA,,,,"Hunter, Desmoplastic Melanoma",Less than the optimal 100 ng input conc. For End Repair,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Tumor,NimV2mix1,DM29_Tumor,NA_DM29_Tumor,,,,,,,,,,,,,,,
DM29_Normal,DM29,L2DR10,CACACA,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Normal,NimV2mix1,DM29_Normal,NA_DM29_Normal,,,,,,,,,,,,,,,
DM34_Tumor,DM34,L2DR11,GTGTTA,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Tumor,NimV2mix1,DM34_Tumor,NA_DM34_Tumor,,,,,,,,,,,,,,,
DM34_Normal,DM34,L2DR12,TGTGAA,,,,"Hunter, Desmoplastic Melanoma",Less than the optimal 100 ng input conc. For End Repair,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Normal,NimV2mix1,DM34_Normal,NA_DM34_Normal,,,,,,,,,,,,,,,
DM55_Tumor,DM55,L2DR13,ACAAAC,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Tumor,NimV2mix1,DM55_Tumor,NA_DM55_Tumor,,,,,,,,,,,,,,,
DM55 Normal,DM55,L2DR14,CACCTC,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Normal,NimV2mix1,DM55_Normal,NA_DM55_Normal,,,,,,,,,,,,,,,
DM79_2_Tumor,DM79,L2DR15,GTGGCC,,,,"Hunter, Desmoplastic Melanoma",Less than the optimal 100 ng input conc. For End Repair,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Tumor,NimV2mix1,DM79_Tumor,NA_DM79_Tumor,,,,,,,,,,,,,,,
DM79_Normal,DM79,L2DR16,TGTTGC,,,,"Hunter, Desmoplastic Melanoma",,Nimblegen12_BB15,BB15_SeqL,BB15_CL,Normal,NimV2mix1,DM79_Normal,NA_DM79_Normal,,,,,,,,,,,,,,,
CGH_11_361,11-78845,L2DR01,AAGGGA,,100,,NTRK1,CGH11-361 Iwei Translocation Project,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,11-78845_Tumor,NA_11-78845_Tumor,11-78845,A,"ATYPICAL SPITZ TUMOR, EXTENDING TO THE TISSUE EDGES",173530,238.2,"Array chromosomal genomic hybridization studies were performed on this case.  They reveal a gain of chromosome 13q.  This finding, while unusual, is not known to be associated with melanoma.  The overall histopathology of this case including enlarged melanocytes and scattered mitotic figures, one of which is atypical remains worrisome however, and the exact biologic potential of this lesion cannot be completely predicted.  Most larger series of this rare diagnostic category indicate that most patients are alive and well after treatment, which includes excision, and can include sentinel lymph node biopsy, (which may show metastatic foci).  Rare patients succumb to metastatic disease.  In this case, since the lesion extends to the edges of the specimen, a full thickness re-excision with a minimum of 5 millimeter margins is recommended.  I have reviewed this case with Dr. LeBoit who concurs with the diagnosis and treatment recommendationl.  The reference below represents one of the larger series related to this entity. Ludgate MW et al The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer. 2009 Feb 1;115(3):631-41.",Sections show enlarged epithelioid melanocytes arranged as large nests at the dermo-epidermal junction and as irregular large and small nests in the dermis.  Some of the dermal melanocytes are smaller.  Scattered mitotic figures are noted near the surface of the lesion and one is atypical.  The overlying epidermis shows focal crusting.,19,,,,,,F,1068293
CGH_11_366,11-81405,L2DR02,CCTTCA,,12.4,,NTRK1,CGH11-366 Iwei Translocation Project,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,11-81405_Tumor,NA_11-81405_Tumor,11-81405,A,"COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, WITH FEATURES FAVORING AN UNUSUAL SPITZ'S NEVUS",713789,238.2,"The architectural features of this lesion differ from those of a classic Spitz's nevus by virtue of having epithelial collarettes and a focally thinned epidermis. The dermal component features striking confluence of nests, and a mitotic rate higher than that in most Spitz's nevi. For these reasons, we performed comparative genomic hybridization. No chromosomal gains or losses were detected. In the context of the histopathologic findings, I favor an unusual Spitz's nevus. The lesion appears to have been narrowly removed.","There is a pedunculated proliferation of large oval melanocytes seen beneath an irregularly hyperplastic and focally atrophic epidermis, encompassed by epithelial collarettes. Extending from the junctional zone to the flat base of the lesion in the upper reticular dermis is a proliferation of large oval melanocytes with relatively monomorphous oval vesicular nuclei that contain small nucleoli. These cells have moderate amounts of eosinophilic cytoplasm. Scattered mitotic figures are present in both the upper and lower portions of the proliferation.",16,,,,,,F,1070853
CGH_11_376,11-85075,L2DR03,GGACCC,,84.3,,BRAF,CGH11-376 Iwei Translocation Project,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,11-85075_Tumor,NA_11-85075_Tumor,11-85075,A,"DESMOPLASTIC COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, CONSISTENT WITH A DESMOPLASTIC SPITZ NEVUS",173727,238.2,"As discussed in your correspondence, the differential diagnosis includes an unconventional desmoplastic Spitz nevus on one hand and spitzoid melanoma on the other, and I believe the former possibility represents the correct interpretation for this case. To further substantiate the nature of this proliferation, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated chromosomal copy number aberrations. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a tiny segmental gain in chromosome 7q with no other associated chromosomal gains or losses. This is an aberration that we have identified in association with a small number of desmoplastic Spitz nevi. As you know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. (Importantly, only a small segmental aberration involving a single chromosome was identified in association with this proliferation, and thus the aCGH profile is not suggestive of melanoma.) In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. I believe this proliferation represents an unusual desmoplastic Spitz nevus. As this biopsy is only partial in nature, further excision is recommended to ensure that local eradication has been accomplished.","Sections show a broad, slightly asymmetrical and compound proliferation of enlarged slightly spindled and epithelioid melanocytes. Within the epidermis, single melanocytes and nests are distributed along the sides and bases of elongated rete, and in one focus there is scatter of melanocytes above the junction. In fibrotic and sclerotic reticular dermis below this, there are partially maturing nests, cords, and fascicles of similar melanocytes distributed broadly, and extension to the inked edges of the specimen is noted. A multifocal juxtaposed lymphocytic infiltrate is present concurrently. The melanocytes in the dermis show avid expression of p16 and have a low Ki-67 cell proliferation index. Dermal melanocytes in mitosis are not easily found.",20,,,,,,F,1074523
CGH_11_388,11-83908,L2DR04,TTCAGC,,69.4,,NTRK1,CGH11-388 Iwei Translocation Project,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,11-83908_Tumor,NA_11-83908_Tumor,11-83908,A,COMPOUND SPITZOID MELANOCYTIC PROLIFERATION,173305,238.2,"This proliferation does not represent a conventional Spitz nevus. Rather, our differential diagnosis included an atypical Spitz nevus on one hand and childhood-type spitzoid melanoma on the other. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show modestly elevated nuclear expression of Ki-67, thus implying that cellular proliferation is elevated. This staining result is of concern but is not specifically diagnostic. To more fully assess the nature of this proliferation, we also completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed equivocal segmental loss in distal chromosome 8p with no other chromosomal gains or losses. As you probably know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The aCGH profile that we have defined here is not specific.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced clear support for a diagnosis of melanoma. Rather, I favor an unconventional (or atypical) Spitz nevus as most likely. The proliferation abuts the specimen periphery in the available sections. In light of this, conservative complete reexcision of this site represents a follow-up step worthy of consideration. If there is no apparent residuum, then close clinical monitoring of the biopsy site could also be considered as a possibility.","Sections show enlarged melanocytes arrayed in compound fashion within a sessile, protuberant skin segment. There are single melanocytes and nests and fascicles of melanocytes within the epidermis, which is thinned, and in the dermis there are partially-maturing nests and sheets of melanocytes coupled with a lymphohistiocytic infiltrate.",4,,,,,,F,1073356
CGH_11_422,11-85859,L2DR05,AAGACG,,100,,BRAF,CGH11-422 Iwei Translocation Project,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,11-85859_Tumor,NA_11-85859_Tumor,11-85859,A,"INTRADERMAL PROLIFERATION OF MELANOCYTES, WITH MANY ATTRIBUTES OF A DEEP PENETRATING MELANOCYTIC NEVUS",173508,238.2,"ADDENDUM, January 10, 2012: As I reported previously, some of the constituent melanocytes have enlarged nuclei, this proliferation could also be interpreted as a spitzoid deep penetrating nevus (or perhaps as a Spitz nevus). Per your request, we completed array-based comparative genomic hybridization (aCGH) assessment of this tumor to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 9 with equivocal segmental loss in chromosomes 7p and 8p. The identification of chromosome 9 loss represents an ambiguous aCGH result. We have identified chromosome 9 loss as a monoaberration in some melanomas, but we have also found chromosome 9 loss in proliferations in which the best expert microscopic interpretation was as a melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced an unequivocal diagnosis. Based solely upon conventional microscopy, I favor an unconventional deep penetrating melanocytic nevus as most likely. The results of our aCGH analysis have additionally raised melanoma of 1.6 mm in thickness as a diagnostic possibility. The proliferation appears excised in the available planes of section in the current specimen. Additional excision and ongoing clinical follow-up will be necessary in light of the fact that melanoma has now been raised as a distinct possibility in the differential diagnosis.","The submitted level sections demonstrate a sessile skin segment that harbors a dermal proliferation of melanocytes arrayed in nested, fascicular, and syncytial fashion. Near the junctional zone, epithelioid melanocytes with pale or finely melanized cytoplasm are arrayed in coalescing fashion, and subjacent to this there are coalescing fascicles of slightly spindled melanocytes with similar cytoplasmic qualities. As one extends more deeply in the dermis, the melanocytes become smaller with descent and occasionally are wrapped around tiny peripheral nerves or abut vascular channels. Extension into the subjacent reticular dermis is coupled with a marked diminishment in cell size and an interstitial distribution. Dermal melanocytes in mitosis are not easily found, and the Ki-67 cell proliferation index appears to be relatively low.",45,,,,,,F,1075307
CGH_12_016,11-95663,L2DR06,CCTCGG,,94.6,,BRAF,CGH12-016 Iwei Translocation Project,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,11-95663_Tumor,NA_11-95663_Tumor,11-95663,A,"INTRADERMAL PROLIFERATION OF LARGE SOMEWHAT SPITZOID MELANOCYTES, WITH GENOMIC FINDINGS WORRISOME FOR MELANOMA",173406,238.2,"The differential diagnosis includes an unusual Spitz's nevus, as well as a low-grade spitzoid melanoma. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation rate (my estimate is between 1 and 3%). A phosphohistone H3 immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows positive nuclei among the large, spindled melanocytes. Comparative genomic hybridization shows gains and losses in portions of both the short and long arms of chromosome 7, and and area of loss near the terminal portion of chromosome 16q. While chromosome 7q gains can occur in some Spitz's nevi, the mixture of gains and losses within the same chromosome seen here favors a spitzoid melanoma. If the lesion has been re-excised, I would prefer to issue a final report after seeing the residuum.","There is a proliferation of large fusiform and oval melanocytes involving the superficial, mid and focally the deep reticular dermis. There are fascicles of cells with large vesicular or diffusely hyperchromatic nuclei and relatively small nucleoli, some positioned along the axes of folliculosebaceous units. There is dispersion from large to smaller groups in the interstitial reticular dermis. I did not detect expansile-appearing aggregations of melanocytes or melanocytes in mitosis.",24,,,,,,F,1085111
DM_4_Tumor,DM4,L2DR07,GGATGT,,33.5,,,Hunter Dermoplastic Melanoma,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,DM4_Tumor,NA_DM4_Tumor,,,,,,,,,,,,,,,
DM_4_Normal,DM4,L2DR08,TTCGCT,,97.8,,,Hunter Dermoplastic Melanoma,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Normal,NimV2mix1,DM4_Normal,NA_DM4_Normal,,,,,,,,,,,,,,,
DM_95_2_Tumor,DM95,L2DR09,ACACGA,,73.6,,,Hunter Dermoplastic Melanoma,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,DM95_Tumor,NA_DM95_Tumor,,,,,,,,,,,,,,,
DM_95_Normal,DM95,L2DR10,CACACA,,100,,,Hunter Dermoplastic Melanoma,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Normal,NimV2mix1,DM95_Normal,NA_DM95_Normal,,,,,,,,,,,,,,,
DM_96_2_Tumor,DM96,L2DR11,GTGTTA,,100,,,Hunter Dermoplastic Melanoma,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,DM96_Tumor,NA_DM96_Tumor,,,,,,,,,,,,,,,
DM_96_Normal,DM96,L2DR13,ACAAAC,,29.5,,,Hunter Dermoplastic Melanoma,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Normal,NimV2mix1,DM96_Normal,NA_DM96_Normal,,,,,,,,,,,,,,,
Kit_8,KIT8,L2DR12,TGTGAA,,100,,WT/Mucosal Oral,Alyssa Kit Mutations,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,KIT8_Tumor,NA_KIT8_Tumor,,,,,,,,,,,,,,,
Kit_21,KIT21,L2DR14,CACCTC,,100,,BRAF/Mucosal Anal,Alyssa Kit Mutations,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,KIT21_Tumor,NA_KIT21_Tumor,,,,,,,,,,,,,,,
Kit_55,KIT55,L2DR15,GTGGCC,,87,,WT/Mucosal Anal,Alyssa Kit Mutations,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,KIT55_Tumor,NA_KIT55_Tumor,,,,,,,,,,,,,,,
Kit_76,KIT76,L2DR16,TGTTGC,,100,,WT/Mucosal Sinus,Alyssa Kit Mutations,Nimblegen13_BB16,BB16_SeqL,BB16_CL,Tumor,NimV2mix1,KIT76_Tumor,NA_KIT76_Tumor,,,,,,,,,,,,,,,
CNS_29_Tumor,W09-1121,L2DR01,AAGGGA,,85.9,,Jantima CNS,N14_1,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,W09-1121_Tumor,NA_W09-1121_Tumor,,,,,,,,,,,,,,,
CNS_29_Normal,W09-1121,L2DR02,CCTTCA,,91.7,,Jantima CNS,N14_2,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Normal,NimV2mix2,W09-1121_Normal,NA_W09-1121_Normal,,,,,,,,,,,,,,,
CNS_30_Tumor,W10-143,L2DR03,GGACCC,,100,,Jantima CNS,N14_3,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,W10-143_Tumor,NA_W10-143_Tumor,,,,,,,,,,,,,,,
CNS_31_Tumor,S94-31062,L2DR04,TTCAGC,,100,,Jantima CNS,N14_4,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,S94-31062_Tumor,NA_S94-31062_Tumor,,,,,,,,,,,,,,,
CNS_33_Tumor,S02-23636A02,L2DR05,AAGACG,,100,,Jantima CNS,N14_5,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,S02-23636A02_Tumor,NA_S02-23636A02_Tumor,,,,,,,,,,,,,,,
CNS_34_Tumor,S02-33818A03,L2DR06,CCTCGG,,100,,Jantima CNS,N14_6,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,S02-33818A03_Tumor,NA_S02-33818A03_Tumor,,,,,,,,,,,,,,,
CNS_34_Normal,S02-33818A03,L2DR07,GGATGT,,80.8,,Jantima CNS,N14_7,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Normal,NimV2mix2,S02-33818A03_Normal,NA_S02-33818A03_Normal,,,,,,,,,,,,,,,
CNS_35_Tumor,S05-7439A12,L2DR08,TTCGCT,,100,,Jantima CNS,N14_8,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,S05-7439A12_Tumor,NA_S05-7439A12_Tumor,,,,,,,,,,,,,,,
CNS_36_Tumor,S05-41924,L2DR09,ACACGA,,100,,Jantima CNS,N14_9,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,S05-41924_Tumor,NA_S05-41924_Tumor,,,,,,,,,,,,,,,
CNS_37_Tumor,S06-47079A02,L2DR10,CACACA,,70.4,,Jantima CNS,N14_10,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,S06-47079A02_Tumor,NA_S06-47079A02_Tumor,,,,,,,,,,,,,,,
CNS_38_Tumor,S08-4544A03,L2DR11,GTGTTA,,100,,Jantima CNS,N14_11,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,S08-4544A03_Tumor,NA_S08-4544A03_Tumor,,,,,,,,,,,,,,,
CNS_39_Tumor,S10-26316A2,L2DR12,TGTGAA,,100,,Jantima CNS,N14_12,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,S10-26316A2_Tumor,NA_S10-26316A2_Tumor,,,,,,,,,,,,,,,
CNS_40_Tumor,S10-44069A4,L2DR13,ACAAAC,,100,,Jantima CNS,N14_13,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,S10-44069A4_Tumor,NA_S10-44069A4_Tumor,,,,,,,,,,,,,,,
CNS_41_Tumor,S11-38910A2,L2DR14,CACCTC,,100,,Jantima CNS,N14_14,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,S11-38910A2_Tumor,NA_S11-38910A2_Tumor,,,,,,,,,,,,,,,
Kit_192,KIT192,L2DR15,GTGGCC,,100,,Acral Mucosal,N14_15,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,KIT192_Tumor,NA_KIT192_Tumor,,,,,,,,,,,,,,,
Kit_203,KIT203,L2DR16,TGTTGC,,100,,Acral Mucosal,N14_16,Nimblegen14_BB17,BB17_SeqL,BB17_CL,Tumor,NimV2mix2,KIT203_Tumor,NA_KIT203_Tumor,,,,,,,,,,,,,,,
KR_166,KR_166,L2DR01,AAGGGA,,53.9,,Kate Rauen RASopathy cases,blood derived.,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_166_Tumor,NA_KR_166_Tumor,,,,,,,,,,,,,,,
KR_2064,KR_2064,L2DR02,CCTTCA,,74.2,,Kate Rauen RASopathy cases,blood derived,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_2064_Tumor,NA_KR_2064_Tumor,,,,,,,,,,,,,,,
KR_2030,KR_2030,L2DR03,GGACCC,,85.8,,Kate Rauen RASopathy cases,blood derived,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_2030_Tumor,NA_KR_2030_Tumor,,,,,,,,,,,,,,,
KR_177,KR_177,L2DR04,TTCAGC,,100,,Kate Rauen RASopathy cases,blood derived,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_177_Tumor,NA_KR_177_Tumor,,,,,,,,,,,,,,,
KR_150,KR_150,L2DR05,AAGACG,,100,,Kate Rauen RASopathy cases,blood derived,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_150_Tumor,NA_KR_150_Tumor,,,,,,,,,,,,,,,
KR_229,KR_229,L2DR06,CCTCGG,,54.1,,Kate Rauen RASopathy cases,blood derived,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_229_Tumor,NA_KR_229_Tumor,,,,,,,,,,,,,,,
KR_203,KR_203,L2DR07,GGATGT,,47.5,,Kate Rauen RASopathy cases,blood derived,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_203_Tumor,NA_KR_203_Tumor,,,,,,,,,,,,,,,
KR_8,KR_8,L2DR08,TTCGCT,,88.6,,Kate Rauen RASopathy cases,blood derived,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_8_Tumor,NA_KR_8_Tumor,,,,,,,,,,,,,,,
KR_5233,KR_5233,L2DR09,ACACGA,,100,,Kate Rauen RASopathy cases,blood,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_5233_Tumor,NA_KR_5233_Tumor,,,,,,,,,,,,,,,
KR_RMK0091B,KR_RMK0091B,L2DR10,CACACA,,100,,Kate Rauen RASopathy cases,skin,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_RMK0091B_Tumor,NA_KR_RMK0091B_Tumor,,,,,,,,,,,,,,,
KR_RMK0194C,KR_RMK0194C,L2DR11,GTGTTA,,100,,Kate Rauen RASopathy cases,Saliva-tube,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_RMK0194C_Tumor,NA_KR_RMK0194C_Tumor,,,,,,,,,,,,,,,
KR_RMK0137C,KR_RMK0137C,L2DR13,ACAAAC,,25,,Kate Rauen RASopathy cases,saliva | Barcode mismatch comment in note,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_RMK0137C_Tumor,NA_KR_RMK0137C_Tumor,,,,,,,,,,,,,,,
KR_RMK0162C,KR_RMK0162C,L2DR12,TGTGAA,,100,,Kate Rauen RASopathy cases,saliva | Barcode mismatch comment in note,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_RMK0162C_Tumor,NA_KR_RMK0162C_Tumor,,,,,,,,,,,,,,,
KR_RMK0168C,KR_RMK0168C,L2DR14,CACCTC,,67.1,,Kate Rauen RASopathy cases,saliva,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Tumor,NimV1mix2,KR_RMK0168C_Tumor,NA_KR_RMK0168C_Tumor,,,,,,,,,,,,,,,
21-5,10-41439,L2DR15,GTGGCC,,100,,Ivanka Normal Resequencing,,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Normal,NimV1mix2,10-41439_Normal,NA_10-41439_Normal,10-41439,A,"MELANOMA, 0.65 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",139524,172.5,"The nevus has a congenital pattern. The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, but has a mitotic figures in its dermal component. Therefore it should be classified as T1b per the 2009 revision of the AJCC staging system for melanoma. A superficial scar is also present. If this area was previously biopsied (we do not know of any in our files), the slides from it should be reviewed to make sure that the prognostic information above is correct.","Sections show a proliferation of melanocytes involving the epidermis, papillary and superficial reticular dermis. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, forming confluent nests, with no maturation and a mitotic figure among the dermal melanocytes.  Beneath this is a zone of paucicellular fibrosis, with horizontally oriented, closely apposed collagen bundles. Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis, in part around epithelial adnexal structures.",67,T1b,0.65,,Primary,,M,936014
24-5,11-23681A+C,L2DR16,TGTTGC,,74.6,,Ivanka Normal Resequencing,,Nimblegen15_BB18,BB18_SeqL,BB18_CL,Normal,NimV1mix2,11-23681A+C_Normal,NA_11-23681A+C_Normal,11-23681,A,"MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",132590,172.5,"Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.","Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",58,T4b,5.5,,Primary,3,F,1013119
DM_10_Tumor,DM10,L2DR01,AAGGGA,,80.6,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Tumor,NimV2mix2,DM10_Tumor,NA_DM10_Tumor,,,,,,,,,,,,,,,
DM_10_Normal,DM10,L2DR02,CCTTCA,,97.8,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Normal,NimV2mix2,DM10_Normal,NA_DM10_Normal,,,,,,,,,,,,,,,
DM_17_Tumor,DM17,L2DR03,GGACCC,,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Tumor,NimV2mix2,DM17_Tumor,NA_DM17_Tumor,,,,,,,,,,,,,,,
DM_17_Normal,DM17,L2DR04,TTCAGC,,31.3,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Normal,NimV2mix2,DM17_Normal,NA_DM17_Normal,,,,,,,,,,,,,,,
DM_18_Tumor,DM18,L2DR05,AAGACG,,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Tumor,NimV2mix2,DM18_Tumor,NA_DM18_Tumor,,,,,,,,,,,,,,,
DM_18_Normal,DM18,L2DR06,CCTCGG,,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Normal,NimV2mix2,DM18_Normal,NA_DM18_Normal,,,,,,,,,,,,,,,
DM_22_Tumor,DM22,L2DR07,GGATGT,,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Tumor,NimV2mix2,DM22_Tumor,NA_DM22_Tumor,,,,,,,,,,,,,,,
DM_22_Normal,DM22,L2DR08,TTCGCT,,12,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Normal,NimV2mix2,DM22_Normal,NA_DM22_Normal,,,,,,,,,,,,,,,
DM_23_Tumor,DM23,L2DR09,ACACGA,,10.3,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Tumor,NimV2mix2,DM23_Tumor,NA_DM23_Tumor,,,,,,,,,,,,,,,
DM_23_Normal,DM23,L2DR10,CACACA,,30.8,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Normal,NimV2mix2,DM23_Normal,NA_DM23_Normal,,,,,,,,,,,,,,,
DM_25_Tumor,DM25,L2DR11,GTGTTA,,24.5,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Tumor,NimV2mix2,DM25_Tumor,NA_DM25_Tumor,,,,,,,,,,,,,,,
DM_25_Normal,DM25,L2DR13,ACAAAC,,76.5,,"Hunter, Desmoplastic Melanoma",| Barcode mismatch comment in note,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Normal,NimV2mix2,DM25_Normal,NA_DM25_Normal,,,,,,,,,,,,,,,
DM_6_Tumor,DM6,L2DR12,TGTGAA,,90.1,,"Hunter, Desmoplastic Melanoma",| Barcode mismatch comment in note,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Tumor,NimV2mix2,DM6_Tumor,NA_DM6_Tumor,,,,,,,,,,,,,,,
DM_37_Tumor,DM37,L2DR14,CACCTC,,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Tumor,NimV2mix2,DM37_Tumor,NA_DM37_Tumor,,,,,,,,,,,,,,,
DM_93_Normal,DM93,L2DR15,GTGGCC,,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Normal,NimV2mix2,DM93_Normal,NA_DM93_Normal,,,,,,,,,,,,,,,
DM_93_cgn,DM93,L2DR16,TGTTGC,,45.7,,"Hunter, Desmoplastic Melanoma",,Nimblegen16_BB19,BB19_SeqL,BB19_CL,Tumor,NimV2mix2,DM93_Tumor,NA_DM93_Tumor,,,,,,,,,,,,,,,
SM_1_Tumor,SM_1,L2DR01,AAGGGA,,100,,Spitzoid Melanoma Maria,,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,SM_1_Tumor,NA_SM_1_Tumor,,,,,,,,,,,,,,,
SM_3_Tumor,SM_3,L2DR02,CCTTCA,,76.2,,Spitzoid Melanoma Maria,,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,SM_3_Tumor,NA_SM_3_Tumor,,,,,,,,,,,,,,,
SM_4_Tumor,SM_4,L2DR03,GGACCC,,95.2,,Spitzoid Melanoma Maria,,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,SM_4_Tumor,NA_SM_4_Tumor,,,,,,,,,,,,,,,
SM_4_Normal,SM_4,L2DR04,TTCAGC,,23.3,,Spitzoid Melanoma Maria,,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Normal,NimV2mix2,SM_4_Normal,NA_SM_4_Normal,,,,,,,,,,,,,,,
SM_5_Tumor,SM_5,L2DR05,AAGACG,,100,,Spitzoid Melanoma Maria,,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,SM_5_Tumor,NA_SM_5_Tumor,,,,,,,,,,,,,,,
SM_5_Normal,SM_5,L2DR06,CCTCGG,,100,,Spitzoid Melanoma Maria,,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Normal,NimV2mix2,SM_5_Normal,NA_SM_5_Normal,,,,,,,,,,,,,,,
SM7_Tumor,SM7,L2DR07,GGATGT,,100,,Spitzoid Melanoma Maria,,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,SM7_Tumor,NA_SM7_Tumor,,,,,,,,,,,,,,,
SM_8_Tumor,SM_8,L2DR08,TTCGCT,,98.4,,Spitzoid Melanoma Maria,,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,SM_8_Tumor,NA_SM_8_Tumor,,,,,,,,,,,,,,,
SM_11_Tumor,SM_11,L2DR09,ACACGA,,100,,Spitzoid Melanoma Maria,,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,SM_11_Tumor,NA_SM_11_Tumor,,,,,,,,,,,,,,,
SM_12_Tumor,SM_12,L2DR10,CACACA,,39.6,,Spitzoid Melanoma Maria,,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,SM_12_Tumor,NA_SM_12_Tumor,,,,,,,,,,,,,,,
SM_16_Tumor,SM_16,L2DR11,GTGTTA,,85.8,,Spitzoid Melanoma Maria,,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,SM_16_Tumor,NA_SM_16_Tumor,,,,,,,,,,,,,,,
SM_16_Normal,SM_16,L2DR13,ACAAAC,,100,,Spitzoid Melanoma Maria,| Barcode mismatch comment in note,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Normal,NimV2mix2,SM_16_Normal,NA_SM_16_Normal,,,,,,,,,,,,,,,
SM_18_Tumor,SM_18,L2DR12,TGTGAA,,100,,Spitzoid Melanoma Maria,| Barcode mismatch comment in note,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,SM_18_Tumor,NA_SM_18_Tumor,,,,,,,,,,,,,,,
DM_42_Tumor,DM42,L2DR14,CACCTC,,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,DM42_Tumor,NA_DM42_Tumor,,,,,,,,,,,,,,,
DM_43_Tumor,DM43,L2DR15,GTGGCC,,91.8,,"Hunter, Desmoplastic Melanoma",,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,DM43_Tumor,NA_DM43_Tumor,,,,,,,,,,,,,,,
DM_48_Tumor,DM48,L2DR16,TGTTGC,,44.8,,"Hunter, Desmoplastic Melanoma",,Nimblegen17_BB20,BB20_SeqL,BB20_CL,Tumor,NimV2mix2,DM48_Tumor,NA_DM48_Tumor,,,,,,,,,,,,,,,
CGH11_292,11-64496,L2DR01,AAGGGA,,100,,"ALK Iwei, Translocation","CGH11-292 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-64496_Tumor,NA_11-64496_Tumor,11-64496,A,"MOSTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES",123289,238.2,"The findings are equivalent to those published in the literature as atypical Spitz tumor. Lesions of this type are generally well circumscribed. In this case, the dermal and subcutaneous margins appear involved, and a narrow reexcision should be performed to prevent regrowth. My experience is that lesions of this type seldom recur with 5 mm margins. Involvement of local lymph nodes is common, but distant metastasis is rare. We obtained comparative genomic hybridization on this case. There is a clear cut loss involving chromosome 1p, without other aberrations. Certain chromosomal gains and losses are typical of melanoma, but this is not one of them. Idiosyncratic ones such as those seen here may occur in so-called atypical Spitz tumors. In general, Spitz's nevi have gains of 11p alone, 7q alone, or no aberrations. Hence, the results are intermediate, and although abnormal are not interpretable as melanoma.  Dr. Boris Bastian, my colleague who developed diagnostic comparative genomic hybridization also reviewed the results of this test and agrees with this interpretation of it.","Sections show a dome-surfaced, somewhat wedge-shaped proliferation of large fusiform melanocytes that extends from the junctional zone into the subcutis. The cellularity of the lesion is densest toward the base. The overlying epidermis has jagged rete ridges, is moderately thickened and contains foci in which there are increased numbers of single melanocytes, some above the basal layer, but is mostly uninvolved. Within the dermis, fascicles of cells with abundant eosinophilic cytoplasm and large, pleomorphic, vesicular nuclei that contain large nucleoli are present within fibrotic stroma. Clefts demarcate adjacent melanocytes from one another. Mitotic figures are rare, but at least one is present a short distance from the base of the lesion. The enclosed immunoperoxidase-stained sections include S100 and Melan-A stains that highlight the fascicular structure of the lesion, and HMB45 stain that shows some positivity throughout the entire thickness of the lesion, and a Ki-67 stain showing what appears to be an elevated proliferation rate (this is difficult to judge, as there are admixed lymphocytes).",5,,,,,,F,1053939
CGH11_305,11-71491,L2DR02,CCTTCA,,54.3,,"NTRK1 Iwei, Translocation","CGH11-305 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-71491_Tumor,NA_11-71491_Tumor,11-71491,A,"COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, CONSISTENT WITH A COMPOUND SPITZ NEVUS",173531,238.2,"This melanocytic proliferation shows some Spitz nevus-like attributes but also some unconventional features, including partial loss of p16 expression and occasional dermal melanocytes in mitosis. In light of this, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies as an additional step in assessment. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal copy number gains or losses. The vast majority of melanomas analyzed by aCGH have associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack demonstrable aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. I continue to favor an unconventional Spitz nevus as the best interpretation of this tumor, which appears excised in the available planes of section.","Sections show enlarged slightly spindled and epithelioid melanocytes arrayed in compound fashion. There is good lateral demarcation and slight asymmetry. Single melanocytes and nests and fascicles of melanocytes are apparent along the junction in concert with epidermal hyperplasia, and some junctional fascicles have encompassing myxoid stroma. There are partially-maturing nests and cords of epithelioid melanocytes in the dermis below this, and cells in mitosis can occasionally be found. A sparse and patchy juxtaposed lymphocytic infiltrate is also noted.",22,,,,,,F,1060934
CGH11_310,11-65756,L2DR03,GGACCC,,54,,"ALK Iwei, Translocation","CGH11-310 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-65756_Tumor,NA_11-65756_Tumor,11-65756,A,SPITZOID MELANOMA,173649,172.6,"I agree with the considerations noted in your report. Given the clinical setting, we obtained comparative genomic hybridization. This shows multiple chromosomal aberrations, which in concert with the histopathologic findings favor interpretation as a spitzoid melanoma rather than as an unusual Spitz's nevus. These aberrations include losses involving most of chromosome 2 (with a gain of a smaller focus in the same chromosome), and gains involving chromosome 7q, 9p, 17q and 19p. Finding gains and losses in the same chromosome, as in chromosome 2 in this case is particularly suggestive of melanoma, as is the sheer number of aberrations; both point to a high degree of genomic instability. Some of the aberrations seen in this case are idiosyncratic (such as the gain in 9p; 9p is usually lost in melanoma) while others are characteristic of melanomas in adults (such as the gain in 7q). The lesion measures 2.2 mm in thickness, and may prove to be thicker on complete excision. Lesions of this type often involve sentinel lymph nodes, but the predictive value vis-a-vis extranodal metastatic spread is limited. If there are interesting or unusual findings in the reexcision specimen, I would be interested in viewing the sections as part of this consultation.","Sections show a somewhat asymmetrical, dome-surfaced proliferation of melanocytes with irregular epidermal hyperplasia in some areas and a relatively thin epidermis in others. Jagged rete ridges, hypergranulosis and a mixture of lamellar hyperkeratosis and compact hyperkeratosis are present. Extending from the junctional zone to the base of the specimen in the superficial reticular dermis are variably confluent nests of large oval melanocytes with striking nuclear pleomorphism. Both large vesicular nuclei with large central nucleoli and hyperchromatic nuclei are present. Some maturation with descent is evident, and the aggregations near the base of the specimen are considerably smaller than those situated more superficially. Many multinucleated melanocytes are also seen. The accompanying immunoperoxidase-stained sections include a p16 stain in which most of the cells fail to react. Among the minority which are positive, a disproportionate number are multinucleated.",2,,,,,,M,1055199
CGH11_319,11-74100,L2DR04,TTCAGC,,100,,"NTRK1 Iwei, Translocation","CGH11-319 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-74100_Tumor,NA_11-74100_Tumor,11-74100,A,"COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, CONSISTENT WITH AN UNCONVENTIONAL COMPOUND SPITZ NEVUS",133559,238.2,"Based upon conventional microscopical attributes, I favored interpretation as an unconventional Spitz nevus occurring in adulthood, although I understand that your group viewed this possibility as improbable. In light of this ambiguous diagnostic situation, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal gains or losses. As you know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced clear support for a diagnosis of melanoma. Rather, I believe this melanocytic proliferation represents an unconventional melanocytic nevus. This process is transected at the periphery of the current specimen. In light of this, further excision is recommended to ensure that local eradication has been accomplished.","Sections show enlarged slightly spindled and epithelioid melanocytes arrayed in compound fashion. There are single melanocytes and nests and fascicles of melanocytes within the epidermis, which is partially acanthotic and hyperkeratotic, and limited intraspinous scatter is noted. There are also many small pink globules within the epidermis. The dermis below this holds maturing nests and fascicles in concert with fibrosis, and a juxtaposed sparse lymphohistiocytic infiltrate is also  noted.",36,,,,,,M,1063547
CGH11_348,11-74517,L2DR05,AAGACG,,60.2,,"NTRK1 Iwei, Translocation","CGH11-348 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-74517_Tumor,NA_11-74517_Tumor,11-74517,A,"SPITZOID MELANOMA, CHILDHOOD TYPE",173304,173.3,"The findings are not those of a conventional Spitz's nevus. The thinned epidermis, mitotic rate and large, confluent nests in the superficial part of the lesion are all worrisome features. Comparative genomic hybridization shows multiple chromosomal losses including 8p, 9, 14 and 16. Several of these, most notably 8p and 9 are commonly lost in melanoma. Given these findings, despite the age of the patient, I believe that this lesion is best viewed as a spitzoid melanoma of childhood. I use this term for an emerging class of lesions that have a spitzoid morphology and a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. This makes sentinel lymph node biopsy less predictive than in adult melanoma. The thickness in this case is at least 1.8 mm as the lesion is transected. Thickness and prognosis are also not coupled in the same manner as in adult melanoma and the prognosis is also considerably better than with an adult lesion of the same thickness. Also, lesions of this type tend to be well circumscribed and excision margins can be considerably less.","There is a dome-surfaced proliferation of large oval melanocytes involving both the junctional zone of a thinned epidermis and the superficial dermis beneath it. Nests predominate over single cells along the junction. The lesional cells have abundant amphophilic cytoplasm and large oval vesicular nuclei with relatively small nucleoli. Many superficial dermal nests are extensively confluent or oddly shaped, and many mitotic figures are present, some of them atypical. Smaller nests composed of more mature-appearing and less mitotically active cells are evident toward the base of the lesion.",7,,,,,,M,1063964
CGH10-028,10-74513,L2DR06,CCTCGG,,100,," Iwei, 7QGain","CGH10-028 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,10-74513_Tumor,NA_10-74513_Tumor,10-74513,A,"MELANOMA OF AT LEAST 1.4 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY",173508,172.5,"Our differential diagnosis included a hypercellular Spitz nevus on one hand and spitzoid melanoma on the other, and the latter possibility proves to represent the correct classification for this tumor. To more fully establish the nature of this process, we completed comparative genomic hybridization via an array methodology (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gains in chromosomes 1q, 6p, 7, and 19, and losses in chromosomes 6q, 9, and 16q were also apparent. The documentation of multiple chromosomal anomalies is strongly supportive of the above diagnosis of melanoma. The above microstage thickness measurement is provisional and should be revised once complete excision has been accomplished. This melanoma is nonulcerated and shows associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show a domed, hypercellular compound proliferation of slender spindled melanocytes distributed as irregular fascicles in compound fashion. The background epidermis is acanthotic in irregular fashion. Toward one edge of the specimen, vertically-oriented and incompletely-maturing fascicles of said melanocytes can be seen, and the dermis encompassing them is coarse and vascularized. Within large fascicles, occasional juxtaposed neutrophils, occasional single necrotic melanocytes, and occasional melanocytes in mitosis can be found. Toward one edge of the specimen, there is an area of lesser cellularity that shows a greater degree of maturation with descent.",44,,1.4,,,,F,969092
CGH10-045,10-80009,L2DR07,GGATGT,,100,," Iwei, 7QGain","CGH10-045 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,10-80009_Tumor,NA_10-80009_Tumor,10-80009,A,"PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES",173525,238.2,"The enclosed images appear to show a relatively low Ki-67 labeling rate in a two-color immunoperoxidase stain (some positive nuclei are present in the enclosed Ki-67 stain, but it is difficult to evaluate how many are in melanocytes). I agree that this lesion has several features that push the limits for the diagnosis of Spitz's nevus, including a relatively thin epidermis, above-average nuclear pleomorphism and the presence of several deep mitotic figures. There are many dermatopathologists who would classify this as a so-called atypical Spitz tumor, a diagnostic term that is, unfortunately, used in different ways by different observers. However, it captures the sense that the lesion does not conform to the standard features of a Spitz's nevus, but does not have sufficiently atypical findings for an outright diagnosis of melanoma. Comparative genomic hybridization with an array based method shows an isolated gain involving the terminal end of 7q. This aberration, when seen without other gains or losses usually occurs in benign lesions (similar to gains of 11p). Hence, an unusual Spitz's nevus is the most likely finding. A narrow re-excision would still be appropriate.","There is a dome-surfaced proliferation of large oval melanocytes involving the junctional zone, a thickened papillary dermis and the upper portion of the reticular dermis centered around a folliculosebaceous unit. The lesion is relatively symmetrical, and well circumscribed. Only a few junctional nests are present, with slightly increased numbers of single melanocytes, mostly over the apex of the lesion. The superficial dermal portion of the proliferation consists of cells with abundant amphophilic cytoplasm and pleomorphic, vesicular nuclei, some of which have large and/or multiple nucleoli. Somewhat smaller cells are seen in smaller aggregations toward the base of the lesion. Several deep mitotic figures are evident, including one within a high power microscopic field of the deep edge of the lesion (a so-called marginal mitosis).",7,,,,,,M,974588
CGH10-062,10-91484,L2DR08,TTCGCT,,100,," Iwei, 7QGain","CGH10-062 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,10-91484_Tumor,NA_10-91484_Tumor,10-91484,A,"MELANOMA OF 1.1 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION",173765,172.7,"My differential diagnosis included a peculiar melanocytic nevus on one hand and melanoma on the other, and I believe the latter possibility represents the best interpretation of this atypical melanocytic proliferation. To more fully evaluate this tumor, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated clear loss of chromosome 9 with possible gain in chromosomes 5 and 7. (Because of a technical shortcoming, we repeated the molecular analysis; I apologize for the delay this provoked.) Loss in chromosome 9 is a common molecular event in association with melanoma and lends support to the above interpretation. This melanoma is non-ulcerated and displays associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show an asymmetrical, incompletely circumscribed, compound proliferation of enlarged spindled and epithelioid melanocytes with finely melanized cytoplasm. Within the background epidermis, which is slightly acanthotic, there are single melanocytes and nests distributed nearly confluently, and prominent suprabasal scatter is appreciable. In the dermis below this, there are partially-maturing nests, cords, and syncytia of cytologically similar melanocytes, and scattered dermal melanophages and lymphocytes can also be seen.",25,,1.1,,,,F,986063
CGH11-011,11-699,L2DR09,ACACGA,,100,," Iwei, 7QGain","CGH11-011 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-699_Tumor,NA_11-699_Tumor,11-699,A,"INTRADERMAL PROLIFERATION OF LARGE, SOMEWHAT SPITZOID MELANOCYTES",174789,238.2,"Comparative genomic hybridization shows an area of loss involving the long arm of chromosome 7, with a gain of the distal portion of the long arm of chromosome 7. The data from this case has been forwarded to Dr. Boris Bastian to try to determine where the breakpoint in this aberrant area is. There is also an area of loss in the terminal portion of chromosome 16q. The findings favor classification as melanoma. Given the monomorphous nuclei and the age of the patient, this may represent a variant with a prognosis different from that which would be inferred by the lesional thickness.","Sections show acral skin with a deep dermal and subcutaneous fibrotic mass containing nests of melanocytes with abundant amphophilic cytoplasm and moderately enlarged oval vesicular nuclei, some of which are diffusely hyperchromatic. There are scattered pyknotic nuclei. Mitotic figures appear rare.",6,,,,,,F,990136
CGH11-072,11-18560,L2DR10,CACACA,,100,," Iwei, 7QGain","CGH11-072 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-18560_Tumor,NA_11-18560_Tumor,11-18560,A,"MELANOMA OF 0.7 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION",133596,172.5,"Our differential diagnosis included a fibrotic dysplastic nevus on one hand and nevoid melanoma on the other, and based solely upon conventional microscopy I favored the latter possibility as most likely. In an effort to provide a more definitive analysis of this proliferation, we completed array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosome 6p and loss in chromosome 7q. The gain in chromosome 6p includes the location of the RREB1 gene, and mutations in RREB1 are common to melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH has confirmed a diagnosis of melanoma. With respect to staging, this melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage T1a per the 2009 revision of the AJCC staging system. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show a broad, incompletely circumscribed compound proliferation of melanocytes. Within the epidermis, which is psoriasiform in some areas and thinned in others, there are single melanocytes and nests distributed broadly. Many of these melanocytes are arrayed in lentiginous fashion along the sides and bases of rete ridges, and limited scatter of melanocytes into the stratum spinosum can also be seen. In fibrotic perijunctional dermis below this, there are partially-maturing nests, cords, and fascicles of similar melanocytes. Many melanocytes, both epidermal and dermal, have scant finely melanized cytoplasm. In the upper dermis, scattered melanophages can be seen. There is also an element of reticular dermal elastosis.",60,T1a,0.7,,Primary,,M,1007998
CGH11-087,11-20772,L2DR11,GTGTTA,,100,," Iwei, 7QGain","CGH11-087 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-20772_Tumor,NA_11-20772_Tumor,11-20772,A,"COMPOUND PROLIFERATION OF LARGE SPINDLED AND EPITHELIOID MELANOCYTES, GENOMICALLY MELANOMA, AT LEAST 3.9 MM IN THICKNESS, EXTENDING TO THE SPECIMEN BASE",173719,172.7,"Thank you for your kind accompanying letter. I agree with you that while a Spitz's nevus seemed possible in initial sections, there are some unconventional features, and rare mitoses are evident in the dermal component, raising the possibility of Spitzoid melanoma. The enclosed Ki-67 immunoperoxidase stains indicates a low proliferation index, however. As you suggested, we performed comparative genomic hybridization to determine whether this tumor contains clonal DNA copy number changes that may be of value in the differential diagnosis. This reveals multiple aberrations, including losses or gains affecting nearly all of chromosomes 7, 8, and 9, and gains on chromosome 5. These results strongly support a diagnosis of melanoma. Of note is that none of these aberrations would have been detected via fluorescence in situ hybridization, and these aberrations are not those associated with spitzoid melanoma of childhood. I have shared this case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with this diagnosis. Histopathologic features of possible prognostic importance include the following. Definitive assessment of prognostic features should be deferred to the excision specimen.  Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: greater than 1/sq mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: cannot assess AJCC stage: T3a preliminary","Sections show a sessile polypoid compound proliferation of large spindled and epithelioid melanocytes, the sparse junctional component of which is arrayed with the lowermost sections of an epithelium that is slightly acanthotic and hyperkeratotic. The dermal component contains similar melanocytes in clusters and sheets. There are rare mitotic figures. The papillary dermis is edematous.",29,T3a,3.9,,Primary,,F,1010210
CGH11-089,11-19877,L2DR13,ACAAAC,,100,," Iwei, 7QGain","CGH11-089 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-19877_Tumor,NA_11-19877_Tumor,11-19877,A,"MELANOMA, 1.1 MM IN THICKNESS",173688,172.6,,"Sections show a predominantly dermal proliferation of melanocytes partially encompassed by epithelial collarettes, with a protuberant configuration. The lesional melanocytes are arranged in discrete nests, cords and strands. Most are plump, oval to small round melanocytes that mature with descent, with a minor population of melanocytes with large, oval vesicular nuclei and more prominent nucleoli.",49,,1.1,,,,F,1009315
CGH11-147,11-35616,L2DR12,TGTGAA,,100,," Iwei, 7QGain","CGH11-147 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-35616_Tumor,NA_11-35616_Tumor,11-35616,A,SPITZOID MELANOMA EXCEEDING 6 MM IN THICKNESS,173712,172.7,"We completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies, per your request. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrates possible loss in distal chromosome 4p and loss in chromosomes 7q and 11 (in actual fact, there are both gains and losses in chromosome 7q; the observed pattern is quite exceptional). There is gain in chromosomes 5p, 8, 9p, 14p, and 20. The presence of multiple chromosomal copy number changes corroborates the above diagnosis of melanoma. Given the number and diversity of the chromosomal aberrations that have been found, the more favorable prognosis that is associated with so-called childhood-type spitzoid melanoma cannot be expected here. I do not have the full thickness of this melanoma apparent in the sections available to me, and thus the above thickness measurement is provisional. This melanoma invades deep into the subcutis and approaches superficial skeletal muscle.","Sections show a sizable, deeply-situated, multinodular dermal and subcutaneous proliferation of enlarged slightly spindled and epithelioid melanocytes, some of which have finely melanized cytoplasm. Others have amphophilic cytoplasm. Gargantuan collections of cells are enmeshed in a sclerotic backdrop in concert with a juxtaposed lymphohistiocytic infiltrate, and melanocytes in mitosis can be found.",17,,6,,,,F,1025054
CGH11-158,11-33856,L2DR14,CACCTC,,100,," Iwei, 7QGain","CGH11-158 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-33856_Tumor,NA_11-33856_Tumor,11-33856,A,"COMPOUND SPITZOID NEOPLASM, CONSISTENT WITH A DESMOPLASTIC COMPOUND SPITZ NEVUS",173600,238.2,"Our differential diagnosis for this proliferation included an unconventional Spitz nevus on one hand and melanoma on the other. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show increased nuclear expression of Ki-67, especially in the upper dermis, thus implying that cellular proliferation is elevated. This staining result was of potential concern but is not diagnostically decisive. In light of diagnostic ambiguity, we next pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosome 11p. A small segmental loss in chromosome 14q was also noted. Gain in chromosome 11p is commonly found as an aberration in desmoplastic Spitz tumors with associated HRAS mutation.  In summary, the combination of results derived from conventional microscopy coupled with aCGH analysis points to interpretation as an unconventional (HRAS-mutated) Spitz nevus. This proliferation is focally transected at the periphery of the current specimen. Further excision is recommended to ensure that local eradication has been accomplished.  A pertinent reference can be found at the following citation: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.","Sections show a broad, somewhat asymmetrical, and incompletely circumscribed compound proliferation of enlarged slightly spindled and epithelioid melanocytes. Only small numbers of melanocytes are distributed along the junction. Within the dermis, there are nests, cords, and fascicles of melanocytes that are similar to those seen intraepidermally, and these cells are entrapped in a coarse collagenous matrix. In some areas, a subjacent lymphohistiocytic infiltrate can be seen, and some of the dermal melanocytes have fine cytoplasmic melanization. Only an occasional melanocyte in mitosis can be found.",29,,,,,,M,1023294
CGH11-166,11-38771,L2DR15,GTGGCC,,100,," Iwei, 7QGain","CGH11-166 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-38771_Tumor,NA_11-38771_Tumor,11-38771,A,"MELANOMA OF 1.75 MM IN THICKNESS, FOCALLY TRANSECTED AT THE SPECIMEN PERIPHERY",173713,172.7,"Based upon conventional microscopy, I believe this proliferation represents melanoma. Per your request, we completed array-based comparative genomic hybridization (aCGH) to screen this tissue for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated focal gain in chromosome 1p, gain in chromosome 7q, and losses in chromosomes 1p, distal 1q, 2p, and 14q. As you know, the identification of multiple genomic gains and losses is incompatible with a diagnosis of melanocytic nevus and points squarely to a diagnosis of melanoma. Given the number of aberrations that are present here, I believe this malignancy represents conventional melanoma and not a form of childhood-type melanoma. This melanoma is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show enlarged epithelioid melanocytes arrayed in compound fashion. Within the acanthotic epidermis, single melanocytes and nests that vary in size can be seen. Non-maturing nests, small syncytia, and cords can be seen in fibrotic upper dermis, and some of these melanocytes are captured in mitosis. The background epidermis, while generally acanthotic, is focally thinned.",17,,1.75,,,,F,1028210
CGH11-172,11-39639,L2DR16,TGTTGC,,100,," Iwei, 7QGain","CGH11-172 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)",Nimblegen18_BB21,BB21_SeqL,BB21_CL,Tumor,NimV2mix2,11-39639_Tumor,NA_11-39639_Tumor,11-39639,A,"MELANOMA, 1.2 MM. IN THICKNESS",173721,172.7,"The neoplasm extends to the base of the specimen. Comparative genomic hybridization shows losses involving chromosomes 7p and 9q. Such focused gains or losses, involving only parts of chromosomes rather than whole ones are not seen in so-called proliferating nodules in congenital nevi. Chromosome 9 losses are common in melanoma. The small size of the cells indicates that this is a nevoid or small cell melanoma. The latter is one of the few forms of melanoma that can occur in children. The configuration suggests that this lesion will be (after complete excision) less than 2 mms, and is most likely T2a in the 2009 AJCC staging schema for melanoma.","Sections show a dome shaped segment of skin with a few well formed junctional nests of melanocytes with abundant, pale cytoplasm and pleomorphic, heterochromatic nuclei, and irregularly shaped aggregations of similar cells, as well as ones with scant cytoplasm in the subjacent dermis. These are positioned between collagen bundles in the superficial reticular dermis toward the base of the lesion. The nuclei are crowded together in some foci. The enclosed immunoperoxidase stains show that no melanocytic nuclei are positive for the mitotic marker, phosphohistone H3.",11,T2a,1.2,,Primary,,M,1029078
CGH10-058,10-88482,L2DR04,TTCAGC,,,,"Iwei CGH, Translocation",CGH10-058 NTRK3,WGS1_BB22,BB22_SeqL,BB22_CL,Tumor,WGSnone,10-88482_Tumor,NA_10-88482_Tumor,10-88482,A,"DESMOPLASTIC MELANOMA, 3.8 MM. IN THICKNESS",173610,238.2,"There are conflicting findings, as noted in your cover letter. The architectural features of the lesion could well be those of a Spitz's nevus, but the setting, in an older patient, in severely sun-damaged skin with, and presence of deep mitotic figures is worrisome. A p16 stain is positive in about 30% of lesional nuclei. Testing with comparative genomic hybridization shows a gain involving much of the long arm of chromosome 15 (15q), and one involving 22q. Although these are not among the very most commonly affected loci in melanoma, gains in both of these areas are seen in a proportion of typical melanomas.  The lesion extends to within 1 mm of the margin in the reticular dermis. It is not ulcerated, and hence is a T3a primary melanoma in the 2009 AJCC staging schema for melanoma.","Sections show markedly sun-damaged skin with a well-circumscribed, wedge-shaped to somewhat rectangular proliferation of melanocytes that mostly involves the dermis. Most of the proliferation is embedded in markedly fibrotic stroma, which displaces the elastotic material. There are large nests of large oval melanocytes superficially. These cells have pale amphophilic cytoplasm with large, relatively monomorphous vesicular nuclei. The aggregates, the cells themselves and the sizes of their nuclei diminish with descent. Although the enclosed Ki-67 double-stained sections show a very low proliferative rate, a mitotic figure is present within a high power field of the base of the specimen.",74,,,,,,M,983061
CGH11-035,11-5482,L2DR09,ACACGA,,,,"Iwei CGH, Translocation",CGH11-035 MET,WGS1_BB22,BB22_SeqL,BB22_CL,Tumor,WGSnone,11-5482_Tumor,NA_11-5482_Tumor,11-5482,A,"CHILDHOOD-TYPE SPITZOID MELANOMA OF AT LEAST 4.0 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY",192799,172.7,"I believe this proliferation represents childhood-type spitzoid melanoma not a peculiar or atypical Spitz nevus. To further substantiate this interpretation, we completed comparative genomic hybridization via array methodology (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis revealed gain in chromosomes 7q and 12p. The presence of multiple chromosomal gains is not known to occur in Spitz nevi and favors instead the above interpretation. The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination.  This tumor is transected at the deep edge of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show an exophytic, eroded compound proliferation of enlarged spindled and epithelioid melanocytes. Intraepidermally, these cells are distributed in concert with marked epidermal hyperplasia. At the junction, there are cellular nests and fascicles of melanocytes that often hold a vertical orientation, and some large nests show central necrosis en masse within them. There are cellular fascicles, cords, and nests of cytologically similar melanocytes that descend into the dermis below this, where partial maturation with descent is appreciable. Dermal melanocytes in mitosis or single necrotic melanocytes are easily found. A juxtaposed sparse lymphohistiocytic infiltrate is apparent within fibrotic peritumoral dermis.",15,,4.0,,,,F,994919
CGH11-194,11-31904,L2DR15,GTGGCC,,,,"Iwei CGH, Translocation",CGH11-194 BRAF,WGS1_BB22,BB22_SeqL,BB22_CL,Tumor,WGSnone,11-31904_Tumor,NA_11-31904_Tumor,11-31904,A,"MELANOMA, 2.65 MM. IN THICKNESS",139522,172.5,"While the pattern at scanning magnification suggested a Spitz's nevus, there were several worrisome morphologic features, including striking confluence of junctional nests, some pagetoid scatter and a so-called marginal mitosis (see microscopic description below). We therefore performed comparative genomic hybridization. This shows a gain involving a discrete area of 7p near its terminal end, a loss involving part of 7q and a gain involving the terminal end of 7q. Gains and losses within the same chromosome reflect severe genetic damage, and in this context favor melanoma. Furthermore, gains involving all, or part of chromosome 7 are common in melanoma.  Given the lack of ulceration, this is a T3a primary lesion in the 2009 AJCC staging schema for melanoma.","There is a broad-based  proliferation of melanocytes involving the epidermis and papillary dermis. There is irregular epidermal hyperplasia with a thick granular and a compact cornified layer. Situated along the junction are confluent nests of large oval melanocytes with pleomorphic, vesicular nuclei. Some pagetoid scatter is present, largely in the center of the lesion. Smaller aggregates of smaller cells are evident in the subjacent dermis. There are rare mitotic figures, one in a melanocyte at the lower edge of the lesion (a so-called marginal mitosis). There are focally dense lymphocytic infiltrates.",39,T3a,2.65,,Primary,,F,1021342
CGH11-252,11-61046,L2DR01,AAGGGA,,,,"Iwei CGH, Translocation",CGH11-252 NTRK3,WGS1_BB22,BB22_SeqL,BB22_CL,Tumor,WGSnone,11-61046_Tumor,NA_11-61046_Tumor,11-61046,A,INTRADERMAL PROLIFERATION OF ENLARGED SPINDLED MELANOCYTES,173439,238.2,"We believe this proliferation falls on the spectrum of a pigmented spindle cell nevus (or plexiform spindle cell nevus). To further assess its nature, we completed immunoperoxidase staining. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show low nuclear expression of Ki-67, thus implying that cellular proliferation is very low, which is reassuring but not definitive. There is also general preservation of p16 expression, which also lends support to a benign interpretation. To definitively assess the nature of this tumor, we also completed array-based comparative genomic hybridization (aCGH), with your approval. This approach was utilized to screen this tumor tissue for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a small segmental loss of chromosome 15q and a small segmental gain in chromosome 19p. Neither of these small aberrations is known to be associated with melanoma. Most melanomas demonstrate multiple chromosomal copy number gains and losses when assessed via aCGH, and this was not apparent in this instance.  In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as an unconventional pigmented spindle cell nevus. This is a most unusual melanocytic proliferation, and we utilized sophisticated techniques to evaluate its nature. Further excision is recommended ensure that local eradication has been accomplished and that persistence cannot ensue.","Sections show a proliferation of large spindled melanocytes arrayed in the dermis as coalescing fascicles that form a larger sessile nodule. There is partial maturation with descent. Many of the constituent melanocytes have finely melanized cytoplasm. Superficially, there is perijunctional fibrosis. The superjacent epidermis is thinned. There are melanophages scattered in the upper dermis as well.",16,,,,,,F,1050489
SM_2_Tumor,08-27590,L2DR01,AAGGGA,,57.6,,Spitzoid Melanoma,,Nimblegen19_BB23,BB23_SeqL,BB23_CL,Tumor,NimV2mix3,08-27590_Tumor,NA_08-27590_Tumor,08-27590,A,"MELANOMA, ABOUT 3 MILLIMETERS IN THICKNESS IN THESE SECTIONS",173740,172.7,"Both Dr. McCalmont and I favor melanoma over a Spitz's nevus; neither of can rule out melanoma arising in a Spitz's nevus (this diagnosis can be difficult to prove!). The central portion of the lesion is ulcerated, has a thin epidermis, is surrounded by epithelial collarettes and contains melanocytes with striking nuclear atypia, even in the lower half of the lesion. The nests in this area are strikingly confluent. The peripheral part of the lesion resembles a Spitz's nevus, with smaller cells in discrete nests along the dermo-epidermal junction, and some Kamino bodies (highlighted in the PAS stain). The thickness of 3.8 mm. may have been established on examination of a different slide from this one.",See above.,24,,3,,,,F,736231
SM_2_Normal,08-27590,L2DR02,CCTTCA,,10.2,,Spitzoid Melanoma,,Nimblegen19_BB23,BB23_SeqL,BB23_CL,Normal,NimV2mix3,08-27590_Normal,NA_08-27590_Normal,08-27590,A,"MELANOMA, ABOUT 3 MILLIMETERS IN THICKNESS IN THESE SECTIONS",173740,172.7,"Both Dr. McCalmont and I favor melanoma over a Spitz's nevus; neither of can rule out melanoma arising in a Spitz's nevus (this diagnosis can be difficult to prove!). The central portion of the lesion is ulcerated, has a thin epidermis, is surrounded by epithelial collarettes and contains melanocytes with striking nuclear atypia, even in the lower half of the lesion. The nests in this area are strikingly confluent. The peripheral part of the lesion resembles a Spitz's nevus, with smaller cells in discrete nests along the dermo-epidermal junction, and some Kamino bodies (highlighted in the PAS stain). The thickness of 3.8 mm. may have been established on examination of a different slide from this one.",See above.,24,,3,,,,F,736231
SM_6_Tumor,06-32942,L2DR03,GGACCC,,69.8,,Spitzoid Melanoma,,Nimblegen19_BB23,BB23_SeqL,BB23_CL,Tumor,NimV2mix3,06-32942_Tumor,NA_06-32942_Tumor,06-32942,A,"MELANOMA OF 3.3 MM IN THICKNESS, FOCALLY TRANSECTED AT THE DEEP BIOPSY MARGIN",222533,172.5,"In terms of staging, this is a focally ulcerated melanoma with a nodular invasive component, with extensive involvement of the reticular dermis (Clark's level IV). I do not see any evidence of vascular invasion, perineural extension, or regression. Further re-excision of this site is of course warranted to be certain that local eradication has been accomplished.","Sections show a broad, asymmetrical, compound proliferation of large and strikingly atypical spindled melanocytes, extensively involving both epidermis and dermis. Along the junction, there are nests and fascicles of melanocytes disposed erratically and somewhat confluently, and many intraepidermal nests are large and irregular. There are confluent nests and fascicles of melanocytes distributed throughout the upper reticular dermis, with little maturation with dermal descent and with dermal mitotic figures readily identifiable. The background epidermis is acanthotic and hyperkeratotic and is centrally partially ablated by ulceration, with superjacent exudate and crust.",36,,3.3,,,,F,578011
SM_7_Tumor,06-52508,L2DR04,TTCAGC,,62.5,,Spitzoid Melanoma,,Nimblegen19_BB23,BB23_SeqL,BB23_CL,Tumor,NimV2mix3,06-52508_Tumor,NA_06-52508_Tumor,06-52508,A,"MELANOMA, APPROXIMATELY 0.5 MM IN THICKNESS, WITH MELANOMA IN SITU EXTENDING CLOSE TO PERIPHERAL MARGINS",173536,172.5,"This neoplasm has some cytologic and architectural features in common with a Spitz's nevus. However, atypical melanocytes are focally confluent, there is significant adnexal extension, as well as significant suprabasal scatter of melanocytes. These changes are in keeping with melanoma. In addition, it appears in slightly sun-damaged skin. In terms of staging, this is a thin primary melanoma, non-ulcerated, of Clark's anatomic level II. The dermis is partially obscured by a dense lichenoid infiltrate, and the thickness above is my best judgment in this context. There is no evidence of neurotropism, vascular invasion, or regression in these sections. Complete reexcision is of course warranted. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with the diagnosis of melanoma.","Sections show an asymmetrical, compound proliferation of melanocytes, many of which have atypical nuclei, many of them with a spindled configuration. There is adnexal extension, focal confluence of junctional melanocytes, and also, adnexal extension. Suprabasal scatter of melanocytes is also present. There are irregular clusters of similar melanocytes in the underlying dermis. There is a bandlike infiltrate of lymphocytes in the papillary dermis. The overlying epidermis is thickened and hyperkeratotic.",63,,0.5,,,,M,597577
SM_7_Normal,06-52508,L2DR05,AAGACG,,39,,Spitzoid Melanoma,,Nimblegen19_BB23,BB23_SeqL,BB23_CL,Normal,NimV2mix3,06-52508_Normal,NA_06-52508_Normal,06-52508,A,"MELANOMA, APPROXIMATELY 0.5 MM IN THICKNESS, WITH MELANOMA IN SITU EXTENDING CLOSE TO PERIPHERAL MARGINS",173536,172.5,"This neoplasm has some cytologic and architectural features in common with a Spitz's nevus. However, atypical melanocytes are focally confluent, there is significant adnexal extension, as well as significant suprabasal scatter of melanocytes. These changes are in keeping with melanoma. In addition, it appears in slightly sun-damaged skin. In terms of staging, this is a thin primary melanoma, non-ulcerated, of Clark's anatomic level II. The dermis is partially obscured by a dense lichenoid infiltrate, and the thickness above is my best judgment in this context. There is no evidence of neurotropism, vascular invasion, or regression in these sections. Complete reexcision is of course warranted. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with the diagnosis of melanoma.","Sections show an asymmetrical, compound proliferation of melanocytes, many of which have atypical nuclei, many of them with a spindled configuration. There is adnexal extension, focal confluence of junctional melanocytes, and also, adnexal extension. Suprabasal scatter of melanocytes is also present. There are irregular clusters of similar melanocytes in the underlying dermis. There is a bandlike infiltrate of lymphocytes in the papillary dermis. The overlying epidermis is thickened and hyperkeratotic.",63,,0.5,,,,M,597577
SM_8_Tumor,07-04365,L2DR06,CCTCGG,,60.4,,Spitzoid Melanoma,,Nimblegen19_BB23,BB23_SeqL,BB23_CL,Tumor,NimV2mix3,07-04365_Tumor,NA_07-04365_Tumor,07-04365,A,,,,,,,,,,,,,
SM_8_Normal,07-04365,L2DR07,GGATGT,,35.5,,Spitzoid Melanoma,,Nimblegen19_BB23,BB23_SeqL,BB23_CL,Normal,NimV2mix3,07-04365_Normal,NA_07-04365_Normal,07-04365,A,,,,,,,,,,,,,
SM_9_Tumor,07-14044A,L2DR08,TTCGCT,,68.9,,Spitzoid Melanoma,,Nimblegen19_BB23,BB23_SeqL,BB23_CL,Tumor,NimV2mix3,07-14044A_Tumor,NA_07-14044A_Tumor,07-14044,A,"MELANOMA, 1.2 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS CLOSE TO THE PERIPHERAL MARGIN",173601,172.6,"Although there are some features reminiscent of a Spitz's nevus, this is a markedly asymmetrical and poorly circumscribed neoplasm. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level IV, expanding the papillary dermis and involving the superficial reticular dermis. There is no evidence of vascular invasion, neurotropism, or regression. Complete excision is of course warranted.","Sections show an asymmetrical, poorly circumscribed, compound proliferation of melanocytes, many of which have atypical nuclei. There are irregular clusters of similar melanocytes in the underlying dermis. Many of the melanocytes are spindled or epithelioid, and some perimelanocytic clefts are evident. Melanocytes are scattered above the basal layer. Mitotic figures are evident within the dermal component which fails to mature with descent in the dermis. The overlying epidermis is thickened and hyperkeratotic. There is focal hemorrhagic crust.",45,,1.2,,,,M,636575
SM_9_Normal,07-14044A,L2DR09,ACACGA,,34.4,,Spitzoid Melanoma,,Nimblegen19_BB23,BB23_SeqL,BB23_CL,Normal,NimV2mix3,07-14044A_Normal,NA_07-14044A_Normal,07-14044,A,"MELANOMA, 1.2 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS CLOSE TO THE PERIPHERAL MARGIN",173601,172.6,"Although there are some features reminiscent of a Spitz's nevus, this is a markedly asymmetrical and poorly circumscribed neoplasm. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level IV, expanding the papillary dermis and involving the superficial reticular dermis. There is no evidence of vascular invasion, neurotropism, or regression. Complete excision is of course warranted.","Sections show an asymmetrical, poorly circumscribed, compound proliferation of melanocytes, many of which have atypical nuclei. There are irregular clusters of similar melanocytes in the underlying dermis. Many of the melanocytes are spindled or epithelioid, and some perimelanocytic clefts are evident. Melanocytes are scattered above the basal layer. Mitotic figures are evident within the dermal component which fails to mature with descent in the dermis. The overlying epidermis is thickened and hyperkeratotic. There is focal hemorrhagic crust.",45,,1.2,,,,M,636575
SM_10_Tumor,07-26247,L2DR10,CACACA,,71.7,,Spitzoid Melanoma,,Nimblegen19_BB23,BB23_SeqL,BB23_CL,Tumor,NimV2mix3,07-26247_Tumor,NA_07-26247_Tumor,07-26247,A,"MELANOMA, AT LEAST 2.3 MM IN THICKNESS, EXTENDING TO THE EDGES AND BASE OF THE SPECIMEN",32765,172.7,"We have examined this problematic lesion on several occasions since its receipt. Although there are some features similar to those seen in a Spitz's nevus, and in fact, we considered an unusual Spitz's nevus as an alternative diagnosis, this proliferation is markedly asymmetrical.  In addition, mitotic figures are readily evident within the dermal component.  I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees that melanoma is a more appropriate diagnosis based on these findings. In terms of staging, this is a nonulcerated primary melanoma of Clark's anatomic level at least IV. There is no evidence of vascular invasion, neurotropism, or regression. Definitive assessment of thickness as well as other prognostic factors should also be deferred to the complete excision specimen.","Sections show a compound proliferation of large spindled and epithelioid melanocytes, the junctional component of which is arrayed with the lowermost sections of an epithelium that is slightly acanthotic and hyperkeratotic. The junctional component is asymmetrical, and extends far lateral to the dermal component at one edge.  Rare melanocytes are positioned above the basal layer, and there is focal crust and serum.  The dermal component is also asymmetrical.  It consists of large and small clusters and syncytia of similar melanocytes, with slight dispersion of the base, but with little diminishment in size with the dermal descent.  Many mitotic figures are identifiable within the dermal component, in the superficial and mid dermal components mainly. Minimal solar elastosis is evident.",46,,2.3,,,,F,208441
SM_18_Tumor,09-37302,L2DR11,GTGTTA,,62.3,,Spitzoid Melanoma,,Nimblegen19_BB23,BB23_SeqL,BB23_CL,Tumor,NimV2mix3,09-37302_Tumor,NA_09-37302_Tumor,09-37302,A,"MELANOMA, 0.8 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE PERIPHERY OF THE BIOPSY",529698,172.6,"This is a non-ulcerated melanoma with associated Clark's level II invasion. The measurement of thickness may be a slight overestimate, as there is epidermal hyperplasia. There is no evidence of associated vascular invasion, perineural invasion, or regression.","Sections show an asymmetrical and poorly circumscribed, compound proliferation of spindled to epithelioid melanocytes, many of which have atypical nuclei, arrayed as irregular nests and single melanocytes within the epidermis, with adnexal extension, and areas of suprabasal scatter.  There are irregular clusters of similar melanocytes in the underlying papillary dermis along with some slightly smaller ones.  The overlying epidermis is thickened, with intertwining rete. There is a patchy infiltrate of lymphocytes.",66,,0.8,,,,M,838065
CHG12-335,12-79358,L2DR12,TGTGAA,,100,,BRAF,"Iwei, Translocation CGH BRAF",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,12-79358_Tumor,NA_12-79358_Tumor,12-79358,A,"MELANOMA, 0.7 MM. IN THICKNESS",173611,172.6,"The differential diagnosis included a combined (deep penetrating or Spitz) and superficial congenital nevus, and melanoma arising in a nevus. Comparative genomic hybridization shows losses involving chromosomes 9p, areas of both 10 p and q and 14. Losses involving chromosomes 9p and 10 are among the most commonly seen in melanoma. While the lesion is not ulcerated, the presence of a melanocytes in mitosis in the dermis (low mitotic rate, 1 per mm2) qualifies this lesion as T1b in the 2009 AJCC staging classification for melanoma. A pre-existent melanocytic nevus with congenital features is also present.","There is a compound proliferation of melanocytes mostly involving the superficial dermis. The surface is slightly domed and slightly papillated. The predominant population consists of large oval melanocytes with pale, variably vacuolated and lightly pigmented cytoplasm with relatively monomorphous oval vesicular nuclei that contain small nucleoli. There are large aggregations of these cells within dermal papillae, and progressively smaller ones, with cytologic maturation toward the upper reticular dermis. Additionally, discrete nests of small round melanocytes are present.",25,T1b,0.7,,Primary,1,M,1165175
CGH12-345,12-81302,L2DR13,ACAAAC,,100,,NTRK1,"CGH12-345 Iwei, Translocation CGH NTRK1",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,12-81302_Tumor,NA_12-81302_Tumor,12-81302,A,"MELANOMA OF AT LEAST 1.8 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY",173788,172.7,"Based upon attributes evaluated by conventional microscopy, I believe this tumor represents melanoma. Per your request, we additionally completed array-based comparative genomic hybridization (aCGH) to screen this tumor for chromosomal copy number abnormalities, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 1q and loss in chromosomes 1p and 9. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is typical of malignancies such as melanoma. This melanoma is probably best considered to represents an example of 'childhood-type spitzoid melanoma'. This designation refers to an emerging entity that we believe may be prognostically distinct from conventional adult melanoma. Such tumors commonly lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination (in comparison to conventional adult melanoma).  In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. This tumor is ulcerated, but the mother has reported to me that pressure from distance running shoes may have been contributory to surface erosion. The final microstage parameters can be reassessed once this melanoma has been fully extirpated.","A shave biopsy has been removed in multiple layers. In the superficial portions of the specimen, there is the surface of a compound proliferation of melanocytes, and central ulceration is prominent. To the side of the ulceration, single melanocytes and nests are sparsely distributed within the epidermis. In the dermis below this, non-maturing nests and sheets of similar melanocytes are apparent. In deeper segments of tissue, there are also similar non-maturing nests and large aggregations. Many of the constituent melanocytes in the dermis have amphophilic or finely melanized cytoplasm, and a juxtaposed infiltrate of lymphocytes and melanophages is also noted.",17,,1.8,,,,F,1167119
CGH12-347,12-81749,L2DR14,CACCTC,,88.5,,NTRK2,"CGH12-347 Iwei, Translocation CGH NTRK2",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,12-81749_Tumor,NA_12-81749_Tumor,12-81749,A,"COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, CONSISTENT WITH AN UNCONVENTIONAL COMPOUND SPITZ NEVUS",173201,238.2,"Our differential diagnosis included a highly unconventional Spitz nevus on one hand and childhood-type spitzoid melanoma on the other. As per your request, we completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number abnormalities, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal gains or losses. As you know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, the results of our assessment favor interpretation as an unconventional melanocytic nevus. Please note that this melanocytic proliferation focally involves the deep edge of the current specimen. Reexcision may be necessary to ensure that local eradication has been accomplished. Close clinical follow-up of the specimen site is warranted at a minimum.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.","Sections show a small excisional specimen that harbors a compound proliferation of enlarged fusiform and epithelioid melanocytes. A modest number of giant fascicles of these melanocytes are distributed asymmetrically along the junction, and portions of the background epidermis show irregular acanthosis. In fibrotic dermis below this, there are large nests, cords, and fascicles of similar melanocytes that extend through the reticular dermis into the upper subcutis. The melanocytes diminish slightly in size with descent in the dermis, but many melanocytes in mitosis can be found, including mitotic figures within deep melanocytic aggregates. The fibroplasia that is present stems, in part, from a prior biopsy in this region.",6,,,,,,M,1167566
CGH13-003,12-97031,L2DR15,GTGGCC,,13.6,,BRAF,"CGH13-003 Iwei, Translocation CGH BRAF",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,12-97031_Tumor,NA_12-97031_Tumor,12-97031,A,"NEVOID MELANOMA OF AT LEAST 0.8 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY",173702,172.7,"ADDENDUM, January 18, 2013: As I indicated previously, cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. Similar to what was seen in your special stain, the MART-positive cells show low nuclear expression of Ki-67, thus implying that cellular proliferation is very low. This finding can be seen in association with melanocytic nevi but is not definitively diagnostic (a low cell proliferation index can also be seen in the context of nevoid melanoma). One of your original slides demonstrates multiple melanocytes in mitosis, and this finding proved to be worrisome for melanoma. To further clarify the nature of this tumor, we completed comparative genomic hybridization (CGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 1q and 7 as well as loss in chromosomes 9, 10q, and 22q. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is stereotypical of malignancies such as melanoma. The genomic profile that we have defined excludes a melanocytic nevus from the differential diagnosis.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has confirmed the diagnosis of melanoma. With respect to staging, this melanoma is less than 1 mm in thickness and lacks associated ulceration, yet melanocytes in mitosis are detectable in its invasive component. Therefore, this provisionally represents melanoma of stage pT1b (2009 AJCC Guidelines). The final microstage parameters can be reassessed once this melanoma has been fully extirpated.","Sections show a domed dermal proliferation of melanocytes arrayed as partially-maturing nests, cords, and small syncytia. The background epidermis is slightly acanthotic and is capped focally by parakeratosis. In the dermis, some perijunctional melanocytes are enlarged and epithelioid.",48,T1b,0.8,,Primary,,F,1182848
CGH13-009,12-98736,L2DR16,TGTTGC,,96.2,,NTRK1,"CGH13-009 Iwei, Translocation CGH NTRK1",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,12-98736_Tumor,NA_12-98736_Tumor,12-98736,A,"MELANOMA OF 1.3 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE SPECIMEN PERIPHERY",173628,172.6,"ADDENDUM, January 25, 2013: As I reported previously, our differential diagnosis included an unconventional Spitz nevus and nevoid/spitzoid melanoma. Your Ki-67 immunostain shows a low cell proliferation index, which is reassuring but not definitive. We also completed a p16 immunostain and demonstrated retention of positive expression, as can be seen with melanocytic nevi. Per your approval, we pursued array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 5q, 7, and 15q. The identification of multiple genomic copy number abnormalities suggests genomic instability and favors melanoma as most likely. However, some of the genomic aberrations that have been identified, such as gain in chromosome 15q, are not anomalies that are specific to melanoma (it can also be seen in some Spitz tumors).  In summary, the combination of results derived from conventional microscopy coupled with aCGH favors a diagnosis melanoma. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration. Therefore, it represents melanoma of stage pT2a (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.","Sections show enlarged epithelioid and fusiform melanocytes arrayed in compound fashion with lateral extension of the intraepidermal component. There are single melanocytes and nests and fascicles of melanocytes in acanthotic epidermis, and some scatter in the stratum spinosum is appreciable. Rare small pink globules are noted. In the dermis, there are nests, cords, and small syncytia of similar melanocytes, and some melanocytes seem to have granular cytoplasm. Partial maturation is noted.",68,T2a,1.3,,Primary,,M,1184553
CGH13-033,13-3874,L2DR01,AAGGGA,,100,,NTRK1,"CGH13-033 Iwei, Translocation CGH NTRK1",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,13-3874_Tumor,NA_13-3874_Tumor,13-3874,A,"PARTIALLY POLYPOID COMPOUND PROLIFERATION OF ENLARGED MELANOCYTES, CONSISTENT WITH A POLYPOID COMPOUND SPITZ NEVUS",173304,238.2,"Our differential diagnosis included an unconventional (and hypercellular) Spitz nevus and spitzoid melanoma. To more fully assess this differential diagnosis, per your request, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal gains or losses. As background for understanding this result, please note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our histopathologic and molecular assessment points to interpretation as a Spitz nevus. This melanocytic tumor appears narrowly excised in the available planes of section.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.","Sections show a protuberant compound proliferation of enlarged melanocytes with a partially polypoid profile. There are single melanocytes and nests and fascicles of melanocytes arrayed relatively confluently along the junction of a hyperkeratotic epidermis, and partially maturing nests, cords, and fascicles of melanocytes reside in the dermis below this, extending deeply. An element of superficial dermal edema is also noted.",2,,,,,,M,1188617
CGH13-034,13-3732,L2DR02,CCTTCA,,68.6,,NTRK1?,"CGH13-034 Iwei, Translocation CGH NTRK1?",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,13-3732_Tumor,NA_13-3732_Tumor,13-3732,A,"MELANOMA OF AT LEAST 1.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A BLUE NEVUS",100678,172.6,"ADDENDUM, February 8, 2013: As I reported previously, my differential diagnosis included a variant of cellular blue nevus, a combined melanocytic nevus, and melanoma ex blue nevus. Your submitted immunostains demonstrate avid expression of HMB-45, as would be expected with a blue nevus or blue nevus-like melanoma. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show slightly elevated nuclear expression of Ki-67, thus implying that cellular proliferation is elevated, which is of potential concern. A p16 immunostain demonstrates preservation of expression, which implies that an underlying anomaly in chromosome 9p is not present. This is the type of challenging case for which array-based comparative genomic hybridization (aCGH) can be applied to screen for genomic copy number anomalies, as can be seen with melanoma. Per your request and approval, completed molecular assessment. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 7, 8, and 22q. The identification of multiple chromosomal copy number aberrations indicates genomic instability, as is stereotypical of malignancies such as melanoma. The aCGH profile that we have defined is incompatible with a benign interpretation.  In summary, the combination of results derived from conventional microscopy coupled with aCGH demonstrates that this atypical melanocytic tumor represents melanoma that has developed secondarily in a blue nevus. This entity can be referred to as 'blue nevus-like melanoma'. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration in the current sections. Therefore, it provisionally represents melanoma of stage pT2a (2009 AJCC Guidelines). The final microstage parameters can be reassessed once this melanoma has been fully extirpated.  This report was reissued on April 24, 2014, to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.","Sections show melanocytes arrayed in largely dermal fashion. Superficially, there are large nests and syncytia of enlarged epithelioid melanocytes in the upper dermis, and these melanocytes have finely melanized cytoplasm. In a recut section, some of these melanocytes appear spitzoid. More deeply, there are fusiform and dendritic melanocytes that are much smaller residing in the reticular dermis, and interstitial melanophages can be seen.",36,T2a,1.8,,Primary,,F,1188475
CGH13-041,13-3889,L2DR03,GGACCC,,29.1,,NTRK3,"CGH13-041 Iwei, Translocation CGH NTRK3",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,13-3889_Tumor,NA_13-3889_Tumor,13-3889,A,"COMPOUND PROLIFERATION OF LARGE, ATYPICAL MELANOCYTES",173620,238.2,"This unusual lesion has some features of a desmoplastic Spitz's nevus, but more nuclei are hyperchromatic than vesicular, and many, even toward the base of the lesion are quite large. Also, the undersurface is more irregular than in most desmoplastic Spitz nevi. For these reasons, we obtained comparative genomic hybridization on this challenging case. This showed a loss of chr. 7p, and a gain involving chr. 15q. Gains, rather than losses of chr. 7p are common in melanoma. Gains of 15q can be seen in melanoma, but usually in concert with other aberrations. Hence, the findings do not provide unequivocal support for melanoma, but do indicate copy number changes not seen in routine Spitz's nevi. I would re-excision this site, and consider this as a lesion with some metastatic potential. I would expect the behavior of a group of lesions with similar findings to these to be better than that of a group of melanomas of comparable thickness.","There is a broad-based proliferation of melanocytes extending from the junctional zone to the deep reticular dermis. The undersurface of the lesion has a jagged border. The epidermis is hyperplastic, with nests of small fusiform cells with lightly pigmented cytoplasm. The most striking findings are in the dermis, where thin fascicles and singly dispersed cells with large, diffusely hyperchromatic nuclei are present between thin but closely apposed collagen bundles. Maturation with descent is imperfect. Neither expansile-appearing aggregations nor mitotic figures in dermal melanocytes are evident. The enclosed immunoperoxidase-stained sections show an absence of HMB45 staining and a very low proliferative rate.",27,,,,,,F,1188632
CGH13-044,13-4090B,L2DR04,TTCAGC,,100,,NTRK3,"CGH13-044 Iwei, Translocation CGH NTRK3",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,13-4090B_Tumor,NA_13-4090B_Tumor,13-4090,B,"MELANOMA, 1.1 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)",100556,172.5,"ADDENDUM, February 21, 2013: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) does not demonstrate mitoses within melanocytes, and only rare cells have nuclear phosphohistone H3 staining.  Comparative genomic hybridization shows gains of chromosome 1q, 6, and 15.  The presence of genomic aberrations in this melanocytic neoplasm argues that this represents melanoma and not a severely atypical dysplastic nevus. The lesion is greater than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T2a per the 2009 revision of the AJCC staging system for melanoma.","Sections show a compound proliferation of melanocytes that is well-circumscribed and symmetric. Large nests of melanocytes with moderately large nuclei and moderate amounts of pale cytoplasm are present at the size and bases of elongated rete ridges. Some adjacent rete ridges are fused at their bases and the underlying papillary dermis is fibrotic.  Centrally, the epidermis is effaced with large nests of melanocytes within sclerotic collagen below. There is a focal patchy lymphocytic infiltrate with scattered melanophages throughout the lesion.  The proliferation demonstrates even maturation with descent into the reticular dermis and there is a periadnexal distribution. One dermal mitosis is noted which may be within a melanocyte.",50,T2a,1.1,None,Primary,,M,1188833
CGH13-046,13-4136,L2DR05,AAGACG,,71.1,,BRAF,"CGH13-046 Iwei, Translocation CGH BRAF",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,13-4136_Tumor,NA_13-4136_Tumor,13-4136,A,"HEALING BIOPSY SITE AND RESIDUAL INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES",173305,238.2,"The residuum has some worrisome features. The changes in the initial biopsy suggested a minor population of cells with copy number aberrations involving whole chromosomes, a pattern usually seen in proliferative nodules rather than in atypical Spitz tumors or spitzoid melanomas. The same findings were seen in the repeat testing, indicating that the copy number aberrations are in a significant portion of the lesion, and not just in a minor component. I favor regarding this lesion as an atypical Spitz tumor and not just as a Spitz's nevus. The removal appears complete. While lesions of this type have a high probability of involving a sentinel lymph node, the predictive value of this for distant metastasis is very low.","There is a roughly wedge-shaped proliferation of large oval and fusiform melanocytes with abundant pale cytoplasm and large oval vesicular nuclei with prominent and sometimes multiple, large central nucleoli. A few mitotic figures are seen amongst the lesional cells. There are some melanocytes with scant cytoplasm and others whose nuclei appear to overlap. The overlying epidermis is irregularly hyperplastic, and subepidermal granulation tissue is focally evident.",5,,,,,,M,1179510
CGH13-058,13-7186,L2DR06,CCTCGG,,100,,NTRK3,"CGH13-058 Iwei, Translocation CGH NTRK3",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,13-7186_Tumor,NA_13-7186_Tumor,13-7186,A,"HYPERCELLULAR COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, FOCALLY TRANSECTED AT THE SPECIMEN PERIPHERY",173727,238.2,"ADDENDUM, March 14, 2013: As I reported previously, my differential diagnosis included an unconventional melanocytic nevus and nevoid melanoma. Your submitted immunoperoxidase stains included a Ki-67 stain that demonstrates a low cell proliferation index. We additionally completed p16 and BAP-1 immunostains in our assessment. There is a marked loss of p16 expression, which implied that underlying loss in chromosome 9p might be present (this proved not to be the case, as is discussed further below). There is preservation of BAP-1 expression, and thus there is not an underlying anomaly in chromosome 3p. Per your approval, we pursued array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed several contiguous areas of gain within chromosome 15q with no other associated chromosomal gains or losses. (With specific reference to chromosome 9, no gain or loss was found.) We have observed gain in chromosome 15q as a monoaberration in a series of atypical Spitz (or pigmented spindle cell) nevi, and this genomic anomaly is not believed to be indicative of a diagnosis of melanoma. Rather, we believe the gain is a consequence of NTRK3 gene rearrangement.  In summary, although I had reservations regarding the possibility of nevoid melanoma based upon conventional histopathologic findings, the combination of results derived from conventional microscopy coupled with aCGH favors instead interpretation as an unconventional melanocytic nevus (or unconventional Spitz/Reed nevus). My colleague, Dr. Boris Bastian, has reviewed the molecular findings for this case and is in agreement with my diagnosis. Given the complexity of this case, it would certainly be reasonable to complete reexcision of this site in follow-up.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.","Sections show a broad, asymmetrical, and incompletely circumscribed compound proliferation of enlarged fusiform and epithelioid melanocytes. These cells are distributed singly and in nests and fascicles along the junction, and areas of thinning are noted. In the dermis below this, the constituent cells mature to form nests, sheets, and syncytia that fill and expand the papillary and superficial reticular dermis. The constituent melanocytes have amphophilic cytoplasm that is sometimes finely melanized, and scattered accompanying melanophages are noted. Only rare dermal mitotic figures can be found. The tumor thickness is 2.2 mm.",59,,,,,,M,1191929
CGH13-011,13-25A,L2DR07,GGATGT,,100,,BRAF,"CGH13-011 Iwei, Translocation CGH BRAF",Nimblegen20_BB24,BB24_SeqL,BB24_CL,Tumor,NimV2mix3,13-25A_Tumor,NA_13-25A_Tumor,13-25,A,"MELANOMA, 1.2 MM. IN THICKNESS",173602,172.6,,"Sections show a relatively narrowly based lesion in which a thickened epidermis with rounded rete ridges overlies a dermal proliferation of melanocytes, with moderate amphophilic cytoplasm and enlarged nuclei, some hyperchromatic, distributed singly or in small collections in the dermis. There is elastotic stroma. The enclosed two-color immunostain shows that there is a low proliferation rate among the lesional melanocytes.",48,,1.2,,,,F,1184767
DPN_1_Tumor,11-71241,L2DR08,TTCGCT,Iwei DPN,76.7,,DPN,,Nimblegen21_BB25,BB25_SeqL,BB25_CL,Tumor,NimV2mix3,11-71241_Tumor,NA_11-71241_Tumor,11-71241,A,DEEP PENETRATING NEVUS,273588,216.5,There is no evidence of melanoma or atypicality. I have shared this case with my colleague Dr. Beth Ruben who agrees with this interpretation.,"Sections show a predominantly intradermal proliferation of melanocytes with abundant, pale, vacuolated, amphophilic cytoplasm with melanin and medium-sized, oval vesicular nuclei with small nucleoli arranged as nests and fascicles with interspersed melanophages in the upper dermis. There is extension of these melanocytes into the deep dermis along adnexae and neurovascular bundles. A focally dense, lymphohistiocytic inflammatory infiltrate is present concurrently. Mitotic figures are rare.",10,,,,,,F,1060684
DPN_3_Tumor,11-26903,L2DR09,ACACGA,Iwei DPN,77.6,,DPN,,Nimblegen21_BB25,BB25_SeqL,BB25_CL,Tumor,NimV2mix3,11-26903_Tumor,NA_11-26903_Tumor,11-26903,A,DEEP PENETRATING NEVUS,139523,216.5,"The lesion has characteristic features of deep penetrating nevus, a benign lesion some consider a variant of blue nevus. It appears excised in planes of section examined. Case reviewed with concurrence by Drs. McCalmont, Ruben and Mully.","Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages.",41,,,,,,M,1016341
DPN_4_Tumor,11-28912B,L2DR10,CACACA,Iwei DPN,99.7,,DPN,,Nimblegen21_BB25,BB25_SeqL,BB25_CL,Tumor,NimV2mix3,11-28912B_Tumor,NA_11-28912B_Tumor,11-28912,B,DEEP PENETRATING NEVUS,173533,216.5,"The neoplasm extends to the base of the specimen in the deeper piece. This is an unusual lesion whose appearance is similar in some respects to that of blue nevus, clinically and histopathologically, but is genomically different. While most of the findings are reassuring, I would still consider a narrow re-excision as there are rare lesions in which the appearance that most of the lesion has been removed is deceptive.","Sections show a dome surfaced, wedge-based proliferation of large oval melanocytes with moderately enlarged oval vesicular nuclei and abundant pale, vacuolated cytoplasms, arranged as large nests and fascicles superficially and as smaller aggregations in the deep reticular dermis. Some nuclear pleomorphism is present. There are evenly distributed melanophages. Mitoses appear to be rare, and mostly superficial.",54,,,,,,M,1018350
DPN_5_Tumor,11-5210D,L2DR11,GTGTTA,Iwei DPN,62.6,,DPN,,Nimblegen21_BB25,BB25_SeqL,BB25_CL,Tumor,NimV2mix3,11-5210D_Tumor,NA_11-5210D_Tumor,11-5210,D,DEEP PENETRATING NEVUS,173726,216.7,,"Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.",46,,,,,,M,873475
DPN_6_Tumor,10-83193,L2DR12,TGTGAA,Iwei DPN,51,,DPN,,Nimblegen21_BB25,BB25_SeqL,BB25_CL,Tumor,NimV2mix3,10-83193_Tumor,NA_10-83193_Tumor,10-83193,A,"BLUE NEVUS, COMPLETELY EXCISED",173688,216.6,,"Sections show a proliferation of spindled melanocytes, with areas composed of compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles.  There are many stromal melanophages.",17,,,,,,F,977772
DPN_7_Tumor,11-95856,L2DR13,ACAAAC,Iwei DPN,76.1,,DPN,,Nimblegen21_BB25,BB25_SeqL,BB25_CL,Tumor,NimV2mix3,11-95856_Tumor,NA_11-95856_Tumor,11-95856,A,"DEEP PENETRATING NEVUS, EXTENDING FOCALLY TO THE EDGE AND BASE OF THE SPECIMEN",173719,216.7,"While the findings are diagnostic of deep penetrating nevus, the melanocytes are large and conservative excision is recommended.  The excision should extend to the subcutaneous fat, as the lesion is broadly transected at the base of the punch specimen, and only needs to be slightly wider than the biopsy, as the lesion extends focally to the peripheral edge of the specimen. Dr. Philip LeBoit has also reviewed this case and agrees with the diagnosis and assessment.","Sections show a relatively symmetric and well-circumscribed, roughly wedge-shaped proliferation of spindled and polygonal large melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis around a follicle.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed densely pigmented melanophages.",32,,,,,,M,1085304
DPN_8_Tumor,10-23569A,L2DR14,CACCTC,Iwei DPN,77.4,,DPN,,Nimblegen21_BB25,BB25_SeqL,BB25_CL,Tumor,NimV2mix3,10-23569A_Tumor,NA_10-23569A_Tumor,10-23569,A,"DEEP PENETRATING NEVUS, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED",174526,216.5,"Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferative rate thereby supporting the above interpretation.","Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages. Mitoses are not readily identified.",29,,,,,,F,918142
DPN_9_Tumor,09-92749,L2DR15,GTGGCC,Iwei DPN,100,,DPN,,Nimblegen21_BB25,BB25_SeqL,BB25_CL,Tumor,NimV2mix3,09-92749_Tumor,NA_09-92749_Tumor,09-92749,A,"DEEP PENETRATING NEVUS, EXCISED IN PLANES OF SECTION EXAMINED",173539,216.5,"There are thickened, sclerotic collagen bundles associated with this nevus.","Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.  Thickened collagen bundles are noted within and adjacent to the melanocytic proliferation.",31,,,,,,M,893515
DPN_10_Tumor,09-72944,L2DR16,TGTTGC,Iwei DPN,53.2,,DPN,,Nimblegen21_BB25,BB25_SeqL,BB25_CL,Tumor,NimV2mix3,09-72944_Tumor,NA_09-72944_Tumor,09-72944,A,"DEEP PENETRATING NEVUS, EXTENDING TO THE TISSUE EDGE",107705,216.7,,"Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.",29,,,,,,F,563362
DPN_11_Tumor,10-46536,L2DR01,AAGGGA,Iwei DPN,76,,DPN,,Nimblegen21_BB25,BB25_SeqL,BB25_CL,Tumor,NimV2mix3,10-46536_Tumor,NA_10-46536_Tumor,10-46536,A,"BLUE NEVUS WITH FEATURES OF DEEP PENETRATING NEVUS, INFLAMED, EXTENDING TO THE EDGE OF THE SPECIMEN",273588,216.5,There is also vacuolar interface change with dyskeratotic keratinocytes.  The epidermal changes and the inflammation surrounding the melanocytic nevus may be related to this patient's recent radio-therapy.  Dr. Philip LeBoit has also reviewed this case and agrees with the diagnosis.,"Sections show a neoplasm composed of fascicles of melanocytes, involving the superficial and deep dermis, with a propensity for nests to surround adnexal structures.  The constituent melanocytes have abundant pale cytoplasm with dusty melanin, and pleomorphic nuclei.  At the periphery of the neoplasm small collections of melanocytes interweave with thickened collagen bundles. They are associated with many melanophages.  There are lymphocytes throughout the neoplasm.   There is also vacuolar interface change with dyskeratotic keratinocytes.",6,,,,,,F,941112
DPN_12_Tumor,10-83613A,L2DR02,CCTTCA,Iwei DPN,96.6,,DPN,,Nimblegen21_BB25,BB25_SeqL,BB25_CL,Tumor,NimV2mix3,10-83613A_Tumor,NA_10-83613A_Tumor,10-83613,A,DEEP PENETRATING NEVUS,101624,216.6,"The lesion appears excised in planes of section examined. The lesion is broad, but mitotic activity is not prominent. A Ki-67/Melan A stain was obtained to evaluate proliferative activity and it is very low, consistent with the H and E impression of a benign nevus. The case (except Ki-67 stain) was reviewed with concurrence by Dr. McCalmont.","Sections show a two stage biopsy of a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the mid reticular dermis, with a couple of clusters in the lower reticular dermis/subcutis interface.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages.",51,,,,,,M,978192
WM3928 F,K1_1,NextFlex 14,AGTTCC,,1000,,Thomas Wild Type Cell Line,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_1_Tumor,NA_K1_1_Tumor,,,,,,,,,,,,,,,
C037,K1_2,NextFlex 15,ATGTCA,,1000,,Thomas Wild Type Cell Line,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_2_Tumor,NA_K1_2_Tumor,,,,,,,,,,,,,,,
C022,K1_3,NextFlex 16,CCGTCC,,1000,,Thomas Wild Type Cell Line,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_3_Tumor,NA_K1_3_Tumor,,,,,,,,,,,,,,,
L20-Mel,London-L20,NextFlex 17,GTAGAG,,84.4,,Hunter Dysplastic Nevus,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Melanoma,NimV2mix3,London-L20_Melanoma,NA_London-L20_Melanoma,,,,,,,,,,,,,,,
L20-NL,London-L20,NextFlex 18,GTCCGC,,39.52,,Hunter Dysplastic Nevus,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Normal,NimV2mix3,London-L20_Normal,NA_London-L20_Normal,,,,,,,,,,,,,,,
L20-Nevus-A,London-L20,NextFlex 19,GTGAAA,,17.172,,Hunter Dysplastic Nevus,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Nevus,NimV2mix3,London-L20_Nevus,NA_London-L20_Nevus,,,,,,,,,,,,,,,
L15-NL,London-L15,NextFlex 20,GTGGCC,,12.441,,Hunter Dysplastic Nevus,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Normal,NimV2mix3,London-L15_Normal,NA_London-L15_Normal,,,,,,,,,,,,,,,
L23C-Dysplastic,London-L23C,NextFlex 21,GTTTCG,,4.968,,Hunter Dysplastic Nevus,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Nevus,NimV2mix3,London-L23C_Nevus,NA_London-L23C_Nevus,,,,,,,,,,,,,,,
UM15,K1_9,NextFlex 22,CGTACG,,5.236,,Uveal Melanoma,"Buzzard, Deborah",Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_9_Tumor,NA_K1_9_Tumor,,,,,,,,,,,,,,,
UM19,K1_10,NextFlex 23,GAGTGG,,7.4,,Uveal Melanoma,"Burnham, M",Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_10_Tumor,NA_K1_10_Tumor,,,,,,,,,,,,,,,
UM20,K1_11,NextFlex 24,GGTAGC,,1000,,Uveal Melanoma,"Spini, Lynda Jean",Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_11_Tumor,NA_K1_11_Tumor,,,,,,,,,,,,,,,
CP-1,K1_12,NextFlex 1,CGATGT,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_12_Tumor,NA_K1_12_Tumor,,,,,,,,,,,,,,,
CP-2,K1_13,NextFlex 2,TGACCA,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_13_Tumor,NA_K1_13_Tumor,,,,,,,,,,,,,,,
CP-3,K1_14,NextFlex 3,ACAGTG,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_14_Tumor,NA_K1_14_Tumor,,,,,,,,,,,,,,,
CP-4,K1_15,NextFlex 4,GCCAAT,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_15_Tumor,NA_K1_15_Tumor,,,,,,,,,,,,,,,
CP-5,K1_16,NextFlex 5,CAGATC,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_16_Tumor,NA_K1_16_Tumor,,,,,,,,,,,,,,,
CP-6,K1_17,NextFlex 6,CTTGTA,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_17_Tumor,NA_K1_17_Tumor,,,,,,,,,,,,,,,
14-18,K1_18,NextFlex 7,ATCACG,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_18_Tumor,NA_K1_18_Tumor,,,,,,,,,,,,,,,
14-19,K1_19,NextFlex 8,TTAGGC,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_19_Tumor,NA_K1_19_Tumor,,,,,,,,,,,,,,,
14-21,K1_20,NextFlex 9,ACTTGA,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,Clinical1_BB26,BB26_SeqL,BB26_CL,Tumor,NimV2mix3,K1_20_Tumor,NA_K1_20_Tumor,,,,,,,,,,,,,,,
DPN_14_Tumor,10-32987,L2DR03,GGACCC,,75.1,,Iwei DPN,,Nimblegen22_BB27,BB27_SeqL,BB27_CL,Tumor,NimV2mix3,10-32987_Tumor,NA_10-32987_Tumor,10-32987,A,DEEP PENETRATING NEVUS (A VARIANT OF BLUE NEVUS),173611,216.6,,"Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular and adventitial dermis.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages, and the stroma is focally sclerotic.",12,,,,,,M,927561
DPN_16_Tumor,06-08042,L2DR04,TTCAGC,,82.4,,Iwei DPN,,Nimblegen22_BB27,BB27_SeqL,BB27_CL,Tumor,NimV2mix3,06-08042_Tumor,NA_06-08042_Tumor,06-08042,A,,,,,,,,,,,,,
DPN_17_Tumor,06-00911,L2DR05,AAGACG,,74.2,,Iwei DPN,,Nimblegen22_BB27,BB27_SeqL,BB27_CL,Tumor,NimV2mix3,06-00911_Tumor,NA_06-00911_Tumor,06-00911,A,,,,,,,,,,,,,
DPN_18_Tumor,06-21363,L2DR06,CCTCGG,,86.1,,Iwei DPN,,Nimblegen22_BB27,BB27_SeqL,BB27_CL,Tumor,NimV2mix3,06-21363_Tumor,NA_06-21363_Tumor,06-21363,A,"HEAVILY PIGMENTED COMPOUND MELANOCYTIC NEVUS, EXCISED IN PLANES OF SECTION EXAMINED",529698,216.6,"This lesion represents a bit of a hybrid, showing some features of a desmoplastic pigmented Spitz's nevus and also some features of a so-called deep penetrating nevus. I do not believe these changes signify melanoma.","Sections show a roughly wedge-shaped infiltrate of spindled and polygonal melanocytes, some of which have ample vacuolated and pigmented cytoplasm, positioned in the superficial dermis and along the epidermal-dermal junction, where rare nests can be found. Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are hard to find. There are interspersed melanophages and also scattered interstitial lymphocytes and histiocytes.",20,,,,,,F,566429
DPN_19_Tumor,06-47334,L2DR07,GGATGT,,75.3,,Iwei DPN,,Nimblegen22_BB27,BB27_SeqL,BB27_CL,Tumor,NimV2mix3,06-47334_Tumor,NA_06-47334_Tumor,06-47334,A,DEEP PENETRATING NEVUS,173601,216.6,"The base of the specimen is focally involved. There are no worrisome features, however.","Sections show a dome surfaced, roughly wedge-shaped proliferation of large oval melanocytes, most of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis.  Some melanocyte nuclei are modestly enlarged.  There are interspersed melanophages.",34,,,,,,F,454219
CNS_42_Tumor,S12-6332A5,L2DR08,TTCGCT,,100,,Jantima CNS,,Nimblegen22_BB27,BB27_SeqL,BB27_CL,Tumor,NimV2mix3,S12-6332A5_Tumor,NA_S12-6332A5_Tumor,,,,,,,,,,,,,,,
CNS_43_Tumor,S11-032523A1,L2DR09,ACACGA,,97,,Jantima CNS,,Nimblegen22_BB27,BB27_SeqL,BB27_CL,Tumor,NimV2mix3,S11-032523A1_Tumor,NA_S11-032523A1_Tumor,,,,,,,,,,,,,,,
CNS_44_Tumor,S08-1463A2,L2DR10,CACACA,,100,,Jantima CNS,,Nimblegen22_BB27,BB27_SeqL,BB27_CL,Tumor,NimV2mix3,S08-1463A2_Tumor,NA_S08-1463A2_Tumor,,,,,,,,,,,,,,,
CNS_48_Tumor,S12-7093NG176-1,L2DR11,GTGTTA,,100,,Jantima CNS,,Nimblegen22_BB27,BB27_SeqL,BB27_CL,Tumor,NimV2mix3,S12-7093NG176-1_Tumor,NA_S12-7093NG176-1_Tumor,,,,,,,,,,,,,,,
CNS_49_Tumor,S10-7937B2,L2DR12,TGTGAA,,95.9,,Jantima CNS,,Nimblegen22_BB27,BB27_SeqL,BB27_CL,Tumor,NimV2mix3,S10-7937B2_Tumor,NA_S10-7937B2_Tumor,,,,,,,,,,,,,,,
CNS_50_Tumor,S11-21025B1,L2DR13,ACAAAC,,100,,Jantima CNS,,Nimblegen22_BB27,BB27_SeqL,BB27_CL,Tumor,NimV2mix3,S11-21025B1_Tumor,NA_S11-21025B1_Tumor,,,,,,,,,,,,,,,
Ivanka_9_1,10-58663,L2DR14,CACCTC,,100,,Melanoma with nevus,13 Cycle Post Hybridization LM-PCR,Nimblegen23_BB28,BB28_SeqL,BB28_CL,Melanoma,NimV2mix3,10-58663_Melanoma,NA_10-58663_Melanoma,10-58663,A,"MELANOMA, 1.7 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS",139524,172.5,"The lesion is not ulcerated, and hence this is a T2a primary melanoma in the 2009 AJCC staging classification. The mitotic rate is low, and I did not encounter other features that would have a significant prognostic impact.","Sections show a broad-based proliferation of melanocytes with a markedly asymmetric configuration, involving the epidermis and superficial dermis. One part of the lesion features interconnecting rete ridges with subjacent nests, cords and strands of small round melanocytes, with clusters of adipocytes admixed with them. The other portion features a thickened epidermis with a relatively flat rete ridge pattern, a basal layer sparsely colonized by melanocytes with large, hyperchromatic nuclei, and a fibrotic stroma containing nests of similar cells, some with scant and some with abundant pale cytoplasm. There is little maturation with descent.",52,T2a,1.7,,Primary,,F,953239
Ivanka_9_2,10-58663,L2DR15,GTGGCC,,100,,Melanoma with nevus,13 Cycle Post Hybridization LM-PCR,Nimblegen23_BB28,BB28_SeqL,BB28_CL,Melanoma,NimV2mix3,10-58663_Melanoma,NA_10-58663_Melanoma,10-58663,A,"MELANOMA, 1.7 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS",139524,172.5,"The lesion is not ulcerated, and hence this is a T2a primary melanoma in the 2009 AJCC staging classification. The mitotic rate is low, and I did not encounter other features that would have a significant prognostic impact.","Sections show a broad-based proliferation of melanocytes with a markedly asymmetric configuration, involving the epidermis and superficial dermis. One part of the lesion features interconnecting rete ridges with subjacent nests, cords and strands of small round melanocytes, with clusters of adipocytes admixed with them. The other portion features a thickened epidermis with a relatively flat rete ridge pattern, a basal layer sparsely colonized by melanocytes with large, hyperchromatic nuclei, and a fibrotic stroma containing nests of similar cells, some with scant and some with abundant pale cytoplasm. There is little maturation with descent.",52,T2a,1.7,,Primary,,F,953239
Ivanka_9_3,10-58663,L2DR16,TGTTGC,,48.1,,Melanoma with nevus,13 Cycle Post Hybridization LM-PCR,Nimblegen23_BB28,BB28_SeqL,BB28_CL,Nevus,NimV2mix3,10-58663_Nevus,NA_10-58663_Nevus,10-58663,A,"MELANOMA, 1.7 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS",139524,172.5,"The lesion is not ulcerated, and hence this is a T2a primary melanoma in the 2009 AJCC staging classification. The mitotic rate is low, and I did not encounter other features that would have a significant prognostic impact.","Sections show a broad-based proliferation of melanocytes with a markedly asymmetric configuration, involving the epidermis and superficial dermis. One part of the lesion features interconnecting rete ridges with subjacent nests, cords and strands of small round melanocytes, with clusters of adipocytes admixed with them. The other portion features a thickened epidermis with a relatively flat rete ridge pattern, a basal layer sparsely colonized by melanocytes with large, hyperchromatic nuclei, and a fibrotic stroma containing nests of similar cells, some with scant and some with abundant pale cytoplasm. There is little maturation with descent.",52,T2a,1.7,,Primary,,F,953239
Ivanka_9_4,10-58663,L2DR01,AAGGGA,,61.5,,Melanoma with nevus,13 Cycle Post Hybridization LM-PCR,Nimblegen23_BB28,BB28_SeqL,BB28_CL,Nevus,NimV2mix3,10-58663_Nevus,NA_10-58663_Nevus,10-58663,A,"MELANOMA, 1.7 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS",139524,172.5,"The lesion is not ulcerated, and hence this is a T2a primary melanoma in the 2009 AJCC staging classification. The mitotic rate is low, and I did not encounter other features that would have a significant prognostic impact.","Sections show a broad-based proliferation of melanocytes with a markedly asymmetric configuration, involving the epidermis and superficial dermis. One part of the lesion features interconnecting rete ridges with subjacent nests, cords and strands of small round melanocytes, with clusters of adipocytes admixed with them. The other portion features a thickened epidermis with a relatively flat rete ridge pattern, a basal layer sparsely colonized by melanocytes with large, hyperchromatic nuclei, and a fibrotic stroma containing nests of similar cells, some with scant and some with abundant pale cytoplasm. There is little maturation with descent.",52,T2a,1.7,,Primary,,F,953239
Ivanka_9_5,10-58663,L2DR02,CCTTCA,,11.3,,Melanoma with nevus,13 Cycle Post Hybridization LM-PCR,Nimblegen23_BB28,BB28_SeqL,BB28_CL,Normal,NimV2mix3,10-58663_Normal,NA_10-58663_Normal,10-58663,A,"MELANOMA, 1.7 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS",139524,172.5,"The lesion is not ulcerated, and hence this is a T2a primary melanoma in the 2009 AJCC staging classification. The mitotic rate is low, and I did not encounter other features that would have a significant prognostic impact.","Sections show a broad-based proliferation of melanocytes with a markedly asymmetric configuration, involving the epidermis and superficial dermis. One part of the lesion features interconnecting rete ridges with subjacent nests, cords and strands of small round melanocytes, with clusters of adipocytes admixed with them. The other portion features a thickened epidermis with a relatively flat rete ridge pattern, a basal layer sparsely colonized by melanocytes with large, hyperchromatic nuclei, and a fibrotic stroma containing nests of similar cells, some with scant and some with abundant pale cytoplasm. There is little maturation with descent.",52,T2a,1.7,,Primary,,F,953239
Ivanka_12_1,08-52519,L2DR03,GGACCC,,100,,Melanoma with nevus,13 Cycle Post Hybridization LM-PCR,Nimblegen23_BB28,BB28_SeqL,BB28_CL,Melanoma,NimV2mix3,08-52519_Melanoma,NA_08-52519_Melanoma,08-52519,A,"MELANOMA, 1.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN",173399,172.3,"In one area, there is a neurotized intradermal nevus. In the larger more polypoid zone adjacent to this, there is a markedly asymmetrical proliferation of more atypical melanocytes, with mitotic figures evident within the dermal component, compatible with melanoma. There is also a population of somewhat smaller melanocytes near the base of this proliferation. Some of these probably represent small cells of melanoma, while there may some nevus present there as well. The measurement of thickness is thus based on my best judgment as to what represents the component of melanoma. In terms of other staging parameters, this is a non-ulcerated primary melanoma of Clark's anatomic level IV. There are no other features which would have a significant impact on prognosis. Complete re-excision is of course warranted. I have also shared this unusual case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with these findings.","Sections show a bilobed, somewhat polypoid proliferation of melanocytes in a biphasic pattern. The smaller lobe contains an intradermal proliferation of bland melanocytes, which demonstrate a degree of neural differentiation (melanocytic nevus). In the other more polypoid zone, there is a markedly asymmetrical proliferation of atypical melanocytes, which are morphologically heterogeneous, arrayed as irregular clusters and syncytia. In many areas, these fail to mature with descent. Mitotic figures are evident within the dermal component. In areas near the base, there is also a population of smaller melanocytes. Some are in continuity with some of the larger ones overlying them, while others are somewhat bland and may demonstrate a degree of maturation with melanocytic descent. There is fibrosis, and a patchy lymphocytic infiltrate, as well as dilated lymphovascular spaces.",68,,1.7,,,,F,761160
Ivanka_12_2,08-52519,L2DR04,TTCAGC,,100,,Melanoma with nevus,13 Cycle Post Hybridization LM-PCR,Nimblegen23_BB28,BB28_SeqL,BB28_CL,Melanoma,NimV2mix3,08-52519_Melanoma,NA_08-52519_Melanoma,08-52519,A,"MELANOMA, 1.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN",173399,172.3,"In one area, there is a neurotized intradermal nevus. In the larger more polypoid zone adjacent to this, there is a markedly asymmetrical proliferation of more atypical melanocytes, with mitotic figures evident within the dermal component, compatible with melanoma. There is also a population of somewhat smaller melanocytes near the base of this proliferation. Some of these probably represent small cells of melanoma, while there may some nevus present there as well. The measurement of thickness is thus based on my best judgment as to what represents the component of melanoma. In terms of other staging parameters, this is a non-ulcerated primary melanoma of Clark's anatomic level IV. There are no other features which would have a significant impact on prognosis. Complete re-excision is of course warranted. I have also shared this unusual case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with these findings.","Sections show a bilobed, somewhat polypoid proliferation of melanocytes in a biphasic pattern. The smaller lobe contains an intradermal proliferation of bland melanocytes, which demonstrate a degree of neural differentiation (melanocytic nevus). In the other more polypoid zone, there is a markedly asymmetrical proliferation of atypical melanocytes, which are morphologically heterogeneous, arrayed as irregular clusters and syncytia. In many areas, these fail to mature with descent. Mitotic figures are evident within the dermal component. In areas near the base, there is also a population of smaller melanocytes. Some are in continuity with some of the larger ones overlying them, while others are somewhat bland and may demonstrate a degree of maturation with melanocytic descent. There is fibrosis, and a patchy lymphocytic infiltrate, as well as dilated lymphovascular spaces.",68,,1.7,,,,F,761160
Ivanka_12_3,08-52519,L2DR05,AAGACG,,65.1,,Melanoma with nevus,13 Cycle Post Hybridization LM-PCR,Nimblegen23_BB28,BB28_SeqL,BB28_CL,Nevus,NimV2mix3,08-52519_Nevus,NA_08-52519_Nevus,08-52519,A,"MELANOMA, 1.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN",173399,172.3,"In one area, there is a neurotized intradermal nevus. In the larger more polypoid zone adjacent to this, there is a markedly asymmetrical proliferation of more atypical melanocytes, with mitotic figures evident within the dermal component, compatible with melanoma. There is also a population of somewhat smaller melanocytes near the base of this proliferation. Some of these probably represent small cells of melanoma, while there may some nevus present there as well. The measurement of thickness is thus based on my best judgment as to what represents the component of melanoma. In terms of other staging parameters, this is a non-ulcerated primary melanoma of Clark's anatomic level IV. There are no other features which would have a significant impact on prognosis. Complete re-excision is of course warranted. I have also shared this unusual case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with these findings.","Sections show a bilobed, somewhat polypoid proliferation of melanocytes in a biphasic pattern. The smaller lobe contains an intradermal proliferation of bland melanocytes, which demonstrate a degree of neural differentiation (melanocytic nevus). In the other more polypoid zone, there is a markedly asymmetrical proliferation of atypical melanocytes, which are morphologically heterogeneous, arrayed as irregular clusters and syncytia. In many areas, these fail to mature with descent. Mitotic figures are evident within the dermal component. In areas near the base, there is also a population of smaller melanocytes. Some are in continuity with some of the larger ones overlying them, while others are somewhat bland and may demonstrate a degree of maturation with melanocytic descent. There is fibrosis, and a patchy lymphocytic infiltrate, as well as dilated lymphovascular spaces.",68,,1.7,,,,F,761160
Ivanka_12_4,08-52519,L2DR06,CCTCGG,,77.1,,Melanoma with nevus,13 Cycle Post Hybridization LM-PCR,Nimblegen23_BB28,BB28_SeqL,BB28_CL,Nevus,NimV2mix3,08-52519_Nevus,NA_08-52519_Nevus,08-52519,A,"MELANOMA, 1.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN",173399,172.3,"In one area, there is a neurotized intradermal nevus. In the larger more polypoid zone adjacent to this, there is a markedly asymmetrical proliferation of more atypical melanocytes, with mitotic figures evident within the dermal component, compatible with melanoma. There is also a population of somewhat smaller melanocytes near the base of this proliferation. Some of these probably represent small cells of melanoma, while there may some nevus present there as well. The measurement of thickness is thus based on my best judgment as to what represents the component of melanoma. In terms of other staging parameters, this is a non-ulcerated primary melanoma of Clark's anatomic level IV. There are no other features which would have a significant impact on prognosis. Complete re-excision is of course warranted. I have also shared this unusual case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with these findings.","Sections show a bilobed, somewhat polypoid proliferation of melanocytes in a biphasic pattern. The smaller lobe contains an intradermal proliferation of bland melanocytes, which demonstrate a degree of neural differentiation (melanocytic nevus). In the other more polypoid zone, there is a markedly asymmetrical proliferation of atypical melanocytes, which are morphologically heterogeneous, arrayed as irregular clusters and syncytia. In many areas, these fail to mature with descent. Mitotic figures are evident within the dermal component. In areas near the base, there is also a population of smaller melanocytes. Some are in continuity with some of the larger ones overlying them, while others are somewhat bland and may demonstrate a degree of maturation with melanocytic descent. There is fibrosis, and a patchy lymphocytic infiltrate, as well as dilated lymphovascular spaces.",68,,1.7,,,,F,761160
Ivanka_12_5,08-52519,L2DR07,GGATGT,,17.6,,Melanoma with nevus,13 Cycle Post Hybridization LM-PCR,Nimblegen23_BB28,BB28_SeqL,BB28_CL,Normal,NimV2mix3,08-52519_Normal,NA_08-52519_Normal,08-52519,A,"MELANOMA, 1.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN",173399,172.3,"In one area, there is a neurotized intradermal nevus. In the larger more polypoid zone adjacent to this, there is a markedly asymmetrical proliferation of more atypical melanocytes, with mitotic figures evident within the dermal component, compatible with melanoma. There is also a population of somewhat smaller melanocytes near the base of this proliferation. Some of these probably represent small cells of melanoma, while there may some nevus present there as well. The measurement of thickness is thus based on my best judgment as to what represents the component of melanoma. In terms of other staging parameters, this is a non-ulcerated primary melanoma of Clark's anatomic level IV. There are no other features which would have a significant impact on prognosis. Complete re-excision is of course warranted. I have also shared this unusual case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with these findings.","Sections show a bilobed, somewhat polypoid proliferation of melanocytes in a biphasic pattern. The smaller lobe contains an intradermal proliferation of bland melanocytes, which demonstrate a degree of neural differentiation (melanocytic nevus). In the other more polypoid zone, there is a markedly asymmetrical proliferation of atypical melanocytes, which are morphologically heterogeneous, arrayed as irregular clusters and syncytia. In many areas, these fail to mature with descent. Mitotic figures are evident within the dermal component. In areas near the base, there is also a population of smaller melanocytes. Some are in continuity with some of the larger ones overlying them, while others are somewhat bland and may demonstrate a degree of maturation with melanocytic descent. There is fibrosis, and a patchy lymphocytic infiltrate, as well as dilated lymphovascular spaces.",68,,1.7,,,,F,761160
Ivanka_16_1,09-8165,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,34.8,,Melanoma with nevus,,Nimblegen24_BB29,BB29_SeqL,BB29_CL,Melanoma,NimV2mix3,09-8165_Melanoma,NA_09-8165_Melanoma,09-8165,A,"MELANOMA, APPROXIMATELY 1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 2 MM OF THE PERIPHERY OF THE EXCISION",173568,172.5,"In terms of staging, this is a probably non-ulcerated, primary melanoma of Clark's anatomic level III/IV, extending to and possibly involving the papillary dermal-superficial reticular dermal interface. Measurement of thickness is an approximation, as the epidermis is disrupted overlying the thickest portion of the neoplasm. While there is near confluence of melanocytes in this zone, it is difficult to know whether ulceration has occurred. I suspect that it has not. There is no evidence of neurotropism, vascular invasion, or regression in these sections. Additional excision is warranted to achieve standard margins for a tumor of these staging parameters. This case was reissued on April 20, 2009 to add the patient's UCSF medical record number.","Sections show a markedly atypical, compound proliferation of melanocytes, with a subtly biphasic pattern. Within the epidermis, there are atypical melanocytes, arrayed as nests, single cells, and in zones of near confluence, with an area in which the epidermis is disrupted. Similar melanocytes are present in clusters and syncytia within the papillary dermis, filling it, and extending to the reticular dermal interface. Near the base of the specimen, there is another population of somewhat smaller bland melanocytes, arrayed as clusters and syncytia, and these demonstrate maturation with melanocytic descent (melanocytic nevus). There is a patchy lymphocytic infiltrate, and scattered melanophages.",59,,1,,,,M,458841
Ivanka_16_2,09-8165,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,39.6,,Melanoma with nevus,,Nimblegen24_BB29,BB29_SeqL,BB29_CL,Melanoma,NimV2mix3,09-8165_Melanoma,NA_09-8165_Melanoma,09-8165,A,"MELANOMA, APPROXIMATELY 1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 2 MM OF THE PERIPHERY OF THE EXCISION",173568,172.5,"In terms of staging, this is a probably non-ulcerated, primary melanoma of Clark's anatomic level III/IV, extending to and possibly involving the papillary dermal-superficial reticular dermal interface. Measurement of thickness is an approximation, as the epidermis is disrupted overlying the thickest portion of the neoplasm. While there is near confluence of melanocytes in this zone, it is difficult to know whether ulceration has occurred. I suspect that it has not. There is no evidence of neurotropism, vascular invasion, or regression in these sections. Additional excision is warranted to achieve standard margins for a tumor of these staging parameters. This case was reissued on April 20, 2009 to add the patient's UCSF medical record number.","Sections show a markedly atypical, compound proliferation of melanocytes, with a subtly biphasic pattern. Within the epidermis, there are atypical melanocytes, arrayed as nests, single cells, and in zones of near confluence, with an area in which the epidermis is disrupted. Similar melanocytes are present in clusters and syncytia within the papillary dermis, filling it, and extending to the reticular dermal interface. Near the base of the specimen, there is another population of somewhat smaller bland melanocytes, arrayed as clusters and syncytia, and these demonstrate maturation with melanocytic descent (melanocytic nevus). There is a patchy lymphocytic infiltrate, and scattered melanophages.",59,,1,,,,M,458841
Ivanka_16_3,09-8165,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,11.4,,Melanoma with nevus,,Nimblegen24_BB29,BB29_SeqL,BB29_CL,Nevus,NimV2mix3,09-8165_Nevus,NA_09-8165_Nevus,09-8165,A,"MELANOMA, APPROXIMATELY 1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 2 MM OF THE PERIPHERY OF THE EXCISION",173568,172.5,"In terms of staging, this is a probably non-ulcerated, primary melanoma of Clark's anatomic level III/IV, extending to and possibly involving the papillary dermal-superficial reticular dermal interface. Measurement of thickness is an approximation, as the epidermis is disrupted overlying the thickest portion of the neoplasm. While there is near confluence of melanocytes in this zone, it is difficult to know whether ulceration has occurred. I suspect that it has not. There is no evidence of neurotropism, vascular invasion, or regression in these sections. Additional excision is warranted to achieve standard margins for a tumor of these staging parameters. This case was reissued on April 20, 2009 to add the patient's UCSF medical record number.","Sections show a markedly atypical, compound proliferation of melanocytes, with a subtly biphasic pattern. Within the epidermis, there are atypical melanocytes, arrayed as nests, single cells, and in zones of near confluence, with an area in which the epidermis is disrupted. Similar melanocytes are present in clusters and syncytia within the papillary dermis, filling it, and extending to the reticular dermal interface. Near the base of the specimen, there is another population of somewhat smaller bland melanocytes, arrayed as clusters and syncytia, and these demonstrate maturation with melanocytic descent (melanocytic nevus). There is a patchy lymphocytic infiltrate, and scattered melanophages.",59,,1,,,,M,458841
Ivanka_16_4,09-8165,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,19.1,,Melanoma with nevus,,Nimblegen24_BB29,BB29_SeqL,BB29_CL,Nevus,NimV2mix3,09-8165_Nevus,NA_09-8165_Nevus,09-8165,A,"MELANOMA, APPROXIMATELY 1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 2 MM OF THE PERIPHERY OF THE EXCISION",173568,172.5,"In terms of staging, this is a probably non-ulcerated, primary melanoma of Clark's anatomic level III/IV, extending to and possibly involving the papillary dermal-superficial reticular dermal interface. Measurement of thickness is an approximation, as the epidermis is disrupted overlying the thickest portion of the neoplasm. While there is near confluence of melanocytes in this zone, it is difficult to know whether ulceration has occurred. I suspect that it has not. There is no evidence of neurotropism, vascular invasion, or regression in these sections. Additional excision is warranted to achieve standard margins for a tumor of these staging parameters. This case was reissued on April 20, 2009 to add the patient's UCSF medical record number.","Sections show a markedly atypical, compound proliferation of melanocytes, with a subtly biphasic pattern. Within the epidermis, there are atypical melanocytes, arrayed as nests, single cells, and in zones of near confluence, with an area in which the epidermis is disrupted. Similar melanocytes are present in clusters and syncytia within the papillary dermis, filling it, and extending to the reticular dermal interface. Near the base of the specimen, there is another population of somewhat smaller bland melanocytes, arrayed as clusters and syncytia, and these demonstrate maturation with melanocytic descent (melanocytic nevus). There is a patchy lymphocytic infiltrate, and scattered melanophages.",59,,1,,,,M,458841
Ivanka_16_5,09-8165,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,20.7,,Melanoma with nevus,,Nimblegen24_BB29,BB29_SeqL,BB29_CL,Normal,NimV2mix3,09-8165_Normal,NA_09-8165_Normal,09-8165,A,"MELANOMA, APPROXIMATELY 1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 2 MM OF THE PERIPHERY OF THE EXCISION",173568,172.5,"In terms of staging, this is a probably non-ulcerated, primary melanoma of Clark's anatomic level III/IV, extending to and possibly involving the papillary dermal-superficial reticular dermal interface. Measurement of thickness is an approximation, as the epidermis is disrupted overlying the thickest portion of the neoplasm. While there is near confluence of melanocytes in this zone, it is difficult to know whether ulceration has occurred. I suspect that it has not. There is no evidence of neurotropism, vascular invasion, or regression in these sections. Additional excision is warranted to achieve standard margins for a tumor of these staging parameters. This case was reissued on April 20, 2009 to add the patient's UCSF medical record number.","Sections show a markedly atypical, compound proliferation of melanocytes, with a subtly biphasic pattern. Within the epidermis, there are atypical melanocytes, arrayed as nests, single cells, and in zones of near confluence, with an area in which the epidermis is disrupted. Similar melanocytes are present in clusters and syncytia within the papillary dermis, filling it, and extending to the reticular dermal interface. Near the base of the specimen, there is another population of somewhat smaller bland melanocytes, arrayed as clusters and syncytia, and these demonstrate maturation with melanocytic descent (melanocytic nevus). There is a patchy lymphocytic infiltrate, and scattered melanophages.",59,,1,,,,M,458841
Ivanka_22_1,08-46462,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,94.9,,Melanoma with nevus,,Nimblegen24_BB29,BB29_SeqL,BB29_CL,Melanoma,NimV2mix3,08-46462_Melanoma,NA_08-46462_Melanoma,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
Ivanka_22_2,08-46462,L2DR14,CACCTC,13 Cycle Post Hybridization LM-PCR,100,,Melanoma with nevus,,Nimblegen24_BB29,BB29_SeqL,BB29_CL,Melanoma,NimV2mix3,08-46462_Melanoma,NA_08-46462_Melanoma,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
Ivanka_22_3,08-46462,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,82.4,,Melanoma with nevus,,Nimblegen24_BB29,BB29_SeqL,BB29_CL,Nevus,NimV2mix3,08-46462_Nevus,NA_08-46462_Nevus,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
Ivanka_22_4,08-46462,L2DR16,TGTTGC,13 Cycle Post Hybridization LM-PCR,20.2,,Melanoma with nevus,,Nimblegen24_BB29,BB29_SeqL,BB29_CL,Nevus,NimV2mix3,08-46462_Nevus,NA_08-46462_Nevus,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
Ivanka_22_5,08-46462,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,10.8,,Melanoma with nevus,,Nimblegen24_BB29,BB29_SeqL,BB29_CL,Normal,NimV2mix3,08-46462_Normal,NA_08-46462_Normal,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
CGH11-115,11-25808,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,45.1,,"Iwei, Translocation CGH, PDGFRB",CGH11-115 ,Nimblegen25_BB30,BB30_SeqL,BB30_CL,Tumor,NimV2mix4,11-25808_Tumor,NA_11-25808_Tumor,11-25808,A,"MELANOMA, 0.7 MM. IN THICKNESS",173726,172.7,"The neoplasm extends to the peripheral edge of the specimen. While the distribution of melanocytes within the epidermis is irregular, and some of the cells in the dermis are moderately enlarged, other features raise the possibility of an unusual congenital nevus. The dermal component matures with descent in areas, and mostly has discrete aggregations of cells. As nevoid melanoma is in the differential diagnosis, I obtained immunoperoxidase stains. These include an HMB45 stain, strongly positive at the dermo-epidermal junction and weakly positive within only the superficial-most melanocytes. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a near zero proliferation rate in the dermal melanocytes.  A scout section (the hematoxylin and eosin stained recut that we obtain at the time that sections are cut for immunoperoxidase stains) contained several melanocytes in mitosis. B  Comparative genomic hybridization shows a gain involving chromosome 7, a loss of chromosome 9, and a gain of most of chromosome 14. This combination of features indicates melanoma. Whether a component of nevus is also present could not be determined.  While the lesion is not ulcerated, the presence of melanocytes in mitosis in the dermis qualifies this lesion as T1b in the 2009 AJCC staging classification for melanoma.","There is a broad-based proliferation of melanocytes involving the epidermis and superficial dermis. The epidermis is hyperplastic, and there are increased numbers of single melanocytes and both small and large nests of them positioned at irregular intervals along the junction. Some branching rete ridges are evident, with subjacent fibrosis. There are nests, cords and strands of plump oval to small round melanocytes in the subjacent dermis, with some tendency to cluster around the upper parts of adnexal structures.",41,T1b,0.7,,Primary,,F,1015246
CGH11-184,11-42027,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,100,,"Iwei, Translocation CGH, PDGFRB",CGH11-184 ,Nimblegen25_BB30,BB30_SeqL,BB30_CL,Tumor,NimV2mix4,11-42027_Tumor,NA_11-42027_Tumor,11-42027,A,"MELANOMA, WITH MULTIPLE GENOMIC ABERRATIONS",173406,172.4,,This material was previously evaluated as our DL11-27112; please see that report for microscopic description.,73,,,,,,M,940410
CGH12-043,12-7775,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,100,,"Iwei, Translocation CGH, MET",CGH12-043 ,Nimblegen25_BB30,BB30_SeqL,BB30_CL,Tumor,NimV2mix4,12-7775_Tumor,NA_12-7775_Tumor,12-7775,A,"COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, WITH FINDINGS FAVORING AN UNUSUAL SPITZ'S NEVUS",173508,238.2,"Comparative genomic hybridization shows a narrow gain involving an area of chromosome 7q and a narrow gain with higher amplitude involving a second area of 7q. Isolated gains involving chromosome 7q can occur in Spitz's nevus. My colleague, Dr. Boris Bastian examined the comparative genomic hybridization examined the comparative genomic hybridization data and notes that the larger gain includes the MET locus. This finding has been seen previously in Spitz's nevus. Given that the changes are less straightforward than the finding of no gains or losses, or of an isolated gain of 11p or of the entire 7q arm, I would like to leave the diagnosis somewhat ambiguous, but favoring a Spitz's nevus. The neoplasm extends to the base of the specimen across a broad front, and if there is a significant residuum on re-excision, I would be interested in viewing the sections.","Sections show a broad based proliferation of large, oval and fusiform melanocytes, positioned as nests along the undersurface of an irregularly hyperplastic epidermis, and as smaller aggregations in a fibrotic superficial dermis. There are clefts between melanocytes and between them and  the adjacent epidermis. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. Several mitotic figures are present, including some near the base of the specimen.",24,,,,,,F,1093591
DM93_2_Tumor,DM93,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,10,,"Hunter, Desmoplastic Melanoma ",,Nimblegen25_BB30,BB30_SeqL,BB30_CL,Tumor,NimV2mix4,DM93_Tumor,NA_DM93_Tumor,,,,,,,,,,,,,,,
DM37_1_Normal,DM37,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,62,,"Hunter, Desmoplastic Melanoma ",,Nimblegen25_BB30,BB30_SeqL,BB30_CL,Normal,NimV2mix4,DM37_Normal,NA_DM37_Normal,,,,,,,,,,,,,,,
DM45_2_Tumor,DM45,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,31.6,,"Hunter, Desmoplastic Melanoma ",,Nimblegen25_BB30,BB30_SeqL,BB30_CL,Tumor,NimV2mix4,DM45_Tumor,NA_DM45_Tumor,,,,,,,,,,,,,,,
DM45_Normal,DM45,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,22,,"Hunter, Desmoplastic Melanoma ",,Nimblegen25_BB30,BB30_SeqL,BB30_CL,Normal,NimV2mix4,DM45_Normal,NA_DM45_Normal,,,,,,,,,,,,,,,
DM16_Tumor,DM16,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,31.3,,"Hunter, Desmoplastic Melanoma ",,Nimblegen25_BB30,BB30_SeqL,BB30_CL,Tumor,NimV2mix4,DM16_Tumor,NA_DM16_Tumor,,,,,,,,,,,,,,,
DM16_Normal,DM16,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma ",,Nimblegen25_BB30,BB30_SeqL,BB30_CL,Normal,NimV2mix4,DM16_Normal,NA_DM16_Normal,,,,,,,,,,,,,,,
DM77_2_Tumor,DM77,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,57.2,,"Hunter, Desmoplastic Melanoma ",,Nimblegen25_BB30,BB30_SeqL,BB30_CL,Tumor,NimV2mix4,DM77_Tumor,NA_DM77_Tumor,,,,,,,,,,,,,,,
DM77_Normal,DM77,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma ",,Nimblegen25_BB30,BB30_SeqL,BB30_CL,Normal,NimV2mix4,DM77_Normal,NA_DM77_Normal,,,,,,,,,,,,,,,
HW_3_Tumor,HW3,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,,,"Hong Wu, Melanoma, Tumor Melanoma, nasal sinus",,Nimblegen26_BB31,BB31_SeqL,BB31_CL,Tumor,NimV2mix4,HW3_Tumor,NA_HW3_Tumor,,,,,,,,,,,,,,,
HW_2_Tumor Dissect,HW2,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,11,,"Hong Wu, Melanoma, Mucosal Melanoma, vulva",,Nimblegen26_BB31,BB31_SeqL,BB31_CL,Tumor,NimV2mix4,HW2_Tumor,NA_HW2_Tumor,,,,,,,,,,,,,,,
HW_Acral_#8_Tumor,HWAcr,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,,,"Hong Wu, FCCC, Dissect, Acral Melanoma, Dissect",,Nimblegen26_BB31,BB31_SeqL,BB31_CL,Tumor,NimV2mix4,HWAcr_Tumor,NA_HWAcr_Tumor,,,,,,,,,,,,,,,
Kit_181_Muc BRAF,KIT181,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,,,"Alyssa Acral Mucosal, Mucosal, BRAF, glans penis",_Muc BRAF,Nimblegen26_BB31,BB31_SeqL,BB31_CL,Tumor,NimV2mix4,KIT181_Tumor,NA_KIT181_Tumor,,,,,,,,,,,,,,,
DM_13_2_Tumor,DM13,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen26_BB31,BB31_SeqL,BB31_CL,Tumor,NimV2mix4,DM13_Tumor,NA_DM13_Tumor,,,,,,,,,,,,,,,
DM_94_Tumor,DM94,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,69.6,,"Hunter, Desmoplastic Melanoma",,Nimblegen26_BB31,BB31_SeqL,BB31_CL,Tumor,NimV2mix4,DM94_Tumor,NA_DM94_Tumor,,,,,,,,,,,,,,,
DM_94_Normal,DM94,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,10.1,,"Hunter, Desmoplastic Melanoma",,Nimblegen26_BB31,BB31_SeqL,BB31_CL,Normal,NimV2mix4,DM94_Normal,NA_DM94_Normal,,,,,,,,,,,,,,,
DM_98_Tumor,DM98,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen26_BB31,BB31_SeqL,BB31_CL,Tumor,NimV2mix4,DM98_Tumor,NA_DM98_Tumor,,,,,,,,,,,,,,,
DM_98_2_Normal,DM98,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,89.6,,"Hunter, Desmoplastic Melanoma",,Nimblegen26_BB31,BB31_SeqL,BB31_CL,Normal,NimV2mix4,DM98_Normal,NA_DM98_Normal,,,,,,,,,,,,,,,
DM_99_Tumor,DM99,L2DR14,CACCTC,13 Cycle Post Hybridization LM-PCR,12.6,,"Hunter, Desmoplastic Melanoma",,Nimblegen26_BB31,BB31_SeqL,BB31_CL,Tumor,NimV2mix4,DM99_Tumor,NA_DM99_Tumor,,,,,,,,,,,,,,,
DM_99_Normal,DM99,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,77.8,,"Hunter, Desmoplastic Melanoma",,Nimblegen26_BB31,BB31_SeqL,BB31_CL,Normal,NimV2mix4,DM99_Normal,NA_DM99_Normal,,,,,,,,,,,,,,,
DM_64_Tumor,DM64,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen27_BB32,BB32_SeqL,BB32_CL,Tumor,NimV2mix4,DM64_Tumor,NA_DM64_Tumor,,,,,,,,,,,,,,,
DM_64_1_Normal,DM64,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,35.8,,"Hunter, Desmoplastic Melanoma",,Nimblegen27_BB32,BB32_SeqL,BB32_CL,Normal,NimV2mix4,DM64_Normal,NA_DM64_Normal,,,,,,,,,,,,,,,
DM_51_Tumor,DM51,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen27_BB32,BB32_SeqL,BB32_CL,Tumor,NimV2mix4,DM51_Tumor,NA_DM51_Tumor,,,,,,,,,,,,,,,
DM_58_Tumor,DM58,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen27_BB32,BB32_SeqL,BB32_CL,Tumor,NimV2mix4,DM58_Tumor,NA_DM58_Tumor,,,,,,,,,,,,,,,
DM_59_Tumor,DM59,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma",,Nimblegen27_BB32,BB32_SeqL,BB32_CL,Tumor,NimV2mix4,DM59_Tumor,NA_DM59_Tumor,,,,,,,,,,,,,,,
DM_31_2_Tumor,DM31,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,16.2,,"Hunter, Desmoplastic Melanoma",,Nimblegen27_BB32,BB32_SeqL,BB32_CL,Tumor,NimV2mix4,DM31_Tumor,NA_DM31_Tumor,,,,,,,,,,,,,,,
DM_36_2_Tumor,DM36,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,28.6,,"Hunter, Desmoplastic Melanoma",,Nimblegen27_BB32,BB32_SeqL,BB32_CL,Tumor,NimV2mix4,DM36_Tumor,NA_DM36_Tumor,,,,,,,,,,,,,,,
DM_74_2_Tumor,DM74,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,12.2,,"Hunter, Desmoplastic Melanoma",,Nimblegen27_BB32,BB32_SeqL,BB32_CL,Tumor,NimV2mix4,DM74_Tumor,NA_DM74_Tumor,,,,,,,,,,,,,,,
DM_10_Tumor,DM10,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,,,"Hunter, Desmoplastic Melanoma",,Nimblegen27_BB32,BB32_SeqL,BB32_CL,Tumor,NimV2mix4,DM10_Tumor,NA_DM10_Tumor,,,,,,,,,,,,,,,
DM_18_Tumor,DM18,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,,,"Hunter, Desmoplastic Melanoma",,Nimblegen27_BB32,BB32_SeqL,BB32_CL,Tumor,NimV2mix4,DM18_Tumor,NA_DM18_Tumor,,,,,,,,,,,,,,,
HW_8_Mucosal_Tumor,HW8,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,100,,Hong Wu,,Nimblegen27_BB32,BB32_SeqL,BB32_CL,Tumor,NimV2mix4,HW8_Tumor,NA_HW8_Tumor,,,,,,,,,,,,,,,
Ivanka_5_1,08-43264,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,21.6,,Ivanka Patient Melanoma,,Nimblegen28_BB33,BB33_SeqL,BB33_CL,Melanoma,NimV2mix3,08-43264_Melanoma,NA_08-43264_Melanoma,08-43264,A,"MELANOMA, 0.5 MM  IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173529,172.5,"The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above. The lesion is not ulcerated, and only involves a portion of the papillary dermis (level II).","Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. A large portion of the lesion is a predominantly intradermal proliferation of melanocytes, in which nests, cords and strands of small, round cells mature as they extend into the superficial reticular dermis.  Near the periphery, there are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in some areas. A few similar cells reside in the subjacent papillary dermis.",50,,0.5,,,,F,179649
Ivanka_5_2,08-43264,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,65.1,,Ivanka Patient Melanoma,,Nimblegen28_BB33,BB33_SeqL,BB33_CL,Melanoma,NimV2mix3,08-43264_Melanoma,NA_08-43264_Melanoma,08-43264,A,"MELANOMA, 0.5 MM  IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173529,172.5,"The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above. The lesion is not ulcerated, and only involves a portion of the papillary dermis (level II).","Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. A large portion of the lesion is a predominantly intradermal proliferation of melanocytes, in which nests, cords and strands of small, round cells mature as they extend into the superficial reticular dermis.  Near the periphery, there are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in some areas. A few similar cells reside in the subjacent papillary dermis.",50,,0.5,,,,F,179649
Ivanka_5_3,08-43264,L2DR14,CACCTC,13 Cycle Post Hybridization LM-PCR,80.6,,Ivanka Patient Melanoma,,Nimblegen28_BB33,BB33_SeqL,BB33_CL,Nevus,NimV2mix3,08-43264_Nevus,NA_08-43264_Nevus,08-43264,A,"MELANOMA, 0.5 MM  IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173529,172.5,"The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above. The lesion is not ulcerated, and only involves a portion of the papillary dermis (level II).","Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. A large portion of the lesion is a predominantly intradermal proliferation of melanocytes, in which nests, cords and strands of small, round cells mature as they extend into the superficial reticular dermis.  Near the periphery, there are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in some areas. A few similar cells reside in the subjacent papillary dermis.",50,,0.5,,,,F,179649
Ivanka_5_4,08-43264,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,93.6,,Ivanka Patient Melanoma,,Nimblegen28_BB33,BB33_SeqL,BB33_CL,Nevus,NimV2mix3,08-43264_Nevus,NA_08-43264_Nevus,08-43264,A,"MELANOMA, 0.5 MM  IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173529,172.5,"The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above. The lesion is not ulcerated, and only involves a portion of the papillary dermis (level II).","Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. A large portion of the lesion is a predominantly intradermal proliferation of melanocytes, in which nests, cords and strands of small, round cells mature as they extend into the superficial reticular dermis.  Near the periphery, there are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in some areas. A few similar cells reside in the subjacent papillary dermis.",50,,0.5,,,,F,179649
Ivanka_5_5,08-43264,L2DR16,TGTTGC,13 Cycle Post Hybridization LM-PCR,42.8,,Ivanka Patient Melanoma,,Nimblegen28_BB33,BB33_SeqL,BB33_CL,Normal,NimV2mix3,08-43264_Normal,NA_08-43264_Normal,08-43264,A,"MELANOMA, 0.5 MM  IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173529,172.5,"The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above. The lesion is not ulcerated, and only involves a portion of the papillary dermis (level II).","Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. A large portion of the lesion is a predominantly intradermal proliferation of melanocytes, in which nests, cords and strands of small, round cells mature as they extend into the superficial reticular dermis.  Near the periphery, there are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in some areas. A few similar cells reside in the subjacent papillary dermis.",50,,0.5,,,,F,179649
Ivanka_10_1,08-51219,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,38.3,,Ivanka Patient Melanoma,,Nimblegen28_BB33,BB33_SeqL,BB33_CL,Melanoma,NimV2mix3,08-51219_Melanoma,NA_08-51219_Melanoma,08-51219,A,"MELANOMA IN SITU, EXTENDING NEAR TO THE PERIPHERY OF THE SPECIMEN",529698,232.6,"I also considered the possibility of a severely dysplastic nevus in my differential diagnosis, but I find the above designation preferable. Further excision of this site is warranted to ensure that local eradication has been accomplished.","Sections show a broad array of melanocytes, positioned as single cells and nests along the sides and bases of elongated and pigmented rete, above marked elastosis in the dermis. Some lesional melanocytes extend into adnexa and rare single cells can be found in the stratum spinosum. There is a sparse superficial lymphohistiocytic infiltrate with admixed melanophages.",65,,,,,,M,754897
Ivanka_10_2,08-51219,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,49,,Ivanka Patient Melanoma,,Nimblegen28_BB33,BB33_SeqL,BB33_CL,Melanoma,NimV2mix3,08-51219_Melanoma,NA_08-51219_Melanoma,08-51219,A,"MELANOMA IN SITU, EXTENDING NEAR TO THE PERIPHERY OF THE SPECIMEN",529698,232.6,"I also considered the possibility of a severely dysplastic nevus in my differential diagnosis, but I find the above designation preferable. Further excision of this site is warranted to ensure that local eradication has been accomplished.","Sections show a broad array of melanocytes, positioned as single cells and nests along the sides and bases of elongated and pigmented rete, above marked elastosis in the dermis. Some lesional melanocytes extend into adnexa and rare single cells can be found in the stratum spinosum. There is a sparse superficial lymphohistiocytic infiltrate with admixed melanophages.",65,,,,,,M,754897
Ivanka_10_3,08-51219,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,100,,Ivanka Patient Melanoma,,Nimblegen28_BB33,BB33_SeqL,BB33_CL,Nevus,NimV2mix3,08-51219_Nevus,NA_08-51219_Nevus,08-51219,A,"MELANOMA IN SITU, EXTENDING NEAR TO THE PERIPHERY OF THE SPECIMEN",529698,232.6,"I also considered the possibility of a severely dysplastic nevus in my differential diagnosis, but I find the above designation preferable. Further excision of this site is warranted to ensure that local eradication has been accomplished.","Sections show a broad array of melanocytes, positioned as single cells and nests along the sides and bases of elongated and pigmented rete, above marked elastosis in the dermis. Some lesional melanocytes extend into adnexa and rare single cells can be found in the stratum spinosum. There is a sparse superficial lymphohistiocytic infiltrate with admixed melanophages.",65,,,,,,M,754897
Ivanka_10_4,08-51219,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,11,,Ivanka Patient Melanoma,,Nimblegen28_BB33,BB33_SeqL,BB33_CL,Nevus,NimV2mix3,08-51219_Nevus,NA_08-51219_Nevus,08-51219,A,"MELANOMA IN SITU, EXTENDING NEAR TO THE PERIPHERY OF THE SPECIMEN",529698,232.6,"I also considered the possibility of a severely dysplastic nevus in my differential diagnosis, but I find the above designation preferable. Further excision of this site is warranted to ensure that local eradication has been accomplished.","Sections show a broad array of melanocytes, positioned as single cells and nests along the sides and bases of elongated and pigmented rete, above marked elastosis in the dermis. Some lesional melanocytes extend into adnexa and rare single cells can be found in the stratum spinosum. There is a sparse superficial lymphohistiocytic infiltrate with admixed melanophages.",65,,,,,,M,754897
Ivanka_10_5,08-51219,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,21.4,,Ivanka Patient Melanoma,,Nimblegen28_BB33,BB33_SeqL,BB33_CL,Normal,NimV2mix3,08-51219_Normal,NA_08-51219_Normal,08-51219,A,"MELANOMA IN SITU, EXTENDING NEAR TO THE PERIPHERY OF THE SPECIMEN",529698,232.6,"I also considered the possibility of a severely dysplastic nevus in my differential diagnosis, but I find the above designation preferable. Further excision of this site is warranted to ensure that local eradication has been accomplished.","Sections show a broad array of melanocytes, positioned as single cells and nests along the sides and bases of elongated and pigmented rete, above marked elastosis in the dermis. Some lesional melanocytes extend into adnexa and rare single cells can be found in the stratum spinosum. There is a sparse superficial lymphohistiocytic infiltrate with admixed melanophages.",65,,,,,,M,754897
Algazi_Tumor,S12-18826,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,40.7,,Alain Algazi,,Nimblegen28_BB33,BB33_SeqL,BB33_CL,Tumor,NimV2mix3,S12-18826_Tumor,NA_S12-18826_Tumor,,,,,,,,,,,,,,,
Ivanka_20_1,11-81851,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,100,,Ivanka Patient Melanoma,,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Melanoma,NimV2mix3,11-81851_Melanoma,NA_11-81851_Melanoma,11-81851,A,"MELANOMA, 1.9 MM IN THICKNESS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY",173404,172.4,The melanoma arose in continuity with an intradermal melanocytic nevus. Histopathologic features of possible prognostic importance include: Level: IV Tumor infiltrating lymphocytes: non-brisk Vascular or lymphatic invasion: non detected Dermal mitotic rate:  5/mm2 Perineural invasion: not detected Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: moderate (non-CSD) WHO type: superficial spreading melanoma,"Sections show nodular aggregations of melanocytes with atypical nuclei in the dermis, lack of maturation of these cells with descent, and their arrangement in irregularly shaped aggregations. There is a flanking intraepidermal component with pagetoid growth pattern.  A second population of small round melanocytes arranged in discrete collections is also present. Some of these melanocytes show neuroid differentiation.",67,,1.9,,,5,F,1071299
Ivanka_20_2,11-81851,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,100,,Ivanka Patient Melanoma,,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Melanoma,NimV2mix3,11-81851_Melanoma,NA_11-81851_Melanoma,11-81851,A,"MELANOMA, 1.9 MM IN THICKNESS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY",173404,172.4,The melanoma arose in continuity with an intradermal melanocytic nevus. Histopathologic features of possible prognostic importance include: Level: IV Tumor infiltrating lymphocytes: non-brisk Vascular or lymphatic invasion: non detected Dermal mitotic rate:  5/mm2 Perineural invasion: not detected Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: moderate (non-CSD) WHO type: superficial spreading melanoma,"Sections show nodular aggregations of melanocytes with atypical nuclei in the dermis, lack of maturation of these cells with descent, and their arrangement in irregularly shaped aggregations. There is a flanking intraepidermal component with pagetoid growth pattern.  A second population of small round melanocytes arranged in discrete collections is also present. Some of these melanocytes show neuroid differentiation.",67,,1.9,,,5,F,1071299
Ivanka_20_3,11-81851,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,41.5,,Ivanka Patient Melanoma,,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Nevus,NimV2mix3,11-81851_Nevus,NA_11-81851_Nevus,11-81851,A,"MELANOMA, 1.9 MM IN THICKNESS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY",173404,172.4,The melanoma arose in continuity with an intradermal melanocytic nevus. Histopathologic features of possible prognostic importance include: Level: IV Tumor infiltrating lymphocytes: non-brisk Vascular or lymphatic invasion: non detected Dermal mitotic rate:  5/mm2 Perineural invasion: not detected Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: moderate (non-CSD) WHO type: superficial spreading melanoma,"Sections show nodular aggregations of melanocytes with atypical nuclei in the dermis, lack of maturation of these cells with descent, and their arrangement in irregularly shaped aggregations. There is a flanking intraepidermal component with pagetoid growth pattern.  A second population of small round melanocytes arranged in discrete collections is also present. Some of these melanocytes show neuroid differentiation.",67,,1.9,,,5,F,1071299
Ivanka_20_4,11-81851,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,61.2,,Ivanka Patient Melanoma,,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Nevus,NimV2mix3,11-81851_Nevus,NA_11-81851_Nevus,11-81851,A,"MELANOMA, 1.9 MM IN THICKNESS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY",173404,172.4,The melanoma arose in continuity with an intradermal melanocytic nevus. Histopathologic features of possible prognostic importance include: Level: IV Tumor infiltrating lymphocytes: non-brisk Vascular or lymphatic invasion: non detected Dermal mitotic rate:  5/mm2 Perineural invasion: not detected Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: moderate (non-CSD) WHO type: superficial spreading melanoma,"Sections show nodular aggregations of melanocytes with atypical nuclei in the dermis, lack of maturation of these cells with descent, and their arrangement in irregularly shaped aggregations. There is a flanking intraepidermal component with pagetoid growth pattern.  A second population of small round melanocytes arranged in discrete collections is also present. Some of these melanocytes show neuroid differentiation.",67,,1.9,,,5,F,1071299
Ivanka_20_5,11-81851,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,10.2,,Ivanka Patient Melanoma,,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Normal,NimV2mix3,11-81851_Normal,NA_11-81851_Normal,11-81851,A,"MELANOMA, 1.9 MM IN THICKNESS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY",173404,172.4,The melanoma arose in continuity with an intradermal melanocytic nevus. Histopathologic features of possible prognostic importance include: Level: IV Tumor infiltrating lymphocytes: non-brisk Vascular or lymphatic invasion: non detected Dermal mitotic rate:  5/mm2 Perineural invasion: not detected Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: moderate (non-CSD) WHO type: superficial spreading melanoma,"Sections show nodular aggregations of melanocytes with atypical nuclei in the dermis, lack of maturation of these cells with descent, and their arrangement in irregularly shaped aggregations. There is a flanking intraepidermal component with pagetoid growth pattern.  A second population of small round melanocytes arranged in discrete collections is also present. Some of these melanocytes show neuroid differentiation.",67,,1.9,,,5,F,1071299
Ivanka_23_1,10-73024,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,22.9,,Ivanka Patient Melanoma,,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Melanoma,NimV2mix3,10-73024_Melanoma,NA_10-73024_Melanoma,10-73024,A,"MELANOMA, 0.32 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, NARROWLY EXCISED",173611,172.6,"Melan-A stains were done and they highlight a broad proliferation of atypical melanocytes at the dermoepidermal junction and above it.  A few nests of atypical melanocytes are also noted in the dermis.  These were difficult to detect on routine staining due to the associated dense band like infiltrate of lymphocytes and melanophages.  The lesion has been completely, but narrowly excised.  Melanoma in situ is present to within 1 millimeter of the 9 o'clock position with the orienting notch designated as 12 o'clock.  In terms of staging this is a thin non-ulcerated melanoma with foci of regression.  No dermal mitotic figures are noted within the small dermal component.  It should be regarded as a pT1a lesion based on the 2009 AJCC melanoma staging system.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  There is an associated dense band like lymphocytic infiltrate with numerous melanophages.  There are foci of epidermal atrophy with an associated paucity of melanocytes.",55,T1a,0.32,,Primary,,M,967603
Ivanka_23_2,10-73024,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,57.2,,Ivanka Patient Melanoma,,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Melanoma,NimV2mix3,10-73024_Melanoma,NA_10-73024_Melanoma,10-73024,A,"MELANOMA, 0.32 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, NARROWLY EXCISED",173611,172.6,"Melan-A stains were done and they highlight a broad proliferation of atypical melanocytes at the dermoepidermal junction and above it.  A few nests of atypical melanocytes are also noted in the dermis.  These were difficult to detect on routine staining due to the associated dense band like infiltrate of lymphocytes and melanophages.  The lesion has been completely, but narrowly excised.  Melanoma in situ is present to within 1 millimeter of the 9 o'clock position with the orienting notch designated as 12 o'clock.  In terms of staging this is a thin non-ulcerated melanoma with foci of regression.  No dermal mitotic figures are noted within the small dermal component.  It should be regarded as a pT1a lesion based on the 2009 AJCC melanoma staging system.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  There is an associated dense band like lymphocytic infiltrate with numerous melanophages.  There are foci of epidermal atrophy with an associated paucity of melanocytes.",55,T1a,0.32,,Primary,,M,967603
Ivanka_23_3,10-73024,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,11,,Ivanka Patient Melanoma,,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Nevus,NimV2mix3,10-73024_Nevus,NA_10-73024_Nevus,10-73024,A,"MELANOMA, 0.32 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, NARROWLY EXCISED",173611,172.6,"Melan-A stains were done and they highlight a broad proliferation of atypical melanocytes at the dermoepidermal junction and above it.  A few nests of atypical melanocytes are also noted in the dermis.  These were difficult to detect on routine staining due to the associated dense band like infiltrate of lymphocytes and melanophages.  The lesion has been completely, but narrowly excised.  Melanoma in situ is present to within 1 millimeter of the 9 o'clock position with the orienting notch designated as 12 o'clock.  In terms of staging this is a thin non-ulcerated melanoma with foci of regression.  No dermal mitotic figures are noted within the small dermal component.  It should be regarded as a pT1a lesion based on the 2009 AJCC melanoma staging system.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  There is an associated dense band like lymphocytic infiltrate with numerous melanophages.  There are foci of epidermal atrophy with an associated paucity of melanocytes.",55,T1a,0.32,,Primary,,M,967603
Ivanka_23_4,10-73024,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,24.2,,Ivanka Patient Melanoma,,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Nevus,NimV2mix3,10-73024_Nevus,NA_10-73024_Nevus,10-73024,A,"MELANOMA, 0.32 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, NARROWLY EXCISED",173611,172.6,"Melan-A stains were done and they highlight a broad proliferation of atypical melanocytes at the dermoepidermal junction and above it.  A few nests of atypical melanocytes are also noted in the dermis.  These were difficult to detect on routine staining due to the associated dense band like infiltrate of lymphocytes and melanophages.  The lesion has been completely, but narrowly excised.  Melanoma in situ is present to within 1 millimeter of the 9 o'clock position with the orienting notch designated as 12 o'clock.  In terms of staging this is a thin non-ulcerated melanoma with foci of regression.  No dermal mitotic figures are noted within the small dermal component.  It should be regarded as a pT1a lesion based on the 2009 AJCC melanoma staging system.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  There is an associated dense band like lymphocytic infiltrate with numerous melanophages.  There are foci of epidermal atrophy with an associated paucity of melanocytes.",55,T1a,0.32,,Primary,,M,967603
Ivanka_23_5,10-73024,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,10.1,,Ivanka Patient Melanoma,,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Normal,NimV2mix3,10-73024_Normal,NA_10-73024_Normal,10-73024,A,"MELANOMA, 0.32 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, NARROWLY EXCISED",173611,172.6,"Melan-A stains were done and they highlight a broad proliferation of atypical melanocytes at the dermoepidermal junction and above it.  A few nests of atypical melanocytes are also noted in the dermis.  These were difficult to detect on routine staining due to the associated dense band like infiltrate of lymphocytes and melanophages.  The lesion has been completely, but narrowly excised.  Melanoma in situ is present to within 1 millimeter of the 9 o'clock position with the orienting notch designated as 12 o'clock.  In terms of staging this is a thin non-ulcerated melanoma with foci of regression.  No dermal mitotic figures are noted within the small dermal component.  It should be regarded as a pT1a lesion based on the 2009 AJCC melanoma staging system.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  There is an associated dense band like lymphocytic infiltrate with numerous melanophages.  There are foci of epidermal atrophy with an associated paucity of melanocytes.",55,T1a,0.32,,Primary,,M,967603
12_M,12_M,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,75.7,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Tumor,Ampliconseq,12_M_Tumor,NA_12_M_Tumor,,,,,,,,,,,,,,,
35_M,35_M,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Tumor,Ampliconseq,35_M_Tumor,NA_35_M_Tumor,,,,,,,,,,,,,,,
49_M,49_M,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Tumor,Ampliconseq,49_M_Tumor,NA_49_M_Tumor,,,,,,,,,,,,,,,
DM_2,DM2,L2DR14,CACCTC,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Tumor,Ampliconseq,DM2_Tumor,NA_DM2_Tumor,,,,,,,,,,,,,,,
bMV_10_0206,10-0206,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Tumor,Ampliconseq,10-0206_Tumor,NA_10-0206_Tumor,10-0206,A,,,,,,,,,,,,,
RPA_09_0209,09-0209,L2DR16,TGTTGC,13 Cycle Post Hybridization LM-PCR,100,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",,Nimblegen29_BB34,BB34_SeqL,BB34_CL,Tumor,Ampliconseq,09-0209_Tumor,NA_09-0209_Tumor,09-0209,A,,,,,,,,,,,,,
MIN_1,13-25110A1,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,46.7,,,,Nimblegen30_BB35,BB35_SeqL,BB35_CL,Melanoma,NimV2mix4,13-25110A1_Melanoma,NA_13-25110A1_Melanoma,13-25110,A,"MELANOMA, 1.2 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED",122741,172.7,"Melanoma in situ is present < 1 millimeter from the edge of the specimen.  This is a non-ulcerated melanoma.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.","There is a proliferation of melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm, arranged in an irregular pattern along the junction and within the dermis.  Suprabasal scatter of melanocytes is prominent in some areas.  In other areas the melanocytes are bland and mature with descent in the dermis.  There is an infiltrate of lymphocytes and melanophages.",29,T2a,1.2,,Primary,,F,1209855
MIN_2,13-25110A1,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,14.3,,,,Nimblegen30_BB35,BB35_SeqL,BB35_CL,Nevus,NimV2mix4,13-25110A1_Nevus,NA_13-25110A1_Nevus,13-25110,A,"MELANOMA, 1.2 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED",122741,172.7,"Melanoma in situ is present < 1 millimeter from the edge of the specimen.  This is a non-ulcerated melanoma.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.","There is a proliferation of melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm, arranged in an irregular pattern along the junction and within the dermis.  Suprabasal scatter of melanocytes is prominent in some areas.  In other areas the melanocytes are bland and mature with descent in the dermis.  There is an infiltrate of lymphocytes and melanophages.",29,T2a,1.2,,Primary,,F,1209855
MIN_3,13-25110A1,L2DR14,CACCTC,13 Cycle Post Hybridization LM-PCR,19,,,,Nimblegen30_BB35,BB35_SeqL,BB35_CL,Normal,NimV2mix4,13-25110A1_Normal,NA_13-25110A1_Normal,13-25110,A,"MELANOMA, 1.2 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED",122741,172.7,"Melanoma in situ is present < 1 millimeter from the edge of the specimen.  This is a non-ulcerated melanoma.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.","There is a proliferation of melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm, arranged in an irregular pattern along the junction and within the dermis.  Suprabasal scatter of melanocytes is prominent in some areas.  In other areas the melanocytes are bland and mature with descent in the dermis.  There is an infiltrate of lymphocytes and melanophages.",29,T2a,1.2,,Primary,,F,1209855
MIN_4,13-45163,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,100,,,,Nimblegen30_BB35,BB35_SeqL,BB35_CL,Melanoma,NimV2mix4,13-45163_Melanoma,NA_13-45163_Melanoma,13-45163,A,"MELANOMA, 0.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY",139524,172.5,"Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excision Tumor site: back Microscopic tumor type: melanoma on non-chronically sun-damaged skin, SSM Breslow thickness: 0.4 Ulceration: no Margins, peripheral and deep: Intraepidermal component extending close to the peripheral margin Mitotic index: none detected Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX Solar elastosis: mild","Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei arranged in wedge-shaped array  (melanocytic nevus).",58,T1a,0.4,"melanoma on non-chronically sun-damaged skin, SSM",Primary,,F,468757
MIN_5,13-45163,L2DR16,TGTTGC,13 Cycle Post Hybridization LM-PCR,30.9,,,,Nimblegen30_BB35,BB35_SeqL,BB35_CL,Nevus,NimV2mix4,13-45163_Nevus,NA_13-45163_Nevus,13-45163,A,"MELANOMA, 0.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY",139524,172.5,"Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excision Tumor site: back Microscopic tumor type: melanoma on non-chronically sun-damaged skin, SSM Breslow thickness: 0.4 Ulceration: no Margins, peripheral and deep: Intraepidermal component extending close to the peripheral margin Mitotic index: none detected Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX Solar elastosis: mild","Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei arranged in wedge-shaped array  (melanocytic nevus).",58,T1a,0.4,"melanoma on non-chronically sun-damaged skin, SSM",Primary,,F,468757
MIN_6,13-45163,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,100,,,,Nimblegen30_BB35,BB35_SeqL,BB35_CL,Normal,NimV2mix4,13-45163_Normal,NA_13-45163_Normal,13-45163,A,"MELANOMA, 0.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY",139524,172.5,"Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excision Tumor site: back Microscopic tumor type: melanoma on non-chronically sun-damaged skin, SSM Breslow thickness: 0.4 Ulceration: no Margins, peripheral and deep: Intraepidermal component extending close to the peripheral margin Mitotic index: none detected Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX Solar elastosis: mild","Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei arranged in wedge-shaped array  (melanocytic nevus).",58,T1a,0.4,"melanoma on non-chronically sun-damaged skin, SSM",Primary,,F,468757
DM_49_2_Tumor,DM49,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,26.9,,desmoplastic melanoma,,Nimblegen30_BB35,BB35_SeqL,BB35_CL,Tumor,NimV2mix4,DM49_Tumor,NA_DM49_Tumor,,,,,,,,,,,,,,,
G3 DP08-21965C Tumor,DP08-21965C,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,14,,Tumor,,Nimblegen30_BB35,BB35_SeqL,BB35_CL,Tumor,NimV2mix4,DP08-21965C_Tumor,NA_DP08-21965C_Tumor,,,,,,,,,,,,,,,
G3 DP08-21965C Normal,DP08-21965C,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,20.5,,Normal,,Nimblegen30_BB35,BB35_SeqL,BB35_CL,Normal,NimV2mix4,DP08-21965C_Normal,NA_DP08-21965C_Normal,,,,,,,,,,,,,,,
G5 DP08-4205A Tumor,DP08-4205A,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,78.5,,Tumor,,Nimblegen30_BB35,BB35_SeqL,BB35_CL,Tumor,NimV2mix4,DP08-4205A_Tumor,NA_DP08-4205A_Tumor,,,,,,,,,,,,,,,
G5 DP08-4205A Normal,DP08-4205A,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,76.3,,Normal,,Nimblegen30_BB35,BB35_SeqL,BB35_CL,Normal,NimV2mix4,DP08-4205A_Normal,NA_DP08-4205A_Normal,,,,,,,,,,,,,,,
CGH11-229,11-50182,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,51.4,,Iwei 7Q Gain,CGH11-229 ,Nimblegen31_BB36,BB36_SeqL,BB36_CL,Tumor,NimV2mix4,11-50182_Tumor,NA_11-50182_Tumor,11-50182,A,"ATYPICAL INTRADERMAL PROLIFERATION OF ENLARGED SPINDLED MELANOCYTES, CONSISTENT WITH MELANOMA OF 1.9 MM IN THICKNESS",173502,172.5,"ADDENDUM, August 18, 2011: Our differential diagnosis included an atypical cellular blue nevus on one hand and blue nevus-like melanoma on the other. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity and a low Ki-67 cell proliferation index. We also completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue bock, application of aCGH demonstrated segmental gain in chromosome 7q and loss of chromosome 9q. The presence of multiple chromosomal losses suggests genomic instability and favors interpretation as melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH favors interpretation as blue nevus-like (or deep penetrating nevus-like) melanoma. With respect to staging, this tumor is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to permit further microstage assessment and to ensure that local eradication has been accomplished.","Sections show a domed segment of skin with a dermal proliferation of enlarged fusiform melanocytes with abundant, pale cytoplasm and dusty appearing melanin. These melanocytes are arranged as thick and thin interconnecting fascicles with interspersed melanophages. The aggregations are more closely apposed in the upper part of the lesion than near the base of the specimen. Mitoses are present (around 1 per 5 400x fields). Some melanocytes have large, hyperchromatic nuclei.",55,,1.9,,,,M,1039621
CGH11-231,11-51553,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,100,,Iwei 7Q Gain,CGH11-231 ,Nimblegen31_BB36,BB36_SeqL,BB36_CL,Tumor,NimV2mix4,11-51553_Tumor,NA_11-51553_Tumor,11-51553,A,ATYPICAL COMPOUND PROLIFERATION OF MELANOCYTES; GAIN IN CHROMOSOMES 7p AND 7q APPARENT VIA COMPARATIVE GENOMIC HYBRIDIZATION,173304,172.3,"The findings are not those of a conventional congenital, Spitz or deep penetrating melanocytic nevus. Immunoperoxidase staining using two colors (with MART-1/tyrosinase labeled red and Ki-67 labeled brown) shows a relatively low cell proliferation index. However, some positively-labeled nuclei are apparent even in the deep dermis, which is of concern. We also completed array-based comparative genomic hybridization (aCGH) to further address the differential diagnosis between melanocytic nevus and melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed segmental gain in chromosome 7p and also in 7q. The presence of multiple chromosomal copy number aberrations indicates genomic instability and favors interpretation as melanoma. We have not observed gain in chromosome 7 in melanocytic nevi of any type.  In summary, the combination of results derived from conventional microscopy coupled with aCGH favors interpretation as an unconventional melanoma occurring in childhood. We refer to tumors within this spectrum as childhood-type melanomas. The designation childhood-type melanoma refers to an emerging tumor category that we believe is distinct from conventional (or adult-type) melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination.  This tumor is 4.2 mm in thickness and is non-ulcerated. Further excision is warranted to ensure that local eradication has been accomplished. I have received a call from Dr. Saadia Raza and will be returning her call to discuss the case.","There is a compound proliferation of melanocytes that extends into the deep reticular dermis. The epidermis overlying the proliferation is thinned. There are nests and single melanocytes along the junction, and most have abundant pale, vacuolated cytoplasm and some have enlarged oval vesicular nuclei. A limited degree of pagetoid scatter is present. Within the subjacent dermis there are coalescing nests, cords, and small syncytia of similar-appearing cells, some of which have even more abundant cytoplasm or larger and more hyperchromatic nuclei. Interspersed amidst these cells are foci in which melanocytes with smaller and more monomorphous nuclei predominate. Near the base of the proliferation are lymphoid nodules. A permeative component to the infiltrate in the reticular dermis is also noted.",14,,,,,,F,1040993
CGH11-232,11-52339,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,67.8,,Iwei 7Q Gain,CGH11-232 ,Nimblegen31_BB36,BB36_SeqL,BB36_CL,Tumor,NimV2mix4,11-52339_Tumor,NA_11-52339_Tumor,11-52339,A,"MELANOMA OF 0.85 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION",173727,172.7,"To assess a differential diagnosis between an unconventional Spitz nevus on one hand and melanoma on the other, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 1p, segmental loss of chromosome 1q, loss in chromosome 2p, 2 segmental gains in chromosome 7q, and loss of chromosome 9. The identification of multiple chromosomal copy number aberrations indicates genomic instability and points to interpretation as melanoma. The identification of multiple chromosomal gains and losses is incompatible with any form of Spitz nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH confirm that this proliferation represents melanoma and not a Spitz nevus. With respect to staging, this melanoma is less than 1 mm in thickness and lacks associated ulceration, yet melanocytes in mitosis are detectable in its dermal component. Therefore, this represents melanoma of stage pT1b (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.","There is a domed and flattish yet asymmetrical proliferation of large ovoid and spindled melanocytes involving the epidermis and dermis. The epidermis overlying the proliferation has a slightly elevated surface and is acanthotic with a thickened granular layer and a thin but partially compact cornified layer. Situated at the junction and focally above the junction are large melanocytes with abundant pale amphophilic cytoplasm and pleomorphic, vesicular and heterochromatic nuclei. Smaller aggregations of similar cells disperse and partially mature toward the base of the lesion. A few mitotic figures are evident in junctional melanocytes and rarely in dermal melanocytes. A juxtaposed lymphohistiocytic infiltrate is present concurrently.",31,T1b,0.85,,Primary,,F,1041779
CGH11-237,11-55993,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,70.9,,Iwei 7Q Gain,CGH11-237 ,Nimblegen31_BB36,BB36_SeqL,BB36_CL,Tumor,NimV2mix4,11-55993_Tumor,NA_11-55993_Tumor,11-55993,A,MELANOMA OF 0.95 MM IN THICKNESS,173765,172.7,"This partial biopsy raised a differential diagnosis between the center of a Spitz nevus on one hand and melanoma on the other. To more fully address this differential, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 4, gain in distal chromosome 7q, loss of chromosome 9, and gain in chromosome 15q. The identification of multiple genomic gains and losses confirms the presence of genomic instability, which is confirmatory of a diagnosis of melanoma. As you probably know, the aCGH profile that has been demonstrated is incompatible with a diagnosis of melanocytic nevus. Please note that this melanoma would not be diagnosable via application of fluorescence in situ hybridization (FISH). The current FISH approach that is utilized analyzes (and thus potentially demonstrates) aberrations involving only chromosomes 6 and 11. This melanoma, which has multiple aberrations involving other chromosomes, would have a normal FISH profile. (This is not uncommon in spitzoid melanomas.)  In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. This is a non-ulcerated melanoma with associated Clark's level IV invasion. The final microstage parameters should be reassessed once this melanoma has been fully extirpated.","Sections show a partial biopsy that contains a compound proliferation of enlarged melanocytes that are slightly spindled or epithelioid in morphology. Within the epidermis, nests and fascicles of enlarged melanocytes are positioned at the junction in concert with acanthosis, and clefts separate some melanocytic fascicles from the epithelium. In the dermis below this, there are maturing nests, cords, and small syncytia of similar melanocytes, and a juxtaposed permeative lymphohistiocytic infiltrate is also noted. An element of reticular dermal elastosis can be seen.",48,,0.95,,,,F,1045436
CGH11-259,11-57051,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,93.5,,Iwei 7Q Gain,CGH11-259 ,Nimblegen31_BB36,BB36_SeqL,BB36_CL,Tumor,NimV2mix4,11-57051_Tumor,NA_11-57051_Tumor,11-57051,A,INFLAMED SOLAR KERATOSIS,173307,702.0,,The interadnexal epidermis is thickened by a proliferation of keratinocytes with large nuclei. There is maturation toward a parakeratotic surface. A lymphocytic infiltrate is present. There is marked solar elastosis.,53,,,,,,M,1046494
CGH11-315,11-71006,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,31.1,,Iwei 7Q Gain,CGH11-315 ,Nimblegen31_BB36,BB36_SeqL,BB36_CL,Tumor,NimV2mix4,11-71006_Tumor,NA_11-71006_Tumor,11-71006,A,"COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, PROBABLY AN UNUSUAL SPITZ'S NEVUS",192799,238.2,"As there were some findings worrisome for a spitzoid melanoma rather than a Spitz's nevus. I proposed obtaining comparative genomic hybridization on this case. This showed an isolated gain of 7q, an aberration that when unaccompanied by others favors a Spitz's nevus. Given the worrisome histopathologic findings, I would still obtain a re-excision if it has not been done, even though the base may have been cauterized. I reviewed the comparative genomic hybridization data with Dr. Boris Bastian, who agreed regarding the implications of this finding.","Sections show a dome shaped segment of skin with irregular epidermal hyperplasia, and confluent nests of large, oval melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei within the dermis. Many necrotic melanocytes are evident. The enclosed immunoperoxidase stains show that there is strong staining for cyclin D1 throughout the thickness of the lesion. There is negligible staining with HMB45.",29,,,,,,F,1060449
CGH11-339,11-76464,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,100,,Iwei 7Q Gain,CGH11-339 ,Nimblegen31_BB36,BB36_SeqL,BB36_CL,Tumor,NimV2mix4,11-76464_Tumor,NA_11-76464_Tumor,11-76464,A,"SPITZ'S NEVUS, COMPOUND",554434,216.4,"Comparative genomic hybridization shows a gain involving chromosome 7q. Isolated 7q gains (such as that seen here) are present in a small group of Spitz's nevus, and we have not yet encountered isolated 7q gains in melanoma. There is diminished binding of the lesional DNA to probes representing chromosome 19, but this is a common artifactual problem due to high GC content. The lesion extends to within 1 mm. of the peripheral edge of the specimen. I would consider a very narrow re-excision to achieve 5 mm margins, but the findings seen here do not, in my opinion, support more than that.","Sections show a well-circumscribed but asymmetrical compound proliferation of melanocytes involving the junctional zone and the superficial dermis, extending within a pilosebaceous unit to the level of the deep reticular dermis in one focus. An aggregate of melanocytes abuts a lymphatic space at the same level. Nests predominate over single cells along the junction, and are in part composed of cells with polygonal outlines, abundant pale, vacuolated cytoplasm, dusty melanin and large but monomorphous vesicular nuclei that contain moderately sized nucleoli. These cells merge with melanocytes that have moderate-sized nuclei and scant cytoplasm toward the base of the lesion. Several mitotic figures are seen in the more pale-appearing melanocytes in the upper part of the proliferation.",7,,,,,,M,1065911
CHG11-402,11-88431,L2DR14,CACCTC,13 Cycle Post Hybridization LM-PCR,22,,Iwei 7Q Gain,,Nimblegen31_BB36,BB36_SeqL,BB36_CL,Tumor,NimV2mix4,11-88431_Tumor,NA_11-88431_Tumor,11-88431,A,"MELANOMA OF AT LEAST 2.3 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY",173622,172.6,"Based upon results derived from conventional microscopy, I favored melanoma over an unconventional Spitz nevus as most likely. To further substantiate this diagnosis, analysis via array-based comparative genomic hybridization (aCGH) was completed to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 12q, 18q, 20q, and 22q as well as loss in chromosomes 3q, 8p, 9p, 12q, 15p, and 16q. The identification of multiple genomic aberrations confirms the presence of genomic instability, as is stereotypical of melanoma. Please note that the aCGH profile that we have defined is incompatible with interpretation as any type of melanocytic nevus. In short, a benign interpretation has been excluded from the differential diagnosis by means of our molecular results. In summary, the combination of results derived from conventional microscopy coupled with has demonstrated that this atypical melanocytic proliferation represents spitzoid melanoma. This melanoma is non-ulcerated and shows Clark's level IV invasion. The final microstage parameters can be reassessed once this melanoma has been fully extirpated.","Sections show enlarged melanocytes arrayed irregularly within the epidermis, which is acanthotic, and non-maturing melanocytes in nests and fascicles are positioned in fibrotic dermis below this. The constituent melanocytes are generally spindled. Some are strikingly nucleomegalic. Dermal melanocytes in mitosis can be found. There is parakeratosis within orthohyperkeratosis above this.",53,,2.3,,,,M,1077879
CGH11-404,11-88432,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,65.5,,Iwei 7Q Gain,CGH11-404 ,Nimblegen31_BB36,BB36_SeqL,BB36_CL,Tumor,NimV2mix4,11-88432_Tumor,NA_11-88432_Tumor,11-88432,A,"MELANOMA OF 2.5 MM IN THICKNESS, FOCALLY INVOLVING THE DEEP EDGE OF THE SPECIMEN",139523,172.5,"My differential diagnosis included a highly unconventional Spitz nevus on one hand and spitzoid melanoma on the other, and after completion of our analysis of this tumor, the latter possibility proves to represent the best diagnosis for this case. To more fully evaluate the nature of this proliferation, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 7q as well as loss in chromosomes 1q, 5q, 7q, 9, 10q, 13p, 14q, and 16q. The identification of multiple genomic aberrations indicates genomic instability, as is stereotypical of melanoma. Please note that the aCGH profile that we have defined is incompatible with interpretation as any type of melanocytic nevus. In short, an atypical Spitz nevus has been excluded from the differential diagnosis by means of our molecular results. In summary, the combination of results derived from conventional microscopy coupled with has demonstrated that this atypical melanocytic proliferation represents spitzoid melanoma. This melanoma is non-ulcerated and shows Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show enlarged slightly spindled and epithelioid melanocytes arrayed in compound fashion within a sessile and partially polypoid skin segment. There are very large nests and fascicles of melanocytes intraepidermally, and similar melanocytes are arrayed in partially maturing fashion in dermis below this. The constituent melanocytes have finely melanized or amphophilic cytoplasm. It is not difficult to identify dermal melanocytes in mitosis.",20,,2.5,,,,F,1077880
CGH11-409,11-88209,L2DR16,TGTTGC,13 Cycle Post Hybridization LM-PCR,100,,Iwei 7Q Gain,CGH11-409 ,Nimblegen31_BB36,BB36_SeqL,BB36_CL,Tumor,NimV2mix4,11-88209_Tumor,NA_11-88209_Tumor,11-88209,A,SPITZOID MELANOMA OF CHILDHOOD,173403,173.4,"Comparative genomic hybridization shows multiple chromosomal aberrations indicative of melanoma. These include a loss involving chromosome 6p, a partial loss of 6q, an amplification (high level copy number gain) of 7q, a loss of 9p and a loss of 9qter. Losses involving 6q and 9p are particularly common in melanoma. While isolated gains involving chromosome 7q can be seen in Spitz's nevus, gene amplifications (gains of not just an extra copy, but many extra copies) are not. Dr. Boris Bastian also reviewed the comparative genomic hybridization data and agrees with this interpretation of it.  The lesion is broadly transected, and may be considerably thicker than the 3.2 mm that I measured on the slide. Given the comparative genomic hybridization results and morphology, I believe that this lesion should be classified as a spitzoid melanoma of childhood, i.e., an emerging class of lesions that usually lack b-raf mutations (which are present in most melanomas) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. Most lesions of this type are well circumscribed and relatively narrow re-excision margins are adequate for local control. The value of sentinel lymph node biopsy seems even less than in adult melanoma, as the predictive value of nodal involvement for distant disease is less, and there is little evidence that completion lymphadenectomy has an effect on survival.","Sections show a papillated segment of skin with a predominantly dermal proliferation of melanocytes, most of which have abundant, pale cytoplasm and large, oval vesicular nuclei. The overlying epidermis is focally hyperplastic. A few junctional nests are present. The dermal aggregations are variably confluent. The cells toward the base of the specimen are smaller, and have smaller and more monomorphous nuclei than those superficially. It is difficult to find mitotic figures. The enclosed immunoperoxidase stains show that the junctional melanocytes and some superficial dermal ones stain with HMB-45 and that the Ki-67 labeling rate is up to 5% or so in some areas.",7,,,,,,M,1071369
Thomas_SK_MEL_23,Thomas_SK_MEL_23,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,45.7,,SKMEL23(Cell Line),,Nimblegen31_BB36,BB36_SeqL,BB36_CL,Tumor,NimV2mix4,Thomas_SK_MEL_23_Tumor,NA_Thomas_SK_MEL_23_Tumor,,,,,,,,,,,,,,,
KIT_134,KIT134,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,96.9,,"Mucosal melanoma, rectal, WT",Alyssa Acral Mucosal DNA,Nimblegen32_BB38,BB38_SeqL,BB38_CL,Tumor,NimV2mix3,KIT134_Tumor,NA_KIT134_Tumor,,,,,,,,,,,,,,,
KIT_191,KIT191,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,100,,"Acral melanoma, heel, WT",Alyssa Acral Mucosal DNA,Nimblegen32_BB38,BB38_SeqL,BB38_CL,Tumor,NimV2mix3,KIT191_Tumor,NA_KIT191_Tumor,,,,,,,,,,,,,,,
KIT_205,KIT205,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,68.8,,"Acral melanoma, toe, WT",Alyssa Acral Mucosal DNA,Nimblegen32_BB38,BB38_SeqL,BB38_CL,Tumor,NimV2mix3,KIT205_Tumor,NA_KIT205_Tumor,,,,,,,,,,,,,,,
KIT_206,KIT206,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,100,,"Mucosal melanoma, ?, WT",Alyssa Acral Mucosal DNA,Nimblegen32_BB38,BB38_SeqL,BB38_CL,Tumor,NimV2mix3,KIT206_Tumor,NA_KIT206_Tumor,,,,,,,,,,,,,,,
KIT_210,KIT210,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,65.2,,"Mucosal melanoma, rectal, WT",Alyssa Acral Mucosal DNA,Nimblegen32_BB38,BB38_SeqL,BB38_CL,Tumor,NimV2mix3,KIT210_Tumor,NA_KIT210_Tumor,,,,,,,,,,,,,,,
KIT_217,KIT217,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,100,,"Mucosal melanoma, vaginal, WT",Alyssa Acral Mucosal DNA,Nimblegen32_BB38,BB38_SeqL,BB38_CL,Tumor,NimV2mix3,KIT217_Tumor,NA_KIT217_Tumor,,,,,,,,,,,,,,,
KIT_225,KIT225,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,100,,"Mucosal melanoma, anal, ",Alyssa Acral Mucosal DNA,Nimblegen32_BB38,BB38_SeqL,BB38_CL,Tumor,NimV2mix3,KIT225_Tumor,NA_KIT225_Tumor,,,,,,,,,,,,,,,
KIT_244,KIT244,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,77.5,,"Mucosal melanoma, urethra, WT",Alyssa Acral Mucosal DNA,Nimblegen32_BB38,BB38_SeqL,BB38_CL,Tumor,NimV2mix3,KIT244_Tumor,NA_KIT244_Tumor,,,,,,,,,,,,,,,
KIT_260,KIT260,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,89.4,,"Mucosal melanoma, perirectal, ",Alyssa Acral Mucosal DNA,Nimblegen32_BB38,BB38_SeqL,BB38_CL,Tumor,NimV2mix3,KIT260_Tumor,NA_KIT260_Tumor,,,,,,,,,,,,,,,
KIT_273,KIT273,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,100,,"Mucosal melanoma, duodenal, NRAS",Alyssa Acral Mucosal DNA,Nimblegen32_BB38,BB38_SeqL,BB38_CL,Tumor,NimV2mix3,KIT273_Tumor,NA_KIT273_Tumor,,,,,,,,,,,,,,,
KIT_295,KIT295,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,39.7,,"Mucosal melanoma, oral, WT",Alyssa Acral Mucosal DNA,Nimblegen32_BB38,BB38_SeqL,BB38_CL,Tumor,NimV2mix3,KIT295_Tumor,NA_KIT295_Tumor,,,,,,,,,,,,,,,
CGH11_109,11-23878,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,100,,"Iwei CGH, Translocation ",CGH11-109 ,Nimblegen33_BB39,BB39_SeqL,BB39_CL,Tumor,NimV2mix3,11-23878_Tumor,NA_11-23878_Tumor,11-23878,A,"SPITZ'S NEVUS, COMPOUND",101625,216.6,"The architectural features of this lesion favor a Spitz's nevus. The fact that there are dermal melanocytes in mitosis is concerning. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a moderate proliferation rate in the upper part of the lesion and a low one in the lower part. Array-based comparative genomic hybridization shows no chromosomal gains or losses. In the context of the findings noted above, I believe that this is best interpreted as a Spitz's nevus. The margins appear clear in the planes of section examined.","Sections show a polypoid compound proliferation of enlarged epithelioid melanocytes distributed along a largely thinned epidermis. There are single melanocytes and nests distributed nearly confluently, and in the dermis below this there are partially-maturing nests and cords of similar melanocytes. In the middle of the proliferation, melanocytes in mitosis are easily found. In a recut section, mitotic figures are again apparent in the upper dermis.",35,,,,,,F,1013316
CGH12_058,12-11041,L2DR14,CACCTC,13 Cycle Post Hybridization LM-PCR,100,,"Iwei CGH, Translocation FLT4",CGH12-058 ,Nimblegen33_BB39,BB39_SeqL,BB39_CL,Tumor,NimV2mix3,12-11041_Tumor,NA_12-11041_Tumor,12-11041,A,"MELANOMA OF 6.5 MM IN THICKNESS, TRANSECTED AT THE SPECIMEN PERIPHERY",173676,172.6,"A SOX-10 immunostain shows diffuse immunopositivity, and this staining result indicates that this atypical proliferation is of melanocytic lineage. With that established, our differential diagnosis included a highly unconventional melanocytic nevus on one hand and spitzoid melanoma on the other. We included array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies, as per your request. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 1q, 5, 8, and 17q, and loss in chromosomes 9 and 12q was also documented. The documentation of multiple chromosomal aberrations confirms genomic instability, as is stereotypical of melanoma. The aCGH profile that we have documented is incompatible with any type of melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. This deeply invasive, thick tumor is non-ulcerated but demonstrates associated subcutaneous involvement. Further excision remains warranted to ensure that local eradication has been accomplished.","Sections show a nodular pan-dermal and superficial subcutaneous proliferation of fusiform and slightly spindled cells with pale or amphophilic cytoplasm. The cells are distributed interstitially in a sclerotic reticular dermis, and extension into the subjacent subcutis in somewhat infiltrative fashion is noted. There is not maturation with descent in the dermis. In both the dermis and subcutis, a nested or fascicular configuration is apparent. With close scrutiny, occasional cells in mitosis can be found.",9,,6.5,,,,F,1096857
CGH12_224,12-55584,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,100,,"Iwei CGH, Translocation ",CGH12-224 ,Nimblegen33_BB39,BB39_SeqL,BB39_CL,Tumor,NimV2mix3,12-55584_Tumor,NA_12-55584_Tumor,12-55584,A,COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES,173305,238.2,"The attached insurance information noted a request for comparative genomic hybridization which has now been performed, and shows multiple aberrations, with losses involving peri-centromeric areas of chromosomes 7q and 12q, and a peri-telomeric focus of 18q. The presence of multiple aberrations is worrisome, and is not in keeping with the diagnosis of a Spitz's nevus. As the aberrations are not typical of melanoma, I would consider this as equivalent to what has been reported in the literature as an atypical Spitz tumor. The vast majority of such cases have a favorable outcome, regardless of sentinel lymph node status. If a re-excision of this site shows a significant residuum, I would be interested in viewing the slides.","There is a compound proliferation of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei. Overlying the lesion is irregular epidermal hyperplasia. There are confluent nests of large oval melanocytes that form sheets in some areas. Many mitotic figures are present superficially, and some in the lower portions of the lesion as well.",6,,,,,,F,1141397
CGH11_410,11-85416,L2DR16,TGTTGC,13 Cycle Post Hybridization LM-PCR,93.2,,"Iwei CGH, 7Q Gain ",CGH11-410 ,Nimblegen33_BB39,BB39_SeqL,BB39_CL,Tumor,NimV2mix3,11-85416_Tumor,NA_11-85416_Tumor,11-85416,A,COMPOUND MELANOCYTIC NEVUS WITH SOME SPITZOID FEATURES,102538,216.5,"In addition to the findings noted below, levels show that the lesion is considerably thicker than in the initial sections, and has more confluence of junctional nests. A zone of paucicellular fibrosis is present beneath part of the lesion, consistent with a scar. Immunoperoxidase stained sections prepared in our laboratory show that a small minority of cells are p16 positive. This finding is less common in nevi than in melanoma. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a very low proliferation rate, which in contrast is a reassuring finding. Similarly, only rare cells are positive in a phosphohistone H3 immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle).  Due to the difficult nature of this case, we obtained comparative genomic hybridization. This showed an isolated gain involving chromosome 7q. We have seen this aberration mainly in Spitz's nevi. While this is not a classic Spitz's nevus, the junctional component has some spitzoid features, and in this context I cannot interpret the current findings as supporting melanoma. Given the unusual nature of this lesion, I would still obtain a narrow re-excision of this site, however.","There is a compound proliferation of melanocytes mostly involving the junctional zone and a thickened papillary dermis.  Nests of, and increased numbers of single melanocytes are situated at the sides and bases of elongated rete ridges. The bases of some adjacent rete ridges are fused by junctional nests, some of which have horizontally oriented spindled cells.  Toward the center of the lesion, smaller melanocytes reside in the papillary dermis. A focally dense lymphocytic infiltrate ascends to the junction.",49,,,,,,F,1074864
CGH11_424,11-94134,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,100,,"Iwei CGH, 7Q Gain ",CGH11-424 ,Nimblegen33_BB39,BB39_SeqL,BB39_CL,Tumor,NimV2mix3,11-94134_Tumor,NA_11-94134_Tumor,11-94134,A,"COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, EXCISED IN THE AVAILABLE PLANES OF SECTION",173720,238.2,"Our differential diagnosis included a highly unconventional Spitz nevus on one hand and nevoid melanoma on the other. As a certain diagnosis often cannot be rendered in this context based solely upon conventional microscopy, we additionally completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a segmental gain in chromosome 7q with no other chromosomal gains or losses. We have identified gain in chromosome 7q in a small series of unconventional Spitz nevi. In contrast, gain in chromosome 7q as a monoaberration has not been documented in melanoma, in my experience. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, I believe this melanocytic proliferation represents an unconventional Spitz nevus.","Sections show enlarged epithelioid and slightly spindled melanocytes arrayed irregularly within the epidermis and dermis. The lesion shows reasonable lateral demarcation but is asymmetrical. Within the epidermis, enlarged melanocytes are present at both the epidermal-dermal junction and also above the junction, particularly toward one edge. In fibrotic dermis below this, partially maturing but enlarged epithelioid melanocytes are apparent, and occasional melanocytes in mitosis can be found. Some melanocytes are also multinucleate.",0,,,,,,F,1083582
CGH12_026,12-2898,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,89.5,,"Iwei CGH, 7Q Gain ",CGH12-026 ,Nimblegen33_BB39,BB39_SeqL,BB39_CL,Tumor,NimV2mix3,12-2898_Tumor,NA_12-2898_Tumor,12-2898,A,"MELANOMA, AT LEAST 2.3 MM. IN THICKNESS",129522,172.5,"Comparative genomic hybridization shows a gain involving chromosome 7, but no other aberrations. Gains of chromosome 7 are relatively common in melanoma. The lesion is not ulcerated, and hence is stage T3a in the 2009 AJCC classification. The configuration suggests that the final thickness will not be substantially greater than that seen here.","Sections show a proliferation of melanocytes with a domed surface and a wedge shaped base. The overlying epidermis is slightly thickened, with a few discrete junctional nests. Within most of the dermal component, small fusiform melanocytes with lightly pigmented cytoplasm predominate. These cells have monomorphous oval, vesicular nuclei with small nucleoli. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. At the flanks of the lesion, smaller melanocytes are evident at the junction and in the superficial dermis. Some of the deeper melanocytes are peri-adnexal or bulge into a lymphatic vessel.",29,T3a,2.3,,Primary,,F,1088714
CGH12_039,12-1782,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,82.9,,"Iwei CGH, 7Q Gain ",CGH12-039 ,Nimblegen33_BB39,BB39_SeqL,BB39_CL,Tumor,NimV2mix3,12-1782_Tumor,NA_12-1782_Tumor,12-1782,A,"MELANOMA, 1.4 MM. IN THICKNESS",173406,172.4,"Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively high proliferation rate in the superficial part of the lesion but a low one in the deeper portions. This finding is not decisive. A p16 stain shows a complete loss of expression in the larger cells, while some smaller melanocytes near the edge of the specimen retain expression. This finding is worrisome for melanoma arising in a nevus. As the changes were somewhat equivocal, we obtained comparative genomic hybridization. This shows set of chromosomal gains and loss diagnostic of melanoma, including a gain involving 3q, complex rearrangements involving chromosomes 5p and 7p, loss of 7qter and 8p, a gain of 8q, a loss involving 9p, and a loss involving 21q. The loss involving 9p correslates with the negative p16 immunoperoxidase stain noted above.  The nevus extends to a peripheral margin, and the melanomatous component to within less than 1 mm of it. The lesion is not ulcerated, making it stage T2a in the 2009 AJCC staging schema for melanoma.","There is a broad-based melanocytic proliferation with a flat peripheral area and a raised central one. The peripheral portion features discrete nests of small round melanocytes. The raised portion has a relatively thin epidermis, large irregularly shaped and focally confluent nests of large oval and fusiform melanocytes superficially, and smaller ones embedded in a dense lymphocytic infiltrate more deeply. The larger melanocytes include some cells with very large, hyperchromatic nuclei, prominent nuclear pseudoinclusions, or large nucleoli. A few mitotic figures are present, mainly in melanocytes in the upper part of the lesion.",37,T2a,1.4,,Primary,,M,1087598
CGH12_040,12-4251,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,100,,"Iwei CGH, 7Q Gain ",CGH12-040 ,Nimblegen33_BB39,BB39_SeqL,BB39_CL,Tumor,NimV2mix3,12-4251_Tumor,NA_12-4251_Tumor,12-4251,A,"COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, WITH UNUSUAL GENOMIC ABERRATIONS",139523,238.2,"There were some features in the hematoxylin and eosin stained sections suggesting a Spitz's nevus with a mutation in the BAP-1 gene. This mutation is often accompanied by loss of chromosome 3p or a segment thereof that can be found by comparative genomic hybridization. However, a BAP-1 immunoperoxidase stain shows no loss of nuclear staining in the large melanocytes, and comparative genomic hybridization shows no loss of chromosome 3p. However, there is a gain involving chromosome 1p, a small gain in 7p and a gain in 7q. Gains in 7q can be seen as isolated findings in some Spitz's nevi, but are also common findings in melanoma. Losses of 1p are typical of a variety of malignancies, including melanoma, but gains of 1p, as are present here, are unusual in melanoma. Given that three aberrations are evident, the lesion may have metastatic potential, but I am not convinced that an outright diagnosis of melanoma is appropriate. I believe that this lesion is equivalent to an atypical Spitz tumor, in which some metastatic potential is present, but not commensurate with lesional thickness (which in this case is around 2 mm.).","There is a pedunculated segment of skin with a compound proliferation of large oval melanocytes. The junctional component is minor, and consists of increased numbers of single cells and small nests. Both the junctional and the dermal cells have abundant homogeneous-appearing pale eosinophilic cytoplasm with a ground-glass appearance, and large, pleomorphic, vesicular nuclei, some with enlarged nucleoli. Focally dense infiltrates of lymphocytes are present in many portions of the lesion.",24,,,,,,F,1090067
CGH12_053,12-8171,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,100,,"Iwei CGH, 7Q Gain ",CGH12-053 ,Nimblegen33_BB39,BB39_SeqL,BB39_CL,Tumor,NimV2mix3,12-8171_Tumor,NA_12-8171_Tumor,12-8171,A,"MELANOMA, 3.3 MM. IN THICKNESS",423456,172.4,"While a combined deep penetrating nevus (with a minor component of conventional intradermal melanocytic nevus) is a plausible diagnosis based only on the morphology of the melanocytes, the lesion is in severely sun damaged skin and has a higher proliferation rate than is typical for such lesions (although this does not translate into a high mitotic rate). Comparative genomic hybridization shows numerous chromosomal aberrations including a rearrangement of 5q, a loss of 6q, a gain of 7q, a gain of 15q, a loss of 18q and a gain of 19. These findings are not compatible with a deep penetrating nevus, and include aberrations typical of melanoma.","Sections show a predominantly dermal proliferation of melanocytes. The overlying epidermis is slightly thickened, with a thick granular layer and compact hyperkeratosis. Within an area of fibrosis in the upper part of the lesion are small discrete aggregations of small, round melanocytes. These abut a larger population of large, oval melanocytes with abundant, pale cytoplasm and dusty appearing melanin, and monomorphous oval vesicular nuclei containing small nucleoli. There are many admixed melanophages. The enclosed immunoperoxidase stains show the melanocytes are strongly and uniformly Melan-A positive, and have (for a melanocytic neoplasm) a relatively high Ki-67 labelling rate (roughly 15-20%).",82,,3.3,,,,M,1093987
CGH12_056,12-10777,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,78.3,,"Iwei CGH, 7Q Gain ",CGH12-056 ,Nimblegen33_BB39,BB39_SeqL,BB39_CL,Tumor,NimV2mix3,12-10777_Tumor,NA_12-10777_Tumor,12-10777,A,"MELANOMA, AT LEAST 1.8 MM IN THICKNESS",173622,172.6,"The differential diagnosis posed by these sections was that between a traumatized Spitz's nevus with unusual features (including striking nuclear pleomorphism) and melanoma. Comparative genomic hybridization shows chromosomal amplifications involving 5p, 7p, 12q and 22q; there is a probable gain involving 6p and one involving 8q as well. The number of aberrations is inconsistent with a Spitz's nevus, as are the multiple amplifications (gains of 11p and 7q can be seen as isolated phenomena in Spitz's nevi, but chromosomal amplifications are not generally found). The final thickness and AJCC stage will need to await complete removal of the remainder of the lesion. Any comments regarding treatment would be premature.","There is a compound proliferation of large oval, fusiform and polygonal melanocytes involving a segment of skin with a raised and slightly papillated surface. The junctional component is limited, consisting of increased numbers of single melanocytes and small nests of them, mostly at one edge of the specimen. Within the dermis are small aggregations of melanocytes with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular, heterochromatic nuclei, embedded in fibrotic stroma. Little mature with descent is evident. There are subepidermal fibrin deposits, with edema and extravasated erythrocytes.",25,,1.8,,,,F,1096593
DT10_63051C,10_63051C,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,100,,Ivanka Normal (for #9) ,,Nimblegen33_BB39,BB39_SeqL,BB39_CL,Normal,NimV2mix3,10_63051C_Normal,NA_10_63051C_Normal,,,,,,,,,,,,,,,
DPN_8_Normal,DPN8,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,67,,Iwei DPN,,Nimblegen34_BB40,BB40_SeqL,BB40_CL,Normal,NimV2mix3,DPN8_Normal,NA_DPN8_Normal,,,,,,,,,,,,,,,
DPN_9_Normal,DPN9,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,22.6,,Iwei DPN,,Nimblegen34_BB40,BB40_SeqL,BB40_CL,Normal,NimV2mix3,DPN9_Normal,NA_DPN9_Normal,,,,,,,,,,,,,,,
DPN_18_Normal,DPN18,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,10.1,,Iwei DPN,,Nimblegen34_BB40,BB40_SeqL,BB40_CL,Normal,NimV2mix3,DPN18_Normal,NA_DPN18_Normal,,,,,,,,,,,,,,,
CGH11_091,11-21178,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,100,,"Iwei CGH, Translocation",CGH11-091 ,Nimblegen34_BB40,BB40_SeqL,BB40_CL,Tumor,NimV2mix3,11-21178_Tumor,NA_11-21178_Tumor,11-21178,A,"INFLAMED COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, PROBABLY AN UNUSUAL SPITZ'S NEVUS",107705,238.2,"The lesion is extensively transected at the base of the specimen. The majority of findings favor an inflamed Spitz's nevus. There are rare cases in which large nodular collections of more atypical-appearing cells are evident in the deep reticular dermis, and are only evident on reexcision. Comparative genomic hybridization shows no detectable chromosomal gains or losses. While the quality of the DNA that we extracted is not optimal, it is reasonable.  Most lesions of this type are well circumscribed. Hence, despite this result, I would still consider a slightly wider, but deeper (full thickness) reexcision to remove the remainder of the lesion and to make sure that a more atypical, deep component is not evident.","Sections show a domed, somewhat papillated segment of skin with a proliferation of large oval melanocytes that extends from the junctional zone to the base of the specimen in the superficial reticular dermis. Large junctional and superficial dermal nests are present, composed of cells with large oval vesicular nuclei, small nucleoli and abundant amphophilic cytoplasm. The sizes of aggregations and of the cells that comprise them diminish toward the base of the specimen, where small nests are positioned between thickened collagen bundles. A focally dense lymphocytic infiltrate is evident. There are scattered mitotic figures.",2,,,,,,F,1010616
AF13_212,13-212,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,71.4,, A. Fouchardiere Project,,Nimblegen34_BB40,BB40_SeqL,BB40_CL,Tumor,NimV2mix3,13-212_Tumor,NA_13-212_Tumor,13-212,A,SEBORRHEIC KERATOSIS,173409,702.19,,"The epidermis is thickened by a proliferation of keratinocytes that form broad interconnecting rete ridges.  Some keratinocytes have deeply pigmented cytoplasm, and melanophages are present in the papillary dermis.",51,,,,,,M,1184954
DM_74_2_Tumor,DM74,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,,,Hunter DM,,Nimblegen34_BB40,BB40_SeqL,BB40_CL,Tumor,NimV2mix3,DM74_Tumor,NA_DM74_Tumor,,,,,,,,,,,,,,,
DM_99_Tumor,DM99,L2DR14,CACCTC,13 Cycle Post Hybridization LM-PCR,,,Hunter DM,,Nimblegen34_BB40,BB40_SeqL,BB40_CL,Tumor,NimV2mix3,DM99_Tumor,NA_DM99_Tumor,,,,,,,,,,,,,,,
KIT_230,KIT230,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,10.3,,Alyssa Acral Mucosal DNA,,Nimblegen34_BB40,BB40_SeqL,BB40_CL,Tumor,NimV2mix3,KIT230_Tumor,NA_KIT230_Tumor,,,,,,,,,,,,,,,
KIT_297,KIT297,L2DR16,TGTTGC,13 Cycle Post Hybridization LM-PCR,100,,Alyssa Acral Mucosal DNA,,Nimblegen34_BB40,BB40_SeqL,BB40_CL,Tumor,NimV2mix3,KIT297_Tumor,NA_KIT297_Tumor,,,,,,,,,,,,,,,
KIT_302,KIT302,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,100,,Alyssa Acral Mucosal DNA,,Nimblegen34_BB40,BB40_SeqL,BB40_CL,Tumor,NimV2mix3,KIT302_Tumor,NA_KIT302_Tumor,,,,,,,,,,,,,,,
KIT_316,KIT316,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,100,,Alyssa Acral Mucosal DNA,,Nimblegen34_BB40,BB40_SeqL,BB40_CL,Tumor,NimV2mix3,KIT316_Tumor,NA_KIT316_Tumor,,,,,,,,,,,,,,,
DM_6_Normal,DM6,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,72,,Hunter Desmoplastic Melanoma,,Nimblegen35_BB41,BB41_SeqL,BB41_CL,Normal,NimV2mix3,DM6_Normal,NA_DM6_Normal,,,,,,,,,,,,,,,
DM_31_Normal,DM31,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,40.3,,Hunter Desmoplastic Melanoma,,Nimblegen35_BB41,BB41_SeqL,BB41_CL,Normal,NimV2mix3,DM31_Normal,NA_DM31_Normal,,,,,,,,,,,,,,,
DM_36_Normal,DM36,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,47.4,,Hunter Desmoplastic Melanoma,,Nimblegen35_BB41,BB41_SeqL,BB41_CL,Normal,NimV2mix3,DM36_Normal,NA_DM36_Normal,,,,,,,,,,,,,,,
DM_42_Normal,DM42,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,35.2,,Hunter Desmoplastic Melanoma,,Nimblegen35_BB41,BB41_SeqL,BB41_CL,Normal,NimV2mix3,DM42_Normal,NA_DM42_Normal,,,,,,,,,,,,,,,
DM_68_Tumor,DM68,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,10,,Hunter Desmoplastic Melanoma,,Nimblegen35_BB41,BB41_SeqL,BB41_CL,Tumor,NimV2mix3,DM68_Tumor,NA_DM68_Tumor,,,,,,,,,,,,,,,
DM_101_Tumor,DM10,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,100,,Hunter Desmoplastic Melanoma,,Nimblegen35_BB41,BB41_SeqL,BB41_CL,Tumor,NimV2mix3,DM10_Tumor,NA_DM10_Tumor,,,,,,,,,,,,,,,
DM_101_Normal,DM10,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,30.7,,Hunter Desmoplastic Melanoma,,Nimblegen35_BB41,BB41_SeqL,BB41_CL,Normal,NimV2mix3,DM10_Normal,NA_DM10_Normal,,,,,,,,,,,,,,,
DM_101_IS,DM10,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,38,,Hunter Desmoplastic Melanoma,,Nimblegen35_BB41,BB41_SeqL,BB41_CL,Tumor,NimV2mix3,DM10_Tumor,NA_DM10_Tumor,,,,,,,,,,,,,,,
CGH11-224,11-50270,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,25.6,,"Iwei CGH, 7Q Gain",CGH11-224 ,Nimblegen35_BB41,BB41_SeqL,BB41_CL,Tumor,NimV2mix3,11-50270_Tumor,NA_11-50270_Tumor,11-50270,A,MELANOMA OF 1.4 MM IN THICKNESS,173507,172.5,"This atypical melanocytic proliferation was evaluated by both immunohistochemistry and by molecular methods. Immunoperoxidase stained sections prepared in our laboratory show that while the intraepidermal component has only patchy expression of p16, the dermal component strongly expresses this determinant. A phosphohistone H3 immunoperoxidase stain (which labels melanocytes in mitosis) labels nuclei in the dermis, but these cells are mostly lymphocytes (that said, melanocytes in mitosis can be seen in conventional sections, so it is clear that cell proliferation was ongoing prior to biopsy). The aforementioned immunostaining results are inconclusive. We also completed array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH demonstrated gains in chromosomes 5p, 6, 7, 12, 21, and 22. A small segmental loss in chromosome 9q was also found. As you probably know, the identification of multiple chromosomal copy number aberrations indicates genomic instability and is stereotypical of melanoma. The finding of multiple genomic anomalies is incompatible with a diagnosis of melanocytic nevus.  In summary, the combination of results derived from conventional microscopy coupled with aCGH analysis points to interpretation as melanoma. This melanoma is non-ulcerated and shows Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished. This melanoma is of stage pT2a (2009 AJCC guidelines).","There is a domed proliferation of large oval and spindled melanocytes with oval vesicular nuclei and amphophilic cytoplasm involving the junctional zone of a thickened epidermis, and stratum spinosum above this, and the subjacent upper dermis. Nests predominate over single melanocytes along the epidermal-dermal junction. A few Kamino bodies are present. Clear suprabasilar scatter of single melanocytes is present within the epidermis. Melanocyte aggregations perhaps diminish in size with descent. There is a lymphohistiocytic infiltrate with admixed melanophages in the dermis. The dermal melanocytes include a few in mitosis. The enclosed immunoperoxidase stains show that most of the dermal melanocytes express HMB-45. When viewed at scanning magnification, the proliferation is asymmetrical. It also shows considerable scatter of melanocytes above the junction at its leading edges.",19,T2a,1.4,,Primary,,F,1039709
CGH12-104,12-23578,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,71.2,,"Iwei CGH, 7Q Gain",CGH12-104 ,Nimblegen35_BB41,BB41_SeqL,BB41_CL,Tumor,NimV2mix3,12-23578_Tumor,NA_12-23578_Tumor,12-23578,A,"RESIDUAL DESMOPLASTIC COMPOUND PROLIFERATION OF MELANOCYTES, EXCISED IN THE AVAILABLE PLANES OF SECTION",222596,238.2,"The residuum seen here posed a microscopic differential diagnosis of a combined Spitz nevus on one hand and spitzoid melanoma arising in association with a congenital melanocytic nevus on the other. Per your request, we pursued array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a small gain in chromosome 7q with no other significant gains or losses. We have encountered this anomaly in a series of spitzoid tumors that either represent unconventional Spitz nevi or represent unclassifiable spitzoid tumors with indolent behavior. The molecular findings that we have identified do not point to interpretation as spitzoid melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of spitzoid melanoma. This unconventional melanocytic proliferation has been excised by means of this specimen.","There is a zone of fibrosing inflammatory alterations beneath which is a proliferation of melanocytes with a wedge shaped configuration. Superficially, there are large ovoid melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei as well as prominent, central nucleoli. These cells are positioned just beneath the epidermis, and a few cells in mitosis are evident. Deeper and to the side in the dermis, small  melanocytes are apparent as maturing nests, cords, and syncytia.",42,,,,,,F,1101847
CGH12-124,12-31421,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,71.6,,"Iwei CGH, 7Q Gain",CGH12-124 ,Nimblegen35_BB41,BB41_SeqL,BB41_CL,Tumor,NimV2mix3,12-31421_Tumor,NA_12-31421_Tumor,12-31421,A,"MELANOMA OF 0.75 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION",102537,172.5,"My differential diagnosis included an unconventional melanocytic nevus and nevoid melanoma, and after completion of molecular analysis, I believe the latter possibility represent the best interpretation for this atypical melanocytic tumor. Immunohistochemistry for p16 has been completed and demonstrates significant loss of expression, and thus an underlying anomaly in chromosome 9p was suspected. To more fully substantiate the nature of this proliferation, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 5p, 5q, and 7q, as well as loss in chromosomes 5q  and 9. The identification of multiple copy number aberrations indicates genomic instability, as is stereotypical of malignancies such as melanoma. Additionally, the fact that chromosome 9 loss has been documented correlates with the loss of p16 expression that was documented immunohistochemically. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as nevoid melanoma. With respect to staging, this melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.","Sections show a slightly asymmetrical, broad, yet laterally demarcated compound proliferation of melanocytes. There are single melanocytes and nests distributed at the junction, and virtually all melanocytes are immediately at the junction. Some of the junctional nests centrally are large. Below the junction, striking lamellar fibroplasia is coupled with a patchy lymphohistiocytic infiltrate with admixed melanophages. Centrally, there are also some partially maturing but large dermal nests, and deep to this, modest elastosis is appreciable.",60,T1a,0.75,,Primary,,M,1117239
BS1,11-13661, NextFlex 1,CGATGT,,,,blue nevus-like melanoma,CGH11-051 ,BioSci1_BB42,BB42_SeqL,BB42_CL,Tumor,NimV2mix3,11-13661_Tumor,NA_11-13661_Tumor,11-13661,A,BLUE NEVUS-LIKE MELANOMA OF 2.9 MM IN THICKNESS,103362,172.3,"Our differential diagnosis included an atypical cellular blue nevus on one hand and blue nevus-like melanoma on the other, and the latter possibility proves to represent the correct interpretation of this proliferation. To further assess the aforementioned differential diagnosis and screen this tissue for melanoma-associated genomic anomalies, we completed array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gains in chromosomes 1, 2, 6p, 7, and 8, as well as losses in chromosomes 6q, 11, and 22q. The identification of multiple chromosomal gains and losses decisively proves that this proliferation does not represent a melanocytic nevus but instead constitutes melanoma. Presuming this to be a primary lesion, the melanoma within this biopsy is non-ulcerated and focally invades the superficial subcutis (Clark's level V). If there is any history of melanoma, the possibility of a blue nevus-like metastasis s of melanoma could also be considered. Further excision is warranted to ensure that local eradication has been accomplished.  This report was reissued on March 29, 2011, after correcting a typographical error.",Sections show an intradermal and superficial subcutaneous proliferation of plump spindled melanocytes distributed in wedge-shaped fashion within a skin segment that shows marked superficial elastosis. Cellularity is accentuated in the perifollicular adventitial dermis. Focal extension into fatty tissue is also apparent.,55,,2.9,,,,M,1003098
BS2,RC11-001, NextFlex 2,TGACCA,,,,blue nevus-like melanoma,,BioSci1_BB42,BB42_SeqL,BB42_CL,Tumor,NimV2mix3,RC11-001_Tumor,NA_RC11-001_Tumor,,,,,,,,,,,,,,,
BS3,RC11-002, NextFlex 3,ACAGTG,,,,blue nevus-like melanoma,,BioSci1_BB42,BB42_SeqL,BB42_CL,Tumor,NimV2mix3,RC11-002_Tumor,NA_RC11-002_Tumor,,,,,,,,,,,,,,,
BS4,RC11-003, NextFlex 4,GCCAAT,,,,blue nevus-like melanoma,,BioSci1_BB42,BB42_SeqL,BB42_CL,Tumor,NimV2mix3,RC11-003_Tumor,NA_RC11-003_Tumor,,,,,,,,,,,,,,,
BS5,RC11-004, NextFlex 5,CAGATC,,,,blue nevus-like melanoma,,BioSci1_BB42,BB42_SeqL,BB42_CL,Tumor,NimV2mix3,RC11-004_Tumor,NA_RC11-004_Tumor,,,,,,,,,,,,,,,
BS6,RC11-005, NextFlex 6,CTTGTA,,,,blue nevus-like melanoma,,BioSci1_BB42,BB42_SeqL,BB42_CL,Tumor,NimV2mix3,RC11-005_Tumor,NA_RC11-005_Tumor,,,,,,,,,,,,,,,
BS7,RC11-021, NextFlex 7,ATCACG,,,,blue nevus-like melanoma,,BioSci1_BB42,BB42_SeqL,BB42_CL,Tumor,NimV2mix3,RC11-021_Tumor,NA_RC11-021_Tumor,,,,,,,,,,,,,,,
BS8,RC11-022, NextFlex 8,TTAGGC,,,,blue nevus-like melanoma,,BioSci1_BB42,BB42_SeqL,BB42_CL,Tumor,NimV2mix3,RC11-022_Tumor,NA_RC11-022_Tumor,,,,,,,,,,,,,,,
BS9,RC11-023, NextFlex 9,ACTTGA,,,,blue nevus-like melanoma,,BioSci1_BB42,BB42_SeqL,BB42_CL,Tumor,NimV2mix3,RC11-023_Tumor,NA_RC11-023_Tumor,,,,,,,,,,,,,,,
BS10,RC11-024, NextFlex 10,GATCAG,,,,blue nevus-like melanoma,,BioSci1_BB42,BB42_SeqL,BB42_CL,Tumor,NimV2mix3,RC11-024_Tumor,NA_RC11-024_Tumor,,,,,,,,,,,,,,,
BS11,Kit298, NextFlex 11,TAGCTT,,,,blue nevus-like melanoma,,BioSci1_BB42,BB42_SeqL,BB42_CL,Tumor,NimV2mix3,Kit298_Tumor,NA_Kit298_Tumor,,,,,,,,,,,,,,,
22_IS,08-46462,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,11.4,,Ivanka Patient Melanoma (Hunter Extraction Rcvd 8-13-13),,Nimblegen36_BB43,BB43_SeqL,BB43_CL,Tumor,NimV2mix4,08-46462_Tumor,NA_08-46462_Tumor,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
22_Nevus,08-46462,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,42.7,,Ivanka Patient Melanoma (Hunter Extraction Rcvd 8-13-13),,Nimblegen36_BB43,BB43_SeqL,BB43_CL,Nevus,NimV2mix4,08-46462_Nevus,NA_08-46462_Nevus,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
22_Melanoma,08-46462,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,39.6,,Ivanka Patient Melanoma (Hunter Extraction Rcvd 8-13-13),,Nimblegen36_BB43,BB43_SeqL,BB43_CL,Tumor,NimV2mix4,08-46462_Tumor,NA_08-46462_Tumor,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
22_Normal,08-46462,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,100,,Ivanka Patient Melanoma (Hunter Extraction Rcvd 8-13-13),,Nimblegen36_BB43,BB43_SeqL,BB43_CL,Normal,NimV2mix4,08-46462_Normal,NA_08-46462_Normal,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
BN_N1,BN_N1,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,100,,Hunter Blue Nevus (Melanoma in Nevus Project),,Nimblegen36_BB43,BB43_SeqL,BB43_CL,Tumor,NimV2mix4,BN_N1_Tumor,NA_BN_N1_Tumor,,,,,,,,,,,,,,,
BN_N2,BN_N2,L2DR14,CACCTC,13 Cycle Post Hybridization LM-PCR,100,,Hunter Blue Nevus (Melanoma in Nevus Project),,Nimblegen36_BB43,BB43_SeqL,BB43_CL,Tumor,NimV2mix4,BN_N2_Tumor,NA_BN_N2_Tumor,,,,,,,,,,,,,,,
BN_M1,BN_M1,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,100,,Hunter Blue Nevus (Melanoma in Nevus Project),,Nimblegen36_BB43,BB43_SeqL,BB43_CL,Tumor,NimV2mix4,BN_M1_Tumor,NA_BN_M1_Tumor,,,,,,,,,,,,,,,
BN_M2,BN_M2,L2DR16,TGTTGC,13 Cycle Post Hybridization LM-PCR,100,,Hunter Blue Nevus (Melanoma in Nevus Project),,Nimblegen36_BB43,BB43_SeqL,BB43_CL,Tumor,NimV2mix4,BN_M2_Tumor,NA_BN_M2_Tumor,,,,,,,,,,,,,,,
DM_74_1_Tumor,DM74,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,36.2,,Hunter Desmoplastic Melanoma,,Nimblegen36_BB43,BB43_SeqL,BB43_CL,Tumor,NimV2mix4,DM74_Tumor,NA_DM74_Tumor,,,,,,,,,,,,,,,
DM_102_Tumor,DM10,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,100,,Hunter Desmoplastic Melanoma,,Nimblegen36_BB43,BB43_SeqL,BB43_CL,Tumor,NimV2mix4,DM10_Tumor,NA_DM10_Tumor,,,,,,,,,,,,,,,
MS_1_Tumor,SQ13-8208B,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,27.1,,"Dr. Perry, Melanocytic Shwannoma",,Nimblegen36_BB43,BB43_SeqL,BB43_CL,Tumor,NimV2mix4,SQ13-8208B_Tumor,NA_SQ13-8208B_Tumor,,,,,,,,,,,,,,,
AM_7_Tumor,98-18400a,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,100,,Iwei Acral Melanoma,,Nimblegen37_BB44,BB44_SeqL,BB44_CL,Tumor,NimV2mix3,98-18400a_Tumor,NA_98-18400a_Tumor,98-18400,A,"MELANOMA, 1.3 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN",176788,172.7,,"Sections show acral skin with a proliferation of atypical melanocytes
arranged in an irregular pattern within the epidermis, and with
similar cells in the papillary dermis.  The pattern along the
junction is confluent, and there are a few detached aggregates (not
in vessels) deeper in the dermis.",46,,1.3,,,,F,155973
AM_9_Tumor,12-11406A,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,67.4,,Iwei Acral Melanoma,,Nimblegen37_BB44,BB44_SeqL,BB44_CL,Tumor,NimV2mix3,12-11406A_Tumor,NA_12-11406A_Tumor,12-11406,A,"MELANOMA, 2.4 MM IN THICKNESS, ABUTTING THE SPECIMEN PERIPHERY",173714,172.5,"The lesion is over 2 mm in thickness, and is not ulcerated. Therefore it should be classified as T3a per the 2009 revision of the AJCC staging system for melanoma.  Of course, further treatment is warranted. This report was reissued on April 23, 2012, after correcting the listed specimen site.","Sections show a segment of acral skin in which there is a broad asymmetrical and poorly circumscribed compound proliferation of melanocytes. Within the epidermis, melanocytes are arranged as single cells and as nests with many melanocytes located in pagetoid scatter. In numerous foci, single melanocytes predominate over nests and melanocytes are also arranged overlying dermal papillae. Within the stratum corneum, abundant pigment is present in a haphazard and random distribution. Large nests of melanocytes are present in the dermis in which the melanocytes are arranged as sheets. The size of the melanocytes does not diminish with descent into the dermis and many atypical enlarged melanocytes are present in the deep aspect of the lesion. The overlying epidermis is acanthotic.",42,T3a,2.4,,Primary,,F,1097222
AM_11_Tumor,08-70283a,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,100,,Iwei Acral Melanoma,,Nimblegen37_BB44,BB44_SeqL,BB44_CL,Tumor,NimV2mix3,08-70283a_Tumor,NA_08-70283a_Tumor,08-70283,A,"MELANOMA, INVOLVING ACRAL SKIN, ULCERATED, AT LEAST 2 MM IN THICKNESS, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN",224789,172.7,"This is an ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV). Definitive assessment of prognostic features should be deferred to the excision specimen. There is no evidence of associated vascular invasion, neurotropism, or regression in these sections.","Sections show acral skin with a proliferation of atypical melanocytes arranged in an irregular and confluent pattern within the epidermis, with suprabasal scatter, and with similar cells in clusters and syncytia in the dermis. Mitotic figures are readily identifiable. There is ulceration with scale-crust formation.",54,,2,,,,F,778923
AM_13_Tumor,03-34051A1,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,100,,Iwei Acral Melanoma,,Nimblegen37_BB44,BB44_SeqL,BB44_CL,Tumor,NimV2mix3,03-34051A1_Tumor,NA_03-34051A1_Tumor,03-34051,A,"ACRAL MELANOMA, AT LEAST 3.5 MM IN THICKNESS, AT LEAST CLARK'S LEVEL IV, WITH ULCERATION AND VASCULAR INVASION, PARTIAL BIOPSY",173731,172.7,"This is a high-risk primary with ulceration and vascular invasion. As this is a partial biopsy, the micro stage assessment given here may be an underestimate.",Sections show acral skin with a broadly ulcerated nodular proliferation of highly atypical melanocytes which descent into the reticular dermis.  The adjacent epidermis is acanthotic and shows a lentiginous proliferation of melanocytes with prominent dendrites.  There are scattered atypical mitotic figures.  There are numerous thin walled vessels.  In some areas melanoma cells are seen within the lumina.,49,,3.5,,,,M,392364
AM_14_Tumor,02-42436,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,100,,Iwei Acral Melanoma,,Nimblegen37_BB44,BB44_SeqL,BB44_CL,Tumor,NimV2mix3,02-42436_Tumor,NA_02-42436_Tumor,02-42436,A,"MELANOMA, APPROXIMATELY 0.8 MM IN THICKNESS",176788,172.7,"The thickness is listed as an approximation as the lesion has a verrucous contour at its thickest point. Melanoma in situ extends to the periphery of the specimen.  I did not detect vascular or perineural invasion.  The mitotic rate appears moderate. Separation between level III and IV is difficult on acral skin, as there is no clear separation between the papillary and reticular dermis.","Sections show acral skin with a very broad, poorly
circumscribed proliferation of melanocytes.  The central portion
consists of rounded junctional nests, with most of the cells in them
having relatively small, monomorphous nuclei.  Occasional cells have
strikingly enlarged, vesicular nuclei with large nucleoli.  The
center of the lesion is slightly papillated, features pagetoid spread
of melanocytes, confluence of junctional nests, and sheets of
atypical melanocytes in the superficial dermis.  There is little
maturation with descent.",53,,0.8,,,,F,347170
DPN_5_Normal,11-38149,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,10.5,,Iwei DPN,,Nimblegen37_BB44,BB44_SeqL,BB44_CL,Normal,NimV2mix3,11-38149_Normal,NA_11-38149_Normal,11-38149,A,"HEALING BIOPSY SITE, WITH NO EVIDENCE OF A RESIDUAL DEEP PENETRATING NEVUS",173533,216.5,,Sections show an area of inflamed granulation tissue with no evidence of residual melanocytic neoplasm.,54,,,,,,M,1018350
DPN_MM 20,13-2939B,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,74.2,,Iwei DPN (DPN like Melanoma),,Nimblegen37_BB44,BB44_SeqL,BB44_CL,Tumor,NimV2mix3,13-2939B_Tumor,NA_13-2939B_Tumor,13-2939,B,"MELANOMA OF 8.3 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE INKED SPECIMEN MARGIN",172599,172.5,"This biopsy demonstrates a 'deep penetrating' melanoma with a nodular invasive component that extends into the upper subcutis. The invasive component has been fully excised, but flanking melanoma in situ is transected at the inked specimen periphery. With respect to staging, this melanoma exceeds 4 mm in thickness and shows focal associated ulceration. Therefore, it represents a melanoma of stage pT4b (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.","There is a nodular proliferation of melanocytes with atypical nuclei in contiguity with the epidermis. The melanocytes are pigmented and epithelioid or fusiform, and coalescing fascicles and sheets of cells are apparent and are accompanied by many melanophages. There is little diminishment in melanocyte size with descent in the dermis. Deep extension into the subcutis is present centrally. To the side of this, many similar epidermal melanocytes are apparent singly and in small nests and fascicles. A perijunctional lymphohistiocytic infiltrate with admixed melanophages is also noted.",71,T4b,8.3,None,Primary,,M,1187682
DPN_MM 21,L13-48798,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,100,,Iwei DPN (DPN like Melanoma),,Nimblegen37_BB44,BB44_SeqL,BB44_CL,Tumor,NimV2mix3,L13-48798_Tumor,NA_L13-48798_Tumor,,,,,,,,,,,,,,,
DPN_MM 22,13-51115A,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,100,,Iwei DPN (DPN like Melanoma),,Nimblegen37_BB44,BB44_SeqL,BB44_CL,Tumor,NimV2mix3,13-51115A_Tumor,NA_13-51115A_Tumor,13-51115,A,INVASIVE MELANOMA,173502,172.5,,"Sections show a proliferation of nested and solitary melanocytes arrayed irregularly and confluently within the epidermis and dermis. The constituent melanocytes display atypical nuclear features and have abundant vacuolated and heavily pigmented cytoplasm, and some melanocytes are scattered above the epidermal-dermal junction. In the dermis, there is a syncytial array of non-maturing melanocytes with associated early necrosis and many melanophages.",68,,,,,,M,380899
DPN_CNN 30,11-73238A,L2DR12,TGTGAA,13 Cycle Post Hybridization LM-PCR,100,,Iwei DPN (Control Normal Nevus),,Nimblegen37_BB44,BB44_SeqL,BB44_CL,Normal,NimV2mix3,11-73238A_Normal,NA_11-73238A_Normal,11-73238,A,"COMPOUND MELANOCYTIC NEVUS, POLYPOID",173530,216.5,,"Sections show skin in a polypoid configuration.  A compound proliferation of melanocytes composed of single cells and nests along the sides and bases of elongated rete ridges is present. Nests, cords and syncytia of melanocytes with small to medium round nuclei and scant amphophilic cytoplasm are present in the papillary dermis and exhibit maturation with descent into the reticular dermis.",56,,,,,,F,987085
DPN_CNN 32,11-73999,L2DR13,ACAAAC,13 Cycle Post Hybridization LM-PCR,93.5,,Iwei DPN (Control Normal Nevus),,Nimblegen37_BB44,BB44_SeqL,BB44_CL,Normal,NimV2mix3,11-73999_Normal,NA_11-73999_Normal,11-73999,A,COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES,173714,216.7,,"Sections show a compound proliferation of melanocytes.  A few small junctional nests of melanocytes are present at the periphery.  Nests, cords and syncytia of melanocytes with small to medium round nuclei and scant amphophilic cytoplasm are present in the papillary dermis and exhibit maturation with descent into the reticular dermis with accentuation around adnexae. The overlying epidermis is papillated.",25,,,,,,F,1063446
DM_43_Normal,DM43,L2DR14,CACCTC,13 Cycle Post Hybridization LM-PCR,100,,Hunter Desmoplastic Melanoma,,Nimblegen38_BB45,BB45_SeqL,BB45_CL,Normal,NimV2mix3,DM43_Normal,NA_DM43_Normal,,,,,,,,,,,,,,,
DM_49_Normal,DM49,L2DR15,GTGGCC,13 Cycle Post Hybridization LM-PCR,100,,Hunter Desmoplastic Melanoma,,Nimblegen38_BB45,BB45_SeqL,BB45_CL,Normal,NimV2mix3,DM49_Normal,NA_DM49_Normal,,,,,,,,,,,,,,,
DM_58_Normal,DM58,L2DR16,TGTTGC,13 Cycle Post Hybridization LM-PCR,100,,Hunter Desmoplastic Melanoma,,Nimblegen38_BB45,BB45_SeqL,BB45_CL,Normal,NimV2mix3,DM58_Normal,NA_DM58_Normal,,,,,,,,,,,,,,,
DM_65_2_Tumor,DM65,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,60.1,,Hunter Desmoplastic Melanoma,,Nimblegen38_BB45,BB45_SeqL,BB45_CL,Tumor,NimV2mix3,DM65_Tumor,NA_DM65_Tumor,,,,,,,,,,,,,,,
DM_93_3_Tumor,DM93,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,100,,Hunter Desmoplastic Melanoma,,Nimblegen38_BB45,BB45_SeqL,BB45_CL,Tumor,NimV2mix3,DM93_Tumor,NA_DM93_Tumor,,,,,,,,,,,,,,,
DM_100_Tumor_Pool,DM10,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,10,,Hunter Desmoplastic Melanoma,,Nimblegen38_BB45,BB45_SeqL,BB45_CL,Tumor,NimV2mix3,DM10_Tumor,NA_DM10_Tumor,,,,,,,,,,,,,,,
DPN_35,13-59840,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,100,,Iwei DPN,,Nimblegen38_BB45,BB45_SeqL,BB45_CL,Tumor,NimV2mix3,13-59840_Tumor,NA_13-59840_Tumor,13-59840,A,"COMBINED MELANOCYTIC NEVUS, WITH SUPERFICIAL CONGENITAL AND DEEP PENETRATING NEVUS COMPONENTS",528599,216.5,,"Sections show a papillated segment of skin in which there is a proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There is a roughly wedge shaped dermal infiltrate of melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm.",52,,,,,,M,352453
DPN_Conv_35,13-59840,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,100,,Iwei DPN,,Nimblegen38_BB45,BB45_SeqL,BB45_CL,Tumor,NimV2mix3,13-59840_Tumor,NA_13-59840_Tumor,13-59840,A,"COMBINED MELANOCYTIC NEVUS, WITH SUPERFICIAL CONGENITAL AND DEEP PENETRATING NEVUS COMPONENTS",528599,216.5,,"Sections show a papillated segment of skin in which there is a proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There is a roughly wedge shaped dermal infiltrate of melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm.",52,,,,,,M,352453
Seider_Uveal Melanoma,Seider_Uveal,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,44.3,,Seider Uveal Melanoma,,Nimblegen38_BB45,BB45_SeqL,BB45_CL,Tumor,NimV2mix3,Seider_Uveal_Tumor,NA_Seider_Uveal_Tumor,,,,,,,,,,,,,,,
Luping_ROS 1,Luping_ROS_1,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,55,,"Bivona Lab, ROS 1",,Nimblegen38_BB45,BB45_SeqL,BB45_CL,Tumor,NimV2mix3,Luping_ROS_1_Tumor,NA_Luping_ROS_1_Tumor,,,,,,,,,,,,,,,
Seider_Roe,Seider_Roe,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,35.4,,Seider Uveal Melanoma,,Nimblegen38_BB45,BB45_SeqL,BB45_CL,Tumor,NimV2mix3,Seider_Roe_Tumor,NA_Seider_Roe_Tumor,,,,,,,,,,,,,,,
G3 DP08-21965C Tumor,DP08-21965C,L2DR01,AAGGGA,13 Cycle Post Hybridization LM-PCR,54.4,,"Gerami, Eruptive Nevi",,Nimblegen39_BB46,BB46_SeqL,BB46_CL,Tumor,NimV2mix3,DP08-21965C_Tumor,NA_DP08-21965C_Tumor,,,,,,,,,,,,,,,
DM_18_2_Tumor,DM18,L2DR02,CCTTCA,13 Cycle Post Hybridization LM-PCR,67.7,,Hunter DM,,Nimblegen39_BB46,BB46_SeqL,BB46_CL,Tumor,NimV2mix3,DM18_Tumor,NA_DM18_Tumor,,,,,,,,,,,,,,,
CGH11-229,11-50182,L2DR03,GGACCC,13 Cycle Post Hybridization LM-PCR,100,,Iwei 7Q Gain,CGH11-229 ,Nimblegen39_BB46,BB46_SeqL,BB46_CL,Tumor,NimV2mix3,11-50182_Tumor,NA_11-50182_Tumor,11-50182,A,"ATYPICAL INTRADERMAL PROLIFERATION OF ENLARGED SPINDLED MELANOCYTES, CONSISTENT WITH MELANOMA OF 1.9 MM IN THICKNESS",173502,172.5,"ADDENDUM, August 18, 2011: Our differential diagnosis included an atypical cellular blue nevus on one hand and blue nevus-like melanoma on the other. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity and a low Ki-67 cell proliferation index. We also completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue bock, application of aCGH demonstrated segmental gain in chromosome 7q and loss of chromosome 9q. The presence of multiple chromosomal losses suggests genomic instability and favors interpretation as melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH favors interpretation as blue nevus-like (or deep penetrating nevus-like) melanoma. With respect to staging, this tumor is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to permit further microstage assessment and to ensure that local eradication has been accomplished.","Sections show a domed segment of skin with a dermal proliferation of enlarged fusiform melanocytes with abundant, pale cytoplasm and dusty appearing melanin. These melanocytes are arranged as thick and thin interconnecting fascicles with interspersed melanophages. The aggregations are more closely apposed in the upper part of the lesion than near the base of the specimen. Mitoses are present (around 1 per 5 400x fields). Some melanocytes have large, hyperchromatic nuclei.",55,,1.9,,,,M,1039621
CGH11-202,11-41004,L2DR04,TTCAGC,13 Cycle Post Hybridization LM-PCR,100,,Iwei 7Q Gain,CGH11-202 ,Nimblegen39_BB46,BB46_SeqL,BB46_CL,Tumor,NimV2mix3,11-41004_Tumor,NA_11-41004_Tumor,11-41004,A,PREDOMINANTLY INTRADERMAL SPITZ'S NEVUS WITH SOME UNUSUAL FEATURES,102353,216.3,"The neoplasm extends to the peripheral dermal edge of the specimen. Many features favor a Spitz's nevus, but there are large aggregations deep in the lesion, a few mitotic figures at the level of the mid-reticular dermis and the melanocytic nuclei are more pleomorphic than usual. Complete excision, despite the cosmetically sensitive area is warranted.  Comparative genomic hybridization shows a gain involving chromosome 11p, and also one involving 7q. Isolated 11p gain usually corresponds to the formation of an isochromosome (two copies of 11p joined by a centromere), and has not been seen to date in melanoma. Spitz's nevi with this aberration are likely to have a mutation involving h-ras, and to deeply infiltrate the reticular dermis as single cells, findings that are present here. In this case, the 11p gain is not isolated but is associated by a gain of 7q. I consulted with Dr. Boris Bastian, at Sloan-Kettering Cancer Center, New York, a colleague whose laboratory developed diagnostic comparative genomic hybridization when he was here at UCSF. He has not seen these two aberrations together, and heretofore regarded them as mutually exclusive. He believes that the current CGH picture still favors Spitz's nevus, even though the 11p aberration is not an isolated one.  References:  van Engen-van Grunsven AC, van Dijk MC, Ruiter DJ, Klaasen A, Mooi WJ, Blokx WA. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. Am J Surg Pathol. 2010 Oct;34(10):1436-41.  Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000 Sep;157(3):967-72.","Sections show a predominantly dermal proliferation of large melanocytes, with a domed surface and a wedge shaped base. The lesional melanocytes are fusiform, with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular and heterochromatic nuclei, some with large nucleoli. A few mitotic figures are present in melanocytes well within the dermis. While there is a greater degree of cellularity in the upper than in the lower part of the lesion, some of the aggregations toward the base of the lesion are substantial. The enclosed immunoperoxidase stains show that many nuclei are Ki-67 positive, but many of these may be those of lymphocytes.",8,,,,,,M,1030443
CGH11-215,11-51223,L2DR05,AAGACG,13 Cycle Post Hybridization LM-PCR,84,,Iwei 7Q Gain,CGH11-215 ,Nimblegen39_BB46,BB46_SeqL,BB46_CL,Tumor,NimV2mix3,11-51223_Tumor,NA_11-51223_Tumor,11-51223,A,CHILDHOOD-TYPE SPITZOID MELANOMA OF 1.3 MM IN THICKNESS,173305,172.3,"Our differential diagnosis included a peculiar pigmented spindle cell nevus on one hand and spitzoid melanoma on the other. To more comprehensively assess this differential diagnosis, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH demonstrated possible gain in chromosome 2q, gain in chromosome 5p, loss in terminal chromosome 5q, loss in 6q, gain in 7q, and segmental gain in 11q. As you know, the identification of multiple genomic gains and losses is indicative of genomic instability and is incompatible with a diagnosis of melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with low risk for widespread dissemination. In our experience, most tumors of this type are of very low grade.  With respect to staging parameters, this melanoma is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.","There is a broad and poorly circumscribed proliferation of melanocytes with a papillated surface. At the periphery, increased numbers of single melanocytes and small nests are present along and above the junction. Many of these cells are spindled, and some have large, hyperchromatic nuclei or pigmented dendrites. The overlying epidermis has pigmentation of its keratinocytes. Centrally, in the papillated part of the proliferation, there are large nests and fascicles of large fusiform melanocytes with lightly pigmented cytoplasm and oval, vesicular nuclei that extend from the junctional zone into the superficial reticular dermis. Some of the superficial nests are confluent and oddly shaped. A few mitotic figures are present among them. They are a few large Kamino bodies. Toward the base of the proliferation, somewhat smaller cells colonize adnexal structures. A perijunctional lymphohistiocytic infiltrate with admixed melanophages is also noted.",10,,1.3,,,,F,1040663
CGH12-088,12-22542,L2DR06,CCTCGG,13 Cycle Post Hybridization LM-PCR,100,,Iwei 7Q Gain,CGH12-088 ,Nimblegen39_BB46,BB46_SeqL,BB46_CL,Tumor,NimV2mix3,12-22542_Tumor,NA_12-22542_Tumor,12-22542,A,"SPITZ'S NEVUS, PREDOMINANTLY INTRADERMAL",672655,216.6,"The configuration of this lesion is unusual (it is more bottom-heavy than most spitzoid proliferations). Comparative genomic hybridization shows a gain of part of chromosome 7q and a loss of part of that chromosome, and a gain of part of chromosome 11p and a loss of part of that chromosome, but no other aberrations. Spitz's nevi with chromosome 11p gains are likely to have a mutation involving h-ras, and to deeply infiltrate the reticular dermis as single cells, findings that are present here. Because of the presence of losses in both chromosomes as well as gains, I asked my colleague, Dr. Boris Bastian to review the findings as well, and he agrees with this interpretation. References:  van Engen-van Grunsven AC, van Dijk MC, Ruiter DJ, Klaasen A, Mooi WJ, Blokx WA. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. Am J Surg Pathol. 2010 Oct;34(10):1436-41.  Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000 Sep;157(3):967-72.","Sections show acral skin with a broad-based pan-dermal and superficial subcutaneous proliferation of large oval melanocytes. The constituent cells are arranged as discrete nests and interconnecting fascicles within fibrotic stroma. The cells have abundant amphophilic cytoplasm and enlarged, oval vesicular nuclei. Scattered mitotic figures are evident. There is no significant intraepidermal component, nor do areas show significant pigmentation. The enclosed immunoperoxidase stains include an S100 preparation labeling nearly all of the constituent cells, paralleled by similar staining with Melan-A and HMB45. There is no loss of nuclear or cytoplasmic staining for p16 protein. A Ki-67 stain shows a low proliferative rate.",62,,,,,,M,1108360
CGH12-188,12-42406,L2DR07,GGATGT,13 Cycle Post Hybridization LM-PCR,100,,Iwei 7Q Gain,CGH12-188 ,Nimblegen39_BB46,BB46_SeqL,BB46_CL,Tumor,NimV2mix3,12-42406_Tumor,NA_12-42406_Tumor,12-42406,A,"COMPOUND PROLIFERATION OF ENLARGED SPINDLED AND EPITHELIOID MELANOCYTES, CONSISTENT WITH AN UNCONVENTIONAL DESMOPLASTIC SPITZ NEVUS",17723,238.2,"ADDENDUM, July 19, 2012: As you know, our differential diagnosis included an unconventional desmoplastic Spitz nevus on one hand and spitzoid melanoma on the other. To more fully address that differential diagnosis, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 11p as well as focal gain and loss in chromosome 7q. The identification of 11p gain indicates a desmoplastic Spitz nevus with associated HRAS mutation (a reference regarding this entity is listed below). The additional identification of an anomaly involving chromosome 7 is meaningless in the context of 11p gain. In our prior evaluation of this tumor, p16 immunostaining was completed and a near-total loss of expression is apparent. This result implied that a genomic copy number anomaly involving chromosome 9p might be present. However, our aCGH analysis proves this is not the case. Rather, molecular assessment proves that a copy number anomaly involving chromosome 9 is not present.  A reexcision from this site has been received as our case 12-46583. Please refer to that case for additional information.  Reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.","Sections show a compound proliferation of melanocytes, many of which are large, and spindled to epithelioid, arrayed as nests and some single cells along the junctional zone, and as clusters and syncytia within the dermis. Some slightly smaller but similar melanocytes are also present, and many melanocytes are positioned between thickened/sclerotic collagen bundles. There is a patchy lymphocytic infiltrate. Occasional dermal mitotic figures are evident.",44,,,,,,M,1128224
CGH12-227,12-55875,L2DR08,TTCGCT,13 Cycle Post Hybridization LM-PCR,100,,Iwei 7Q Gain,CGH12-227 ,Nimblegen39_BB46,BB46_SeqL,BB46_CL,Tumor,NimV2mix3,12-55875_Tumor,NA_12-55875_Tumor,12-55875,A,"SPITZOID MELANOMA, CHILDHOOD TYPE",173507,173.5,"I note the considerations in Dr. Barnhill's report, and in large part agree. The extreme nuclear pleomorphism, with large bizarre nuclei, some containing macronucleoli and configuration of the lesion are findings by light microscopy against a conventional Spitz's nevus, or a well characterized variant. Morphologically, I favored designation as spitzoid melanoma of childhood. After discussion of the case with the child's dermatologist, Dr. Aimee Smidt, we have proceeded with comparative genomic hybridization. This showed multiple aberrations, consistent with melanoma. These included a set of aberrations involving chromosome 6p, with high level amplifications of the peri-telomeric and peri-centromeric areas, and a loss of the broader area in between them. Other losses include 8p, 11q and 19q, with a gain involving 19p.  The lesion is over 7 mm in thickness, which ordinarily would qualify this non-ulcerated neoplasm as stage T4 melanoma. While there is a propensity for lesions like this one to involve local lymph nodes, systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. This lessens the predictive value of sentinel lymph node biopsy and the therapeutic value of completion lymphadenectomy even when nodes are positive.","There is a large, a pedunculated segment of skin with a proliferation of large, oval, fusiform and spindled cells throughout the dermis. The overlying epidermis is irregularly hyperplastic. The lesional melanocytes form closely apposed fascicles, and have homogeneous appearing eosinophilic cytoplasm, with adjacent cells delineated by clefts. Some cells have coarse chromatin, large, and sometimes multiple nucleoli. Scattered mitotic figures are present. Little diminution in cellularity is present toward the base of the specimen.",5,,,,,,M,1141688
CGH12-376,12-88454,L2DR09,ACACGA,13 Cycle Post Hybridization LM-PCR,100,,Iwei 7Q Gain,CGH12-376 ,Nimblegen39_BB46,BB46_SeqL,BB46_CL,Tumor,NimV2mix3,12-88454_Tumor,NA_12-88454_Tumor,12-88454,A,"MELANOMA, 0.6 MM. IN THICKNESS",173531,172.5,"The pagetoid scatter (revealed in your Melan-A immunoperoxidase stain) and the confluence of nests in the superficial dermis are findings worrisome for melanoma. The mostly nested pattern seen here would be unusual for a dysplastic (Clark's) nevus in a patient of this age. On the other hand, immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) performed in our laboratory shows almost no labelling of the nuclei of dermal melanocytes with Ki-67. Because of these conflicting criteria, we obtained comparative genomic hybridization. This showed multiple chromosomal aberrations indicative of melanoma. The include gains involving chromosomes 1p, 6p and 7q, with a loss involving 9q. Several of these aberrations are typical ones seen in melanoma.  The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.","Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. There are plump, oval melanocytes with moderate amounts of pale cytoplasm and monomorphous small nuclei arranged as nests along the dermo-epidermal junction, with large, confluent nests in the subjacent papillary dermis. Some pagetoid scatter of single melanocytes is present, much better seen in the Melan-A immunoperoxidase stain than in the hematoxylin and eosin stained sections.",67,T1a,0.6,,Primary,,M,1174271
CGH13-007,12-98328,L2DR10,CACACA,13 Cycle Post Hybridization LM-PCR,100,,Iwei 7Q Gain,CGH13-007 ,Nimblegen39_BB46,BB46_SeqL,BB46_CL,Tumor,NimV2mix3,12-98328_Tumor,NA_12-98328_Tumor,12-98328,A,COMPOUND SPITZ'S NEVUS,123746,216.7,"An ALK stain was negative (performed as some spitzoid lesions with very long vertically oriented fascicles are ALK positive). Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively high proliferation rate in deep dermal melanocytes, with about 10% of nuclei positive in some aggregations). A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows scattered mitotic figures in both superficial and deep melanocytes. The proliferation rate and lack of maturation with descent are worrisome, raising the possibility of a spitzoid melanoma. Comparative genomic hybridization shows gains involving the distal portion of chromosome 7q and 11p. These two aberrations are found in a minority of Spitz's nevi, usually in isolation, but occasionally together. The deeply infiltrative pattern is one associated with 11p gain; we are in the process of analyzing the findings in Spitz's nevi with 7q gain, and those with both aberrations. Given this result, I would follow the site clinically.","There is a broad-based, roughly wedge-shaped pan-dermal and superficial subcutaneous proliferation of large oval and fusiform melanocytes. The overlying epidermis is irregularly hyperplastic, with, in one focus, a subjacent area of inflamed fibrosing granulation tissue containing histiocytes with granular material in their cytoplasm (aluminum chloride residue). The subjacent melanocytic proliferation consists of thin fascicles of cells with abundant pale amphophilic cytoplasm and oval vesicular nuclei with variable chromatin (finely stippled in some cells, and with large nucleoli in others). An infiltrate of lymphocytes, plasma cells and eosinophils is present.",8,,,,,,M,1176562
CGH13-011,13-25A,L2DR11,GTGTTA,13 Cycle Post Hybridization LM-PCR,45.1,,Iwei 7Q Gain,CGH13-011 ,Nimblegen39_BB46,BB46_SeqL,BB46_CL,Tumor,NimV2mix3,13-25A_Tumor,NA_13-25A_Tumor,13-25,A,"MELANOMA, 1.2 MM. IN THICKNESS",173602,172.6,,"Sections show a relatively narrowly based lesion in which a thickened epidermis with rounded rete ridges overlies a dermal proliferation of melanocytes, with moderate amphophilic cytoplasm and enlarged nuclei, some hyperchromatic, distributed singly or in small collections in the dermis. There is elastotic stroma. The enclosed two-color immunostain shows that there is a low proliferation rate among the lesional melanocytes.",48,,1.2,,,,F,1184767
DPN_CNN 23,12-762B,L2DR01,AAGGGA,,2.35,,Iwei DPN (Control Normal Nevus),,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Normal,NimV2mix3,12-762B_Normal,NA_12-762B_Normal,12-762,B,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS,173312,216.3,,"Sections show is a dome surfaced segment of skin with nests of small, round melanocytes in the dermis with increased numbers distributed around adnexal structures.",51,,,,,,M,1086578
DPN_CNN 25,12-168B,L2DR02,CCTTCA,,2.86,,Iwei DPN (Control Normal Nevus),,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Normal,NimV2mix3,12-168B_Normal,NA_12-168B_Normal,12-168,B,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH CONGENITAL FEATURES,173340,216.3,,"Sections show a domed segment of skin, with nests, cords and strands of small round melanocytes in the dermis, in part in a peri-adnexal pattern.",71,,,,,,M,1080712
DPN_CNN 26,11-75173,L2DR03,GGACCC,,3.46,,Iwei DPN (Control Normal Nevus),,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Normal,NimV2mix3,11-75173_Normal,NA_11-75173_Normal,11-75173,A,COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES,173525,216.5,,"Sections show a compound proliferation of melanocytes composed of single cells and nests along the sides and bases of elongated rete ridges. Nests, cords and syncytia of melanocytes with small to medium round nuclei and scant amphophilic cytoplasm are present in the papillary dermis and exhibit maturation with descent into the superficial reticular dermis.  Overlying rete ridges are elongated and interanastomosing.",52,,,,,,F,1064620
DPN_CNN 27,12-167B,L2DR04,TTCAGC,,5.04,,Iwei DPN (Control Normal Nevus),,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Normal,NimV2mix3,12-167B_Normal,NA_12-167B_Normal,12-167,B,PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH CONGENITAL FEATURES,333504,216.5,,"Sections show nests, cords and strands of small, round melanocytes in the dermis.  Strands of melanocytes lie between collagen bundles in the reticular dermis and around adnexal structures.",32,,,,,,F,671051
DPN 34 pool,13-47668,L2DR05,AAGACG,,8.57,,Iwei DPN  ,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Tumor,NimV2mix3,13-47668_Tumor,NA_13-47668_Tumor,13-47668,A,"COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION",424655,216.6,This melanocytic nevus shows features of both a conventional melanocytic nevus and a deep penetrating nevus.,"Sections show a proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There is a roughly wedge shaped dermal infiltrate of melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another more superficial component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm. Solar elastosis is present in the dermis.",65,,,,,,F,298118
DPN 34 Conv pool,13-47668,L2DR06,CCTCGG,,1.97,,Iwei DPN  ,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Tumor,NimV2mix3,13-47668_Tumor,NA_13-47668_Tumor,13-47668,A,"COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION",424655,216.6,This melanocytic nevus shows features of both a conventional melanocytic nevus and a deep penetrating nevus.,"Sections show a proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There is a roughly wedge shaped dermal infiltrate of melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another more superficial component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm. Solar elastosis is present in the dermis.",65,,,,,,F,298118
DPN 36 pool,12-66661,L2DR07,GGATGT,,3.75,,Iwei DPN  ,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Tumor,NimV2mix3,12-66661_Tumor,NA_12-66661_Tumor,12-66661,A,"COMBINED MELANOCYTIC NEVUS, WITH COMPONENTS OF ORDINARY MELANOCYTIC NEVUS AND DEEP PENETRATING NEVUS",173121,216.1,"The nevus has combined components, the deep penetrating nevus portion of which may account for a darker portion clinically. This is a benign variant that has also been given other names such as clonal nevus and others.","Sections show a melanocytic proliferation composed of cells with two distinct cytologic appearances.  One population is composed of cells with abundant pale cytoplasm, arranged in small clusters accompanied by melanophages. The other consists of small melanocytes with round to oval nuclei, arranged in nests and cords.",51,,,,,,F,1152477
DPN 37 pool,13-47621,L2DR08,TTCGCT,,2.53,,Iwei DPN  ,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Tumor,NimV2mix3,13-47621_Tumor,NA_13-47621_Tumor,13-47621,A,COMBINED MELANOCYTIC NEVUS,528522,216.5,This neoplasm has features of both a superficial congenital melanocytic nevus and a deep penetrating nevus. There is no evidence of melanoma or atypicality.,"Sections show a compound proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There are melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm.",24,,,,,,F,1288923
DPN Conv 37,13-47621,L2DR09,ACACGA,,3,,Iwei DPN  ,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Tumor,NimV2mix3,13-47621_Tumor,NA_13-47621_Tumor,13-47621,A,COMBINED MELANOCYTIC NEVUS,528522,216.5,This neoplasm has features of both a superficial congenital melanocytic nevus and a deep penetrating nevus. There is no evidence of melanoma or atypicality.,"Sections show a compound proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There are melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm.",24,,,,,,F,1288923
DPN 38,13-37371,L2DR10,CACACA,,4.49,,Iwei DPN  ,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Tumor,NimV2mix3,13-37371_Tumor,NA_13-37371_Tumor,13-37371,A,"COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION",173688,216.6,This biphasic melanocytic nevus includes the commingling of congenital melanocytic nevus with deep penetrating nevus.,"Sections show a compound proliferation of small melanocytes with ovoid nuclei, and slight diminishment in the size of melanocytes with descent in the dermis is appreciable.  Most of the dermal melanocytes are arrayed as syncytia. Some dermal melanocytes have ample, finely melanized cytoplasm and are slightly larger in size.  There are many surrounding melanophages in the dermis.",29,,,,,,F,1278673
DPN Conv 38,13-37371,L2DR11,GTGTTA,,4.73,,Iwei DPN  ,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Tumor,NimV2mix3,13-37371_Tumor,NA_13-37371_Tumor,13-37371,A,"COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION",173688,216.6,This biphasic melanocytic nevus includes the commingling of congenital melanocytic nevus with deep penetrating nevus.,"Sections show a compound proliferation of small melanocytes with ovoid nuclei, and slight diminishment in the size of melanocytes with descent in the dermis is appreciable.  Most of the dermal melanocytes are arrayed as syncytia. Some dermal melanocytes have ample, finely melanized cytoplasm and are slightly larger in size.  There are many surrounding melanophages in the dermis.",29,,,,,,F,1278673
DM11_Tert_Amplicon,DM11,L2DR12,TGTGAA,,3.66,,Hunter DM Amplicon Sequencing,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Tumor,,DM11_Tumor,NA_DM11_Tumor,,,,,,,,,,,,,,,
DM14_Tert_Amplicon,DM14,L2DR13,ACAAAC,,2.37,,Hunter DM Amplicon Sequencing,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Tumor,,DM14_Tumor,NA_DM14_Tumor,,,,,,,,,,,,,,,
MIN_1_Tert_Amplicon,13-25110A1,L2DR14,CACCTC,,2.64,,Hunter Melanoma in Nevus Amplicon Sequencing,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Melanoma,,13-25110A1_Melanoma,NA_13-25110A1_Melanoma,13-25110,A,"MELANOMA, 1.2 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED",122741,172.7,"Melanoma in situ is present < 1 millimeter from the edge of the specimen.  This is a non-ulcerated melanoma.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.","There is a proliferation of melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm, arranged in an irregular pattern along the junction and within the dermis.  Suprabasal scatter of melanocytes is prominent in some areas.  In other areas the melanocytes are bland and mature with descent in the dermis.  There is an infiltrate of lymphocytes and melanophages.",29,T2a,1.2,,Primary,,F,1209855
MIN_3_Tert_Amplicon,13-25110A1,L2DR15,GTGGCC,,4.66,,Hunter Melanoma in Nevus Amplicon Sequencing,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Normal,,13-25110A1_Normal,NA_13-25110A1_Normal,13-25110,A,"MELANOMA, 1.2 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED",122741,172.7,"Melanoma in situ is present < 1 millimeter from the edge of the specimen.  This is a non-ulcerated melanoma.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.","There is a proliferation of melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm, arranged in an irregular pattern along the junction and within the dermis.  Suprabasal scatter of melanocytes is prominent in some areas.  In other areas the melanocytes are bland and mature with descent in the dermis.  There is an infiltrate of lymphocytes and melanophages.",29,T2a,1.2,,Primary,,F,1209855
MIN_6_Tert_Amplicon,13-45163,L2DR16,TGTTGC,,2.83,,Hunter Melanoma in Nevus Amplicon Sequencing,,Nimblegen40_BB47,BB47_SeqL,BB47_CL,Normal,,13-45163_Normal,NA_13-45163_Normal,13-45163,A,"MELANOMA, 0.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY",139524,172.5,"Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excision Tumor site: back Microscopic tumor type: melanoma on non-chronically sun-damaged skin, SSM Breslow thickness: 0.4 Ulceration: no Margins, peripheral and deep: Intraepidermal component extending close to the peripheral margin Mitotic index: none detected Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX Solar elastosis: mild","Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei arranged in wedge-shaped array  (melanocytic nevus).",58,T1a,0.4,"melanoma on non-chronically sun-damaged skin, SSM",Primary,,F,468757
Acral_11_Tumor,Acral-11,L2DR01,AAGGGA,,,,,_Tumor,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Tumor,NimV2mix3,Acral-11_Tumor,NA_Acral-11_Tumor,,,,,,,,,,,,,,,
Acral_11_Cntl,Acral-11,L2DR02,CCTTCA,,,,,_Cntl,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Normal,NimV2mix3,Acral-11_Normal,NA_Acral-11_Normal,,,,,,,,,,,,,,,
Acral_12_Tumor,Acral-12,L2DR03,GGACCC,,,,,_Tumor,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Tumor,NimV2mix3,Acral-12_Tumor,NA_Acral-12_Tumor,,,,,,,,,,,,,,,
Acral_12_Cntl,Acral-12,L2DR04,TTCAGC,,,,,_Cntl,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Normal,NimV2mix3,Acral-12_Normal,NA_Acral-12_Normal,,,,,,,,,,,,,,,
Mucosal_02-2599_Primary A,02-2599,L2DR05,AAGACG,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Tumor,NimV2mix3,02-2599_Tumor,NA_02-2599_Tumor,02-2599,A,ACQUIRED DIGITAL FIBROKERATOMA,666689,757.33,"This lesion displays adipocytes within its core, an alteration similar to that seen in nevus lipomatosus. This is probably a reflection of the hamartomatous nature of this lesion.","Sections show a domed segment of skin, with a slightly hyperkeratotic
epidermis above a proliferation of spindled cells and thin-walled
blood vessels.  There are adipocytes within the core of the lesion.",51,,,,,,M,307333
Mucosal_02-2599_Primary B,02-2599,L2DR06,CCTCGG,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Tumor,NimV2mix3,02-2599_Tumor,NA_02-2599_Tumor,02-2599,A,ACQUIRED DIGITAL FIBROKERATOMA,666689,757.33,"This lesion displays adipocytes within its core, an alteration similar to that seen in nevus lipomatosus. This is probably a reflection of the hamartomatous nature of this lesion.","Sections show a domed segment of skin, with a slightly hyperkeratotic
epidermis above a proliferation of spindled cells and thin-walled
blood vessels.  There are adipocytes within the core of the lesion.",51,,,,,,M,307333
Mucosal_02-2599_Control,02-2599C,L2DR07,GGATGT,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Tumor,NimV2mix3,02-2599C_Tumor,NA_02-2599C_Tumor,02-2599,C,,,,,,,,,,,,M,307333
Mucosal_02-2599_Met,02-2599,L2DR08,TTCGCT,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Tumor,NimV2mix3,02-2599_Tumor,NA_02-2599_Tumor,02-2599,A,ACQUIRED DIGITAL FIBROKERATOMA,666689,757.33,"This lesion displays adipocytes within its core, an alteration similar to that seen in nevus lipomatosus. This is probably a reflection of the hamartomatous nature of this lesion.","Sections show a domed segment of skin, with a slightly hyperkeratotic
epidermis above a proliferation of spindled cells and thin-walled
blood vessels.  There are adipocytes within the core of the lesion.",51,,,,,,M,307333
DM_48_Normal,DM48,L2DR09,ACACGA,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Normal,NimV2mix3,DM48_Normal,NA_DM48_Normal,,,,,,,,,,,,,,,
DM_59_Normal,DM59,L2DR10,CACACA,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Normal,NimV2mix3,DM59_Normal,NA_DM59_Normal,,,,,,,,,,,,,,,
DM_68_Normal,DM68,L2DR11,GTGTTA,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Normal,NimV2mix3,DM68_Normal,NA_DM68_Normal,,,,,,,,,,,,,,,
DM_95_Tert,DM95,L2DR12,TGTGAA,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,Tumor,,DM95_Tumor,NA_DM95_Tumor,,,,,,,,,,,,,,,
Ivanka_22_Nevus_Tert,08-46462,L2DR13,ACAAAC,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,,,,,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
Ivanka_22_IS_Tert,08-46462,L2DR14,CACCTC,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,,,,,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
Ivanka_22_Normal_Tert,08-46462,L2DR15,GTGGCC,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,,,,,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
Ivanka_22_Mel_Tert,08-46462,L2DR16,TGTTGC,,,,,,Nimblegen41_BB48,BB48_SeqL,BB48_CL,,,,,08-46462,A,"MELANOMA, APPROXIMATELY 1.2 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173532,172.5,"The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many* Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  * the extent to which this may be a reaction to ulceration is difficult to judge  Please note that the thickness is approximated, as the lesion is ulcerated over its thickest portion.","There are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in areas. Extensive ulceration is present. Within the papillary dermis are nests of melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm and dusty appearing melanin, as well as melanocytes with scant cytoplasm and coarse chromatin. There are patchy infiltrates of lymphocytes. At the base of the lesion are small, round melanocytes arranged nests, cords and strands around adnexa.",28,,1.2,,,,M,755103
CNS20-Tumor,T07-1120,L2DR01,AAGGGA,,5.1792,,,,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,NimV2mix3,T07-1120_Tumor,NA_T07-1120_Tumor,,,,,,,,,,,,,,,
CNS21-Tumor,T09-8069,L2DR02,CCTTCA,,7.8214,,,,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,NimV2mix3,T09-8069_Tumor,NA_T09-8069_Tumor,,,,,,,,,,,,,,,
CNS22-Tumor,T02-16195,L2DR03,GGACCC,,15.959,,,,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,NimV2mix3,T02-16195_Tumor,NA_T02-16195_Tumor,,,,,,,,,,,,,,,
CNS23-Tumor,T00-12011,L2DR04,TTCAGC,,8.9639,,,,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,NimV2mix3,T00-12011_Tumor,NA_T00-12011_Tumor,,,,,,,,,,,,,,,
CNS24-Tumor,T06-6855,L2DR05,AAGACG,,1.0365,,,,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,NimV2mix3,T06-6855_Tumor,NA_T06-6855_Tumor,,,,,,,,,,,,,,,
CNS51-Tumor,12-18832AA,L2DR06,CCTCGG,,16.6144,,,,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,NimV2mix3,12-18832AA_Tumor,NA_12-18832AA_Tumor,12-18832,A,SOLAR KERATOSIS,100058,702.0,Level sections show similar findings.,"Sections show an intraepithelial proliferation of atypical keratinocytes confined largely to the interadnexal epidermis, with overlying parakeratosis.",70,,,,,,F,1104649
CNS52-Tumor,CNS52,L2DR07,GGATGT,,0.2966,,,,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,NimV2mix3,CNS52_Tumor,NA_CNS52_Tumor,,,,,,,,,,,,,,,
CNS53-Tumor,CNS53,L2DR08,TTCGCT,,9.2806,,,,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,NimV2mix3,CNS53_Tumor,NA_CNS53_Tumor,,,,,,,,,,,,,,,
CNS54-Tumor,CNS54,L2DR09,ACACGA,,6.3439,,,,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,NimV2mix3,CNS54_Tumor,NA_CNS54_Tumor,,,,,,,,,,,,,,,
CNS57-Tumor,CNS57,L2DR10,CACACA,,13.1388,,,,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,NimV2mix3,CNS57_Tumor,NA_CNS57_Tumor,,,,,,,,,,,,,,,
CNS57-Normal,CNS57,L2DR11,GTGTTA,,13.2164,,,,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Normal,NimV2mix3,CNS57_Normal,NA_CNS57_Normal,,,,,,,,,,,,,,,
BN-N1-Tert,BN-N1-Tert,L2DR12,TGTGAA,,0.1454,,,Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus),Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,,BN-N1-Tert_Tumor,NA_BN-N1-Tert_Tumor,,,,,,,,,,,,,,,
BN-N2-Tert,BN-N2-Tert,L2DR13,ACAAAC,,0.1761,,,Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus),Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,,BN-N2-Tert_Tumor,NA_BN-N2-Tert_Tumor,,,,,,,,,,,,,,,
BN-M1-Tert,BN-M1-Tert,L2DR14,CACCTC,,0.179,,,Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus),Nimblegen42_BB49,BB49_SeqL,BB49_CL,Tumor,,BN-M1-Tert_Tumor,NA_BN-M1-Tert_Tumor,,,,,,,,,,,,,,,
Ivanka-5-4-Tert,08-43264,L2DR15,GTGGCC,,0.0728,,,Amplicon Seq: Ivanka Patient Melanoma  ,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Nevus,,08-43264_Nevus,NA_08-43264_Nevus,08-43264,A,"MELANOMA, 0.5 MM  IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS WITH CONGENITAL FEATURES",173529,172.5,"The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above. The lesion is not ulcerated, and only involves a portion of the papillary dermis (level II).","Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. A large portion of the lesion is a predominantly intradermal proliferation of melanocytes, in which nests, cords and strands of small, round cells mature as they extend into the superficial reticular dermis.  Near the periphery, there are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in some areas. A few similar cells reside in the subjacent papillary dermis.",50,,0.5,,,,F,179649
Ivanka-9-1-Tert,10-58663,L2DR16,TGTTGC,,0.2129,,,Amplicon Seq: Ivanka Patient Melanoma  ,Nimblegen42_BB49,BB49_SeqL,BB49_CL,Melanoma,,10-58663_Melanoma,NA_10-58663_Melanoma,10-58663,A,"MELANOMA, 1.7 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS",139524,172.5,"The lesion is not ulcerated, and hence this is a T2a primary melanoma in the 2009 AJCC staging classification. The mitotic rate is low, and I did not encounter other features that would have a significant prognostic impact.","Sections show a broad-based proliferation of melanocytes with a markedly asymmetric configuration, involving the epidermis and superficial dermis. One part of the lesion features interconnecting rete ridges with subjacent nests, cords and strands of small round melanocytes, with clusters of adipocytes admixed with them. The other portion features a thickened epidermis with a relatively flat rete ridge pattern, a basal layer sparsely colonized by melanocytes with large, hyperchromatic nuclei, and a fibrotic stroma containing nests of similar cells, some with scant and some with abundant pale cytoplasm. There is little maturation with descent.",52,T2a,1.7,,Primary,,F,953239
AM_1_Tumor,12-12039B,L2DR01,AAGGGA,,,,Iwei Acral Melanoma,,Nimblegen43_BB50,BB50_SeqL,BB50_CL,Tumor,NimV2mix4,12-12039B_Tumor,NA_12-12039B_Tumor,12-12039,B,"MELANOMA, 0.35 MM. IN THICKNESS",176788,172.7,"The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.","Sections show acral skin with a proliferation of melanocytes arranged singly and in small nests along the dermo-epidermal junction in a broad area. There is a small focus in which the melanocytes have abundant, pale amphophilic cytoplasm and enlarged nuclei, with pagetoid scatter in the epidermis and clusters of similar cells in the superficial dermis, accompanied there by fibrosis and a patchy lymphocytic infiltrate.",35,T1a,0.35,,Primary,,M,1097855
AM_2_Tumor,12-22776B3,L2DR02,CCTTCA,,,,Iwei Acral Melanoma,,Nimblegen43_BB50,BB50_SeqL,BB50_CL,Tumor,NimV2mix4,12-22776B3_Tumor,NA_12-22776B3_Tumor,12-22776,B,"BIOPSY SITE WITH RESIDUAL ACRAL MELANOMA, 1.5 MM IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)",666955,172.9,We do not have a record of a prior biopsy on this site. Can you please forward a copy of the previous pathology report to our office. Histopathologic features of possible prognostic importance include:  Level: IV Vascular or lymphatic invasion: absent Dermal mitotic rate: rare mitotic figures Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: not detected Stage: pT2a,"Sections show a biopsy site on acral skin with an adjacent, broad proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells extending broadly into the dermis. There is a dense lichenoid lymphocytic infiltrate. In some areas melanocytes are present in pagetoid array within the epidermis.",36,T2a,1.5,,Primary,,M,1096148
AM_3_Tumor,99-29482,L2DR03,GGACCC,,,,Iwei Acral Melanoma,,Nimblegen43_BB50,BB50_SeqL,BB50_CL,Tumor,NimV2mix4,99-29482_Tumor,NA_99-29482_Tumor,99-29482,A,"MELANOMA, FINAL THICKNESS TO AWAIT COMPLETE EXCISION",173713,172.7,The neoplasm measures over 1 mm. in these sections.,"Sections show acral skin with a proliferation of atypical melanocytes
arranged in a pagetoid pattern within the epidermis, and with similar
cells in the deep reticular dermis.  There is confluence of
melanocytes at the junction.",46,,,,,,?,205015
AM_4_Tumor,99-15313,L2DR04,TTCAGC,,,,Iwei Acral Melanoma,,Nimblegen43_BB50,BB50_SeqL,BB50_CL,Tumor,NimV2mix4,99-15313_Tumor,NA_99-15313_Tumor,99-15313,A,"MELANOMA, INVOLVING ACRAL SKIN, 2.0 MM IN THICKNESS; FINAL THICKNESS TO AWAIT COMPLETE EXCISION",173622,172.6,A PAS-D stain ordered at the time that this specimen was grossed in does not reveal dermatophytes.,"There is a proliferation of atypical melanocytes, arranged as
confluent nests at the junctions with focal pagetoid spread, with
extension of smaller but cytologically atypical melanocytes into the
subjacent dermis.  Squamatization of eccrine ducts in prominent.",55,,2.0,,,,F,190846
AM_5_Tumor,99-885,L2DR05,AAGACG,,,,Iwei Acral Melanoma,,Nimblegen43_BB50,BB50_SeqL,BB50_CL,Tumor,NimV2mix4,99-885_Tumor,NA_99-885_Tumor,99-885,A,"MELANOMA, 0.70 MM IN THICKNESS, INVOLVING ACRAL SKIN, EXTENDING TO THE PERIPHERAL MARGIN",323788,172.7,,"Sections show acral skin with a proliferation of atypical melanocytes
arranged in an irregular pattern within the epidermis, and with
similar cells in the papillary dermis.  There are foci of pagetoid
upward spread.  While some of the dermal cells are small, others have
large nuclei and are different in appearance from their counterparts
at the same level of the dermis.",25,,0.70,,,,M,176418
AM_6_Tumor,98-37643,L2DR06,CCTCGG,,,,Iwei Acral Melanoma,,Nimblegen43_BB50,BB50_SeqL,BB50_CL,Tumor,NimV2mix4,98-37643_Tumor,NA_98-37643_Tumor,98-37643,A,"MELANOMA, 0.7 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN",173717,172.7,"In light of the presence of some degree of epidermal hyperplasia, the microstage measurement listed above probably overestimates the prognostic risk of this lesion, as the measurement is inflated by the epidermal changes.","Sections show acral skin with a proliferation of atypical melanocytes
arranged in an irregular pattern within the epidermis, and with
similar cells in the papillary dermis.  The pattern is predominantly
nested, with striking irregularity among nests.",44,,0.7,,,,M,175216
AM_8_Tumor,13-25288,L2DR07,GGATGT,,,,Iwei Acral Melanoma,,Nimblegen43_BB50,BB50_SeqL,BB50_CL,Tumor,NimV2mix4,13-25288_Tumor,NA_13-25288_Tumor,13-25288,A,"MELANOMA, INVOLVING ACRAL SKIN, FRAGMENTED",582753,172.7,"The tumor is sampled in a fragmented manner, and thus a meaningful estimate of thickness is not possible. It involves the dermis without further orientation. I identified a mitotic figure in routine sections. Occasional mitotic figures are also evident in a phosphohistone H3 immunostain, but such results are used for diagnostic purposes but not currently for staging purposes. There are also areas suspicious for lymphovascular invasion, but this could not be confirmed in  D2-40 immunoperoxidase stain. In short, definitive assessment of prognostic features should be deferred to the excision specimen. In these sections, there does not appear to be ulceration, and thus the staging is T1b preliminarily. This report was reissued on May 28, 2013 to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.","Sections show acral skin with a fragmented compound proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells in the dermis. There are also many melanophages and dilated lymphovascular spaces.",54,T1b,,,Primary,,M,1210033
AM_10_Tumor,09-29997,L2DR08,TTCGCT,,,,Iwei Acral Melanoma,,Nimblegen43_BB50,BB50_SeqL,BB50_CL,Tumor,NimV2mix4,09-29997_Tumor,NA_09-29997_Tumor,09-29997,A,"SUBUNGUAL MELANOMA, AT LEAST 1 MM IN THICKNESS, EXTENDING TO THE PERIPHERY OF THE BIOPSY",252688,172.6,"I have also had the opportunity to review the prior biopsy from this patient, and the current findings are now diagnostic for melanoma. The lineage of the neoplastic cells was confirmed in a Melan-A immunostain, as the tumor displays only scant pigment. With regard to the staging of subungual melanoma, Clark's levels are not reported, as the typical arrangement of papillary and reticular dermis is not present in the nail unit per se. The exception is for Clark's level V, which is assigned when periosteal involvement is present. That finding cannot be assessed in the current sections. There is no evidence of lymphovascular or perineural invasion in these sections. However, given the potentially large size of the area of involvement indicated in the clinical photographs we received previously, definitive assessment of all prognostic features should be deferred to the complete reexcision specimen.","Sections show distorted nail bed epithelium, containing a proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells in sheets in the dermis. Only scant melanin pigment is present. In the portion of epithelium, there is suprabasal scatter of melanocytes, and they may also be present in the overlying stratum corneum. The nail plate is markedly dystrophic.",53,,1,,,,M,310907
AM_12_Tumor,04-11158,L2DR09,ACACGA,,,,Iwei Acral Melanoma,,Nimblegen43_BB50,BB50_SeqL,BB50_CL,Tumor,NimV2mix4,04-11158_Tumor,NA_04-11158_Tumor,04-11158,A,MELANOMA,173616,172.6,"This appears to be a primary melanoma of about 2 mm in thickness.  The final thickness measurement should be made after complete excision.  There may be cells of a pre-existent nevus as well (but I cannot distinguish them with certainty from small melanoma cells),","Sections show acral skin with a proliferation of strikingly atypical melanocytes arranged in an irregular and focally pagetoid pattern within the epidermis, and with sheets similar cells throughout the dermis.  Slightly smaller ones are present near one edge.",54,,,,,,F,427557
UM4,UM4,L2DR10,CACACA,,,,Uveal Melanoma,,Nimblegen43_BB50,BB50_SeqL,BB50_CL,Tumor,NimV2mix4,UM4_Tumor,NA_UM4_Tumor,,,,,,,,,,,,,,,
UM5,UM5,L2DR11,GTGTTA,,,,Uveal Melanoma,,Nimblegen43_BB50,BB50_SeqL,BB50_CL,Tumor,NimV2mix4,UM5_Tumor,NA_UM5_Tumor,,,,,,,,,,,,,,,
Ivanka_13_1,08-84352, NextFlex 1,CGATGT,,,,Ivanka Patient Melanoma,,BioSci2_BB51,BB51_SeqL,BB51_CL,Melanoma,NimV2mix3,08-84352_Melanoma,NA_08-84352_Melanoma,08-84352,A,"MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 1 MM OF THE PERIPHERAL EDGE AND BASE OF THE SPECIMEN",123493,172.4,"In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level III/IV, abutting the reticular dermal interface. There is no evidence of associated vascular invasion, neurotropism, or regression. Additional excision is of course warranted to ensure that this lesion has been removed in its entirety.","Sections show an asymmetrical, compound melanocytic proliferation with a biphasic pattern. One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone. Similar melanocytes are present in the subjacent dermis. There are mitotic figures within the epidermis, and within the perijunctional and deeper dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). This latter population is arrayed as nests and single cells along the sides and bases of elongate and focally fused rete ridges, with similar small melanocytes present within a fibrotic papillary dermis.",36,,0.9,,,,M,792993
Ivanka_13_2,08-84352, NextFlex 2,TGACCA,,,,Ivanka Patient Melanoma,,BioSci2_BB51,BB51_SeqL,BB51_CL,Melanoma,NimV2mix3,08-84352_Melanoma,NA_08-84352_Melanoma,08-84352,A,"MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 1 MM OF THE PERIPHERAL EDGE AND BASE OF THE SPECIMEN",123493,172.4,"In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level III/IV, abutting the reticular dermal interface. There is no evidence of associated vascular invasion, neurotropism, or regression. Additional excision is of course warranted to ensure that this lesion has been removed in its entirety.","Sections show an asymmetrical, compound melanocytic proliferation with a biphasic pattern. One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone. Similar melanocytes are present in the subjacent dermis. There are mitotic figures within the epidermis, and within the perijunctional and deeper dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). This latter population is arrayed as nests and single cells along the sides and bases of elongate and focally fused rete ridges, with similar small melanocytes present within a fibrotic papillary dermis.",36,,0.9,,,,M,792993
Ivanka_13_3,08-84352, NextFlex 3,ACAGTG,,,,Ivanka Patient Melanoma,,BioSci2_BB51,BB51_SeqL,BB51_CL,Nevus,NimV2mix3,08-84352_Nevus,NA_08-84352_Nevus,08-84352,A,"MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 1 MM OF THE PERIPHERAL EDGE AND BASE OF THE SPECIMEN",123493,172.4,"In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level III/IV, abutting the reticular dermal interface. There is no evidence of associated vascular invasion, neurotropism, or regression. Additional excision is of course warranted to ensure that this lesion has been removed in its entirety.","Sections show an asymmetrical, compound melanocytic proliferation with a biphasic pattern. One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone. Similar melanocytes are present in the subjacent dermis. There are mitotic figures within the epidermis, and within the perijunctional and deeper dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). This latter population is arrayed as nests and single cells along the sides and bases of elongate and focally fused rete ridges, with similar small melanocytes present within a fibrotic papillary dermis.",36,,0.9,,,,M,792993
Ivanka_13_5,08-84352, NextFlex 4,GCCAAT,,,,Ivanka Patient Melanoma,,BioSci2_BB51,BB51_SeqL,BB51_CL,Normal,NimV2mix3,08-84352_Normal,NA_08-84352_Normal,08-84352,A,"MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 1 MM OF THE PERIPHERAL EDGE AND BASE OF THE SPECIMEN",123493,172.4,"In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level III/IV, abutting the reticular dermal interface. There is no evidence of associated vascular invasion, neurotropism, or regression. Additional excision is of course warranted to ensure that this lesion has been removed in its entirety.","Sections show an asymmetrical, compound melanocytic proliferation with a biphasic pattern. One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone. Similar melanocytes are present in the subjacent dermis. There are mitotic figures within the epidermis, and within the perijunctional and deeper dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). This latter population is arrayed as nests and single cells along the sides and bases of elongate and focally fused rete ridges, with similar small melanocytes present within a fibrotic papillary dermis.",36,,0.9,,,,M,792993
Ivanka_25_1,11-88792, NextFlex 5,CAGATC,,,,Ivanka Patient Melanoma,,BioSci2_BB51,BB51_SeqL,BB51_CL,Melanoma,NimV2mix3,11-88792_Melanoma,NA_11-88792_Melanoma,11-88792,A,"MELANOMA, 0.45 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173710,172.7,"Melanoma in situ extends along eccrine glands to the base of the specimen.  In terms of staging, this is a thin, non-ulcerated melanoma.  No dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with numerous cells present above the basal layer.  There are similar melanocytes in the subjacent dermis and some of them surround eccrine ducts.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  These cells tend to mature with descent.",56,T1a,0.45,,Primary,,M,787073
Ivanka_25_2,11-88792, NextFlex 6,CTTGTA,,,,Ivanka Patient Melanoma,,BioSci2_BB51,BB51_SeqL,BB51_CL,Melanoma,NimV2mix3,11-88792_Melanoma,NA_11-88792_Melanoma,11-88792,A,"MELANOMA, 0.45 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173710,172.7,"Melanoma in situ extends along eccrine glands to the base of the specimen.  In terms of staging, this is a thin, non-ulcerated melanoma.  No dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with numerous cells present above the basal layer.  There are similar melanocytes in the subjacent dermis and some of them surround eccrine ducts.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  These cells tend to mature with descent.",56,T1a,0.45,,Primary,,M,787073
Ivanka_25_3,11-88792, NextFlex 7,ATCACG,,,,Ivanka Patient Melanoma,,BioSci2_BB51,BB51_SeqL,BB51_CL,Nevus,NimV2mix3,11-88792_Nevus,NA_11-88792_Nevus,11-88792,A,"MELANOMA, 0.45 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173710,172.7,"Melanoma in situ extends along eccrine glands to the base of the specimen.  In terms of staging, this is a thin, non-ulcerated melanoma.  No dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with numerous cells present above the basal layer.  There are similar melanocytes in the subjacent dermis and some of them surround eccrine ducts.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  These cells tend to mature with descent.",56,T1a,0.45,,Primary,,M,787073
Ivanka_25_4,11-88792, NextFlex 8,TTAGGC,,,,Ivanka Patient Melanoma,,BioSci2_BB51,BB51_SeqL,BB51_CL,Nevus,NimV2mix3,11-88792_Nevus,NA_11-88792_Nevus,11-88792,A,"MELANOMA, 0.45 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173710,172.7,"Melanoma in situ extends along eccrine glands to the base of the specimen.  In terms of staging, this is a thin, non-ulcerated melanoma.  No dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with numerous cells present above the basal layer.  There are similar melanocytes in the subjacent dermis and some of them surround eccrine ducts.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  These cells tend to mature with descent.",56,T1a,0.45,,Primary,,M,787073
Ivanka_25_5,11-88792, NextFlex 9,ACTTGA,,,,Ivanka Patient Melanoma,,BioSci2_BB51,BB51_SeqL,BB51_CL,Normal,NimV2mix3,11-88792_Normal,NA_11-88792_Normal,11-88792,A,"MELANOMA, 0.45 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173710,172.7,"Melanoma in situ extends along eccrine glands to the base of the specimen.  In terms of staging, this is a thin, non-ulcerated melanoma.  No dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with numerous cells present above the basal layer.  There are similar melanocytes in the subjacent dermis and some of them surround eccrine ducts.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  These cells tend to mature with descent.",56,T1a,0.45,,Primary,,M,787073
CGH13_324,13-74952, NextFlex 10,GATCAG,,,,Iwei DPN,CGH13-324 ,BioSci2_BB51,BB51_SeqL,BB51_CL,Tumor,NimV2mix3,13-74952_Tumor,NA_13-74952_Tumor,13-74952,A,"PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, BEST REGARDED AS AN ATYPICAL SPITZ TUMOR",173304,238.2,"The differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. To provide some context for the eventual findings, I performed a few immunostains. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows many nuclei with what appear to be mitotic figures in melanocytes in the lower half of the lesion. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product. Comparative genomic hybridization shows gains involving chromosomes 12p and 15q. This is an unusual result. I shared the comparative genomic hybridization data with my colleagues, Drs. Boris Bastian and Iwei Yeh. They do not regard these aberrations as indicating melanoma, as more typical ones would. There may be a gene fusion mechanism in this case, as has been seen with other spitzoid lesions in studies from their lab.  An atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have feature more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. If there are significant findings on re-excision, I would appreciate a chance to see the sections. Most lesions of this type are well circumscribed, and the re-excision should be deeper, but necessarily more than a few mms. wider that the prior biopsy site or an visible residuum.","There is a mostly intradermal proliferation of large, oval melanocytes with abundant pale cytoplasm and large, but monomorphous oval vesicular nuclei. The overlying epidermis is thinned, with much of the lesion in an expanded papillary dermis, surrounded by epithelial collarettes. There are patchy lymphocytic infiltrates throughout the lesion. There are scattered mitotic figures. There is limited maturation with descent.",2,,,,,,M,1316957
CGH13_331,13-75067, NextFlex 11,TAGCTT,,,,Iwei Translocation,CGH13-331 ETV6 Fusion,BioSci2_BB51,BB51_SeqL,BB51_CL,Tumor,NimV2mix3,13-75067_Tumor,NA_13-75067_Tumor,13-75067,A,"DEEP PENETRATING NEVUS WITH SOME ATYPICAL FEATURES, WITH NO  ABERRATIONS SEEN WITH COMPARATIVE GENOMIC HYBRIDIZATION",173305,216.3,"ADDENDUM, October  4, 2013: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: The overall findings are those of a so-called deep penetrating nevus. These are unusual melanocytic lesions with some features similar to those of blue nevus, but with a different genomic origin and the presence of some junctional nests. There are deep penetrating nevus-like melanomas, and in some controversies about the essential nature of this entity. Hence, I performed immunostaining. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a high proliferative rate in the lesional cells, with up to 30% of the cells in occasional nests having positively stained nuclei. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows only rare positive nuclei. A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product.  Given the unusual features in the hematoxylin and eosin-stained sections (the degree of confluence of dermal aggregations, and the degree of nuclear pleomorphism), as well as the high proliferative rate noted above, one would ideally achieve unequivocally clear margins around such a lesion. The current margins are less than 0.2 mm.  Following our discussion, and the history of brain tumor followed by radiation, I have requested a p53 immunoperoxidase stain, as some neoplasms due to radiation have p53 mutations that stabilize the protein, and lead to immunohistochemical positivity. The staining is negative.  Comparative genomic hybridization did not show chromosomal gains or losses, a finding that is strongly against melanoma.","Sections show a compound, wedge-shaped proliferation of large oval melanocytes with  pleomorphic vesicular nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. Only a few junctional nests are present. The apex of the lesion is in the superficial subcutis dermis. There are evenly distributed melanophages.",10,,,,,,M,1317072
Spitz_M1,Spitz_M1, NextFlex 2,TGACCA,,,,Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples,,BioSci3_BB53,BB53_SeqL,BB53_CL,Tumor,NimV2mix3,Spitz_M1_Tumor,NA_Spitz_M1_Tumor,,,,,,,,,,,,,,,
Spitz_M2 (?),Spitz_M2_(?), NextFlex 3,ACAGTG,,,,Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples,,BioSci3_BB53,BB53_SeqL,BB53_CL,Tumor,NimV2mix3,Spitz_M2_(?)_Tumor,NA_Spitz_M2_(?)_Tumor,,,,,,,,,,,,,,,
Spitz_N1,Spitz_N1, NextFlex 4,GCCAAT,,,,Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples,,BioSci3_BB53,BB53_SeqL,BB53_CL,Tumor,NimV2mix3,Spitz_N1_Tumor,NA_Spitz_N1_Tumor,,,,,,,,,,,,,,,
Spitz_N2,Spitz_N2, NextFlex 5,CAGATC,,,,Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples,,BioSci3_BB53,BB53_SeqL,BB53_CL,Tumor,NimV2mix3,Spitz_N2_Tumor,NA_Spitz_N2_Tumor,,,,,,,,,,,,,,,
Spitz_N3,Spitz_N3, NextFlex 6,CTTGTA,,,,Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples,,BioSci3_BB53,BB53_SeqL,BB53_CL,Tumor,NimV2mix3,Spitz_N3_Tumor,NA_Spitz_N3_Tumor,,,,,,,,,,,,,,,
BN_Normal,BN, NextFlex 7,ATCACG,,,,Hunter Melanoma in Nevus: Blue Nevus Normal,,BioSci3_BB53,BB53_SeqL,BB53_CL,Normal,NimV2mix3,BN_Normal,NA_BN_Normal,,,,,,,,,,,,,,,
CGH13-016,13-159, NextFlex 8,TTAGGC,,,,Iwei 7Q Gain,CGH13-016 ,BioSci3_BB53,BB53_SeqL,BB53_CL,Tumor,NimV2mix3,13-159_Tumor,NA_13-159_Tumor,13-159,A,"MELANOMA, 3.1 MILLIMETERS IN THICKNESS, EXTENDING TO THE TISSUE EDGES",101721,172.7,"Thank you also for informing me that the lesion has been present on the patient since age four and has grown steadily with the patient. However, the patient recently noted a more rapid rate of growth. My initial differential diagnosis included an unusual nevus with Spitzoid features and melanoma. To further evaluate for this differential diagnosis, I performed comparative genomic hybridization on this specimen. This is a molecular technique that evaluates for the presence of chromosomal gains or losses. It is based on the presence of chromosomal gains and losses in about 95% of melanomas, but with the exception of a gain of 11p, a lack of them in Spitz's nevi.  The comparative genomic hybridization has now been completed and it shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi.  In particular there is a loss of chromosome 6q, a gain of chromosome 7q, both a loss and a gain of chromosome 12p and a gain of chromosome 18q. The presence of multiple gains and losses supports the diagnosis of melanoma.  With regard to staging, the melanoma is between 2-4 millimeters in thickness and is not ulcerated. Therefore it should be classified as pT3a per the 2009 revision of the AJCC staging system for melanoma.  My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this diagnosis and assessment.","Sections show a dome-shaped segment of acral skin in which there is a compound proliferation of melanocytes, some of which are large and epithelioid, and the junctional component of which is arrayed with the lowermost sections of an epithelium that is slightly acanthotic and hyperkeratotic. Many of the lesional cells contain large nucleoli. In some areas within the dermis, the lesional cells are configured as confluence sheets without significant intervening stroma. The size of the melanocytes does not diminish with descent into the dermis.",17,T3a,3.1,,Primary,,F,1183551
CGH12_163,12-43016, NextFlex 9,ACTTGA,,,,Iwei Translocation,CGH12-163 ,BioSci3_BB53,BB53_SeqL,BB53_CL,Tumor,NimV2mix3,12-43016_Tumor,NA_12-43016_Tumor,12-43016,A,COMPOUND PROLIFERATION OF MELANOCYTES WITH UNUSUAL FEATURES,321300,238.2,"The differential diagnosis included both an unusual nevus (probably the upper part of a superficial congenital nevus) and nevoid melanoma. The latter diagnosis is raised by the presence of very large nests, and the somewhat unusual cytologic features. Comparative genomic hybridization shows losses involving parts of chromosome 15 (discrete areas on both the short and long arms, but not the entire chromosome). This chromosome is not commonly lost in melanoma, and the meaning of this finding is not clear. I believe that the best interpretation is as a partially transformed lesion that is not diagnostic of melanoma, but should be completely excised.","There is a somewhat dome-shaped segment of skin that extends to the level of the superficial reticular dermis. There are large, compactly arranged nests of plump oval to slightly spindled melanocytes both at the junction and in the subjacent, fibrotic dermis. These cells have relatively monomorphous nuclei, diffuse hyperchromasia, and relatively abundant pale, somewhat fibrillar-appearing cytoplasm. There are areas in which some maturation and dispersion with descent appear to be present. The accompanying immunoperoxidase-stained sections show a very low proliferative rate amongst the dermal melanocytes with a Ki-67/Melan-A double stain, and HMB45 staining is limited to the junctional zone.",72,,,,,,F,1128829
CGH13_166,13-34291, NextFlex 10,GATCAG,,,,Iwei Translocation,CGH13-166 ,BioSci3_BB53,BB53_SeqL,BB53_CL,Tumor,NimV2mix3,13-34291_Tumor,NA_13-34291_Tumor,13-34291,A,"MELANOMA OF 1.7 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION",120288,172.2,"My differential diagnosis included both an atypical combined melanocytic nevus on one hand and nevoid (or deep penetrating) melanoma on the other. To more fully assess this differential diagnosis and to screen for genomic copy number anomalies, as can be seen with melanoma, we pursued array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss of chromosome 6q and gain in chromosome 15q. (The loss in chromosome 6q includes the location of the MYB gene that is assayed as part of standard fluorescence in situ hybridization copy number analysis of melanocytic tumors.) No other substantive chromosomal copy number gains or losses were noted. The identification of multiple copy number abnormalities suggests genomic instability, as is typical of malignancies such as melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH favors interpretation as nevoid melanoma. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration. Therefore, it represents melanoma of stage pT2a (2009 AJCC Guidelines). Further excision is warranted to ensure that local control has been established.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.","Sections show an asymmetrical compound proliferation of melanocytes that is distinctly biphasic in its composition. One population consists of melanocytes with small amounts of amphophilic or vacuolated cytoplasm. These cells are distributed singly and in many nests within the epidermis and focally within adnexa, and maturing nests, cords, and syncytia of similar melanocytes can be seen in the dermis below this. The second population of larger epithelioid melanocytes has pale, ballooned, or finely pigmented cytoplasm. These cells are distributed erratically along the junction and in pagetoid fashion within adnexa, and several large nests of these melanocytes are present in the dermis as well. A patchy infiltrate of lymphocytes and melanophages is present in the dermis, concurrently. There is marked elastosis. In accompanying immunostains, the Ki-67 cell proliferation index is low.",47,T2a,1.7,,Primary,,M,1275593
GAK_DNA,GAK_DNA, NextFlex 11,TAGCTT,,,,Iwei Cell Line DNA,,BioSci3_BB53,BB53_SeqL,BB53_CL,Tumor,NimV2mix3,GAK_DNA_Tumor,NA_GAK_DNA_Tumor,,,,,,,,,,,,,,,
Yurif_DNA,Yurif_DNA, NextFlex 12,GGCTAC,,,,Iwei Cell Line DNA,,BioSci3_BB53,BB53_SeqL,BB53_CL,Tumor,NimV2mix3,Yurif_DNA_Tumor,NA_Yurif_DNA_Tumor,,,,,,,,,,,,,,,
Acral 11 Tumor,Acral-11,L2DR01,AAGGGA,,,,Hong Wu Acral Melanoma,Tumor,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,NimV2mix4,Acral-11_Tumor,NA_Acral-11_Tumor,,,,,,,,,,,,,,,
Acral 11 Cntl,Acral-11,L2DR02,CCTTCA,,,,Hong Wu Acral Melanoma,Cntl,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Normal,NimV2mix4,Acral-11_Normal,NA_Acral-11_Normal,,,,,,,,,,,,,,,
DPN_CNN 26,DPN26,L2DR03,GGACCC,,,,Iwei DPN,,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,NimV2mix4,DPN26_Tumor,NA_DPN26_Tumor,,,,,,,,,,,,,,,
DPN 34,13-47668,L2DR05,AAGACG,,,,"Iwei DPN, T13-47668",,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,NimV2mix4,13-47668_Tumor,NA_13-47668_Tumor,13-47668,A,"COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION",424655,216.6,This melanocytic nevus shows features of both a conventional melanocytic nevus and a deep penetrating nevus.,"Sections show a proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There is a roughly wedge shaped dermal infiltrate of melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another more superficial component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm. Solar elastosis is present in the dermis.",65,,,,,,F,298118
DPN Conv 34,13-47668,L2DR06,CCTCGG,,,,"Iwei DPN, T13-47668",,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,NimV2mix4,13-47668_Tumor,NA_13-47668_Tumor,13-47668,A,"COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION",424655,216.6,This melanocytic nevus shows features of both a conventional melanocytic nevus and a deep penetrating nevus.,"Sections show a proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There is a roughly wedge shaped dermal infiltrate of melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another more superficial component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm. Solar elastosis is present in the dermis.",65,,,,,,F,298118
DPN 37,13-47621,L2DR08,TTCGCT,,,,"Iwei DPN, T13-47621",,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,NimV2mix4,13-47621_Tumor,NA_13-47621_Tumor,13-47621,A,COMBINED MELANOCYTIC NEVUS,528522,216.5,This neoplasm has features of both a superficial congenital melanocytic nevus and a deep penetrating nevus. There is no evidence of melanoma or atypicality.,"Sections show a compound proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There are melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm.",24,,,,,,F,1288923
DPN Conv 37,13-47621,L2DR09,ACACGA,,,,"Iwei DPN, T13-47621",,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,NimV2mix4,13-47621_Tumor,NA_13-47621_Tumor,13-47621,A,COMBINED MELANOCYTIC NEVUS,528522,216.5,This neoplasm has features of both a superficial congenital melanocytic nevus and a deep penetrating nevus. There is no evidence of melanoma or atypicality.,"Sections show a compound proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There are melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm.",24,,,,,,F,1288923
DPN 38,13-37371,L2DR10,CACACA,,,,"Iwei DPN, T13-37371",,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,NimV2mix4,13-37371_Tumor,NA_13-37371_Tumor,13-37371,A,"COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION",173688,216.6,This biphasic melanocytic nevus includes the commingling of congenital melanocytic nevus with deep penetrating nevus.,"Sections show a compound proliferation of small melanocytes with ovoid nuclei, and slight diminishment in the size of melanocytes with descent in the dermis is appreciable.  Most of the dermal melanocytes are arrayed as syncytia. Some dermal melanocytes have ample, finely melanized cytoplasm and are slightly larger in size.  There are many surrounding melanophages in the dermis.",29,,,,,,F,1278673
DPN Conv 38,13-37371,L2DR11,GTGTTA,,,,"Iwei DPN, T13-37371",,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,NimV2mix4,13-37371_Tumor,NA_13-37371_Tumor,13-37371,A,"COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION",173688,216.6,This biphasic melanocytic nevus includes the commingling of congenital melanocytic nevus with deep penetrating nevus.,"Sections show a compound proliferation of small melanocytes with ovoid nuclei, and slight diminishment in the size of melanocytes with descent in the dermis is appreciable.  Most of the dermal melanocytes are arrayed as syncytia. Some dermal melanocytes have ample, finely melanized cytoplasm and are slightly larger in size.  There are many surrounding melanophages in the dermis.",29,,,,,,F,1278673
DM45 2 Tumor,DM45,L2DR07,GGATGT,,,,Hunter Desmoplastic Melanoma,,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,NimV2mix4,DM45_Tumor,NA_DM45_Tumor,,,,,,,,,,,,,,,
DM58 Tumor,DM58,L2DR04,TTCAGC,,,,Hunter Desmoplastic Melanoma,,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,NimV2mix4,DM58_Tumor,NA_DM58_Tumor,,,,,,,,,,,,,,,
DM1_Tert_Amplicon,DM1,L2DR12,TGTGAA,,,,Hunter Amplicon Sequencing,Hunter Amplicon Sequencing,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,,DM1_Tumor,NA_DM1_Tumor,,,,,,,,,,,,,,,
DM2_Tert_Amplicon,DM2,L2DR13,ACAAAC,,,,Hunter Amplicon Sequencing,Hunter Amplicon Sequencing,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,,DM2_Tumor,NA_DM2_Tumor,,,,,,,,,,,,,,,
DM45_NFKBIE_Amplicon,DM45,L2DR14,CACCTC,,,,Hunter Amplicon Sequencing,Hunter Amplicon Sequencing,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,,DM45_Tumor,NA_DM45_Tumor,,,,,,,,,,,,,,,
DM79_NFKBIE_Amplicon,DM79,L2DR15,GTGGCC,,,,Hunter Amplicon Sequencing,Hunter Amplicon Sequencing,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,,DM79_Tumor,NA_DM79_Tumor,,,,,,,,,,,,,,,
DM93_NFKBIE_Amplicon,DM93,L2DR16,TGTTGC,,,,Hunter Amplicon Sequencing,Hunter Amplicon Sequencing,Nimblegen43_BB54,BB54_SeqL,BB54_CL,Tumor,,DM93_Tumor,NA_DM93_Tumor,,,,,,,,,,,,,,,
DPN_MM 20,13-2939B,N37_7 (BB44),L2DR01,AAGGGA,100,,"Iwei DPN, T13-2939B",13 Cycle Post Hybridization LM-PCR,Nimblegen45_BB55,BB55_SeqL,BB55_CL,Tumor,NimV2mix4,13-2939B_Tumor,NA_13-2939B_Tumor,13-2939,B,"MELANOMA OF 8.3 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE INKED SPECIMEN MARGIN",172599,172.5,"This biopsy demonstrates a 'deep penetrating' melanoma with a nodular invasive component that extends into the upper subcutis. The invasive component has been fully excised, but flanking melanoma in situ is transected at the inked specimen periphery. With respect to staging, this melanoma exceeds 4 mm in thickness and shows focal associated ulceration. Therefore, it represents a melanoma of stage pT4b (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.","There is a nodular proliferation of melanocytes with atypical nuclei in contiguity with the epidermis. The melanocytes are pigmented and epithelioid or fusiform, and coalescing fascicles and sheets of cells are apparent and are accompanied by many melanophages. There is little diminishment in melanocyte size with descent in the dermis. Deep extension into the subcutis is present centrally. To the side of this, many similar epidermal melanocytes are apparent singly and in small nests and fascicles. A perijunctional lymphohistiocytic infiltrate with admixed melanophages is also noted.",71,T4b,8.3,None,Primary,,M,1187682
DPN_CNN 30,11-73238A,N37 (BB44),L2DR02,CCTTCA,100,,"Iwei DPN, 11-73238A",13 Cycle Post Hybridization LM-PCR,Nimblegen45_BB55,BB55_SeqL,BB55_CL,Tumor,NimV2mix4,11-73238A_Tumor,NA_11-73238A_Tumor,11-73238,A,"COMPOUND MELANOCYTIC NEVUS, POLYPOID",173530,216.5,,"Sections show skin in a polypoid configuration.  A compound proliferation of melanocytes composed of single cells and nests along the sides and bases of elongated rete ridges is present. Nests, cords and syncytia of melanocytes with small to medium round nuclei and scant amphophilic cytoplasm are present in the papillary dermis and exhibit maturation with descent into the reticular dermis.",56,,,,,,F,987085
AM_3_Tumor,99-29482,N43_3 (BB50),L2DR03,GGACCC,,,"Iwei Acral Melanoma, 99-29482",13 Cycle Post Hybridization LM-PCR,Nimblegen45_BB55,BB55_SeqL,BB55_CL,Tumor,NimV2mix4,99-29482_Tumor,NA_99-29482_Tumor,99-29482,A,"MELANOMA, FINAL THICKNESS TO AWAIT COMPLETE EXCISION",173713,172.7,The neoplasm measures over 1 mm. in these sections.,"Sections show acral skin with a proliferation of atypical melanocytes
arranged in a pagetoid pattern within the epidermis, and with similar
cells in the deep reticular dermis.  There is confluence of
melanocytes at the junction.",46,,,,,,?,205015
AM_8_Tumor,13-25288,N43_7 (BB50),L2DR04,TTCAGC,11,,"Iwei Acral Melanoma, 13-25288",13 Cycle Post Hybridization LM-PCR,Nimblegen45_BB55,BB55_SeqL,BB55_CL,Tumor,NimV2mix4,13-25288_Tumor,NA_13-25288_Tumor,13-25288,A,"MELANOMA, INVOLVING ACRAL SKIN, FRAGMENTED",582753,172.7,"The tumor is sampled in a fragmented manner, and thus a meaningful estimate of thickness is not possible. It involves the dermis without further orientation. I identified a mitotic figure in routine sections. Occasional mitotic figures are also evident in a phosphohistone H3 immunostain, but such results are used for diagnostic purposes but not currently for staging purposes. There are also areas suspicious for lymphovascular invasion, but this could not be confirmed in  D2-40 immunoperoxidase stain. In short, definitive assessment of prognostic features should be deferred to the excision specimen. In these sections, there does not appear to be ulceration, and thus the staging is T1b preliminarily. This report was reissued on May 28, 2013 to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.","Sections show acral skin with a fragmented compound proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells in the dermis. There are also many melanophages and dilated lymphovascular spaces.",54,T1b,,,Primary,,M,1210033
AM_12_Tumor,04-11158,N43_9 (BB50),L2DR05,AAGACG,10.7,,"Iwei Acral Melanoma, 04-11158",13 Cycle Post Hybridization LM-PCR,Nimblegen45_BB55,BB55_SeqL,BB55_CL,Tumor,NimV2mix4,04-11158_Tumor,NA_04-11158_Tumor,04-11158,A,MELANOMA,173616,172.6,"This appears to be a primary melanoma of about 2 mm in thickness.  The final thickness measurement should be made after complete excision.  There may be cells of a pre-existent nevus as well (but I cannot distinguish them with certainty from small melanoma cells),","Sections show acral skin with a proliferation of strikingly atypical melanocytes arranged in an irregular and focally pagetoid pattern within the epidermis, and with sheets similar cells throughout the dermis.  Slightly smaller ones are present near one edge.",54,,,,,,F,427557
CGH10-013,10-55707,N5_8 (BB008),L2DR08,TTCGCT,,,"ALK, Iwei Translocations",CGH10-013 13 Cycle Post Hybridization LM-PCR,Nimblegen45_BB55,BB55_SeqL,BB55_CL,Tumor,NimV2mix4,10-55707_Tumor,NA_10-55707_Tumor,10-55707,A,CHILDHOOD-TYPE SPITZOID MELANOMA OF 2.9 MM IN THICKNESS,173300,172.3,"ADDENDUM, November 10, 2010: Per a clinical request, we completed comparative genomic hybridization (CGH) analysis of this tumor. Genomic analysis revealed loss in chromosomes 2p, 6q, 8p, and 12q, and loss of the entirety of chromosome 18 is also apparent. The presence of multiple genomic anomalies points to spitzoid melanoma as the best interpretation. Please note that childhood-type spitzoid melanoma represents an emerging entity that we believe is distinct from conventional adult melanoma. Cases reported in the literature as malignant Spitz nevus probably represent the same entity. With respect to clinical behavior, there is a risk for extension to regional lymph nodes, but our experience to date suggests that the risk for seeding of widespread metastatic disease is low. This proliferation is narrowly excised in the available sections. Further excision remains warranted to ensure that local eradication has been accomplished.  As we reported previously, our differential diagnosis included a cellular epithelioid Spitz nevus on one hand and so-called childhood-type spitzoid melanoma on the other. The latter has now been proven as the diagnosis for this case based upon the results of aCGH analysis. We also completed immunoperoxidase staining utilizing a two-color development system (with MART-1 labeled red and Ki-67 labeled brown) was included in our evaluation. By this staining method, we found diffuse MART-1 reactivity. Although the overall labeling index is modest, the MART-positive cells show focally increased nuclear expression of Ki-67, especially in the upper half of the proliferation, thus implying that cellular proliferation is focally elevated. This staining result is diagnostically inconclusive.","Sections show a domed, cellular, laterally demarcated compound proliferation of enlarged epithelioid melanocytes. The background epidermis is acanthotic but is also focally thinned. Within the epidermis and along the junction, there are single melanocytes and nests distributed relatively densely, and some of the junctional nests are sizable. In the dermis below this, nests and cords of coalescing and partially-maturing melanocytes extend relatively deeply, where a flanking lymphohistiocytic infiltrate can also be seen.",21,,2.9,,,,F,950283
CGH11-153,11-34950,N5_9 (BB008),L2DR09,ACACGA,,,"ALK, Iwei Translocations",CGH11-153 13 Cycle Post Hybridization LM-PCR,Nimblegen45_BB55,BB55_SeqL,BB55_CL,Tumor,NimV2mix4,11-34950_Tumor,NA_11-34950_Tumor,11-34950,A,"DESMOPLASTIC COMPOUND SPITZOID NEOPLASM, CONSISTENT WITH A DESMOPLASTIC COMPOUND SPITZ NEVUS",173625,238.2,"I believe this proliferation represents an unusual compound desmoplastic Spitz nevus. To further assess spitzoid melanoma as a potential consideration in the differential diagnosis, we pursued array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis did not reveal any chromosomal gains or losses. As you probably know, the identification of genomic gain or loss is common to the vast majority of melanomas. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as a desmoplastic Spitz nevus rather than melanoma. This proliferation is focally present at the periphery of this biopsy. Further excision can be considered to ensure that local eradication has been accomplished and that persistence does not ensue.","Sections show a domed compound proliferation of enlarged slightly spindled melanocytes that is somewhat asymmetrical. The background epidermis is acanthotic and hyperkeratotic, and a rare large nest can be found at the junction. In fibrotic dermis below this, there are nests, cords, and fascicles of similar melanocytes that mature with descent in the dermis. One peripheral edge of the specimen lacks clears circumscription, and an increase in vasculature can be found around the proliferation as well. Rare superficial dermal melanocytes in mitosis can be seen. There is also a juxtaposed patchy lymphocytic infiltrate.",35,,,,,,F,1024388
CGH11-036,11-8228,N5_10 (BB008),L2DR10,CACACA,,,"ALK, Iwei Translocations",CGH11-036 13 Cycle Post Hybridization LM-PCR,Nimblegen45_BB55,BB55_SeqL,BB55_CL,Tumor,NimV2mix4,11-8228_Tumor,NA_11-8228_Tumor,11-8228,A,ULCERATED COMPOUND PROLIFERATION OF STRIKINGLY HYPERPIGMENTED/SPINDLED MELANOCYTES,173417,238.2,"Our differential diagnosis included an unusual hypermelanotic spindled melanocytic nevus on one hand and childhood-type melanoma on the other. To more fully assess this differential, array-based comparative genomic hybridization (aCGH) was utilized to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis did not demonstrate chromosomal gains or losses. GNAQ and GNA11 gene sequencing was also completed, and GNAQ exon 5 and GNA11 exon 5 were both found to be wild-type (non-mutated). Based upon the results derived from conventional microscopy and molecular assessment, I offer the following conclusions:  1. The lack of genomic aberrations, as demonstrated by aCGH analysis, speaks against melanoma as a possibility and favors interpretation as a peculiar melanocytic nevus. I do not believe this lesion should be interpreted as a pigmented epithelioid melanocytoma (with respect to that diagnostic term, this proliferation is composed of melanocytes that have distinctly spindled cytomorphology).  2. The lack of mutation in GNAQ or GNA11 suggests that this proliferation fits better on the spectrum of pigmented spindle cell nevus or plexiform spindle cell nevus rather than blue nevus.  3. The proliferation is unusual and involves the deep edge of this biopsy. Further excision is thus warranted to ensure that local eradication has been accomplished and that persistence cannot ensue.","Sections show an asymmetrical and focally ulcerated compound proliferation of slender spindled melanocytes with heavily melanized cytoplasm. There is a small junctional component jointly with marked acanthosis, and below this coalescing fascicles of non-maturing melanocytes reside in the dermis, where many interstitial melanophages are apparent.",4,,,,,,M,997665
CGH11-386,11-84681,N5_11 (BB008),L2DR11,GTGTTA,,,"ROS1, Iwei Translocations",CGH11-386 13 Cycle Post Hybridization LM-PCR,Nimblegen45_BB55,BB55_SeqL,BB55_CL,Tumor,NimV2mix4,11-84681_Tumor,NA_11-84681_Tumor,11-84681,A,MELANOMA WITH SPITZOID FEATURES,987777,173.7,"Comparative genomic hybridization shows losses involving chromosomes 6q, 10q and 12q. Loss of 6q and involving chromosome 10 are among the most common aberrations in melanoma. The final thickness measurement should be made after complete excision. The portion of the lesion seen in these sections is just over 1 mm in thickness, but not ulcerated. The final thickness measurement should be made after complete excision. In determining re-excision margins, please keep in mind that most spitzoid melanomas in children are well circumscribed and recurrence at the biopsy site due to residual neoplastic melanocytes is rare, regardless of thickness, even with very narrow (e.g. 5 mm) margins. Also, involvement of sentinel lymph nodes is more common than in adult melanoma, but distant metastasis is much less frequent. Therefore, the role of sentinel lymph node biopsy is questionable.","There is a broad-based, dome-surfaced proliferation of large oval melanocytes coupled with irregular epidermal hyperplasia, compact hyperkeratosis and a proliferation of melanocytes that is broadly transected at the base of the specimen in the superficial reticular dermis. The lesional cells are large, fusiform or polygonal, and have large, pleomorphic heterochromatic nuclei, some with prominent intranuclear inclusions.",9,,,,,,F,1074129
CGH11-229,11-50182,N39_3 (BB46),L2DR06,CCTCGG,100,,,CGH11-229 13 Cycle Post Hybridization LM-PCR,Nimblegen45_BB55,BB55_SeqL,BB55_CL,Tumor,NimV2mix4,11-50182_Tumor,NA_11-50182_Tumor,11-50182,A,"ATYPICAL INTRADERMAL PROLIFERATION OF ENLARGED SPINDLED MELANOCYTES, CONSISTENT WITH MELANOMA OF 1.9 MM IN THICKNESS",173502,172.5,"ADDENDUM, August 18, 2011: Our differential diagnosis included an atypical cellular blue nevus on one hand and blue nevus-like melanoma on the other. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity and a low Ki-67 cell proliferation index. We also completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue bock, application of aCGH demonstrated segmental gain in chromosome 7q and loss of chromosome 9q. The presence of multiple chromosomal losses suggests genomic instability and favors interpretation as melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH favors interpretation as blue nevus-like (or deep penetrating nevus-like) melanoma. With respect to staging, this tumor is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to permit further microstage assessment and to ensure that local eradication has been accomplished.","Sections show a domed segment of skin with a dermal proliferation of enlarged fusiform melanocytes with abundant, pale cytoplasm and dusty appearing melanin. These melanocytes are arranged as thick and thin interconnecting fascicles with interspersed melanophages. The aggregations are more closely apposed in the upper part of the lesion than near the base of the specimen. Mitoses are present (around 1 per 5 400x fields). Some melanocytes have large, hyperchromatic nuclei.",55,,1.9,,,,M,1039621
MIN_7_Normal,MIN_7, NextFlex 3,ACAGTG,,,,Hunter Melanoma In Nevus,,BioSci4_BB56,BB56_SeqL,BB56_CL,Normal,NimV2mix3,MIN_7_Normal,NA_MIN_7_Normal,,,,,,,,,,,,,,,
MIN_7_Nevus,MIN_7, NextFlex 4,GCCAAT,,,,Hunter Melanoma In Nevus,,BioSci4_BB56,BB56_SeqL,BB56_CL,Nevus,NimV2mix3,MIN_7_Nevus,NA_MIN_7_Nevus,,,,,,,,,,,,,,,
MIN_7_Melanoma,MIN_7, NextFlex 5,CAGATC,,,,Hunter Melanoma In Nevus,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,MIN_7_Tumor,NA_MIN_7_Tumor,,,,,,,,,,,,,,,
MIN_8_Normal,MIN_8, NextFlex 6,CTTGTA,,,,Hunter Melanoma In Nevus,,BioSci4_BB56,BB56_SeqL,BB56_CL,Normal,NimV2mix3,MIN_8_Normal,NA_MIN_8_Normal,,,,,,,,,,,,,,,
MIN_8_Nevus,MIN_8, NextFlex 7,ATCACG,,,,Hunter Melanoma In Nevus,,BioSci4_BB56,BB56_SeqL,BB56_CL,Nevus,NimV2mix3,MIN_8_Nevus,NA_MIN_8_Nevus,,,,,,,,,,,,,,,
MIN_8_Melanoma,MIN_8, NextFlex 8,TTAGGC,,,,Hunter Melanoma In Nevus,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,MIN_8_Tumor,NA_MIN_8_Tumor,,,,,,,,,,,,,,,
501_Mel,501_Mel, NextFlex 9,ACTTGA,,,,Iwei Cell Line DNA,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,501_Mel_Tumor,NA_501_Mel_Tumor,,,,,,,,,,,,,,,
Sk_Mel_1,Sk_Mel_1, NextFlex 10,GATCAG,,,,Iwei Cell Line DNA,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,Sk_Mel_1_Tumor,NA_Sk_Mel_1_Tumor,,,,,,,,,,,,,,,
DPN_CNN 24,DPN24,NextFlex 11,TAGCTT,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN24_Tumor,NA_DPN24_Tumor,,,,,,,,,,,,,,,
DPN_CNN 28,DPN28,NextFlex 12,GGCTAC,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN28_Tumor,NA_DPN28_Tumor,,,,,,,,,,,,,,,
DPN_CNN 29,DPN29,NextFlex 13,AGTCAA,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN29_Tumor,NA_DPN29_Tumor,,,,,,,,,,,,,,,
DPN_CNN 31,DPN31,NextFlex 14,AGTTCC,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN31_Tumor,NA_DPN31_Tumor,,,,,,,,,,,,,,,
DPN_CNN 33,DPN33,NextFlex 15,ATGTCA,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN33_Tumor,NA_DPN33_Tumor,,,,,,,,,,,,,,,
DPN 40 A,DPN40,NextFlex 16,CCGTCC,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN40_Tumor,NA_DPN40_Tumor,,,,,,,,,,,,,,,
DPN 40 B,DPN40,NextFlex 17,GTAGAG,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN40_Tumor,NA_DPN40_Tumor,,,,,,,,,,,,,,,
DPN 41,DPN41,NextFlex 18,GTCCGC,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN41_Tumor,NA_DPN41_Tumor,,,,,,,,,,,,,,,
DPN42,DPN42,NextFlex 19,GTGAAA,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN42_Tumor,NA_DPN42_Tumor,,,,,,,,,,,,,,,
DPN44,DPN44,NextFlex 20,GTGGCC,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN44_Tumor,NA_DPN44_Tumor,,,,,,,,,,,,,,,
DPN 45,DPN45,NextFlex 21,GTTTCG,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN45_Tumor,NA_DPN45_Tumor,,,,,,,,,,,,,,,
DPN 46,DPN46,NextFlex 22,CGTACG,,,,Iwei DPN,,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,DPN46_Tumor,NA_DPN46_Tumor,,,,,,,,,,,,,,,
UM_6,UM_6,NextFlex 23,GAGTGG,,,,Dr. Seider Uveal Melanoma,"Hilliard, J",BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,UM_6_Tumor,NA_UM_6_Tumor,,,,,,,,,,,,,,,
Birt_Hogg_Dube,Birt_Hogg_Dube,NextFlex 24,GGTAGC,,,,"Metastatic Melanoma (KIT, NRAS, BRAF)",,BioSci4_BB56,BB56_SeqL,BB56_CL,Tumor,NimV2mix3,Birt_Hogg_Dube_Tumor,NA_Birt_Hogg_Dube_Tumor,,,,,,,,,,,,,,,
CGH13-027,13-1939, NextFlex 1,CGATGT,,,,Iwei Translocation,CGH13-027 NTRK3,BioSci5_BB57,BB57_SeqL,BB57_CL,Tumor,NimV2mix3,13-1939_Tumor,NA_13-1939_Tumor,13-1939,A,COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES WITH A BAP-1 ABERRATION,173505,238.2,"Comparative genomic hybridization shows an isolated loss of an interstitial area in chromosome 3p that contains the BAP-1 gene. Immunoperoxidase staining for BAP-1 shows loss of nuclear staining in the lesional melanocytes implying a mutation in the remaining allele; this aberration has been seen in a recently described subset of spitzoid lesions: 1: Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, Bastian BC. A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression. Am J Surg Pathol. 2012 Jun;36(6):818-30. PMID: 22367297.  2: Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rtten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011 Aug 28;43(10):1018-21. doi: 10.1038/ng.910. PubMed PMID: 21874003.  I would look at the clinical images in paper #2 and biopsy any nevi similar to this one, or to those in the article. A family history of ocular or cutaneous melanoma, or synovial sarcoma should also be obtained. Most lesions of this type are spontaneous, however. A very narrow re-excision to prevent regrowth would be prudent. If there was a pre-operative photograph, we would greatly appreciate having it for our teaching collection.  To date, there is no link between tanning booth or UV exposure and nevi of this type.","There is a compound proliferation of large, oval melanocytes with abundant, pale slightly vacuolated amphophilic cytoplasm and large, vesicular nuclei with large central nucleoli. The lesion has a raised, slightly papillated surface, and a relatively thin epidermis. The lesional melanocytes are in closely apposed aggregations in the upper part of the lesion with a more dispersed pattern lower in it. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. The enclosed two-color immunostain shows that there is a low proliferation rate among the lesional melanocytes. A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product.",26,,,,,,F,1186681
CGH13-268,13-51657, NextFlex 2,TGACCA,,,,Iwei Translocation,CGH13-268 MET,BioSci5_BB57,BB57_SeqL,BB57_CL,Tumor,NimV2mix3,13-51657_Tumor,NA_13-51657_Tumor,13-51657,A,"COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, CONSISTENT WITH THE SURFACE OF AN UNCONVENTIONAL COMPOUND SPITZ NEVUS",173304,238.2,"ADDENDUM, August 9, 2013: As I reported previously, I am in general agreement with your suggested interpretation of this case. I favor the surface of a compound Spitz nevus, but some unconventional (or atypical) features are present, and the extent of subjacent dermal involvement cannot be evaluated because of the superficial nature of the biopsy. There are at least two ways to proceed in the management of this case. One is to complete conservative reexcision of this site and obtain any residuum for further histopathologic assessment. The other is to pursue comparative genomic hybridization (CGH) to screen this tumor for chromosomal copy number abnormalities, as can be found in association with spitzoid melanoma. (The latter option was selected, as is discussed further below.) Per a clinical request, we completed CGH analysis to screen for genomic copy number anomalies. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in distal chromosome 7q with no other chromosomal gains or losses. As background for understanding this result, please note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while most melanocytic nevi lack such aberrations. We have identified gain in chromosome 7q as a monoaberration in a subset of unconventional Spitz nevi.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of spitzoid melanoma. Rather, our analysis supports interpretation as an unconventional Spitz nevus. Given the complexity of this assessment, reexcision of this site would be reasonable to ensure local control and prevent persistence.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.","Sections show a domed compound proliferation of enlarged fusiform melanocytes with amphophilic cytoplasm. These cells are distributed singly and in nests and large fascicles within the epidermis, which is acanthotic, and limited scatter above the junction can be seen. Some large nests are accompanied by perijunctional edema, and some mitotic figures can be found within large junctional collections. In fibrotic dermis below this, there are much smaller nests and cords of similar melanocytes, but most of the dermis cannot be visualized because of the superficial nature of the biopsy.",9,,,,,,F,1293660
CGH13-365,13-89069, NextFlex 3,ACAGTG,,,,Iwei DPN,CGH13-365 DPN-like Melanoma,BioSci5_BB57,BB57_SeqL,BB57_CL,Tumor,NimV2mix3,13-89069_Tumor,NA_13-89069_Tumor,13-89069,A,"BIPHASIC COMPOUND PROLIFERATION OF HEAVILY PIGMENTED MELANOCYTES, INCLUDING A COMPONENT OF BLUE NEVUS",173406,172.4,"The histopathologic findings in this initial biopsy were worrisome for melanoma ex blue nevus. We completed comparative genomic hybridization (CGH) to screen for chromosomal copy number abnormalities, as can be seen in association with melanoma, and the results of this analysis are discussed in association with the specimen that follows.","Sections show a punch biopsy harboring a compound proliferation of heavily pigmented melanocytes that is biphasic in its composition. Deep within the specimen, there are dendritic and thin spindled melanocytes distributed interstitially amongst coarse collagenous stroma in concert with numerous melanophages, and this comprises one population of cells. In the upper dermis, the epidermis, and the perifollicular dermis, there is a second population of larger ovoid and fusiform melanocytes with abundant pale cytoplasm. These cells are also accompanied by many melanophages and have a slightly elevated cell proliferation index. Within the epidermis, scatter of some melanocytes above the junction can be seen.",17,,,,,,F,1331074
CGH11-018,11-1051A, NextFlex 4,GCCAAT,,,,Iwei Blue Nevus Melanoma,CGH11-018 ,BioSci5_BB57,BB57_SeqL,BB57_CL,Tumor,NimV2mix3,11-1051A_Tumor,NA_11-1051A_Tumor,11-1051,A,"MELANOMA, ARISING IN ASSOCIATION WITH A CELLULAR BLUE NEVUS",173504,172.5,,"Sections show lactiferous ducts in fibrofatty tissue, with masses of plump oval melanocytes that have monomorphous, vesicular nuclei and inconspicuous cytoplasm in several areas. There are scattered melanophages in some areas, as well as clusters of bipolar, dendritic melanocytes in others. The most cellular areas of the proliferation have crowded, somewhat larger oval vesicular nuclei with many pyknotic cells amongst them. Mitotic figures are difficult to find.",30,,,,,,M,990488
CGH11-027,11-5480, NextFlex 5,CAGATC,,,,Iwei Blue Nevus Melanoma,CGH11-027 ,BioSci5_BB57,BB57_SeqL,BB57_CL,Tumor,NimV2mix3,11-5480_Tumor,NA_11-5480_Tumor,11-5480,A,"BLUE NEVUS-LIKE MELANOMA, ARISING WITHIN AN INTRAMAMMARY CELLULAR BLUE NEVUS",173505,172.5,"Based solely upon conventional microscopical assessment, I was agreement with the interpretation of Dr. Wick: I favored interpretation of this proliferation as a cellular blue nevus and was not convinced that a component of melanoma was present. However, given the diagnostic controversy that had surrounded this case, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block (from a hypercellular focus), aCGH analysis was completed and demonstrated gains in chromosomes 6p, 8q, and 17q as well as losses in chromosomes 6q, 9p, 11q, and 16q. The presence of multiple chromosomal gains and losses is not an alteration that is known to occur in cellular blue nevi (or even in so-called atypical cellular blue nevi) and suggests instead that a component of melanoma is present. In summary, based upon the combination of results derived from conventional microscopy and aCGH, I believe this breast lesion includes a component of blue nevus-like melanoma that developed within a background of cellular blue nevus. The component of melanoma is not obvious and fully distinctive microscopically, at least to my eye, and thus molecular assessment proved to be instrumental in rendering the above interpretation. This melanoma cannot be staged by conventional microscopical parameters.  I do not know the status of the final surgical margin for this case. The fact that this specimen is listed as a mastectomy specimen leads me to presume that complete excision has been achieved.","Sections show segments of breast parenchyma, and within these segments there is a proliferation of plump spindled and slender dendritic melanocytes encompassed by a sclerotic fibrous matrix. In many areas, the proliferation consists of small dendritic melanocytes encompassed by this matrix and accompanied by an infiltrate of many melanophages. In other, more cellular foci, there are nodules composed of coalescing fascicles of plump spindled melanocytes with pale or faintly melanized cytoplasm. In these cellular areas, melanophages are few in number. Cells in mitosis are focally present but are not readily identifiable. The Ki-67 cell proliferation index is extremely low.",72,,,,,,F,994917
Ivanka_23_Tumor,10-73024, NextFlex 6,CTTGTA,,,,Ivanka Patient Melanoma (Hunter Extraction),,BioSci5_BB57,BB57_SeqL,BB57_CL,Tumor,NimV2mix3,10-73024_Tumor,NA_10-73024_Tumor,10-73024,A,"MELANOMA, 0.32 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, NARROWLY EXCISED",173611,172.6,"Melan-A stains were done and they highlight a broad proliferation of atypical melanocytes at the dermoepidermal junction and above it.  A few nests of atypical melanocytes are also noted in the dermis.  These were difficult to detect on routine staining due to the associated dense band like infiltrate of lymphocytes and melanophages.  The lesion has been completely, but narrowly excised.  Melanoma in situ is present to within 1 millimeter of the 9 o'clock position with the orienting notch designated as 12 o'clock.  In terms of staging this is a thin non-ulcerated melanoma with foci of regression.  No dermal mitotic figures are noted within the small dermal component.  It should be regarded as a pT1a lesion based on the 2009 AJCC melanoma staging system.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  There is an associated dense band like lymphocytic infiltrate with numerous melanophages.  There are foci of epidermal atrophy with an associated paucity of melanocytes.",55,T1a,0.32,,Primary,,M,967603
Ivanka_23_Normal,10-73024, NextFlex 7,ATCACG,,,,Ivanka Patient Melanoma (Hunter Extraction),,BioSci5_BB57,BB57_SeqL,BB57_CL,Normal,NimV2mix3,10-73024_Normal,NA_10-73024_Normal,10-73024,A,"MELANOMA, 0.32 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, NARROWLY EXCISED",173611,172.6,"Melan-A stains were done and they highlight a broad proliferation of atypical melanocytes at the dermoepidermal junction and above it.  A few nests of atypical melanocytes are also noted in the dermis.  These were difficult to detect on routine staining due to the associated dense band like infiltrate of lymphocytes and melanophages.  The lesion has been completely, but narrowly excised.  Melanoma in situ is present to within 1 millimeter of the 9 o'clock position with the orienting notch designated as 12 o'clock.  In terms of staging this is a thin non-ulcerated melanoma with foci of regression.  No dermal mitotic figures are noted within the small dermal component.  It should be regarded as a pT1a lesion based on the 2009 AJCC melanoma staging system.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  There is an associated dense band like lymphocytic infiltrate with numerous melanophages.  There are foci of epidermal atrophy with an associated paucity of melanocytes.",55,T1a,0.32,,Primary,,M,967603
Ivanka_2-1,09-33283, NexFlex 8,TTAGGC,,,,Ivanka Patient Melanoma  ,,BioSci5_BB57,BB57_SeqL,BB57_CL,Melanoma,NimV2mix3,09-33283_Melanoma,NA_09-33283_Melanoma,09-33283,A,"NODULAR BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY",173441,173.4,,"Sections show nodular aggregations of atypical, peripherally palisaded basaloid cells. Very focally, tiny angulate aggregations of similar cells are apparent in infiltrative array. There is enveloping inflamed cellular stroma.",42,,,,,,M,834046
Ivanka_2-2,09-33283, NextFlex 9,ACTTGA,,,,Ivanka Patient Melanoma  ,,BioSci5_BB57,BB57_SeqL,BB57_CL,Melanoma,NimV2mix3,09-33283_Melanoma,NA_09-33283_Melanoma,09-33283,A,"NODULAR BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY",173441,173.4,,"Sections show nodular aggregations of atypical, peripherally palisaded basaloid cells. Very focally, tiny angulate aggregations of similar cells are apparent in infiltrative array. There is enveloping inflamed cellular stroma.",42,,,,,,M,834046
Ivanka_2-3,09-33283, NextFlex 10,GATCAG,,,,Ivanka Patient Melanoma  ,,BioSci5_BB57,BB57_SeqL,BB57_CL,Nevus,NimV2mix3,09-33283_Nevus,NA_09-33283_Nevus,09-33283,A,"NODULAR BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY",173441,173.4,,"Sections show nodular aggregations of atypical, peripherally palisaded basaloid cells. Very focally, tiny angulate aggregations of similar cells are apparent in infiltrative array. There is enveloping inflamed cellular stroma.",42,,,,,,M,834046
Ivanka_2-4,09-33283,NextFlex 11,TAGCTT,,,,Ivanka Patient Melanoma  ,,BioSci5_BB57,BB57_SeqL,BB57_CL,Nevus,NimV2mix3,09-33283_Nevus,NA_09-33283_Nevus,09-33283,A,"NODULAR BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY",173441,173.4,,"Sections show nodular aggregations of atypical, peripherally palisaded basaloid cells. Very focally, tiny angulate aggregations of similar cells are apparent in infiltrative array. There is enveloping inflamed cellular stroma.",42,,,,,,M,834046
Ivanka_3-1,09-31895,NextFlex 12,GGCTAC,,,,Ivanka Patient Melanoma  ,,BioSci5_BB57,BB57_SeqL,BB57_CL,Melanoma,NimV2mix3,09-31895_Melanoma,NA_09-31895_Melanoma,09-31895,A,"MELANOMA OF 0.55 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173649,172.6,"This biopsy contains two populations of melanocytes within it, with one population representing superficially invasive melanoma and with the other population representing a longstanding melanocytic nevus. This is a non-ulcerated melanoma with associated Clark's level III invasion. There is no evidence of associated vascular or perineural invasion. Associated partial regression is apparent; in light of the associated regression, the microstage measurement listed above may underestimate the prognostic impact of this melanoma. Melanoma is transected at the periphery of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.",,80,,0.55,,,,M,79298
Ivanka_3-2,09-31895,NextFlex 13,AGTCAA,,,,Ivanka Patient Melanoma  ,,BioSci5_BB57,BB57_SeqL,BB57_CL,Melanoma,NimV2mix3,09-31895_Melanoma,NA_09-31895_Melanoma,09-31895,A,"MELANOMA OF 0.55 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173649,172.6,"This biopsy contains two populations of melanocytes within it, with one population representing superficially invasive melanoma and with the other population representing a longstanding melanocytic nevus. This is a non-ulcerated melanoma with associated Clark's level III invasion. There is no evidence of associated vascular or perineural invasion. Associated partial regression is apparent; in light of the associated regression, the microstage measurement listed above may underestimate the prognostic impact of this melanoma. Melanoma is transected at the periphery of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.",,80,,0.55,,,,M,79298
Ivanka_3-3,09-31895,NextFlex 14,AGTTCC,,,,Ivanka Patient Melanoma  ,,BioSci5_BB57,BB57_SeqL,BB57_CL,Nevus,NimV2mix3,09-31895_Nevus,NA_09-31895_Nevus,09-31895,A,"MELANOMA OF 0.55 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173649,172.6,"This biopsy contains two populations of melanocytes within it, with one population representing superficially invasive melanoma and with the other population representing a longstanding melanocytic nevus. This is a non-ulcerated melanoma with associated Clark's level III invasion. There is no evidence of associated vascular or perineural invasion. Associated partial regression is apparent; in light of the associated regression, the microstage measurement listed above may underestimate the prognostic impact of this melanoma. Melanoma is transected at the periphery of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.",,80,,0.55,,,,M,79298
Ivanka_3-4,09-31895,NextFlex 15,ATGTCA,,,,Ivanka Patient Melanoma  ,,BioSci5_BB57,BB57_SeqL,BB57_CL,Nevus,NimV2mix3,09-31895_Nevus,NA_09-31895_Nevus,09-31895,A,"MELANOMA OF 0.55 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173649,172.6,"This biopsy contains two populations of melanocytes within it, with one population representing superficially invasive melanoma and with the other population representing a longstanding melanocytic nevus. This is a non-ulcerated melanoma with associated Clark's level III invasion. There is no evidence of associated vascular or perineural invasion. Associated partial regression is apparent; in light of the associated regression, the microstage measurement listed above may underestimate the prognostic impact of this melanoma. Melanoma is transected at the periphery of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.",,80,,0.55,,,,M,79298
Ivanka_3-5,09-31895,NextFlex 16,CCGTCC,,,,Ivanka Patient Melanoma  ,,BioSci5_BB57,BB57_SeqL,BB57_CL,Normal,NimV2mix3,09-31895_Normal,NA_09-31895_Normal,09-31895,A,"MELANOMA OF 0.55 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173649,172.6,"This biopsy contains two populations of melanocytes within it, with one population representing superficially invasive melanoma and with the other population representing a longstanding melanocytic nevus. This is a non-ulcerated melanoma with associated Clark's level III invasion. There is no evidence of associated vascular or perineural invasion. Associated partial regression is apparent; in light of the associated regression, the microstage measurement listed above may underestimate the prognostic impact of this melanoma. Melanoma is transected at the periphery of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.",,80,,0.55,,,,M,79298
PMM_1_Tumor,R29032-05,NextFlex 17,GTAGAG,,,,Iwei Pediatric Melanoma,,BioSci5_BB57,BB57_SeqL,BB57_CL,Tumor,NimV2mix3,R29032-05_Tumor,NA_R29032-05_Tumor,,,,,,,,,,,,,,,
PMM_1_Normal,R29032-05,NextFlex 18,GTCCGC,,,,Iwei Pediatric Melanoma,,BioSci5_BB57,BB57_SeqL,BB57_CL,Normal,NimV2mix3,R29032-05_Normal,NA_R29032-05_Normal,,,,,,,,,,,,,,,
PMM_3_A_Tumor,01-8297,NextFlex 19,GTGAAA,,,,Iwei Pediatric Melanoma,,BioSci5_BB57,BB57_SeqL,BB57_CL,Tumor,NimV2mix3,01-8297_Tumor,NA_01-8297_Tumor,01-8297,A,DERMATOPHYTOSIS,173610,110.9,3/15/2001:  A PAS-D stain confirms the presence of hyphae in the cornified layer.   3/12/2001:  I suspect dermatophytosis.,Sections show spongiosis with an altered cornified layer.,34,,,,,,F,264700
PMM_3_A_Normal,01-8297,NextFlex 20,GTGGCC,,,,Iwei Pediatric Melanoma,,BioSci5_BB57,BB57_SeqL,BB57_CL,Normal,NimV2mix3,01-8297_Normal,NA_01-8297_Normal,01-8297,A,DERMATOPHYTOSIS,173610,110.9,3/15/2001:  A PAS-D stain confirms the presence of hyphae in the cornified layer.   3/12/2001:  I suspect dermatophytosis.,Sections show spongiosis with an altered cornified layer.,34,,,,,,F,264700
PMM_3_B_Tumor,8298-01,NextFlex 21,GTTTCG,,,,Iwei Pediatric Melanoma,,BioSci5_BB57,BB57_SeqL,BB57_CL,Tumor,NimV2mix3,8298-01_Tumor,NA_8298-01_Tumor,,,,,,,,,,,,,,,
PMM_3_B_Normal,8298-01,NextFlex 22,CGTACG,,,,Iwei Pediatric Melanoma,,BioSci5_BB57,BB57_SeqL,BB57_CL,Normal,NimV2mix3,8298-01_Normal,NA_8298-01_Normal,,,,,,,,,,,,,,,
Ivanka_11-1,08-53951, NextFlex 3,ACAGTG,,,,Ivanka Patient Melanoma,,BioSci6_BB58,BB58_SeqL,BB58_CL,Melanoma,NimV2mix3,08-53951_Melanoma,NA_08-53951_Melanoma,08-53951,A,"MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO PERIPHERAL EXCISION MARGINS",191323,172.3,"Although nevi on the scalp and hairline on children can demonstrate unusual features, the findings in a portion of this lesion exceed what would be expected in that setting. These include a markedly irregular distribution of atypical melanocytes which appear morphologically distinct from those of the surrounding nevus, as well significant suprabasal scatter of melanocytes, and a lack of maturation of the dermal component in that area. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this diagnosis. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level III, with atypical melanocytes expanding the papillary dermis and abutting the reticular dermis. There are no other features which would have an impact on prognosis apart from those given above. Reexcision of this site with standard margins is of course warranted.","Sections show an asymmetrical, compound proliferation of melanocytes which is well-circumscribed. There is a slightly biphasic pattern, with larger atypical melanocytes with more abundant dusty cytoplasmic melanin within the epidermis arrayed irregularly as nests and single cells. Melanocytes are scattered above the basal layer in this zone as well. Similar melanocytes are present within the dermis as clusters which demonstrate deficient maturation with descent. Mitotic figures are evident within the epidermal component, but not within the dermal component in this area. At the periphery, there is also a compound proliferation of smaller and bland melanocytes, arrayed as small nests along the junction, and as nests and syncytia in the dermis. These melanocytes mature with descent. Some of them contain dusty cytoplasmic melanin, but less abundant than those in the aforementioned atypical zone. There is a patchy lymphocytic infiltrate, especially surrounding the population of larger atypical melanocytes.",17,,0.9,,,,F,596372
Ivanka_11-2,08-53951, NextFlex 4,GCCAAT,,,,Ivanka Patient Melanoma,,BioSci6_BB58,BB58_SeqL,BB58_CL,Melanoma,NimV2mix3,08-53951_Melanoma,NA_08-53951_Melanoma,08-53951,A,"MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO PERIPHERAL EXCISION MARGINS",191323,172.3,"Although nevi on the scalp and hairline on children can demonstrate unusual features, the findings in a portion of this lesion exceed what would be expected in that setting. These include a markedly irregular distribution of atypical melanocytes which appear morphologically distinct from those of the surrounding nevus, as well significant suprabasal scatter of melanocytes, and a lack of maturation of the dermal component in that area. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this diagnosis. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level III, with atypical melanocytes expanding the papillary dermis and abutting the reticular dermis. There are no other features which would have an impact on prognosis apart from those given above. Reexcision of this site with standard margins is of course warranted.","Sections show an asymmetrical, compound proliferation of melanocytes which is well-circumscribed. There is a slightly biphasic pattern, with larger atypical melanocytes with more abundant dusty cytoplasmic melanin within the epidermis arrayed irregularly as nests and single cells. Melanocytes are scattered above the basal layer in this zone as well. Similar melanocytes are present within the dermis as clusters which demonstrate deficient maturation with descent. Mitotic figures are evident within the epidermal component, but not within the dermal component in this area. At the periphery, there is also a compound proliferation of smaller and bland melanocytes, arrayed as small nests along the junction, and as nests and syncytia in the dermis. These melanocytes mature with descent. Some of them contain dusty cytoplasmic melanin, but less abundant than those in the aforementioned atypical zone. There is a patchy lymphocytic infiltrate, especially surrounding the population of larger atypical melanocytes.",17,,0.9,,,,F,596372
Ivanka_11-3,08-53951, NextFlex 5,CAGATC,,,,Ivanka Patient Melanoma,,BioSci6_BB58,BB58_SeqL,BB58_CL,Nevus,NimV2mix3,08-53951_Nevus,NA_08-53951_Nevus,08-53951,A,"MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO PERIPHERAL EXCISION MARGINS",191323,172.3,"Although nevi on the scalp and hairline on children can demonstrate unusual features, the findings in a portion of this lesion exceed what would be expected in that setting. These include a markedly irregular distribution of atypical melanocytes which appear morphologically distinct from those of the surrounding nevus, as well significant suprabasal scatter of melanocytes, and a lack of maturation of the dermal component in that area. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this diagnosis. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level III, with atypical melanocytes expanding the papillary dermis and abutting the reticular dermis. There are no other features which would have an impact on prognosis apart from those given above. Reexcision of this site with standard margins is of course warranted.","Sections show an asymmetrical, compound proliferation of melanocytes which is well-circumscribed. There is a slightly biphasic pattern, with larger atypical melanocytes with more abundant dusty cytoplasmic melanin within the epidermis arrayed irregularly as nests and single cells. Melanocytes are scattered above the basal layer in this zone as well. Similar melanocytes are present within the dermis as clusters which demonstrate deficient maturation with descent. Mitotic figures are evident within the epidermal component, but not within the dermal component in this area. At the periphery, there is also a compound proliferation of smaller and bland melanocytes, arrayed as small nests along the junction, and as nests and syncytia in the dermis. These melanocytes mature with descent. Some of them contain dusty cytoplasmic melanin, but less abundant than those in the aforementioned atypical zone. There is a patchy lymphocytic infiltrate, especially surrounding the population of larger atypical melanocytes.",17,,0.9,,,,F,596372
Ivanka_11-4,08-53951, NextFlex 6,CTTGTA,,,,Ivanka Patient Melanoma,,BioSci6_BB58,BB58_SeqL,BB58_CL,Nevus,NimV2mix3,08-53951_Nevus,NA_08-53951_Nevus,08-53951,A,"MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO PERIPHERAL EXCISION MARGINS",191323,172.3,"Although nevi on the scalp and hairline on children can demonstrate unusual features, the findings in a portion of this lesion exceed what would be expected in that setting. These include a markedly irregular distribution of atypical melanocytes which appear morphologically distinct from those of the surrounding nevus, as well significant suprabasal scatter of melanocytes, and a lack of maturation of the dermal component in that area. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this diagnosis. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level III, with atypical melanocytes expanding the papillary dermis and abutting the reticular dermis. There are no other features which would have an impact on prognosis apart from those given above. Reexcision of this site with standard margins is of course warranted.","Sections show an asymmetrical, compound proliferation of melanocytes which is well-circumscribed. There is a slightly biphasic pattern, with larger atypical melanocytes with more abundant dusty cytoplasmic melanin within the epidermis arrayed irregularly as nests and single cells. Melanocytes are scattered above the basal layer in this zone as well. Similar melanocytes are present within the dermis as clusters which demonstrate deficient maturation with descent. Mitotic figures are evident within the epidermal component, but not within the dermal component in this area. At the periphery, there is also a compound proliferation of smaller and bland melanocytes, arrayed as small nests along the junction, and as nests and syncytia in the dermis. These melanocytes mature with descent. Some of them contain dusty cytoplasmic melanin, but less abundant than those in the aforementioned atypical zone. There is a patchy lymphocytic infiltrate, especially surrounding the population of larger atypical melanocytes.",17,,0.9,,,,F,596372
AF13_212,13000212, NextFlex 7,ATCACG,,,,Dr. A. Fouchardiere Project,,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,13000212_Tumor,NA_13000212_Tumor,,,,,,,,,,,,,,,
PMM_5_Tumor,8528-05, NextFlex 8,TTAGGC,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,8528-05_Tumor,NA_8528-05_Tumor,,,,,,,,,,,,,,,
PMM_6_Tumor,1286184b, NextFlex 9,ACTTGA,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,1286184b_Tumor,NA_1286184b_Tumor,,,,,,,,,,,,,,,
PMM_6_Normal,1286184b, NextFlex 10,GATCAG,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Normal,NimV2mix3,1286184b_Normal,NA_1286184b_Normal,,,,,,,,,,,,,,,
PMM_7_Tumor,206436,NextFlex 11,TAGCTT,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,206436_Tumor,NA_206436_Tumor,,,,,,,,,,,,,,,
PMM_8_Tumor,35942-04,NextFlex 12,GGCTAC,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,35942-04_Tumor,NA_35942-04_Tumor,,,,,,,,,,,,,,,
PMM_8_Normal,15329-03,NextFlex 13,AGTCAA,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Normal,NimV2mix3,15329-03_Normal,NA_15329-03_Normal,,,,,,,,,,,,,,,
PMM_10_Tumor,Z1188-03,NextFlex 14,AGTTCC,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,Z1188-03_Tumor,NA_Z1188-03_Tumor,,,,,,,,,,,,,,,
PMM_10_Normal,1185-03,NextFlex 15,ATGTCA,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Normal,NimV2mix3,1185-03_Normal,NA_1185-03_Normal,,,,,,,,,,,,,,,
PMM_12_Tumor,14514-02,NextFlex 16,CCGTCC,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,14514-02_Tumor,NA_14514-02_Tumor,,,,,,,,,,,,,,,
PMM_12_Normal,15102-02,NextFlex 17,GTAGAG,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Normal,NimV2mix3,15102-02_Normal,NA_15102-02_Normal,,,,,,,,,,,,,,,
PMM_13_Tumor,9116-05,NextFlex 18,GTCCGC,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,9116-05_Tumor,NA_9116-05_Tumor,,,,,,,,,,,,,,,
PMM_14_Tumor,24516-06,NextFlex 19,GTGAAA,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,24516-06_Tumor,NA_24516-06_Tumor,,,,,,,,,,,,,,,
PMM_14_Normal,24516-06,NextFlex 20,GTGGCC,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Normal,NimV2mix3,24516-06_Normal,NA_24516-06_Normal,,,,,,,,,,,,,,,
PMM_15_Tumor,07-3078,NextFlex 21,GTTTCG,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,07-3078_Tumor,NA_07-3078_Tumor,07-3078,A,"MELANOMA IN SITU, TRANSECTED AT THE PERIPHERAL BIOPSY MARGIN",733602,232.6,Further re-excision of this site is warranted to ensure that local eradication has been accomplished.,"Sections show a melanocytic proliferation composed largely of single cells arrayed in near-continuous fashion within some parts of the lower epidermis, above a reticular dermis with considerable elastosis. Some single cells are scattered above the junction.",68,,,,,,F,625607
PMM_17_Tumor,B06-37358,NextFlex 22,CGTACG,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,B06-37358_Tumor,NA_B06-37358_Tumor,,,,,,,,,,,,,,,
PMM_18_Tumor,21590,NextFlex 23,GAGTGG,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Tumor,NimV2mix3,21590_Tumor,NA_21590_Tumor,,,,,,,,,,,,,,,
PMM_18_Normal,21590,NextFlex 24,GGTAGC,,,,Iwei Pediatric Melanoma (PMM),,BioSci6_BB58,BB58_SeqL,BB58_CL,Normal,NimV2mix3,21590_Normal,NA_21590_Normal,,,,,,,,,,,,,,,
PMM_19_Tumor,A2A79@, NextFlex 1,CGATGT,,,,Iwei Pediatric Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,A2A79@_Tumor,NA_A2A79@_Tumor,,,,,,,,,,,,,,,
PMM_20_Tumor,356A3-075, NextFlex 2,TGACCA,,,,Iwei Pediatric Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,356A3-075_Tumor,NA_356A3-075_Tumor,,,,,,,,,,,,,,,
PMM_20_Normal,20847-09, NextFlex 3,ACAGTG,,,,Iwei Pediatric Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Normal,NimV2mix3,20847-09_Normal,NA_20847-09_Normal,,,,,,,,,,,,,,,
PMM_22_Tumor,525, NextFlex 4,GCCAAT,,,,Iwei Pediatric Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,525_Tumor,NA_525_Tumor,,,,,,,,,,,,,,,
PMM_23_Tumor,PMM_23, NextFlex 5,CAGATC,,,,Iwei Pediatric Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,PMM_23_Tumor,NA_PMM_23_Tumor,,,,,,,,,,,,,,,
PMM_23_Normal,PMM_23, NextFlex 6,CTTGTA,,,,Iwei Pediatric Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Normal,NimV2mix3,PMM_23_Normal,NA_PMM_23_Normal,,,,,,,,,,,,,,,
UM7,UM7,NextFlex 13,AGTCAA,,,,Uveal Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,UM7_Tumor,NA_UM7_Tumor,,,,,,,,,,,,,,,
UM8,UM8,NextFlex 14,AGTTCC,,,,Uveal Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,UM8_Tumor,NA_UM8_Tumor,,,,,,,,,,,,,,,
UM9,UM9,NextFlex 15,ATGTCA,,,,Uveal Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,UM9_Tumor,NA_UM9_Tumor,,,,,,,,,,,,,,,
UM10,UM10,NextFlex 16,CCGTCC,,,,Uveal Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,UM10_Tumor,NA_UM10_Tumor,,,,,,,,,,,,,,,
UM11,UM11,NextFlex 17,GTAGAG,,,,Uveal Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,UM11_Tumor,NA_UM11_Tumor,,,,,,,,,,,,,,,
Xanthoma_Disseminatum,Xanthoma_Disseminatum,NextFlex 18,GTCCGC,,,,Dr. Shulman Xanthoma Disseminatum,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,Xanthoma_Disseminatum_Tumor,NA_Xanthoma_Disseminatum_Tumor,,,,,,,,,,,,,,,
AM_4_Tumor,99-15313, NextFlex 7,ATCACG,,,,Iwei Acral Melanoma,Nimblegen43 (BB50),BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,99-15313_Tumor,NA_99-15313_Tumor,99-15313,A,"MELANOMA, INVOLVING ACRAL SKIN, 2.0 MM IN THICKNESS; FINAL THICKNESS TO AWAIT COMPLETE EXCISION",173622,172.6,A PAS-D stain ordered at the time that this specimen was grossed in does not reveal dermatophytes.,"There is a proliferation of atypical melanocytes, arranged as
confluent nests at the junctions with focal pagetoid spread, with
extension of smaller but cytologically atypical melanocytes into the
subjacent dermis.  Squamatization of eccrine ducts in prominent.",55,,2.0,,,,F,190846
AM_6_Tumor,98-37643, NextFlex 8,TTAGGC,,,,Iwei Acral Melanoma,Nimblegen43 (BB50),BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,98-37643_Tumor,NA_98-37643_Tumor,98-37643,A,"MELANOMA, 0.7 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN",173717,172.7,"In light of the presence of some degree of epidermal hyperplasia, the microstage measurement listed above probably overestimates the prognostic risk of this lesion, as the measurement is inflated by the epidermal changes.","Sections show acral skin with a proliferation of atypical melanocytes
arranged in an irregular pattern within the epidermis, and with
similar cells in the papillary dermis.  The pattern is predominantly
nested, with striking irregularity among nests.",44,,0.7,,,,M,175216
AM_10_Tumor,09-29997, NextFlex 9,ACTTGA,,,,Iwei Acral Melanoma,Nimblegen43 (BB50),BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,09-29997_Tumor,NA_09-29997_Tumor,09-29997,A,"SUBUNGUAL MELANOMA, AT LEAST 1 MM IN THICKNESS, EXTENDING TO THE PERIPHERY OF THE BIOPSY",252688,172.6,"I have also had the opportunity to review the prior biopsy from this patient, and the current findings are now diagnostic for melanoma. The lineage of the neoplastic cells was confirmed in a Melan-A immunostain, as the tumor displays only scant pigment. With regard to the staging of subungual melanoma, Clark's levels are not reported, as the typical arrangement of papillary and reticular dermis is not present in the nail unit per se. The exception is for Clark's level V, which is assigned when periosteal involvement is present. That finding cannot be assessed in the current sections. There is no evidence of lymphovascular or perineural invasion in these sections. However, given the potentially large size of the area of involvement indicated in the clinical photographs we received previously, definitive assessment of all prognostic features should be deferred to the complete reexcision specimen.","Sections show distorted nail bed epithelium, containing a proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells in sheets in the dermis. Only scant melanin pigment is present. In the portion of epithelium, there is suprabasal scatter of melanocytes, and they may also be present in the overlying stratum corneum. The nail plate is markedly dystrophic.",53,,1,,,,M,310907
CGH13-392,13-94981, NextFlex 10,GATCAG,,,,Iwei Translocation,CGH13-392 ,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,13-94981_Tumor,NA_13-94981_Tumor,13-94981,A,"COMPOUND PROLIFERATION OF LARGE, ATYPICAL MELANOCYTES, BEST REGARDED AS AN ATYPICAL SPITZ TUMOR",173530,238.2,"This spitzoid proliferation has marked confluence of both junctional nests and dermal ones, and in the thinner sections, some pulverocytes.* It also has an uneven lower border. These findings raised the possibility of a spitzoid melanoma. Comparative genomic hybridization shows chromosomal amplifications involving areas on 7p (near the terminal end) and 7q. The latter includes part of the b-raf gene. The fusion partner for b-raf in this case may be MAD1L1, a gene that has been seen as a fusion partner in other such cases. My colleague, Dr. Iwei Yeh also reveiwed the comparative genomic hybridization data and agrees with this interpretation of it.  Spitzoid lesions with b-raf fusions lack b-raf mutations (i.e. the sequence of the gene is wild type, but there is a break in the gene and the chromosome is attached at the breakpoint to its fusion partner). This mechanism can occur in Spitz's nevi, atypical Spitz tumors and in melanoma. An overview of the subject of braf fusions is in the paper from our group referenced below. The absence of other abberations in this lesion, with the exception of a low level loss involving chromosome 14q is against an outright diagnosis of spitzoid melanoma.  An atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have feature more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy.  Reference:  Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res. 2013 Nov;26(6):845-51. doi: 10.1111/pcmr.12148. Epub 2013 Aug 19. PubMed PMID: 23890088; PubMed Central PMCID: PMC3808507.   *This term is introduced in Massi G, LeBoit P. Histologic Diagnosis of Nevi and Melanoma, 2nd Edition, Springer-Verlag, Berlin Heidelberg, 2014 p. 57, and refers to cells with abundant, pale cytoplasm and dusty appearing melanin, deriving from the Latin term for dust","There is a relatively narrowly based, and somewhat wedge-shaped compound proliferation of melanocytes that mostly involves the junctional zone and superficial dermis. There are nests of large oval cells at the junction, with some confluence of them. Some of these have homogeneous, and some vacuolated cytoplasm with dusty melanin. There are pleomorphic, vesicular nuclei with large nucleoli. Nuclear maturation and dispersion are both evident with descent. There are focally dense lymphocytic infiltrates. A mitotic figure is present in the mid-dermal portion of the lesion, either in a melanocyte or in a stromal cell. The enclosed Mart-1 stained sections highlight that the lesion has an irregular lower contour. A gradient of HMB-45 staining is present, mostly at the junction.",25,,,,,,M,1336996
CGH13-399,13-99411A,NextFlex 11,TAGCTT,,,,Iwei Translocation,CGH13-399 ,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,13-99411A_Tumor,NA_13-99411A_Tumor,13-99411,A,ATYPICAL POLYPOID COMPOUND PROLIFERATION OF MELANOCYTES; GENOMIC LOSSES HAVE BEEN IDENTIFIED VIA COMPARATIVE GENOMIC HYBRIDIZATION,101406,238.2,"To further assess this proliferation, limited immunoperoxidase staining was first completed as part of our assessment. CD34 staining demonstrates relatively diffuse fingerprint positivity, thereby corroborating that neural differentiation is present. An EMA immunostain proved to be completely negative, and thus there is not proof of perineurial differentiation (nevertheless, I suspect it may be present). Per the request of Dr. Vetto, we additionally completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number abnormalities. as can be seen with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in in chromosome 9, loss of much of chromosome 7, and loss of distal chromosome 2. The identification of multiple chromosomal copy number abnormalities, with loss of chromosome 9 as the dominant finding, indicates that melanoma cannot be excluded from the differential diagnosis. However, based upon conventional microscopy, I cannot render a conclusive diagnosis of melanoma.  In short, this represents an ambiguous melanocytic tumor. If interpreted as melanoma, the tumor is 1.95 mm in thickness and is non-ulcerated.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.","An asymmetrical polypoid compound proliferation of melanocytes is quite protuberant. Near the base of the polyp, a small junctional component that consists of single melanocytes and pigmented nests can be seen. In the dermis below this, a syncytial array of fusiform and epithelioid melanocytes with slightly enlarged nuclei can be seen. In some areas, the background stroma is collagenous and has a vaguely whorled configuration. Although the constituent melanocytes are enlarged, cells in mitosis are not easily found.",17,,,,,,F,1341428
CGH13-394,13-94484,NextFlex 12,GGCTAC,,,,Iwei Translocation,CGH13-394 ,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,13-94484_Tumor,NA_13-94484_Tumor,13-94484,A,"POLYPOID COMPOUND PROLIFERATION OF ENLARGED EPITHELIOID MELANOCYTES, CONSISTENT WITH AN UNCONVENTIONAL POLYPOID SPITZ NEVUS",173707,238.2,"This large polypoid tumor does not represent a variant of conventional Spitz nevus. Rather, our differential diagnosis includes an unusual combined melanocytic nevus or unconventional Spitz nevus, an 'atypical Spitz tumor' (a provisional diagnostic category), and childhood spitzoid melanoma. We completed BAP-1 immunoperoxidase staining as part of our evaluation, as BAP-1 loss (within chromosome 3p) can be detected in a subset of Spitz tumors with enlarged epithelioid melanocytes, similar to those seen here. The BAP-1 immunostain demonstrates preserved nuclear positivity throughout, thereby indicating that BAP-1 loss is not present. This is the type of challenging tumor for which array-based comparative genomic hybridization (aCGH) can be of value. This technique was applied, as per your approval. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in distal chromosome 7 with no other associated chromosomal gains or losses. Gain in chromosome 7q suggests a Spitz nevus with associated MET genetic fusion. MET immunostaining was additionally completed and demonstrates positivity, thereby corroborating the possibility suggested in the preceding sentence.  This is an unusual melanocytic tumor. I believe it is benign, but follow-up studies of tumors of this type have not been completed. Conservative complete reexcision of this site would be reasonable to consider to ensure complete tumor removal and prevent persistence.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.","Sections show melanocytes arrayed in compound fashion in a large polypoid skin segment. There are single melanocytes and large pale nests of melanocytes within the epidermis, and limited intraspinous scatter is noted. In the vast subjacent dermis in the center of the polyp, there is a large nodular population of melanocytes that is somewhat biphasic. There are smaller ovoid and fusiform melanocytes arrayed as nests, cords, fascicles, and syncytia, and there is also a large syncytial population of enlarged epithelioid melanocytes with amphophilic or pale cytoplasm. A patchy lymphohistiocytic infiltrate is noted as well.",3,,,,,,F,1336499
DM_27_Tumor,DM27,NextFlex 19,GTGAAA,,,,Hunter Desmoplastic Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,DM27_Tumor,NA_DM27_Tumor,,,,,,,,,,,,,,,
DM_32_Tumor,DM32,NextFlex 20,GTGGCC,,,,Hunter Desmoplastic Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,DM32_Tumor,NA_DM32_Tumor,,,,,,,,,,,,,,,
DM_35_Tumor,DM35,NextFlex 21,GTTTCG,,,,Hunter Desmoplastic Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,DM35_Tumor,NA_DM35_Tumor,,,,,,,,,,,,,,,
DM_40_Tumor,DM40,NextFlex 22,CGTACG,,,,Hunter Desmoplastic Melanoma,,BioSci7_BB59,BB59_SeqL,BB59_CL,Tumor,NimV2mix3,DM40_Tumor,NA_DM40_Tumor,,,,,,,,,,,,,,,
Ivanka_24-1_Tert,11-23681,NextFlex 23,GAGTGG,,,,Hunter Tert Amplicon ,,BioSci7_BB59,BB59_SeqL,BB59_CL,Melanoma,,11-23681_Melanoma,NA_11-23681_Melanoma,11-23681,A,"MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",132590,172.5,"Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.","Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",58,T4b,5.5,,Primary,3,F,1013119
Ivanka_24-2_Tert,11-23681,NextFlex 24,GGTAGC,,,,Hunter Tert Amplicon ,,BioSci7_BB59,BB59_SeqL,BB59_CL,Melanoma,,11-23681_Melanoma,NA_11-23681_Melanoma,11-23681,A,"MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",132590,172.5,"Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.","Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",58,T4b,5.5,,Primary,3,F,1013119
Dummer-KF1-Primary,Dummer-KF1-Primary, NextFlex 3,ACAGTG,,,,"Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, H01.10457/II ",,BioSci8_BB60,BB60_SeqL,BB60_CL,Primary,NimV2mix3,H01.10457/II_Primary,NA_H01.10457/II_Primary,,,,,,,,,,,,,,,
Dummer-KF1-Normal,Dummer-KF1, NextFlex 4,GCCAAT,,,,"Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, H01.10457/II ",,BioSci8_BB60,BB60_SeqL,BB60_CL,Normal,NimV2mix3,H01.10457/II_Normal,NA_H01.10457/II_Normal,,,,,,,,,,,,,,,
Dummer-KF1-Met1,Dummer-KF1-Met1, NextFlex 5,CAGATC,,,,"Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, 14.20/II ",,BioSci8_BB60,BB60_SeqL,BB60_CL,Met1,NimV2mix3,14.20/II_Met1,NA_14.20/II_Met1,,,,,,,,,,,,,,,
Dummer-KF1-Met2,Dummer-KF1-Met2, NextFlex 6,CTTGTA,,,,"Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.18/I ",,BioSci8_BB60,BB60_SeqL,BB60_CL,Met2,NimV2mix3,HS14.18/I_Met2,NA_HS14.18/I_Met2,,,,,,,,,,,,,,,
Dummer-KF2-Primary,Dummer-KF2-Primary, NextFlex 7,ATCACG,,,,"Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.19/D ",,BioSci8_BB60,BB60_SeqL,BB60_CL,Primary,NimV2mix3,HS14.19/D_Primary,NA_HS14.19/D_Primary,,,,,,,,,,,,,,,
Dummer-KF2-Nevus,Dummer-KF2, NextFlex 8,TTAGGC,,,,"Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.19/D ",,BioSci8_BB60,BB60_SeqL,BB60_CL,Nevus,NimV2mix3,HS14.19/D_Nevus,NA_HS14.19/D_Nevus,,,,,,,,,,,,,,,
Dummer-KF2-Met1,Dummer-KF2-Met1, NextFlex 9,ACTTGA,,,,"Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS2014.15/7 ",,BioSci8_BB60,BB60_SeqL,BB60_CL,Met1,NimV2mix3,HS2014.15/7_Met1,NA_HS2014.15/7_Met1,,,,,,,,,,,,,,,
Dummer-KF2-Normal,Dummer-KF2, NextFlex 10,GATCAG,,,,"Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS2014.15/7 ",,BioSci8_BB60,BB60_SeqL,BB60_CL,Normal,NimV2mix3,HS2014.15/7_Normal,NA_HS2014.15/7_Normal,,,,,,,,,,,,,,,
Dummer-KF3-Primary,Dummer-KF3-Primary,NextFlex 11,TAGCTT,,,,"Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.16 ",,BioSci8_BB60,BB60_SeqL,BB60_CL,Primary,NimV2mix3,HS14.16_Primary,NA_HS14.16_Primary,,,,,,,,,,,,,,,
Dummer-KF3-Normal,Dummer-KF3,NextFlex 12,GGCTAC,,,,"Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.16 ",,BioSci8_BB60,BB60_SeqL,BB60_CL,Normal,NimV2mix3,HS14.16_Normal,NA_HS14.16_Normal,,,,,,,,,,,,,,,
Dummer-KF3-Met1,Dummer-KF3-Met1,NextFlex 13,AGTCAA,,,,"Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.17/I ",,BioSci8_BB60,BB60_SeqL,BB60_CL,Met1,NimV2mix3,HS14.17/I_Met1,NA_HS14.17/I_Met1,,,,,,,,,,,,,,,
Long-TN1-Normal,Long-TN1,NextFlex 14,AGTTCC,,,,"Triple Negative Metastatic Melanomas (""wild type""), Georgina Long, Australia, SP-12-18648, Nugent",,BioSci8_BB60,BB60_SeqL,BB60_CL,Normal,NimV2mix3,Long-TN1_Normal,NA_Long-TN1_Normal,,,,,,,,,,,,,,,
Long-TN1-Tumor,Long-TN1,NextFlex 15,ATGTCA,,,,"Triple Negative Metastatic Melanomas (""wild type""), Georgina Long, Australia, SP-13-3349, Nugent",,BioSci8_BB60,BB60_SeqL,BB60_CL,Tumor,NimV2mix3,Long-TN1_Tumor,NA_Long-TN1_Tumor,,,,,,,,,,,,,,,
Long-TN2-Normal,Long-TN2,NextFlex 16,CCGTCC,,,,"Triple Negative Metastatic Melanomas (""wild type""), Georgina Long, Australia, SP-12-13739, Phu",,BioSci8_BB60,BB60_SeqL,BB60_CL,Normal,NimV2mix3,Long-TN2_Normal,NA_Long-TN2_Normal,,,,,,,,,,,,,,,
Long-TN2-Tumor,Long-TN2,NextFlex 17,GTAGAG,,,,"Triple Negative Metastatic Melanomas (""wild type""), Georgina Long, Australia, SP-13-7093, Phu",,BioSci8_BB60,BB60_SeqL,BB60_CL,Tumor,NimV2mix3,Long-TN2_Tumor,NA_Long-TN2_Tumor,,,,,,,,,,,,,,,
D326-1,D326,NextFlex 18,GTCCGC,,,,Iwei Blue Nevus-like Melanoma,,BioSci8_BB60,BB60_SeqL,BB60_CL,Tumor,NimV2mix3,D326_Tumor,NA_D326_Tumor,,,,,,,,,,,,,,,
D326-2,D326,NextFlex 19,GTGAAA,,,,Iwei Blue Nevus-like Melanoma,,BioSci8_BB60,BB60_SeqL,BB60_CL,Tumor,NimV2mix3,D326_Tumor,NA_D326_Tumor,,,,,,,,,,,,,,,
D366,D366,NextFlex 20,GTGGCC,,,,Iwei Blue Nevus-like Melanoma: S06-35322,,BioSci8_BB60,BB60_SeqL,BB60_CL,Tumor,NimV2mix3,D366_Tumor,NA_D366_Tumor,,,,,,,,,,,,,,,
D366-A,D366,NextFlex 21,GTTTCG,,,,Iwei Blue Nevus-like Melanoma,,BioSci8_BB60,BB60_SeqL,BB60_CL,Tumor,NimV2mix3,D366_Tumor,NA_D366_Tumor,,,,,,,,,,,,,,,
DPN 48,DPN48,NextFlex 22,CGTACG,,,,DPN-like Melanoma: MSK 13-53190-1,,BioSci8_BB60,BB60_SeqL,BB60_CL,Tumor,NimV2mix3,DPN48_Tumor,NA_DPN48_Tumor,,,,,,,,,,,,,,,
CGH11-023,11-2532,NextFlex 23,GAGTGG,,,,Iwei Blue Nevus Like Melanoma,CGH11-023 ,BioSci8_BB60,BB60_SeqL,BB60_CL,Tumor,NimV2mix3,11-2532_Tumor,NA_11-2532_Tumor,11-2532,A,"BLUE NEVUS-LIKE MELANOMA OF 5.6 MM IN THICKNESS, PARTIALLY CAPTURED VIA BIOPSY",102499,172.4,"Our differential diagnosis included so-called atypical cellular blue nevus on one hand and blue nevus-like melanoma on the other, and the latter possibility proves to represent the correct interpretation for this atypical melanocytic proliferation. To further establish the diagnosis for this tumor, we employed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block aCGH analysis revealed loss in chromosome 3 (3p and 3q) as well as losses in distal chromosome 9q and chromosome 19p. The documentation of multiple chromosomal gains and losses supports interpretation as melanoma, and the documentation of chromosome 3 loss, in particular, has been associated with blue nevus-like melanoma. I also considered the possibility of a metastasis of melanoma in my differential diagnosis, but I view this as unlikely. If there is any history of melanoma in this patient, please keep me informed.  This melanoma is non-ulcerated and shows associated Clark's level V invasion. Further excision is warranted to ensure that local eradication has been accomplished.","Sections show a cellular nodular proliferation of plump spindled melanocytes that spans the full reticular dermis and focally juts into the uppermost subcutis. The lesional melanocytes are slightly spindled and have cytoplasmic pigmentation that varies in degree. Centrally, the degree of cytoplasmic melanization is marked. Melanocytes in mitosis are easily found. In one of the two available sections, there is a central focus of degeneration that is colonized by many melanophages.",64,,5.6,,,,F,991969
AST-1-Tumor,AST-1,NextFlex 24,GGTAGC,,,,Dermpath - Atypical Spitz Tumor,,BioSci8_BB60,BB60_SeqL,BB60_CL,Tumor,NimV2mix3,AST-1_Tumor,NA_AST-1_Tumor,,,,,,,,,,,,,,,
WTMM-1-Tumor,08-18595B, NextFlex 4,GCCAAT,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,08-18595B_Tumor,NA_08-18595B_Tumor,08-18595,B,,,,,,,,,,,,M,711218
WTMM-2-Tumor,13-60273, NextFlex 5,CAGATC,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,13-60273_Tumor,NA_13-60273_Tumor,13-60273,A,"MELANOMA, NO MUTATIONS DETECTED IN BRAF, KIT AND NRAS",173316,172.3,"The histopathological diagnosis was established by pathology report S13-16054:A of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal mutations.",,60,,,,,,M,841587
WTMM-3-Tumor,12-52454, NextFlex 6,CTTGTA,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,12-52454_Tumor,NA_12-52454_Tumor,12-52454,A,"MELANOMA, APPROXIMATELY 5.0 MILLIMETERS IN THICKNESS, EXTENDING TO THE TISSUE EDGES",173410,172.4,No connection to the epidermis is seen and as before a metastasis is possible.  Foci of perineural infiltration are identified.  If this is a primary lesion it would be a stage pT4a melanoma based on the 2009 AJCC melanoma staging system.,Sections show a dermal neoplasm comprised of markedly atypical pigmented and spindled melanocytes arranged as cellular fascicles.  Numerous mitotic figures are noted throughout the full thickness of the lesion.  The atypical melanocytes encircle small nerve twigs.,89,T4a,5.0,,Primary,,M,1032345
WTMM-4-Tumor,12-75125, NextFlex 7,ATCACG,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,12-75125_Tumor,NA_12-75125_Tumor,12-75125,A,"INTRADERMAL ATYPICAL MELANOCYTIC PROLIFERATION, GENOMICALLY CONSISTENT WITH MELANOMA",102735,238.2,"My initial differential diagnosis included an unusual combined melanocytic nevus with features of a deep penetrating nevus and other features of a Spitz's nevus and melanoma. To further evaluate for this differential diagnosis, I initially performed a phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle). The stain showed only a few melanocytes in mitosis or near to mitosis, which was reassuring.  Nonetheless, as an additional diagnositic maneuver, I performed comparative genomic hybridization on this case after receiving authorization from the clinical team who had discussed the testing with the family. This is a technique that assesses chromosomal gains or losses, which are found in melanoma and not in nevi.  The comparative genomic hybridization showed losses involving portions of chromosome 9p and 10q. The presence of two chromosomal losses is abnormal and supportive of melanoma. The melanoma measures 2.6 millimeter in thickness and is present in the tip margin. Therefore, by conventional AJCC melanoma staging guidelines, this would be considered a pT3a melanoma. However, given the spitzoid morphology of many of the cells, it is possible that this melanoma would behave in a less aggressive fashion compared with a conventional melanoma of equivalent thickness. My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this assessment.  This report was reissued on November 27, 2012 to add the patient's UCSF Medical Record number.","Sections show a neoplasm composed of fascicles of melanocytes, involving the superficial and deep dermis, with a wedge-shaped configuration.  Some of the constituent melanocytes have abundant pale cytoplasm with dusty melanin and pleomorphic nuclei while others have abundant dull pink eosinophilic cytoplasm.  There are many admixed melanophages. In general, the size of the melanocytes does not diminish with descent into the dermis and many of the lesional melanocytes have prominent nucleoli.",26,,,,,,F,1160942
WTMM-5-Tumor,12-98235A, NextFlex 8,TTAGGC,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,12-98235A_Tumor,NA_12-98235A_Tumor,12-98235,A,"MELANOMA, 5.5 MM. IN THICKNESS",102285,172.2,"The epidermal margin is clear by about 1 mm., and the deep margin by 1.7 mm. in most of the cross-sections, but margins cannot be evaluated in one cross section. Even though an intraepidermal component is not present, the multinodular configuration suggests are primary melanoma, rather than a metastasis to this site. Given the ulceration, this is a stage T4b lesion in the 2009 AJCC staging schema for melanoma.","There is an ulcerated, multi-nodular proliferation of large, atypical melanocytes in partial apposition to a thinned epidermis. The lesional melanocytes have variably pigmented cytoplasm, large, hyperchromatic nuclei and a high mitotic rate. Maturation with descent is faulty. A focally dense lymphocytic infiltrate with melanophages is present.",60,T4b,5.5,,Primary,,M,1184052
WTMM-6-Tumor,13-3619B, NextFlex 9,ACTTGA,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,13-3619B_Tumor,NA_13-3619B_Tumor,13-3619,B,"MELANOMA, APPROXIMATELY 2.1 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED",173711,172.7,Melanoma in situ is present 1-2 millimeters from the lateral margins.  This melanoma is ulcerated.  It should be regarded as a pT3b lesion.,"Sections show a proliferation of markedly atypical melanocytes arranged as large, irregular confluent nests at the dermo-epidermal junction and above it and as smaller irregular nest in the dermis.  Many of the melanocytes have ample cytoplasm that contains melanin pigment.  Numerous melanophages are also noted.  The epidermis has a papillated contour and shows ulceration.",72,T3b,2.1,None,Primary,,M,1188362
XD-1-Normal,13-67500AL, NextFlex 10,GATCAG,,,,Dr. Schulman Xanthoma Disseminatum,,BioSci9_BB61,BB61_SeqL,BB61_CL,Normal,NimV2mix3,13-67500AL_Normal,NA_13-67500AL_Normal,13-67500,A,XANTHOGRANULOMA,100556,216.5,"Immunoperoxidase studies performed in our laboratory show that the large pale cells are S100 negative, against an unusual presentation of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). The vacuolated cells are adipophilin positive, consistent with their being lipid-laden histiocytes. There are many admixed factor XIIIa-positive cells, some of them small and dendritic, but others large and more histiocytic-appearing. This mixture of cells is consistent with an adult analogue of juvenile xanthogranuloma, presenting as a particularly large lesion.","There is a massive polypoid segment of skin with a fibrotic dermis, within which there are aggregates of foamy histiocytes, as well as scattered giant cells, some of them Touton-type and some of them Langhans' type. There are focally dense lymphocytic infiltrates as well.",27,,,,,,M,1309505
WTMM-8-Tumor,13-19205,NextFlex 11,TAGCTT,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,13-19205_Tumor,NA_13-19205_Tumor,13-19205,A,"MELANOMA, APPROXIMATELY 2.1 MILLIMETERS IN THICKNESS",173502,172.5,"Invasive melanoma abuts the edge of the specimen.  Focal ulceration is also noted.  Based on the 2009 AJCC melanoma staging system, this is a pT3b lesion.","Sections show a broad and poorly circumscribed proliferation of atypical epithelioid melanocytes.  Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The papillary and reticular dermis contains aggregates of similar cells.  The epidermis shows focal ulceration and there is an overlying hemorrhagic scale crust.",74,T3b,2.1,,Primary,,F,1203948
WTMM-9-Tumor,13-48330,NextFlex 12,GGCTAC,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,13-48330_Tumor,NA_13-48330_Tumor,13-48330,A,METASTATIC MELANOMA,"POSTAUR,R",198.2,,Sections show dermal nodule composed of sheets and cords of melanocytes with atypical nuclei. There are scattered mitotic figures as well as areas of pigmentation. A surrounding sparse lymphoplasmacytic infiltrate is also present. A junctional melanocytic proliferation is not present. The dermis is altered by solar elastosis.,82,,,,,,F,467959
WTMM-10-Tumor,13-11086,NextFlex 13,AGTCAA,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,13-11086_Tumor,NA_13-11086_Tumor,13-11086,A,MELANOMA,173714,172.7,"The histopathological diagnosis was established by pathology report S13-1165 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 9, 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal any mutations.",,79,,,,,,F,1158926
WTMM-11-Tumor,13-15966,NextFlex 14,AGTTCC,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,13-15966_Tumor,NA_13-15966_Tumor,13-15966,A,MELANOMA,222922,172.9,"The histopathological diagnosis was established by pathology report S12-25910 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 9, 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, were performed on block (A2) and no mutations were detected. Because there was only a tiny focus from which pure populations of neoplastic cells could be microdissected, the risk of a false negative results is increased.",,65,,,,,,F,1200709
WTMM-12-Tumor,13-39228,NextFlex 15,ATGTCA,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,13-39228_Tumor,NA_13-39228_Tumor,13-39228,A,"MELANOMA, MUTATIONAL ANALYSIS FOR BRAF, NRAS, AND KIT DID NOT DETECT ANY MUTATIONS",173417,172.4,"The histopathological diagnosis was established by pathology report S12-7524 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal any mutations.",,77,,,,,,M,1104118
WTMM-13-Tumor,13-45942,NextFlex 16,CCGTCC,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,13-45942_Tumor,NA_13-45942_Tumor,13-45942,A,"METASTATIC MELANOMA, NO KIT MUTATIONS DETECTED",925,198.2,"The histopathological diagnosis was established by pathology report S11-9752 of UCSF Surgical Pathology. Sanger sequencing of exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots, did not yield any mutations.",,69,,,,,,M,1005877
WTMM-14-Tumor,13-49600,NextFlex 17,GTAGAG,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,13-49600_Tumor,NA_13-49600_Tumor,13-49600,A,"MELANOMA, NO MUTATIONS DETECTED IN BRAF, NRAS, AND KIT",666955,172.9,"The histopathological diagnosis was established by pathology report S13-12304 of UCSF Surgical Pathology. No mutations were detected by Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes.",,66,,,,,,M,61201
WTMM-15-Tumor,13-59640,NextFlex 18,GTCCGC,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,13-59640_Tumor,NA_13-59640_Tumor,13-59640,A,"METASTATIC MELANOMA, NO MUTATION IN BRAF DETECTED",222922,198.2,The histopathological diagnosis was established by pathology report S13-14324 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF did not reveal mutations.,,69,,,,,,F,1276884
WTMM-16-Tumor,13-67817,NextFlex 19,GTGAAA,,,,UCSF Wild Type Melanoma,,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,13-67817_Tumor,NA_13-67817_Tumor,13-67817,A,"METASTATIC MELANOMA, WITH NO DETECTED MUTATIONS OF KIT, BRAF AND NRAS",176788,198.2,"The histopathological diagnosis was established by pathology report S13-8339 of UCSF Surgical Pathology. I reviewed the sections, and marked them for microdissection. The results of Sanger sequencing are as follows:  BRAF exon 15: wild-type. NRAS exons 1 and 2: wild-type. KIT exons 11, 13, 17 and 18:  wild-type.",,71,,,,,,M,1199676
Long-TN3-Normal,"Russel,SP-12-5612(1K)",NextFlex 20,GTGGCC,,,,"Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)",,BioSci9_BB61,BB61_SeqL,BB61_CL,Normal,NimV2mix3,"Russel,SP-12-5612(1K)_Normal","NA_Russel,SP-12-5612(1K)_Normal",,,,,,,,,,,,,,,
Long-TN3-Tumor,"Russel,SP-13-14992(1A)",NextFlex 21,GTTTCG,,,,"Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)",,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,"Russel,SP-13-14992(1A)_Tumor","NA_Russel,SP-13-14992(1A)_Tumor",,,,,,,,,,,,,,,
Long-TN4-Normal,"Larcombe,SP-12-2294-2(2A)",NextFlex 22,CGTACG,,,,"Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)",,BioSci9_BB61,BB61_SeqL,BB61_CL,Normal,NimV2mix3,"Larcombe,SP-12-2294-2(2A)_Normal","NA_Larcombe,SP-12-2294-2(2A)_Normal",,,,,,,,,,,,,,,
Long-TN4-Tumor,"Larcombe,SP-13-17075(1B)",NextFlex 23,GAGTGG,,,,"Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)",,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,"Larcombe,SP-13-17075(1B)_Tumor","NA_Larcombe,SP-13-17075(1B)_Tumor",,,,,,,,,,,,,,,
Long-TN5-Normal,"Thomas,SP-42-10361(1A)",NextFlex 24,GGTAGC,,,,"Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)",,BioSci9_BB61,BB61_SeqL,BB61_CL,Normal,NimV2mix3,"Thomas,SP-42-10361(1A)_Normal","NA_Thomas,SP-42-10361(1A)_Normal",,,,,,,,,,,,,,,
Long-TN5-Tumor,"Thomas,SP-13-1038(1A)",NextFlex 1,CGATGT,,,,"Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)",,BioSci9_BB61,BB61_SeqL,BB61_CL,Tumor,NimV2mix3,"Thomas,SP-13-1038(1A)_Tumor","NA_Thomas,SP-13-1038(1A)_Tumor",,,,,,,,,,,,,,,
AGL14-89-Tumor,S13-13286A6, NextFlex 5,CAGATC,,98.56,,Iwei Translocation,NTRK3,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S13-13286A6_Tumor,NA_S13-13286A6_Tumor,,,,,,,,,,,,,,,
AGL14-89-Normal,S13-13286A6, NextFlex 6,CTTGTA,,99.22,,Iwei Translocation,MET,BioSci10_BB62,BB62_SeqL,BB62_CL,Normal,NimV2mix3,S13-13286A6_Normal,NA_S13-13286A6_Normal,,,,,,,,,,,,,,,
AGL14-92-Tumor,S11-20884A-A1, NextFlex 7,ATCACG,,102,,Iwei DPN,DPN-like Melanoma,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S11-20884A-A1_Tumor,NA_S11-20884A-A1_Tumor,,,,,,,,,,,,,,,
AGL14-92-Normal,S11-20884A-A1, NextFlex 8,TTAGGC,,101.06,,Iwei Blue Nevus Melanoma,,BioSci10_BB62,BB62_SeqL,BB62_CL,Normal,NimV2mix3,S11-20884A-A1_Normal,NA_S11-20884A-A1_Normal,,,,,,,,,,,,,,,
AGL14-91-Tumor,S12-6218A-D3, NextFlex 9,ACTTGA,,101.66,,Iwei Blue Nevus Melanoma,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S12-6218A-D3_Tumor,NA_S12-6218A-D3_Tumor,,,,,,,,,,,,,,,
AGL14-91-Normal,S12-6218A-D3, NextFlex 10,GATCAG,,100.8,,Ivanka Patient Melanoma (Hunter Extraction),,BioSci10_BB62,BB62_SeqL,BB62_CL,Normal,NimV2mix3,S12-6218A-D3_Normal,NA_S12-6218A-D3_Normal,,,,,,,,,,,,,,,
AGL4-Tumor,ZS06-11249A-C2,NextFlex 11,TAGCTT,,99.45,,Ivanka Patient Melanoma (Hunter Extraction),,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,ZS06-11249A-C2_Tumor,NA_ZS06-11249A-C2_Tumor,,,,,,,,,,,,,,,
AGL14-96-Tumor,S12-26125A2,NextFlex 12,GGCTAC,,100.54,,Ivanka Patient Melanoma  ,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S12-26125A2_Tumor,NA_S12-26125A2_Tumor,,,,,,,,,,,,,,,
AGL14-94-Tumor,S12-28585A6,NextFlex 13,AGTCAA,,99.12,,Ivanka Patient Melanoma  ,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S12-28585A6_Tumor,NA_S12-28585A6_Tumor,,,,,,,,,,,,,,,
AGL14-97-Tumor,S11-2018B5,NextFlex 14,AGTTCC,,100.25,,Ivanka Patient Melanoma  ,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S11-2018B5_Tumor,NA_S11-2018B5_Tumor,,,,,,,,,,,,,,,
AGL14-93-Tumor,S13-11748F5,NextFlex 15,ATGTCA,,101.8,,Ivanka Patient Melanoma  ,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S13-11748F5_Tumor,NA_S13-11748F5_Tumor,,,,,,,,,,,,,,,
AGL9-Tumor,S12-7250E3,NextFlex 16,CCGTCC,,98.7,,Ivanka Patient Melanoma  ,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S12-7250E3_Tumor,NA_S12-7250E3_Tumor,,,,,,,,,,,,,,,
AGL14-95-Tumor,S13-3401B3,NextFlex 17,GTAGAG,,102.3,,Ivanka Patient Melanoma  ,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S13-3401B3_Tumor,NA_S13-3401B3_Tumor,,,,,,,,,,,,,,,
AGL11-Tumor,S13-12947A2,NextFlex 18,GTCCGC,,97.8,,Ivanka Patient Melanoma  ,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S13-12947A2_Tumor,NA_S13-12947A2_Tumor,,,,,,,,,,,,,,,
AGL12-Tumor,S13-18444A16,NextFlex 19,GTGAAA,,98.56,,Ivanka Patient Melanoma  ,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S13-18444A16_Tumor,NA_S13-18444A16_Tumor,,,,,,,,,,,,,,,
AGL13-Tumor,ZS07-1210F6,NextFlex 20,GTGGCC,,100.75,,Ivanka Patient Melanoma  ,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,ZS07-1210F6_Tumor,NA_ZS07-1210F6_Tumor,,,,,,,,,,,,,,,
AGL14-Tumor,ZS10-11930B12,NextFlex 21,GTTTCG,,99.6,,Iwei Pediatric Melanoma,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,ZS10-11930B12_Tumor,NA_ZS10-11930B12_Tumor,,,,,,,,,,,,,,,
AGL15-Tumor,S12-28988,NextFlex 22,CGTACG,,100.38,,Iwei Pediatric Melanoma,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S12-28988_Tumor,NA_S12-28988_Tumor,,,,,,,,,,,,,,,
AGL16-Tumor,SSS13-1652B2,NextFlex 23,GAGTGG,,102.06,,Iwei Pediatric Melanoma,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,SSS13-1652B2_Tumor,NA_SSS13-1652B2_Tumor,,,,,,,,,,,,,,,
AGL17-Tumor,S13-5249,NextFlex 24,GGTAGC,,99.75,,Iwei Pediatric Melanoma,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,S13-5249_Tumor,NA_S13-5249_Tumor,,,,,,,,,,,,,,,
PMM_20_Tumor,356A3-075,NextFlex 1,CGATGT,,52.8,,Iwei Pediatric Melanoma,,BioSci10_BB62,BB62_SeqL,BB62_CL,Tumor,NimV2mix3,356A3-075_Tumor,NA_356A3-075_Tumor,,,,,,,,,,,,,,,
PMM_20_Normal,20847-09,NextFlex 2,TGACCA,,71.2,,Iwei Pediatric Melanoma,,BioSci10_BB62,BB62_SeqL,BB62_CL,Normal,NimV2mix3,20847-09_Normal,NA_20847-09_Normal,,,,,,,,,,,,,,,
L1-Normal,London-L1, NextFlex 6,CTTGTA,,46,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,Normal,NimV2mix3,London-L1_Normal,NA_London-L1_Normal,,,,,,,,,,,,,,,
L1-DN,London-L1, NextFlex 7,ATCACG,,68.4,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,Nevus,NimV2mix3,London-L1_Nevus,NA_London-L1_Nevus,,,,,,,,,,,,,,,
L1-MIS,London-L1, NextFlex 8,TTAGGC,,40,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,MIS,NimV2mix3,London-L1_MIS,NA_London-L1_MIS,,,,,,,,,,,,,,,
L1-INV,London-L1, NextFlex 9,ACTTGA,,68.4,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,Melanoma,NimV2mix3,London-L1_Melanoma,NA_London-L1_Melanoma,,,,,,,,,,,,,,,
L14-Normal,London-L14, NextFlex 10,GATCAG,,40,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,Normal,NimV2mix3,London-L14_Normal,NA_London-L14_Normal,,,,,,,,,,,,,,,
L14-Nevus-A,London-L14,NextFlex 11,TAGCTT,,59.6,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,Nevus,NimV2mix3,London-L14_Nevus,NA_London-L14_Nevus,,,,,,,,,,,,,,,
L14-Nevus-B,London-L14,NextFlex 12,GGCTAC,,73.6,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,Nevus,NimV2mix3,London-L14_Nevus,NA_London-L14_Nevus,,,,,,,,,,,,,,,
L14-Mel-Comb,London-L14,NextFlex 13,AGTCAA,,52.4,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,Melanoma,NimV2mix3,London-L14_Melanoma,NA_London-L14_Melanoma,,,,,,,,,,,,,,,
L14-Mel-S,London-L14,NextFlex 14,AGTTCC,,50.4,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,Melanoma,NimV2mix3,London-L14_Melanoma,NA_London-L14_Melanoma,,,,,,,,,,,,,,,
L14-Mel-Deep,London-L14,NextFlex 15,ATGTCA,,70.8,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,Melanoma,NimV2mix3,London-L14_Melanoma,NA_London-L14_Melanoma,,,,,,,,,,,,,,,
L14C-Normal,London-L14C,NextFlex 16,CCGTCC,,40,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,Normal,NimV2mix3,London-L14C_Normal,NA_London-L14C_Normal,,,,,,,,,,,,,,,
L14C-HGD,London-L14C,NextFlex 17,GTAGAG,,49.6,,Dysplastic Nevus,,BioSci11_BB63,BB63_SeqL,BB63_CL,Intermediate,NimV2mix3,London-L14C_Intermediate,NA_London-L14C_Intermediate,,,,,,,,,,,,,,,
Ivanka-6-1,08-79358,NextFlex 18,GTCCGC,,70.4,,Ivanka Patient Melanoma,,BioSci11_BB63,BB63_SeqL,BB63_CL,Melanoma,NimV2mix3,08-79358_Melanoma,NA_08-79358_Melanoma,08-79358,A,"COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGE AND BASE OF THE SPECIMEN",139522,216.5,The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.,"Sections show a well-circumscribed compound proliferation of melanocytes limited to the junctional zone and superficial dermis.  Junctional nests extend beyond the dermal component, bridge rete ridges in some areas, and are accompanied by lamellar fibrosis. There is solar elastosis. There are zones within the epidermis characterized by cytoplasmic vacuolization of keratinocytes, coarse keratohyaline and trichohyaline-like granules, and hyperkeratosis.",61,,,,,,M,172751
Ivanka-6-2,08-79358,NextFlex 19,GTGAAA,,89.6,,Ivanka Patient Melanoma,,BioSci11_BB63,BB63_SeqL,BB63_CL,Melanoma,NimV2mix3,08-79358_Melanoma,NA_08-79358_Melanoma,08-79358,A,"COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGE AND BASE OF THE SPECIMEN",139522,216.5,The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.,"Sections show a well-circumscribed compound proliferation of melanocytes limited to the junctional zone and superficial dermis.  Junctional nests extend beyond the dermal component, bridge rete ridges in some areas, and are accompanied by lamellar fibrosis. There is solar elastosis. There are zones within the epidermis characterized by cytoplasmic vacuolization of keratinocytes, coarse keratohyaline and trichohyaline-like granules, and hyperkeratosis.",61,,,,,,M,172751
Ivanka-6-3,08-79358,NextFlex 20,GTGGCC,,81.2,,Ivanka Patient Melanoma,,BioSci11_BB63,BB63_SeqL,BB63_CL,Nevus,NimV2mix3,08-79358_Nevus,NA_08-79358_Nevus,08-79358,A,"COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGE AND BASE OF THE SPECIMEN",139522,216.5,The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.,"Sections show a well-circumscribed compound proliferation of melanocytes limited to the junctional zone and superficial dermis.  Junctional nests extend beyond the dermal component, bridge rete ridges in some areas, and are accompanied by lamellar fibrosis. There is solar elastosis. There are zones within the epidermis characterized by cytoplasmic vacuolization of keratinocytes, coarse keratohyaline and trichohyaline-like granules, and hyperkeratosis.",61,,,,,,M,172751
Ivanka-6-5,08-79358,NextFlex 21,GTTTCG,,100.86,,Ivanka Patient Melanoma,,BioSci11_BB63,BB63_SeqL,BB63_CL,Normal,NimV2mix3,08-79358_Normal,NA_08-79358_Normal,08-79358,A,"COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGE AND BASE OF THE SPECIMEN",139522,216.5,The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.,"Sections show a well-circumscribed compound proliferation of melanocytes limited to the junctional zone and superficial dermis.  Junctional nests extend beyond the dermal component, bridge rete ridges in some areas, and are accompanied by lamellar fibrosis. There is solar elastosis. There are zones within the epidermis characterized by cytoplasmic vacuolization of keratinocytes, coarse keratohyaline and trichohyaline-like granules, and hyperkeratosis.",61,,,,,,M,172751
Ivanka-27-1,09-45509,NextFlex 22,CGTACG,,100.62,,Ivanka Patient Melanoma,,BioSci11_BB63,BB63_SeqL,BB63_CL,Melanoma,NimV2mix3,09-45509_Melanoma,NA_09-45509_Melanoma,09-45509,A,"MELANOMA, 0.9 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",173688,172.6,"The nevus extends to a peripheral edge, and the melanoma nearly to the base of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low (one mitotic figure identified; 1/mm2)* Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  * some studies have found that melanomas in which a mitotic figure is present in the dermis have a less favorable prognosis than do ones with without this finding.","Sections show sun damaged skin with a proliferation of melanocytes involving the superficial dermis. There are nests, cords and strands of small, round melanocytes that mature with descent, flanking a central focus in which large melanocytes with abundant, pale cytoplasm and dusty appearing melanin and large, pleomorphic vesicular nuclei are present in fibrotic stroma, with incomplete maturation toward the base of the lesion.",55,,0.9,,,1,F,846272
Ivanka-27-2,09-45509,NextFlex 23,GAGTGG,,98.5,,Ivanka Patient Melanoma,,BioSci11_BB63,BB63_SeqL,BB63_CL,Melanoma,NimV2mix3,09-45509_Melanoma,NA_09-45509_Melanoma,09-45509,A,"MELANOMA, 0.9 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",173688,172.6,"The nevus extends to a peripheral edge, and the melanoma nearly to the base of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low (one mitotic figure identified; 1/mm2)* Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  * some studies have found that melanomas in which a mitotic figure is present in the dermis have a less favorable prognosis than do ones with without this finding.","Sections show sun damaged skin with a proliferation of melanocytes involving the superficial dermis. There are nests, cords and strands of small, round melanocytes that mature with descent, flanking a central focus in which large melanocytes with abundant, pale cytoplasm and dusty appearing melanin and large, pleomorphic vesicular nuclei are present in fibrotic stroma, with incomplete maturation toward the base of the lesion.",55,,0.9,,,1,F,846272
Ivanka-27-3,09-45509,NextFlex 24,GGTAGC,,76.8,,Ivanka Patient Melanoma,,BioSci11_BB63,BB63_SeqL,BB63_CL,Nevus,NimV2mix3,09-45509_Nevus,NA_09-45509_Nevus,09-45509,A,"MELANOMA, 0.9 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",173688,172.6,"The nevus extends to a peripheral edge, and the melanoma nearly to the base of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low (one mitotic figure identified; 1/mm2)* Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  * some studies have found that melanomas in which a mitotic figure is present in the dermis have a less favorable prognosis than do ones with without this finding.","Sections show sun damaged skin with a proliferation of melanocytes involving the superficial dermis. There are nests, cords and strands of small, round melanocytes that mature with descent, flanking a central focus in which large melanocytes with abundant, pale cytoplasm and dusty appearing melanin and large, pleomorphic vesicular nuclei are present in fibrotic stroma, with incomplete maturation toward the base of the lesion.",55,,0.9,,,1,F,846272
Ivanka-27-5,09-45509,NextFlex 1,CGATGT,,47.2,,Ivanka Patient Melanoma,,BioSci11_BB63,BB63_SeqL,BB63_CL,Normal,NimV2mix3,09-45509_Normal,NA_09-45509_Normal,09-45509,A,"MELANOMA, 0.9 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS",173688,172.6,"The nevus extends to a peripheral edge, and the melanoma nearly to the base of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low (one mitotic figure identified; 1/mm2)* Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  * some studies have found that melanomas in which a mitotic figure is present in the dermis have a less favorable prognosis than do ones with without this finding.","Sections show sun damaged skin with a proliferation of melanocytes involving the superficial dermis. There are nests, cords and strands of small, round melanocytes that mature with descent, flanking a central focus in which large melanocytes with abundant, pale cytoplasm and dusty appearing melanin and large, pleomorphic vesicular nuclei are present in fibrotic stroma, with incomplete maturation toward the base of the lesion.",55,,0.9,,,1,F,846272
DM_50_Tumor,DM50,NextFlex 2,TGACCA,,98.81,,Desmoplastic Melanoma,,BioSci11_BB63,BB63_SeqL,BB63_CL,Tumor,NimV2mix3,DM50_Tumor,NA_DM50_Tumor,,,,,,,,,,,,,,,
DM_56_Tumor,DM56, NextFlex 3,ACAGTG,,60,,Desmoplastic Melanoma,,BioSci11_BB63,BB63_SeqL,BB63_CL,Tumor,NimV2mix3,DM56_Tumor,NA_DM56_Tumor,,,,,,,,,,,,,,,
Ivanka-26-1,11-94204, NextFlex 7,ATCACG,,98.91,,Ivanka Patient Melanoma,,BioSci12_BB64,BB64_SeqL,BB64_CL,Melanoma,NimV2mix3,11-94204_Melanoma,NA_11-94204_Melanoma,11-94204,A,"MELANOMA, 1.1 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173509,172.5,"The lesion is very narrowly excised and melanoma in present to within a millimeter of the peripheral margin.  This is non-ulcerated lesion.  No regression, lymphatic, or vascular invasion is noted.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm.  These cells are irregularly distributed along the dermal-epidermal junction as mostly single cells with some present above the basal layer.  There are similar melanocytes arranged as expansile nests in the subjacent dermis. Melanocytes in mitosis are noted throughout the full thickness of this area.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",46,T2a,1.1,,Primary,,M,1083652
Ivanka-26-3,11-94204, NextFlex 8,TTAGGC,,76,,Ivanka Patient Melanoma,,BioSci12_BB64,BB64_SeqL,BB64_CL,Nevus,NimV2mix3,11-94204_Nevus,NA_11-94204_Nevus,11-94204,A,"MELANOMA, 1.1 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173509,172.5,"The lesion is very narrowly excised and melanoma in present to within a millimeter of the peripheral margin.  This is non-ulcerated lesion.  No regression, lymphatic, or vascular invasion is noted.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm.  These cells are irregularly distributed along the dermal-epidermal junction as mostly single cells with some present above the basal layer.  There are similar melanocytes arranged as expansile nests in the subjacent dermis. Melanocytes in mitosis are noted throughout the full thickness of this area.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",46,T2a,1.1,,Primary,,M,1083652
Ivanka-26-5,11-94204, NextFlex 9,ACTTGA,,41.2,,Ivanka Patient Melanoma,,BioSci12_BB64,BB64_SeqL,BB64_CL,Normal,NimV2mix3,11-94204_Normal,NA_11-94204_Normal,11-94204,A,"MELANOMA, 1.1 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173509,172.5,"The lesion is very narrowly excised and melanoma in present to within a millimeter of the peripheral margin.  This is non-ulcerated lesion.  No regression, lymphatic, or vascular invasion is noted.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm.  These cells are irregularly distributed along the dermal-epidermal junction as mostly single cells with some present above the basal layer.  There are similar melanocytes arranged as expansile nests in the subjacent dermis. Melanocytes in mitosis are noted throughout the full thickness of this area.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",46,T2a,1.1,,Primary,,M,1083652
L10-Normal,London-L10, NextFlex 10,GATCAG,,46.8,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Normal,NimV2mix3,London-L10_Normal,NA_London-L10_Normal,,,,,,,,,,,,,,,
L10-MIS,London-L10,NextFlex 11,TAGCTT,,99.62,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,MIS,NimV2mix3,London-L10_MIS,NA_London-L10_MIS,,,,,,,,,,,,,,,
L10-INV,London-L10,NextFlex 12,GGCTAC,,98.56,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Melanoma,NimV2mix3,London-L10_Melanoma,NA_London-L10_Melanoma,,,,,,,,,,,,,,,
L10-HGD,London-L10,NextFlex 13,AGTCAA,,40,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Intermediate,NimV2mix3,London-L10_Intermediate,NA_London-L10_Intermediate,,,,,,,,,,,,,,,
L12-Normal,London-L12,NextFlex 14,AGTTCC,,100.8,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Normal,NimV2mix3,London-L12_Normal,NA_London-L12_Normal,,,,,,,,,,,,,,,
L12-Nevus,London-L12,NextFlex 15,ATGTCA,,98.28,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Nevus,NimV2mix3,London-L12_Nevus,NA_London-L12_Nevus,,,,,,,,,,,,,,,
L12-HGD,London-L12,NextFlex 16,CCGTCC,,99.28,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Intermediate,NimV2mix3,London-L12_Intermediate,NA_London-L12_Intermediate,,,,,,,,,,,,,,,
L16-Nevus-A,London-L16,NextFlex 17,GTAGAG,,40,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Nevus,NimV2mix3,London-L16_Nevus,NA_London-L16_Nevus,,,,,,,,,,,,,,,
L16-Mel-Deep,London-L16,NextFlex 18,GTCCGC,,99.33,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Melanoma,NimV2mix3,London-L16_Melanoma,NA_London-L16_Melanoma,,,,,,,,,,,,,,,
L16A-Normal,London-L16A,NextFlex 19,GTGAAA,,71.2,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Normal,NimV2mix3,London-L16A_Normal,NA_London-L16A_Normal,,,,,,,,,,,,,,,
L16A-Nevus-B,London-L16A,NextFlex 20,GTGGCC,,40.4,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Nevus,NimV2mix3,London-L16A_Nevus,NA_London-L16A_Nevus,,,,,,,,,,,,,,,
L16A-Mel-Sup,London-L16A,NextFlex 21,GTTTCG,,100,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Melanoma,NimV2mix3,London-L16A_Melanoma,NA_London-L16A_Melanoma,,,,,,,,,,,,,,,
L16B-Lesion-A,London-L16B,NextFlex 22,CGTACG,,97.2,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Intermediate,NimV2mix3,London-L16B_Intermediate,NA_London-L16B_Intermediate,,,,,,,,,,,,,,,
L16B-Lesion-B,London-L16B,NextFlex 23,GAGTGG,,93.6,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Intermediate,NimV2mix3,London-L16B_Intermediate,NA_London-L16B_Intermediate,,,,,,,,,,,,,,,
L16B-NL,London-L16B,NextFlex 24,GGTAGC,,101.06,,Dysplastic Nevus,,BioSci12_BB64,BB64_SeqL,BB64_CL,Normal,NimV2mix3,London-L16B_Normal,NA_London-L16B_Normal,,,,,,,,,,,,,,,
DM15 Tumor,DM15,NextFlex 1,CGATGT,,40,,Desmoplastic Melanoma,,BioSci12_BB64,BB64_SeqL,BB64_CL,Tumor,NimV2mix3,DM15_Tumor,NA_DM15_Tumor,,,,,,,,,,,,,,,
DM19,DM19,NextFlex 2,TGACCA,,48,,Desmoplastic Melanoma,,BioSci12_BB64,BB64_SeqL,BB64_CL,Tumor,NimV2mix3,DM19_Tumor,NA_DM19_Tumor,,,,,,,,,,,,,,,
DM19-2,DM19, NextFlex 3,ACAGTG,,45.6,,Desmoplastic Melanoma,,BioSci12_BB64,BB64_SeqL,BB64_CL,Tumor,NimV2mix3,DM19_Tumor,NA_DM19_Tumor,,,,,,,,,,,,,,,
DM_46_Tumor,DM46, NextFlex 4,GCCAAT,,43.6,,Desmoplastic Melanoma,,BioSci12_BB64,BB64_SeqL,BB64_CL,Tumor,NimV2mix3,DM46_Tumor,NA_DM46_Tumor,,,,,,,,,,,,,,,
Heinzerling-1-Tumor,140038340,TTAGGC,,,100.1,,"Kinase Fusions (University Hospital Erlangen, Germany)",,BioSci13_BB65,BB65_SeqL,BB65_CL,Tumor,NimV2mix3,140038340_Tumor,NA_140038340_Tumor,,,,,,,,,,,,,,,
Heinzerling-1-Normal,140092090,ACTTGA,,,50.4,,"Kinase Fusions (University Hospital Erlangen, Germany)",,BioSci13_BB65,BB65_SeqL,BB65_CL,Normal,NimV2mix3,140092090_Normal,NA_140092090_Normal,,,,,,,,,,,,,,,
UM13,UM13,GATCAG,,,50,,Uveal Melanoma,,BioSci13_BB65,BB65_SeqL,BB65_CL,Tumor,NimV2mix3,UM13_Tumor,NA_UM13_Tumor,,,,,,,,,,,,,,,
UM14,UM14,TAGCTT,,,62.4,,Uveal Melanoma,,BioSci13_BB65,BB65_SeqL,BB65_CL,Tumor,NimV2mix3,UM14_Tumor,NA_UM14_Tumor,,,,,,,,,,,,,,,
UM16,UM16,GGCTAC,,,48,,Uveal Melanoma,,BioSci13_BB65,BB65_SeqL,BB65_CL,Tumor,NimV2mix3,UM16_Tumor,NA_UM16_Tumor,,,,,,,,,,,,,,,
L17-Normal,London-L17,NextFlex 13,AGTCAA,,42,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,Normal,NimV2mix3,London-L17_Normal,NA_London-L17_Normal,,,,,,,,,,,,,,,
L17-Nevus-A,London-L17,NextFlex 14,AGTTCC,,101.32,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,Nevus,NimV2mix3,London-L17_Nevus,NA_London-L17_Nevus,,,,,,,,,,,,,,,
L17-Nevus-B,London-L17,NextFlex 15,ATGTCA,,99.82,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,Nevus,NimV2mix3,London-L17_Nevus,NA_London-L17_Nevus,,,,,,,,,,,,,,,
L17-Mel-S,London-L17,NextFlex 16,CCGTCC,,98.75,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,Melanoma,NimV2mix3,London-L17_Melanoma,NA_London-L17_Melanoma,,,,,,,,,,,,,,,
L17-Mel-Deep,London-L17,NextFlex 17,GTAGAG,,98.4,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,Melanoma,NimV2mix3,London-L17_Melanoma,NA_London-L17_Melanoma,,,,,,,,,,,,,,,
GAK,GAK,NextFlex 18,GTCCGC,,60.4,,Iwei Cell Line DNA,,BioSci13_BB65,BB65_SeqL,BB65_CL,Tumor,NimV2mix3,GAK_Tumor,NA_GAK_Tumor,,,,,,,,,,,,,,,
Yurif,Yurif,NextFlex 19,GTGAAA,,69.6,,Iwei Cell Line DNA,,BioSci13_BB65,BB65_SeqL,BB65_CL,Tumor,NimV2mix3,Yurif_Tumor,NA_Yurif_Tumor,,,,,,,,,,,,,,,
Ivanka-11-Nevus,08-53951,NextFlex 20,GTGGCC,,46.8,,Ivanka Patient Melanoma (Hunter Extraction),,BioSci13_BB65,BB65_SeqL,BB65_CL,Nevus,NimV2mix3,08-53951_Nevus,NA_08-53951_Nevus,08-53951,A,"MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO PERIPHERAL EXCISION MARGINS",191323,172.3,"Although nevi on the scalp and hairline on children can demonstrate unusual features, the findings in a portion of this lesion exceed what would be expected in that setting. These include a markedly irregular distribution of atypical melanocytes which appear morphologically distinct from those of the surrounding nevus, as well significant suprabasal scatter of melanocytes, and a lack of maturation of the dermal component in that area. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this diagnosis. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level III, with atypical melanocytes expanding the papillary dermis and abutting the reticular dermis. There are no other features which would have an impact on prognosis apart from those given above. Reexcision of this site with standard margins is of course warranted.","Sections show an asymmetrical, compound proliferation of melanocytes which is well-circumscribed. There is a slightly biphasic pattern, with larger atypical melanocytes with more abundant dusty cytoplasmic melanin within the epidermis arrayed irregularly as nests and single cells. Melanocytes are scattered above the basal layer in this zone as well. Similar melanocytes are present within the dermis as clusters which demonstrate deficient maturation with descent. Mitotic figures are evident within the epidermal component, but not within the dermal component in this area. At the periphery, there is also a compound proliferation of smaller and bland melanocytes, arrayed as small nests along the junction, and as nests and syncytia in the dermis. These melanocytes mature with descent. Some of them contain dusty cytoplasmic melanin, but less abundant than those in the aforementioned atypical zone. There is a patchy lymphocytic infiltrate, especially surrounding the population of larger atypical melanocytes.",17,,0.9,,,,F,596372
Ivanka-11-M1,08-53951,NextFlex 21,GTTTCG,,40.4,,Ivanka Patient Melanoma (Hunter Extraction),,BioSci13_BB65,BB65_SeqL,BB65_CL,M1,NimV2mix3,08-53951_M1,NA_08-53951_M1,08-53951,A,"MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO PERIPHERAL EXCISION MARGINS",191323,172.3,"Although nevi on the scalp and hairline on children can demonstrate unusual features, the findings in a portion of this lesion exceed what would be expected in that setting. These include a markedly irregular distribution of atypical melanocytes which appear morphologically distinct from those of the surrounding nevus, as well significant suprabasal scatter of melanocytes, and a lack of maturation of the dermal component in that area. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this diagnosis. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level III, with atypical melanocytes expanding the papillary dermis and abutting the reticular dermis. There are no other features which would have an impact on prognosis apart from those given above. Reexcision of this site with standard margins is of course warranted.","Sections show an asymmetrical, compound proliferation of melanocytes which is well-circumscribed. There is a slightly biphasic pattern, with larger atypical melanocytes with more abundant dusty cytoplasmic melanin within the epidermis arrayed irregularly as nests and single cells. Melanocytes are scattered above the basal layer in this zone as well. Similar melanocytes are present within the dermis as clusters which demonstrate deficient maturation with descent. Mitotic figures are evident within the epidermal component, but not within the dermal component in this area. At the periphery, there is also a compound proliferation of smaller and bland melanocytes, arrayed as small nests along the junction, and as nests and syncytia in the dermis. These melanocytes mature with descent. Some of them contain dusty cytoplasmic melanin, but less abundant than those in the aforementioned atypical zone. There is a patchy lymphocytic infiltrate, especially surrounding the population of larger atypical melanocytes.",17,,0.9,,,,F,596372
Ivanka-11-M2,08-53951,NextFlex 22,CGTACG,,40.8,,Ivanka Patient Melanoma (Hunter Extraction),,BioSci13_BB65,BB65_SeqL,BB65_CL,M2,NimV2mix3,08-53951_M2,NA_08-53951_M2,08-53951,A,"MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO PERIPHERAL EXCISION MARGINS",191323,172.3,"Although nevi on the scalp and hairline on children can demonstrate unusual features, the findings in a portion of this lesion exceed what would be expected in that setting. These include a markedly irregular distribution of atypical melanocytes which appear morphologically distinct from those of the surrounding nevus, as well significant suprabasal scatter of melanocytes, and a lack of maturation of the dermal component in that area. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this diagnosis. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level III, with atypical melanocytes expanding the papillary dermis and abutting the reticular dermis. There are no other features which would have an impact on prognosis apart from those given above. Reexcision of this site with standard margins is of course warranted.","Sections show an asymmetrical, compound proliferation of melanocytes which is well-circumscribed. There is a slightly biphasic pattern, with larger atypical melanocytes with more abundant dusty cytoplasmic melanin within the epidermis arrayed irregularly as nests and single cells. Melanocytes are scattered above the basal layer in this zone as well. Similar melanocytes are present within the dermis as clusters which demonstrate deficient maturation with descent. Mitotic figures are evident within the epidermal component, but not within the dermal component in this area. At the periphery, there is also a compound proliferation of smaller and bland melanocytes, arrayed as small nests along the junction, and as nests and syncytia in the dermis. These melanocytes mature with descent. Some of them contain dusty cytoplasmic melanin, but less abundant than those in the aforementioned atypical zone. There is a patchy lymphocytic infiltrate, especially surrounding the population of larger atypical melanocytes.",17,,0.9,,,,F,596372
L18-Normal,London-L18,NextFlex 23,GAGTGG,,44,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,Normal,NimV2mix3,London-L18_Normal,NA_London-L18_Normal,,,,,,,,,,,,,,,
L18-Nevus-A,London-L18,NextFlex 24,GGTAGC,,40,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,Nevus,NimV2mix3,London-L18_Nevus,NA_London-L18_Nevus,,,,,,,,,,,,,,,
L18-Mel-S,London-L18,NextFlex 1,CGATGT,,65.6,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,Melanoma,NimV2mix3,London-L18_Melanoma,NA_London-L18_Melanoma,,,,,,,,,,,,,,,
L18-Mel-D,London-L18,NextFlex 2,TGACCA,,101.01,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,Melanoma,NimV2mix3,London-L18_Melanoma,NA_London-L18_Melanoma,,,,,,,,,,,,,,,
L21-MIS-Lesion-A,London-L21, NextFlex 3,ACAGTG,,101.36,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,MIS,NimV2mix3,London-L21_MIS,NA_London-L21_MIS,,,,,,,,,,,,,,,
L21-LesionB,London-L21, NextFlex 4,GCCAAT,,98.79,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,Intermediate,NimV2mix3,London-L21_Intermediate,NA_London-L21_Intermediate,,,,,,,,,,,,,,,
L21-NL,London-L21, NextFlex 5,CAGATC,,40.4,,Dysplastic Nevus,,BioSci13_BB65,BB65_SeqL,BB65_CL,Normal,NimV2mix3,London-L21_Normal,NA_London-L21_Normal,,,,,,,,,,,,,,,
CGH14-059,14-16247, NextFlex 9,ACTTGA,13 Cycle Post Hybridization LM-PCR,100,,Iwei Translocation,CGH14-059 ,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,14-16247_Tumor,NA_14-16247_Tumor,14-16247,A,"COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, BEST REGARDED AS AN ATYPICAL SPITZ TUMOR",173796,238.2,"The silhouette is that of a Spitz's nevus, but I am concerned about the crowding of nuclei and the presence of a focally high mitotic rate. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively high proliferation rate in the dermal component (about 10-15%). A p16 immunoperoxidase stain show a mosaic pattern of loss of that tumor suppressor gene product, an indeterminate pattern. Comparative genomic hybridization shows a gain involving chr. 2p, and a complex combination of gains and losses involving chr. 7q. The breakpoints suggest a gene fusion involving MET on chr. 7 and DTCN1 on chr. 2p, a combination that Dr. Iwei Yeh, who also viewed the comparative genomic hybridization data has previously noted. This may lead to upregulation of braf (near one of the other breakpoints on 7q), in the absence of braf mutation. While the absence of other chromosomal gains and losses is somewhat reassuring, it would be best to view this as a lesion with limited but non-zero metastatic potential, e.g. as an atypical Spitz. These are neoplasms that have feature more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy.","There is a dome-surfaced compound proliferation of melanocytes featuring markedly elongated, jagged ridges and large oval and fusiform cells with variable amounts of amphophilic cytoplasm and large nuclei, amongst which mitotic figures can be discerned. Fewer of these, and some maturation are present at the base of the lesion, which is relatively flat, and beneath which is a dense lymphocytic infiltrate.",31,,,,,,F,1366169
WTMM-17-Tumor,13-35959, NextFlex 10,GATCAG,13 Cycle Post Hybridization LM-PCR,100,,UCSF Wild Type Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,13-35959_Tumor,NA_13-35959_Tumor,13-35959,A,"MELANOMA, NO BRAF MUTATION DETECTED",333504,172.5,The histopathological diagnosis was established by our previous pathology report DL13-32481. Sanger sequencing of exon 15 of BRAF revealed no mutation.,,43,,,,,,F,1217226
WTMM-18-Tumor,13-102610,NextFlex 11,TAGCTT,13 Cycle Post Hybridization LM-PCR,100,,UCSF Wild Type Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,13-102610_Tumor,NA_13-102610_Tumor,13-102610,A,METASTATIC MELANOMA,173726,198.2,"As has been documented in UCSF Cytopathology report  C13-20923, this needle aspiration biopsy demonstrates metastatic melanoma. Using this metastatic tumor, we completed BRAF and NRAS mutation analysis via Sanger sequencing. The following results were obtained: BRAF exon 15: wild-type (non-mutated). NRAS exons 1 and 2: wild-type (non-mutated).  Subsequently, HRAS mutation was completed, and the following additional results were obtained:  HRAS exon 2: Q61L mutation. HRAS exon 1: wild-type (non-mutated).",,50,,,,,,F,1138765
WTMM-19-Tumor,13-99417,NextFlex 12,GGCTAC,13 Cycle Post Hybridization LM-PCR,100,,UCSF Wild Type Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,13-99417_Tumor,NA_13-99417_Tumor,13-99417,A,"MELANOMA, NO MUTATIONS DETECTED IN KIT OR BRAF",222922,172.9,"Please refer to UCSF Surgical Pathology report S13-26334 for the histopathologic analysis regarding this tumor. Sanger sequencing of exon 15 of BRAF,  and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal any mutations.",,68,,,,,,F,2344638
WTMM-20-Tumor,13-98534,NextFlex 13,AGTCAA,13 Cycle Post Hybridization LM-PCR,100,,UCSF Wild Type Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,13-98534_Tumor,NA_13-98534_Tumor,13-98534,A,"MELANOMA, NO BRAF MUTATION DETECTED",173405,172.4,The histopathological diagnosis was established by pathology report S13-23549 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF revealed no mutation.,,45,,,,,,M,1340550
WTMM-21-Tumor,13-32982A,NextFlex 14,AGTTCC,13 Cycle Post Hybridization LM-PCR,100,,UCSF Wild Type Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,13-32982A_Tumor,NA_13-32982A_Tumor,13-32982,A,"SCAR, WITH RESIDUAL MELANOMA, 1.05 MILLIMETERS IN THICKNESS, ABUTTING THE INKED MARGINS",582753,172.7,"It is now evident that this neoplasm represents a melanoma of 1.05 millimeters in thickness. A melanocytic nevus is also present intermingled with the melanoma, and thus the melanoma likely arose within the nevus. Given the thickness of the melanoma in combination with the proximity of it to the inked margin, a re-excision at this site is warranted. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: Excision Tumor site:  R. lateral foot Microscopic tumor type:  Melanoma Breslow thickness: 1.05 millimeters Ulceration: no Margins, peripheral and deep: 0.4 millimeters to the deep margin and 1.5 millimeters to the peripheral margins Mitotic index: < 1/mm2, although a dermal mitotic figure was identified in the initial biopsy of the melanoma (13-25288) Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2aNXMX  I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.  This report was reissued on May 28, 2013 to add the patient's UCSF Medical Record number.","Sections show a segment of acral skin in which there is a scar. In addition, there is a biphasic proliferation of melanocytes. One population is composed of both spindled and epithelioid melanocytes, many of which contain dusty melanin within their cytoplasm.  These melanocytes are configured as single cells and nests along the dermo-epidermal junction and as nests, cords and single cells in the underlying dermis. The size of the melanocytes does not diminish with descent into the dermis. There is also a population of cytologically bland cells arranged as nests along the junction and as maturing nests cords and strands in the underlying dermis.",54,T2a,1.05, Melanoma,Primary,1,M,1210033
WTMM-22-Tumor,13-9916,NextFlex 15,ATGTCA,13 Cycle Post Hybridization LM-PCR,100,,UCSF Wild Type Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,13-9916_Tumor,NA_13-9916_Tumor,13-9916,A,MELANOMA,173604,172.6,"The histopathological diagnosis was established by pathology report PS12-4904 of Mills Peninsula Health Services. Sanger sequencing of exon 15 of BRAF and exons 1 and 2 of NRAS, which include the known mutational hotspots of these genes, was performed. No mutations were detected.",,82,,,,,,M,1194427
WTMM-23-Tumor,11-44609F,NextFlex 16,CCGTCC,13 Cycle Post Hybridization LM-PCR,100,,UCSF Wild Type Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,11-44609F_Tumor,NA_11-44609F_Tumor,11-44609,F,"DESMOPLASTIC MELANOMA, 4.8 MM. IN THICKNESS",173316,172.3,"An extensive area of melanoma in situ is present. The invasive melanoma is essentially entirely desmoplastic. Some studies have suggested that pure desmoplastic melanomas have a more favorable prognosis, vis a vis distant metastasis, especially to sentinel nodes than do melanomas in which only part of the invasive component is desmoplastic. Some perineural invasion is present, within 3 mm of the yellow inked margin in slide F (near 9 o'clock, with your suture designated as 12 o'clock). There is melanoma in situ and within 1 mm of the blue inked margin in slides F and G (near 3 o'clock, with your suture designated as 12 o'clock). Extensive solar keratosis is also evident. Several old scars are present in the dermis as well, one accounting for the pale area in the gross description.  Reference:  George E, McClain SE, Slingluff CL, Polissar NL, Patterson JW. Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis. J Cutan Pathol. 2009 Apr;36(4):425-32.","Sections show a proliferation of spindled melanocytes with hyperchromatic nuclei, positioned between markedly thickened collagen bundles in the dermis in broad areas. Some multinucleate melanocytes are present. The cellularity of the lesion diminishes toward the deep reticular dermis. To the side of these changes, melanocytes with enlarged nuclei are present singly and in small nests in the basal layer of the epidermis in a poorly circumscribed pattern. Atypical keratinocytes thicken the epidermis, forming buds that protrude into the papillary dermis but mature toward a parakeratotic surface in diverse other foci. There is marked solar elastosis.",91,None,4.8,None,None,,M,1029070
WTMM-24-Tumor,12-98575A1,NextFlex 17,GTAGAG,13 Cycle Post Hybridization LM-PCR,100,,UCSF Wild Type Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,12-98575A1_Tumor,NA_12-98575A1_Tumor,12-98575,A,METASTATIC MELANOMA,666955,198.2,"No mutations were found in the oncogenes that we sequenced. The specific results are below: BRAF exon 15: wild-type. NRAS exons 1 and 2: wild-type. KIT exons 9, 11, 13, 17 and 18:  wild-type.","Sections show pulmonary parenchyma with fascicles of spindled cells with large, hyperchromatic nuclei embedded in fibrotic stroma, with S100 and Sox-10 positivity in the immunoperoxidase stained sections.",62,,,,,,F,824297
DM-60-Tumor,DM60,NextFlex 18,GTCCGC,13 Cycle Post Hybridization LM-PCR,49.6,,Hunter Desmoplastic Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,DM60_Tumor,NA_DM60_Tumor,,,,,,,,,,,,,,,
DM-61-Tumor,DM61,NextFlex 19,GTGAAA,13 Cycle Post Hybridization LM-PCR,54,,Hunter Desmoplastic Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,DM61_Tumor,NA_DM61_Tumor,,,,,,,,,,,,,,,
DM-62-Tumor,DM62,NextFlex 20,GTGGCC,13 Cycle Post Hybridization LM-PCR,90,,Hunter Desmoplastic Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,DM62_Tumor,NA_DM62_Tumor,,,,,,,,,,,,,,,
DM-63-Tumor,DM63,NextFlex 21,GTTTCG,13 Cycle Post Hybridization LM-PCR,86.8,,Hunter Desmoplastic Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,DM63_Tumor,NA_DM63_Tumor,,,,,,,,,,,,,,,
DM-66-Tumor,DM66,NextFlex 22,CGTACG,13 Cycle Post Hybridization LM-PCR,40,,Hunter Desmoplastic Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,DM66_Tumor,NA_DM66_Tumor,,,,,,,,,,,,,,,
DM-67-Tumor,DM67,NextFlex 23,GAGTGG,13 Cycle Post Hybridization LM-PCR,45.2,,Hunter Desmoplastic Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,DM67_Tumor,NA_DM67_Tumor,,,,,,,,,,,,,,,
DM-69-Tumor,DM69,NextFlex 24,GGTAGC,13 Cycle Post Hybridization LM-PCR,60,,Hunter Desmoplastic Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,DM69_Tumor,NA_DM69_Tumor,,,,,,,,,,,,,,,
DM-70-Tumor,DM70,NextFlex 1,CGATGT,13 Cycle Post Hybridization LM-PCR,100,,Hunter Desmoplastic Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,DM70_Tumor,NA_DM70_Tumor,,,,,,,,,,,,,,,
DM-81-Tumor,DM81,NextFlex 2,TGACCA,13 Cycle Post Hybridization LM-PCR,100,,Hunter Desmoplastic Melanoma,,BioSci15_BB67,BB67_SeqL,BB67_CL,Tumor,??,DM81_Tumor,NA_DM81_Tumor,,,,,,,,,,,,,,,
L2-Normal,London-L2, NextFlex 3,ACAGTG,13 Cycle Post Hybridization LM-PCR,85.2,,Hunter Dysplastic Nevus,,BioSci15_BB67,BB67_SeqL,BB67_CL,Normal,??,London-L2_Normal,NA_London-L2_Normal,,,,,,,,,,,,,,,
L2-HGD,London-L2, NextFlex 4,GCCAAT,13 Cycle Post Hybridization LM-PCR,96.4,,Hunter Dysplastic Nevus,,BioSci15_BB67,BB67_SeqL,BB67_CL,Intermediate,??,London-L2_Intermediate,NA_London-L2_Intermediate,,,,,,,,,,,,,,,
L3-Normal,London-L3, NextFlex 5,CAGATC,13 Cycle Post Hybridization LM-PCR,40,,Hunter Dysplastic Nevus,,BioSci15_BB67,BB67_SeqL,BB67_CL,Normal,??,London-L3_Normal,NA_London-L3_Normal,,,,,,,,,,,,,,,
L3-HGD,London-L3, NextFlex 6,CTTGTA,13 Cycle Post Hybridization LM-PCR,70,,Hunter Dysplastic Nevus,,BioSci15_BB67,BB67_SeqL,BB67_CL,Intermediate,??,London-L3_Intermediate,NA_London-L3_Intermediate,,,,,,,,,,,,,,,
JBP-1-Norm,S12-27617B9,NextFlex 10,GATCAG,,100,,Jamal Benhamida Melanoma and Metastasis Project (Lymph Node),,BioSci16_BB68,BB68_SeqL,BB68_CL,Normal,NimV2mix3,S12-27617B9_Normal,NA_S12-27617B9_Normal,,,,,,,,,,,,,,,
JBP-1-MM,"S12-25164A3,A4,A5",NextFlex 11,TAGCTT,,100,,Jamal Benhamida Melanoma and Metastasis Project (Lymph Node),,BioSci16_BB68,BB68_SeqL,BB68_CL,Tumor,NimV2mix3,"S12-25164A3,A4,A5_Tumor","NA_S12-25164A3,A4,A5_Tumor",,,,,,,,,,,,,,,
JBP-1-Met,S12-25164C1,NextFlex 12,GGCTAC,,100,,Jamal Benhamida Melanoma and Metastasis Project (Lymph Node),,BioSci16_BB68,BB68_SeqL,BB68_CL,Tumor,NimV2mix3,S12-25164C1_Tumor,NA_S12-25164C1_Tumor,,,,,,,,,,,,,,,
L19-Normal,London-L19,NextFlex 13,AGTCAA,,76.8,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Normal,NimV2mix3,London-L19_Normal,NA_London-L19_Normal,,,,,,,,,,,,,,,
L19-Nevus-A,London-L19,NextFlex 14,AGTTCC,,47.6,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Nevus,NimV2mix3,London-L19_Nevus,NA_London-L19_Nevus,,,,,,,,,,,,,,,
L19-Mel,London-L19,NextFlex 15,ATGTCA,,100,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Melanoma,NimV2mix3,London-L19_Melanoma,NA_London-L19_Melanoma,,,,,,,,,,,,,,,
L19E-NL,London-L19E,NextFlex 16,CCGTCC,,57.6,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Normal,NimV2mix3,London-L19E_Normal,NA_London-L19E_Normal,,,,,,,,,,,,,,,
L19E-Nevus,London-L19E,NextFlex 17,GTAGAG,,94,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Nevus,NimV2mix3,London-L19E_Nevus,NA_London-L19E_Nevus,,,,,,,,,,,,,,,
L19E-MM,London-L19E,NextFlex 18,GTCCGC,,100,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Melanoma,NimV2mix3,London-L19E_Melanoma,NA_London-L19E_Melanoma,,,,,,,,,,,,,,,
L22-MIS,London-L22,NextFlex 19,GTGAAA,,68.4,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,MIS,NimV2mix3,London-L22_MIS,NA_London-L22_MIS,,,,,,,,,,,,,,,
L22-Melanoma,London-L22,NextFlex 20,GTGGCC,,92.4,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Melanoma,NimV2mix3,London-L22_Melanoma,NA_London-L22_Melanoma,,,,,,,,,,,,,,,
L22-NL,London-L22,NextFlex 21,GTTTCG,,89.6,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Normal,NimV2mix3,London-L22_Normal,NA_London-L22_Normal,,,,,,,,,,,,,,,
L23-MM-Deep,London-L23,NextFlex 22,CGTACG,,100,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Melanoma,NimV2mix3,London-L23_Melanoma,NA_London-L23_Melanoma,,,,,,,,,,,,,,,
L23C-NL,London-L23C,NextFlex 23,GAGTGG,,68,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Normal,NimV2mix3,London-L23C_Normal,NA_London-L23C_Normal,,,,,,,,,,,,,,,
L23C-Mel-Sup,London-L23C,NextFlex 24,GGTAGC,,100,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Melanoma,NimV2mix3,London-L23C_Melanoma,NA_London-L23C_Melanoma,,,,,,,,,,,,,,,
L23D-NL,London-L23D,NextFlex 1,CGATGT,,41.6,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Normal,NimV2mix3,London-L23D_Normal,NA_London-L23D_Normal,,,,,,,,,,,,,,,
L23D-HGD,London-L23D,NextFlex 2,TGACCA,,47.2,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Intermediate,NimV2mix3,London-L23D_Intermediate,NA_London-L23D_Intermediate,,,,,,,,,,,,,,,
L6-Normal,London-L6, NextFlex 3,ACAGTG,,100,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Normal,NimV2mix3,London-L6_Normal,NA_London-L6_Normal,,,,,,,,,,,,,,,
L6-LGD-Super,London-L6, NextFlex 4,GCCAAT,,100,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Nevus,NimV2mix3,London-L6_Nevus,NA_London-L6_Nevus,,,,,,,,,,,,,,,
L6-LGD-Deep,London-L6, NextFlex 5,CAGATC,,40.4,,Dysplastic Nevus,,BioSci16_BB68,BB68_SeqL,BB68_CL,Nevus,NimV2mix3,London-L6_Nevus,NA_London-L6_Nevus,,,,,,,,,,,,,,,
XD-2-Tumor,XD-2, NextFlex 6,CTTGTA,,100,,Xanthoma Disseminatum Project,,BioSci16_BB68,BB68_SeqL,BB68_CL,Tumor,NimV2mix3,XD-2_Tumor,NA_XD-2_Tumor,,,,,,,,,,,,,,,
XD-2-Normal,XD-2, NextFlex 7,ATCACG,,100,,Xanthoma Disseminatum Project,,BioSci16_BB68,BB68_SeqL,BB68_CL,Normal,NimV2mix3,XD-2_Normal,NA_XD-2_Normal,,,,,,,,,,,,,,,
Long-TN6-Normal,SP-13-006364,NextFlex 11,TAGCTT,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Nelson, L.J. ",BioSci17_BB69,BB69_SeqL,BB69_CL,Normal,NimV2mix3,SP-13-006364_Normal,NA_SP-13-006364_Normal,,,,,,,,,,,,,,,
Long-TN6-Tumor,SP-14-001249,NextFlex 12,GGCTAC,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Nelson, L.J. ",BioSci17_BB69,BB69_SeqL,BB69_CL,Tumor,NimV2mix3,SP-14-001249_Tumor,NA_SP-14-001249_Tumor,,,,,,,,,,,,,,,
Long-TN7-Normal,SP-13-0185993A,NextFlex 13,AGTCAA,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Parkyns, K",BioSci17_BB69,BB69_SeqL,BB69_CL,Normal,NimV2mix3,SP-13-0185993A_Normal,NA_SP-13-0185993A_Normal,,,,,,,,,,,,,,,
Long-TN7-Tumor,SP-13-0185992B,NextFlex 14,AGTTCC,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Parkyns, K",BioSci17_BB69,BB69_SeqL,BB69_CL,Tumor,NimV2mix3,SP-13-0185992B_Tumor,NA_SP-13-0185992B_Tumor,,,,,,,,,,,,,,,
Long-TN8-Normal,SP-12-003309B,NextFlex 15,ATGTCA,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Wilson, I",BioSci17_BB69,BB69_SeqL,BB69_CL,Normal,NimV2mix3,SP-12-003309B_Normal,NA_SP-12-003309B_Normal,,,,,,,,,,,,,,,
Long-TN8-Tumor,SP-13-0212981A,NextFlex 16,CCGTCC,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Wilson, I",BioSci17_BB69,BB69_SeqL,BB69_CL,Tumor,NimV2mix3,SP-13-0212981A_Tumor,NA_SP-13-0212981A_Tumor,,,,,,,,,,,,,,,
Long-TN9-Normal,SP-13-0068754A,NextFlex 17,GTAGAG,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Lockeridge, J",BioSci17_BB69,BB69_SeqL,BB69_CL,Normal,NimV2mix3,SP-13-0068754A_Normal,NA_SP-13-0068754A_Normal,,,,,,,,,,,,,,,
Long-TN9-Tumor,SP-13-0068751C,NextFlex 18,GTCCGC,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Lockeridge, J",BioSci17_BB69,BB69_SeqL,BB69_CL,Tumor,NimV2mix3,SP-13-0068751C_Tumor,NA_SP-13-0068751C_Tumor,,,,,,,,,,,,,,,
Long-TN10-Normal,SP-07-0116602,NextFlex 19,GTGAAA,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Giles, S",BioSci17_BB69,BB69_SeqL,BB69_CL,Normal,NimV2mix3,SP-07-0116602_Normal,NA_SP-07-0116602_Normal,,,,,,,,,,,,,,,
Long-TN10-Tumor,12GS-2466,NextFlex 20,GTGGCC,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Giles, S",BioSci17_BB69,BB69_SeqL,BB69_CL,Tumor,NimV2mix3,12GS-2466_Tumor,NA_12GS-2466_Tumor,,,,,,,,,,,,,,,
Long-TN11-Normal,SP-09-0150202A,NextFlex 21,GTTTCG,,54,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Moore, R.S.",BioSci17_BB69,BB69_SeqL,BB69_CL,Normal,NimV2mix3,SP-09-0150202A_Normal,NA_SP-09-0150202A_Normal,,,,,,,,,,,,,,,
Long-TN11-Tumor,SP-13-006535C,NextFlex 22,CGTACG,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Moore, R.S.",BioSci17_BB69,BB69_SeqL,BB69_CL,Tumor,NimV2mix3,SP-13-006535C_Tumor,NA_SP-13-006535C_Tumor,,,,,,,,,,,,,,,
Long-TN12-Normal,SP-10-003167A,NextFlex 23,GAGTGG,,67.6,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Parsons, G.E.",BioSci17_BB69,BB69_SeqL,BB69_CL,Normal,NimV2mix3,SP-10-003167A_Normal,NA_SP-10-003167A_Normal,,,,,,,,,,,,,,,
Long-TN12-Tumor,SP-13-009897,NextFlex 24,GGTAGC,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Parsons, G.E.",BioSci17_BB69,BB69_SeqL,BB69_CL,Tumor,NimV2mix3,SP-13-009897_Tumor,NA_SP-13-009897_Tumor,,,,,,,,,,,,,,,
Long-TN13-Normal,SP-12-0087723B,NextFlex 1,CGATGT,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","McCowage, P.A. ",BioSci17_BB69,BB69_SeqL,BB69_CL,Normal,NimV2mix3,SP-12-0087723B_Normal,NA_SP-12-0087723B_Normal,,,,,,,,,,,,,,,
Long-TN13-Tumor,SP-12-020017C,NextFlex 2,TGACCA,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","McCowage, P.A. ",BioSci17_BB69,BB69_SeqL,BB69_CL,Tumor,NimV2mix3,SP-12-020017C_Tumor,NA_SP-12-020017C_Tumor,,,,,,,,,,,,,,,
Long-TN14-Normal,SP-12-0032671A, NextFlex 3,ACAGTG,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Jenner, A",BioSci17_BB69,BB69_SeqL,BB69_CL,Normal,NimV2mix3,SP-12-0032671A_Normal,NA_SP-12-0032671A_Normal,,,,,,,,,,,,,,,
Long-TN14-Tumor,SP-13-006337A, NextFlex 4,GCCAAT,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Jenner, A",BioSci17_BB69,BB69_SeqL,BB69_CL,Tumor,NimV2mix3,SP-13-006337A_Tumor,NA_SP-13-006337A_Tumor,,,,,,,,,,,,,,,
Long-TN15-Normal,SP-12-0228802A, NextFlex 5,CAGATC,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Bowden , M. E. ",BioSci17_BB69,BB69_SeqL,BB69_CL,Normal,NimV2mix3,SP-12-0228802A_Normal,NA_SP-12-0228802A_Normal,,,,,,,,,,,,,,,
Long-TN15-Tumor,SP-12-0228801A, NextFlex 6,CTTGTA,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Bowden , M. E. ",BioSci17_BB69,BB69_SeqL,BB69_CL,Tumor,NimV2mix3,SP-12-0228801A_Tumor,NA_SP-12-0228801A_Tumor,,,,,,,,,,,,,,,
Long-TN16-Normal,SP-12-0146612A, NextFlex 7,ATCACG,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Heywood, P.C.",BioSci17_BB69,BB69_SeqL,BB69_CL,Normal,NimV2mix3,SP-12-0146612A_Normal,NA_SP-12-0146612A_Normal,,,,,,,,,,,,,,,
Long-TN16-Tumor,SP-12-01466111A, NextFlex 8,TTAGGC,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia","Heywood, P.C.",BioSci17_BB69,BB69_SeqL,BB69_CL,Tumor,NimV2mix3,SP-12-01466111A_Tumor,NA_SP-12-01466111A_Tumor,,,,,,,,,,,,,,,
Long-TN17-Normal,"West,D.SP-10-004335",NextFlex 12,GGCTAC,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia",,BioSci18_BB70,BB70_SeqL,BB70_CL,Normal,NimV2mix3,"West,D.SP-10-004335_Normal","NA_West,D.SP-10-004335_Normal",,,,,,,,,,,,,,,
Long-TN17-Tumor,"West,D.SP-13-000848",NextFlex 13,AGTCAA,,100,,"Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia",,BioSci18_BB70,BB70_SeqL,BB70_CL,Tumor,NimV2mix3,"West,D.SP-13-000848_Tumor","NA_West,D.SP-13-000848_Tumor",,,,,,,,,,,,,,,
M230,M230,NextFlex 14,AGTTCC,,100,,Thomas Wild Type Cell Line DNA,,BioSci18_BB70,BB70_SeqL,BB70_CL,Tumor,NimV2mix3,M230_Tumor,NA_M230_Tumor,,,,,,,,,,,,,,,
M257,M257,NextFlex 15,ATGTCA,,100,,Thomas Wild Type Cell Line DNA,,BioSci18_BB70,BB70_SeqL,BB70_CL,Tumor,NimV2mix3,M257_Tumor,NA_M257_Tumor,,,,,,,,,,,,,,,
M285,M285,NextFlex 16,CCGTCC,,100,,Thomas Wild Type Cell Line DNA,,BioSci18_BB70,BB70_SeqL,BB70_CL,Tumor,NimV2mix3,M285_Tumor,NA_M285_Tumor,,,,,,,,,,,,,,,
M368,M368,NextFlex 17,GTAGAG,,100,,Thomas Wild Type Cell Line DNA,,BioSci18_BB70,BB70_SeqL,BB70_CL,Tumor,NimV2mix3,M368_Tumor,NA_M368_Tumor,,,,,,,,,,,,,,,
M375,M375,NextFlex 18,GTCCGC,,100,,Thomas Wild Type Cell Line DNA,,BioSci18_BB70,BB70_SeqL,BB70_CL,Tumor,NimV2mix3,M375_Tumor,NA_M375_Tumor,,,,,,,,,,,,,,,
M418,M418,NextFlex 19,GTGAAA,,100,,Thomas Wild Type Cell Line DNA,,BioSci18_BB70,BB70_SeqL,BB70_CL,Tumor,NimV2mix3,M418_Tumor,NA_M418_Tumor,,,,,,,,,,,,,,,
C8161,C8161,NextFlex 20,GTGGCC,,100,,Thomas Wild Type Cell Line DNA,,BioSci18_BB70,BB70_SeqL,BB70_CL,Tumor,NimV2mix3,C8161_Tumor,NA_C8161_Tumor,,,,,,,,,,,,,,,
L4-Normal,London-L4,NextFlex 21,GTTTCG,,42.4,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Normal,NimV2mix3,London-L4_Normal,NA_London-L4_Normal,,,,,,,,,,,,,,,
L4-LGD,London-L4,NextFlex 22,CGTACG,,53.6,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Nevus,NimV2mix3,London-L4_Nevus,NA_London-L4_Nevus,,,,,,,,,,,,,,,
L5-Normal,London-L5,NextFlex 23,GAGTGG,,40.4,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Normal,NimV2mix3,London-L5_Normal,NA_London-L5_Normal,,,,,,,,,,,,,,,
L5-LGD,London-L5,NextFlex 24,GGTAGC,,41.2,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Nevus,NimV2mix3,London-L5_Nevus,NA_London-L5_Nevus,,,,,,,,,,,,,,,
L8-Normal,London-L8,NextFlex 1,CGATGT,,51.6,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Normal,NimV2mix3,London-L8_Normal,NA_London-L8_Normal,,,,,,,,,,,,,,,
L8-LGD,London-L8,NextFlex 2,TGACCA,,40.4,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Nevus,NimV2mix3,London-L8_Nevus,NA_London-L8_Nevus,,,,,,,,,,,,,,,
L9-Normal,London-L9, NextFlex 3,ACAGTG,,40,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Normal,NimV2mix3,London-L9_Normal,NA_London-L9_Normal,,,,,,,,,,,,,,,
L9-HGD,London-L9, NextFlex 4,GCCAAT,,94.8,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Intermediate,NimV2mix3,London-L9_Intermediate,NA_London-L9_Intermediate,,,,,,,,,,,,,,,
L13-Normal,London-L13, NextFlex 5,CAGATC,,64.8,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Normal,NimV2mix3,London-L13_Normal,NA_London-L13_Normal,,,,,,,,,,,,,,,
L13-Lesion-A,London-L13, NextFlex 6,CTTGTA,,64.4,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Intermediate,NimV2mix3,London-L13_Intermediate,NA_London-L13_Intermediate,,,,,,,,,,,,,,,
L13-Lesion-B,London-L13, NextFlex 7,ATCACG,,100,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Intermediate,NimV2mix3,London-L13_Intermediate,NA_London-L13_Intermediate,,,,,,,,,,,,,,,
L15-DysPN,London-L15, NextFlex 8,TTAGGC,,70.4,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Nevus,NimV2mix3,London-L15_Nevus,NA_London-L15_Nevus,,,,,,,,,,,,,,,
L15-MM,London-L15, NextFlex 9,ACTTGA,,100,,Dysplastic Nevus,,BioSci18_BB70,BB70_SeqL,BB70_CL,Melanoma,NimV2mix3,London-L15_Melanoma,NA_London-L15_Melanoma,,,,,,,,,,,,,,,
1212,1212,NextFlex 1,CGATGT,,,,AGL Samples,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,1212_Tumor,NA_1212_Tumor,,,,,,,,,,,,,,,
1213,1213,NextFlex 2,TGACCA,,,,AGL Samples,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,1213_Tumor,NA_1213_Tumor,,,,,,,,,,,,,,,
1214,1214,NextFlex 3,ACAGTG,,,,AGL Samples,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,1214_Tumor,NA_1214_Tumor,,,,,,,,,,,,,,,
3860,3860,NextFlex 4,GCCAAT,,,,AGL Samples,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,3860_Tumor,NA_3860_Tumor,,,,,,,,,,,,,,,
PMM_1_Tumor,R29032-05, NextFlex 5,CAGATC,,94.4,,Iwei Pediatric Melanoma,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,R29032-05_Tumor,NA_R29032-05_Tumor,,,,,,,,,,,,,,,
PMM_3_A_Tumor,01-8297,NextFlex 19,GTGAAA,,,,Iwei Pediatric Melanoma,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,01-8297_Tumor,NA_01-8297_Tumor,01-8297,A,DERMATOPHYTOSIS,173610,110.9,3/15/2001:  A PAS-D stain confirms the presence of hyphae in the cornified layer.   3/12/2001:  I suspect dermatophytosis.,Sections show spongiosis with an altered cornified layer.,34,,,,,,F,264700
PMM_3_B_Tumor,8298-01,NextFlex 21,GTTTCG,,,,Iwei Pediatric Melanoma,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,8298-01_Tumor,NA_8298-01_Tumor,,,,,,,,,,,,,,,
PMM_10_Tumor,Z1188-03,NextFlex 14,AGTTCC,,,,Iwei Pediatric Melanoma,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,Z1188-03_Tumor,NA_Z1188-03_Tumor,,,,,,,,,,,,,,,
PMM_14_Tumor,24516-06, NextFlex 7,ATCACG,,86.4,,Iwei Pediatric Melanoma,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,24516-06_Tumor,NA_24516-06_Tumor,,,,,,,,,,,,,,,
UM17,UM17, NextFlex 8,TTAGGC,,101.44,,Uveal Melanoma,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,UM17_Tumor,NA_UM17_Tumor,,,,,,,,,,,,,,,
JBP-2-Norm,S12-23475A6, NextFlex 9,ACTTGA,,99.36,,Jamal Benhamida Lymph Node Metastasis,,BioSci19_BB71,BB71_SeqL,BB71_CL,Normal,NimV2mix3,S12-23475A6_Normal,NA_S12-23475A6_Normal,,,,,,,,,,,,,,,
JBP-2-MM,"S12-23475A4,A5", NextFlex 10,GATCAG,,101.06,,Jamal Benhamida Lymph Node Metastasis,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,"S12-23475A4,A5_Tumor","NA_S12-23475A4,A5_Tumor",,,,,,,,,,,,,,,
JBP-2-Met,S12-23475C1,NextFlex 11,TAGCTT,,99,,Jamal Benhamida Lymph Node Metastasis,,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,S12-23475C1_Tumor,NA_S12-23475C1_Tumor,,,,,,,,,,,,,,,
Long-TN18-Normal,13-21725,NextFlex 12,GGCTAC,,99.12,,"G. Long, Triple Negative ""Wild Type"" MM Cases (Australia)",,BioSci19_BB71,BB71_SeqL,BB71_CL,Normal,NimV2mix3,13-21725_Normal,NA_13-21725_Normal,13-21725,A,"HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL LYMPHOMA",173620,238.2,,"Sections show an area of inflammation and granulation tissue, with no evidence of a lymphoma.",48,,,,,,F,1175186
Long-TN18-Tumor,SP-14-68521D,NextFlex 13,AGTCAA,,97.92,,"G. Long, Triple Negative ""Wild Type"" MM Cases (Australia)",,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,SP-14-68521D_Tumor,NA_SP-14-68521D_Tumor,,,,,,,,,,,,,,,
Long-TN19-Normal,SP-13-208365A,NextFlex 15,ATGTCA,,98.4,,"G. Long, Triple Negative ""Wild Type"" MM Cases (Australia)",,BioSci19_BB71,BB71_SeqL,BB71_CL,Normal,NimV2mix3,SP-13-208365A_Normal,NA_SP-13-208365A_Normal,,,,,,,,,,,,,,,
Long-TN19-Tumor,SP-14-36134A,NextFlex 16,CCGTCC,,102.27,,"G. Long, Triple Negative ""Wild Type"" MM Cases (Australia)",,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,SP-14-36134A_Tumor,NA_SP-14-36134A_Tumor,,,,,,,,,,,,,,,
Long-TN20-Normal,SP-14-73676A,NextFlex 17,GTAGAG,,97.2,,"G. Long, Triple Negative ""Wild Type"" MM Cases (Australia)",,BioSci19_BB71,BB71_SeqL,BB71_CL,Normal,NimV2mix3,SP-14-73676A_Normal,NA_SP-14-73676A_Normal,,,,,,,,,,,,,,,
Long-TN20-Tumor,SP-14-73671M,NextFlex 18,GTCCGC,,100.59,,"G. Long, Triple Negative ""Wild Type"" MM Cases (Australia)",,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,SP-14-73671M_Tumor,NA_SP-14-73671M_Tumor,,,,,,,,,,,,,,,
Long-TN21-Normal,SP-14-7691A,NextFlex 20,GTGGCC,,101.14,,"G. Long, Triple Negative ""Wild Type"" MM Cases (Australia)",,BioSci19_BB71,BB71_SeqL,BB71_CL,Normal,NimV2mix3,SP-14-7691A_Normal,NA_SP-14-7691A_Normal,,,,,,,,,,,,,,,
Long-TN21-Tumor,SP-14-7691A,NextFlex 22,CGTACG,,102.17,,"G. Long, Triple Negative ""Wild Type"" MM Cases (Australia)",,BioSci19_BB71,BB71_SeqL,BB71_CL,Tumor,NimV2mix3,SP-14-7691A_Tumor,NA_SP-14-7691A_Tumor,,,,,,,,,,,,,,,
WM3928 F,WM3928F,NextFlex 14,AGTTCC,,1000,,Thomas Wild Type Cell Line,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,WM3928F_Tumor,NA_WM3928F_Tumor,,,,,,,,,,,,,,,
C037,C037,NextFlex 15,ATGTCA,,1000,,Thomas Wild Type Cell Line,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,C037_Tumor,NA_C037_Tumor,,,,,,,,,,,,,,,
C022,C022,NextFlex 16,CCGTCC,,1000,,Thomas Wild Type Cell Line,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,C022_Tumor,NA_C022_Tumor,,,,,,,,,,,,,,,
L20-Mel,London-L20,NextFlex 17,GTAGAG,,84.4,,Hunter Dysplastic Nevus,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Melanoma,NimV2mix3,London-L20_Melanoma,NA_London-L20_Melanoma,,,,,,,,,,,,,,,
L20-NL,London-L20,NextFlex 18,GTCCGC,,39.52,,Hunter Dysplastic Nevus,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Normal,NimV2mix3,London-L20_Normal,NA_London-L20_Normal,,,,,,,,,,,,,,,
L20-Nevus-A,London-L20,NextFlex 19,GTGAAA,,17.172,,Hunter Dysplastic Nevus,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Nevus,NimV2mix3,London-L20_Nevus,NA_London-L20_Nevus,,,,,,,,,,,,,,,
L15-NL,London-L15,NextFlex 20,GTGGCC,,12.441,,Hunter Dysplastic Nevus,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Normal,NimV2mix3,London-L15_Normal,NA_London-L15_Normal,,,,,,,,,,,,,,,
L23C-Dysplastic,London-L23C,NextFlex 21,GTTTCG,,4.968,,Hunter Dysplastic Nevus,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Nevus,NimV2mix3,London-L23C_Nevus,NA_London-L23C_Nevus,,,,,,,,,,,,,,,
UM15,UM15,NextFlex 22,CGTACG,,5.236,,Uveal Melanoma,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,UM15_Tumor,NA_UM15_Tumor,,,,,,,,,,,,,,,
UM19,UM19,NextFlex 23,GAGTGG,,7.4,,Uveal Melanoma,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,UM19_Tumor,NA_UM19_Tumor,,,,,,,,,,,,,,,
UM20,UM20,NextFlex 24,GGTAGC,,1000,,Uveal Melanoma,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,UM20_Tumor,NA_UM20_Tumor,,,,,,,,,,,,,,,
CP-1,CP-1,NextFlex 1,CGATGT,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,CP-1_Tumor,NA_CP-1_Tumor,,,,,,,,,,,,,,,
CP-2,CP-2,NextFlex 2,TGACCA,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,CP-2_Tumor,NA_CP-2_Tumor,,,,,,,,,,,,,,,
CP-3,CP-3,NextFlex 3,ACAGTG,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,CP-3_Tumor,NA_CP-3_Tumor,,,,,,,,,,,,,,,
CP-4,CP-4,NextFlex 4,GCCAAT,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,CP-4_Tumor,NA_CP-4_Tumor,,,,,,,,,,,,,,,
CP-5,CP-5,NextFlex 5,CAGATC,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,CP-5_Tumor,NA_CP-5_Tumor,,,,,,,,,,,,,,,
CP-6,CP-6,NextFlex 6,CTTGTA,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,CP-6_Tumor,NA_CP-6_Tumor,,,,,,,,,,,,,,,
14-18,14-18,NextFlex 7,ATCACG,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,14-18_Tumor,NA_14-18_Tumor,14-18,A,ULCERATION WITH HYPERKERATOSIS AND GRANULATION TISSUE,100432,707.9,"Thank you for sending the clinical image of this patient's lesion. I do not see evidence of a malignancy in this biopsy. There are some bacteria, but they are superficial and likely represent secondary impetiginization rather than a primary infection. The clinical and histopathologic findings seem to fit closest with those seen in erosive pustular dermatosis of the scalp.","Sections show a zone of ulceration, with necrosis and a fibrinopurulent exudate, as well as an adjacent proliferation of small vessels arrayed in inflamed stroma. There is hyperkeratotic debris with neutrophils and bacteria.",73,,,,,,F,703498
14-19,14-19,NextFlex 8,TTAGGC,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,14-19_Tumor,NA_14-19_Tumor,14-19,A,"ATYPICAL INTRAEPIDERMAL MELANOCYTIC PROLIFERATION, CONSISTENT WITH SUBTLE MELANOMA IN SITU",173305,172.3,"Level sections and a Sox-10 stain show a subtle proliferation of melanocytes with atypical nuclei above elastosis. While the melanocytic density is not very high, the findings are more consistent with early melanoma in situ than a solar lentigo. The proliferation extends to the specimen periphery. Additional treatment to ensure complete removal would be prudent. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation.","Sections show basilar pigmentation with prominent, enlarged single melanocytes along the dermo-epidermal junction. There is solar elastosis.",70,,,,,,F,1349938
14-21,14-21,NextFlex 9,ACTTGA,"(unknown, prepped by AGL)",,,AGL Sample,13 Cycle Post Hybridization LM-PCR,KAPA1_BB72,BB72_SeqL,BB72_CL,Tumor,NimV2mix3,14-21_Tumor,NA_14-21_Tumor,14-21,A,"MELANOMA IN SITU, ARISING IN ASSOCIATION WITH A PERSISTENT ACRAL MELANOCYTIC NEVUS",173788,172.7,"I believe there are two populations of melanocytes within this specimen, with the badly circumscribed intraepidermal population of melanocytes representing melanoma in situ and with the smaller subjacent dermal melanocytes representing persistent melanocytic nevus. The component of melanoma in situ appears narrowly excised in the available planes of section. I do believe that reexcision of this site would be appropriate.","An excisional specimen demonstrates a compound proliferation of melanocytes that is subtly biphasic in configuration. Centrally, hypocellular sclerotic scarring is noted, and this stems from prior biopsies in this vicinity. Above this, there is a broad and badly circumscribed intraepidermal population of enlarged melanocytes. These cells are distributed singly and in small nests in lentiginous fashion along the junction, and prominent scatter of melanocytes above the junction is also noted. In various areas in the dermis below this, maturing nests, cords, and small syncytia of smaller melanocytes are noted.",65,,,,,,M,1349940
XD-1-Tumor,XD-1,NextFlex 10,GATCAG,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,XD-1_Tumor,NA_XD-1_Tumor,,,,,,,,,,,,,,,
XD-1.1-Tumor,XD-1.1,NextFlex 11,TAGCTT,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,XD-1.1_Tumor,NA_XD-1.1_Tumor,,,,,,,,,,,,,,,
PMM-8-Tumor,PMM-8,NextFlex 12,GGCTAC,13 Cycle Post Hybridization LM-PCR,,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,PMM-8_Tumor,NA_PMM-8_Tumor,,,,,,,,,,,,,,,
Long-TN10-Normal,Long-TN10,NextFlex 13,AGTCAA,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Normal,NimV2mix3,Long-TN10_Normal,NA_Long-TN10_Normal,,,,,,,,,,,,,,,
Long-TN10-Tumor,Long-TN10,NextFlex 14,AGTTCC,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,Long-TN10_Tumor,NA_Long-TN10_Tumor,,,,,,,,,,,,,,,
Long-TN11-Normal,Long-TN11,NextFlex 15,ATGTCA,13 Cycle Post Hybridization LM-PCR,39.4,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Normal,NimV2mix3,Long-TN11_Normal,NA_Long-TN11_Normal,,,,,,,,,,,,,,,
Long-TN11-Tumor,Long-TN11,NextFlex 16,CCGTCC,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,Long-TN11_Tumor,NA_Long-TN11_Tumor,,,,,,,,,,,,,,,
JBP-3-Norm,JBP-3,NextFlex 17,GTAGAG,13 Cycle Post Hybridization LM-PCR,63,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Normal,NimV2mix3,JBP-3_Normal,NA_JBP-3_Normal,,,,,,,,,,,,,,,
JBP-3-MM,JBP-3-MM,NextFlex 18,GTCCGC,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,JBP-3-MM_Tumor,NA_JBP-3-MM_Tumor,,,,,,,,,,,,,,,
JBP-3-Met1,JBP-3-Met1,NextFlex 19,GTGAAA,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,JBP-3-Met1_Tumor,NA_JBP-3-Met1_Tumor,,,,,,,,,,,,,,,
JBP-3-Met2,S12-15765B3,NextFlex 20,GTGGCC,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,S12-15765B3_Tumor,NA_S12-15765B3_Tumor,,,,,,,,,,,,,,,
JBP-4-Norm,S12-4365A8,NextFlex 21,GTTTCG,13 Cycle Post Hybridization LM-PCR,241.5,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Normal,NimV2mix3,S12-4365A8_Normal,NA_S12-4365A8_Normal,,,,,,,,,,,,,,,
JBP-4-MM,"S12-4365A7,A8",NextFlex 22,CGTACG,13 Cycle Post Hybridization LM-PCR,85.5,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,"S12-4365A7,A8_Tumor","NA_S12-4365A7,A8_Tumor",,,,,,,,,,,,,,,
JBP-4-Met1,S12-4365B1,NextFlex 23,GAGTGG,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,S12-4365B1_Tumor,NA_S12-4365B1_Tumor,,,,,,,,,,,,,,,
JBP-4-Met2,"S12-4365C1,C2",NextFlex 24,GGTAGC,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,"S12-4365C1,C2_Tumor","NA_S12-4365C1,C2_Tumor",,,,,,,,,,,,,,,
JBP-5-Norm,S12-9606C4,NextFlex 1,CGATGT,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Normal,NimV2mix3,S12-9606C4_Normal,NA_S12-9606C4_Normal,,,,,,,,,,,,,,,
JBP-5-MM,"S12-9606E4,E9",NextFlex 2,TGACCA,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,"S12-9606E4,E9_Tumor","NA_S12-9606E4,E9_Tumor",,,,,,,,,,,,,,,
JBP-5-Met,S12-9606A2,NextFlex 3,ACAGTG,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,S12-9606A2_Tumor,NA_S12-9606A2_Tumor,,,,,,,,,,,,,,,
JBP-7-Norm,ZS10-972C2,NextFlex 4,GCCAAT,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Normal,NimV2mix3,ZS10-972C2_Normal,NA_ZS10-972C2_Normal,,,,,,,,,,,,,,,
JBP-7-MM,"ZS10-972A9,10,17",NextFlex 5,CAGATC,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,"ZS10-972A9,10,17_Tumor","NA_ZS10-972A9,10,17_Tumor",,,,,,,,,,,,,,,
JBP-7-Met,JBP-7-Met,NextFlex 6,CTTGTA,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Tumor,NimV2mix3,JBP-7-Met_Tumor,NA_JBP-7-Met_Tumor,,,,,,,,,,,,,,,
JBP-9-Norm,ZS10-1843A5,NextFlex 7,ATCACG,13 Cycle Post Hybridization LM-PCR,250,,,,Kapa3_BB73,BB73_SeqL,BB73_CL,Normal,NimV2mix3,ZS10-1843A5_Normal,NA_ZS10-1843A5_Normal,,,,,,,,,,,,,,,
JBP-9-MM,ZS10-8439A4,NextFlex 11,TAGCTT,,89.3,,Jamal MM,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,ZS10-8439A4_Tumor,NA_ZS10-8439A4_Tumor,,,,,,,,,,,,,,,
JBP-9-Met,ZS10-1843A4,NextFlex 12,GGCTAC,,250,,Jamal MM,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,ZS10-1843A4_Tumor,NA_ZS10-1843A4_Tumor,,,,,,,,,,,,,,,
JBP-6-Norm,ZS10-10558B1,NextFlex 13,AGTCAA,,250,,Jamal MM,,Kapa3_BB74,BB74_SeqL,BB74_CL,Normal,NimV2mix3,ZS10-10558B1_Normal,NA_ZS10-10558B1_Normal,,,,,,,,,,,,,,,
JBP-6-MM,ZS10-10558A10,NextFlex 14,AGTTCC,,250,,Jamal MM,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,ZS10-10558A10_Tumor,NA_ZS10-10558A10_Tumor,,,,,,,,,,,,,,,
JBP-6-Met,ZS10-10558C1,NextFlex 15,ATGTCA,,250,,Jamal MM,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,ZS10-10558C1_Tumor,NA_ZS10-10558C1_Tumor,,,,,,,,,,,,,,,
JBP-11-Norm,ZS10-3560F1,NextFlex 16,CCGTCC,,250,,Jamal MM,,Kapa3_BB74,BB74_SeqL,BB74_CL,Normal,NimV2mix3,ZS10-3560F1_Normal,NA_ZS10-3560F1_Normal,,,,,,,,,,,,,,,
JBP-11-MM,"ZS10-3560A3,A4,A10",NextFlex 17,GTAGAG,,250,,Jamal MM,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,"ZS10-3560A3,A4,A10_Tumor","NA_ZS10-3560A3,A4,A10_Tumor",,,,,,,,,,,,,,,
JBP-11-Met,ZS10-3560C1,NextFlex 18,GTCCGC,,250,,Jamal MM,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,ZS10-3560C1_Tumor,NA_ZS10-3560C1_Tumor,,,,,,,,,,,,,,,
UM23,UM23,NextFlex 19,GTGAAA,,250,,Uveal Melanoma,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,UM23_Tumor,NA_UM23_Tumor,,,,,,,,,,,,,,,
UM24,UM24,NextFlex 20,GTGGCC,,13.536,,Uveal Melanoma,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,UM24_Tumor,NA_UM24_Tumor,,,,,,,,,,,,,,,
UM25,UM25,NextFlex 21,GTTTCG,,31.396,,Uveal Melanoma,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,UM25_Tumor,NA_UM25_Tumor,,,,,,,,,,,,,,,
UM26,UM26,NextFlex 22,CGTACG,,2.35,,Uveal Melanoma,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,UM26_Tumor,NA_UM26_Tumor,,,,,,,,,,,,,,,
TCR-Beta-1,TCR-Beta-1,NextFlex 23,GAGTGG,,250,,Eric TCR Beta,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,TCR-Beta-1_Tumor,NA_TCR-Beta-1_Tumor,,,,,,,,,,,,,,,
TCR-Beta-2,TCR-Beta-2,NextFlex 24,GGTAGC,,250,,Eric TCR Beta,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,TCR-Beta-2_Tumor,NA_TCR-Beta-2_Tumor,,,,,,,,,,,,,,,
CP1-80,CP1-80,NextFlex 1,CGATGT,,250,,AGL,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,CP1-80_Tumor,NA_CP1-80_Tumor,,,,,,,,,,,,,,,
CP1-40,CP1-40,NextFlex 2,TGACCA,,250,,AGL,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,CP1-40_Tumor,NA_CP1-40_Tumor,,,,,,,,,,,,,,,
CP1-20,CP1-20,NextFlex 3,ACAGTG,,250,,AGL,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,CP1-20_Tumor,NA_CP1-20_Tumor,,,,,,,,,,,,,,,
CP1-10,CP1-10,NextFlex 4,GCCAAT,,250,,AGL,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,CP1-10_Tumor,NA_CP1-10_Tumor,,,,,,,,,,,,,,,
CP1-5,CP1-5,NextFlex 5,CAGATC,,250,,AGL,,Kapa3_BB74,BB74_SeqL,BB74_CL,Tumor,NimV2mix3,CP1-5_Tumor,NA_CP1-5_Tumor,,,,,,,,,,,,,,,
CP1-Norm,CP1,NextFlex 6,CTTGTA,,250,,AGL,,Kapa3_BB74,BB74_SeqL,BB74_CL,Normal,NimV2mix3,CP1_Normal,NA_CP1_Normal,,,,,,,,,,,,,,,
ADM_1,SMU10-0457,807,CAGATCAT,,,,Hunter Australian DM,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,SMU10-0457_Tumor,NA_SMU10-0457_Tumor,,,,,,,,,,,,,,,
ADM_2,SMU10-0206,808,ACTTGATA,,,,Hunter Australian DM,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,SMU10-0206_Tumor,NA_SMU10-0206_Tumor,,,,,,,,,,,,,,,
ADM_3,SMU10-0240,809,GATCAGGT,,,,Hunter Australian DM,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,SMU10-0240_Tumor,NA_SMU10-0240_Tumor,,,,,,,,,,,,,,,
ADM_4,SCC10-0092,812,CTTGTACG,,,,Hunter Australian DM,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,SCC10-0092_Tumor,NA_SCC10-0092_Tumor,,,,,,,,,,,,,,,
ADM_5,MASCRI-432,813,AGGTTTAC,,,,Hunter Australian DM,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,MASCRI-432_Tumor,NA_MASCRI-432_Tumor,,,,,,,,,,,,,,,
ADM_6,RPA08-0209,814,AGTCAACA,,,,Hunter Australian DM,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,RPA08-0209_Tumor,NA_RPA08-0209_Tumor,,,,,,,,,,,,,,,
ADM_7,RPA08-0315,815,AGTTCCGT,,,,Hunter Australian DM,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,RPA08-0315_Tumor,NA_RPA08-0315_Tumor,,,,,,,,,,,,,,,
NZM52,NZM52,816,ATGTCAGA,,,,Jillian Cell Lines,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,NZM52_Tumor,NA_NZM52_Tumor,,,,,,,,,,,,,,,
NZM40,NZM40,817,AGATAGTT,,,,Jillian Cell Lines,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,NZM40_Tumor,NA_NZM40_Tumor,,,,,,,,,,,,,,,
NZM91,NZM91,818,AGCATCAT,,,,Jillian Cell Lines,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,NZM91_Tumor,NA_NZM91_Tumor,,,,,,,,,,,,,,,
C022,C022,866,ATCTATTT,,,,Thomas Cell Line,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,C022_Tumor,NA_C022_Tumor,,,,,,,,,,,,,,,
C022,C022,866,ATCTATTT,,,,Thomas Cell Line,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,C022_Tumor,NA_C022_Tumor,,,,,,,,,,,,,,,
JBP-1-MM,JBP-1-MM,885,GCAAGGGT,,,,Jamal Metastatic Melanoma,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,JBP-1-MM_Tumor,NA_JBP-1-MM_Tumor,,,,,,,,,,,,,,,
JBP-1-MM,JBP-1-MM,885,GCAAGGGT,,,,Jamal Metastatic Melanoma,,Kapa3_BB75,BB75_SeqL,BB75_CL,Tumor,NimV2mix3,JBP-1-MM_Tumor,NA_JBP-1-MM_Tumor,,,,,,,,,,,,,,,
Long-TN22-Tumor,SP-13-198211A,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",DH,Kapa3_BB76,BB76_SeqL,BB76_CL,Tumor,NimV2mix3,SP-13-198211A_Tumor,NA_SP-13-198211A_Tumor,,,,,,,,,,,,,,,
Long-TN22-Normal,RNS11P15316B1,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",DH,Kapa3_BB76,BB76_SeqL,BB76_CL,Normal,NimV2mix3,RNS11P15316B1_Normal,NA_RNS11P15316B1_Normal,,,,,,,,,,,,,,,
Long-TN23-Tumor,9246581-A3,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",JG,Kapa3_BB76,BB76_SeqL,BB76_CL,Tumor,NimV2mix3,9246581-A3_Tumor,NA_9246581-A3_Tumor,,,,,,,,,,,,,,,
Long-TN23-Normal,9246581-A6,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",JG,Kapa3_BB76,BB76_SeqL,BB76_CL,Normal,NimV2mix3,9246581-A6_Normal,NA_9246581-A6_Normal,,,,,,,,,,,,,,,
Long-TN24-Tumor,DHM4855-14MP,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",MLH,Kapa3_BB76,BB76_SeqL,BB76_CL,Tumor,NimV2mix3,DHM4855-14MP_Tumor,NA_DHM4855-14MP_Tumor,,,,,,,,,,,,,,,
Long-TN24-Normal,SNPN08289D,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",MLH,Kapa3_BB76,BB76_SeqL,BB76_CL,Normal,NimV2mix3,SNPN08289D_Normal,NA_SNPN08289D_Normal,,,,,,,,,,,,,,,
Long-TN25-Tumor,SP-10-143551E,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",JM,Kapa3_BB76,BB76_SeqL,BB76_CL,Tumor,NimV2mix3,SP-10-143551E_Tumor,NA_SP-10-143551E_Tumor,,,,,,,,,,,,,,,
Long-TN25-Normal,SP-10-143552A,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",JM,Kapa3_BB76,BB76_SeqL,BB76_CL,Normal,NimV2mix3,SP-10-143552A_Normal,NA_SP-10-143552A_Normal,,,,,,,,,,,,,,,
Long-TN26-Tumor,04-SW-12-31366B1,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",AH,Kapa3_BB76,BB76_SeqL,BB76_CL,Tumor,NimV2mix3,04-SW-12-31366B1_Tumor,NA_04-SW-12-31366B1_Tumor,,,,,,,,,,,,,,,
Long-TN26-Normal,04-SW-12-31366B6,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",AH,Kapa3_BB76,BB76_SeqL,BB76_CL,Normal,NimV2mix3,04-SW-12-31366B6_Normal,NA_04-SW-12-31366B6_Normal,,,,,,,,,,,,,,,
Long-TN27-Tumor,SP-13-63011A,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",FN,Kapa3_BB76,BB76_SeqL,BB76_CL,Tumor,NimV2mix3,SP-13-63011A_Tumor,NA_SP-13-63011A_Tumor,,,,,,,,,,,,,,,
Long-TN27-Normal,SP-11-160493A,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",FN,Kapa3_BB76,BB76_SeqL,BB76_CL,Normal,NimV2mix3,SP-11-160493A_Normal,NA_SP-11-160493A_Normal,,,,,,,,,,,,,,,
Long-TN28-Tumor,SP-13-87981B,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",GJ,Kapa3_BB76,BB76_SeqL,BB76_CL,Tumor,NimV2mix3,SP-13-87981B_Tumor,NA_SP-13-87981B_Tumor,,,,,,,,,,,,,,,
Long-TN28-Normal,SP-11-40641B,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",GJ,Kapa3_BB76,BB76_SeqL,BB76_CL,Normal,NimV2mix3,SP-11-40641B_Normal,NA_SP-11-40641B_Normal,,,,,,,,,,,,,,,
Long-TN29-Tumor,SP-14-125801B,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",CG,Kapa3_BB76,BB76_SeqL,BB76_CL,Tumor,NimV2mix3,SP-14-125801B_Tumor,NA_SP-14-125801B_Tumor,,,,,,,,,,,,,,,
Long-TN29-Normal,SP-14-125802A,,,,,,"Triple Negative Metastatic Melanomas (""wild type"")",CG,Kapa3_BB76,BB76_SeqL,BB76_CL,Normal,NimV2mix3,SP-14-125802A_Normal,NA_SP-14-125802A_Normal,,,,,,,,,,,,,,,
KAM17-T,WCRS97-025628,Dual_AD707 Duplex,CTGAAGCT,,184.5,,Kaiser Acral Melanoma,17,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,WCRS97-025628_Tumor,NA_WCRS97-025628_Tumor,,,,,,,,,,,,,,,
KAM41-T,SCHS10-026422,Dual_AD708 Duplex,TAATGCGC,,190.35,,Kaiser Acral Melanoma,41,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,SCHS10-026422_Tumor,NA_SCHS10-026422_Tumor,,,,,,,,,,,,,,,
KAM90-T,SROS12-001198,Dual_AD709 Duplex,CGGCTATG,,250,,Kaiser Acral Melanoma,90,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,SROS12-001198_Tumor,NA_SROS12-001198_Tumor,,,,,,,,,,,,,,,
KAM92-T,SROS09-001574,Dual_AD710 Duplex,TCCGCGAA,,250,,Kaiser Acral Melanoma,92,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,SROS09-001574_Tumor,NA_SROS09-001574_Tumor,,,,,,,,,,,,,,,
KAM93-T,SCHS09-005840-B5,Dual_AD711 Duplex,TCTCGCGC,,250,,Kaiser Acral Melanoma,93,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,SCHS09-005840-B5_Tumor,NA_SCHS09-005840-B5_Tumor,,,,,,,,,,,,,,,
KAM99-T,SACS05-011507,Dual_AD712 Duplex,AGCGATAG,,250,,Kaiser Acral Melanoma,99,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,SACS05-011507_Tumor,NA_SACS05-011507_Tumor,,,,,,,,,,,,,,,
KAM105-T-A1,FRSS09-009402-A1,Dual_AD801 Duplex,ATCACGGT,,250,,Kaiser Acral Melanoma,105,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,FRSS09-009402-A1_Tumor,NA_FRSS09-009402-A1_Tumor,,,,,,,,,,,,,,,
KAM28-T-B1,RCHS07-000380-B1,Dual_AD802 Duplex,CGATGTCA,,250,,Kaiser Acral Melanoma,28,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,RCHS07-000380-B1_Tumor,NA_RCHS07-000380-B1_Tumor,,,,,,,,,,,,,,,
KAM30-T,SROS11-005030,Dual_AD803 Duplex,TTAGGCGA,,250,,Kaiser Acral Melanoma,30,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,SROS11-005030_Tumor,NA_SROS11-005030_Tumor,,,,,,,,,,,,,,,
KAM72-T,VALS09-000266,Dual_AD804 Duplex,TGACCACG,,250,,Kaiser Acral Melanoma,72,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,VALS09-000266_Tumor,NA_VALS09-000266_Tumor,,,,,,,,,,,,,,,
KAM18-T,SFOS09-007093,Dual_AD805 Duplex,ACAGTGAC,,250,,Kaiser Acral Melanoma,18,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,SFOS09-007093_Tumor,NA_SFOS09-007093_Tumor,,,,,,,,,,,,,,,
KAM63-T,FRSS09-008805,Dual_AD806 Duplex,GCCAATTT,,250,,Kaiser Acral Melanoma,63,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,FRSS09-008805_Tumor,NA_FRSS09-008805_Tumor,,,,,,,,,,,,,,,
KAM70-T,RCHS06-004567,Dual_AD807 Duplex,CAGATCAT,,250,,Kaiser Acral Melanoma,70,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,RCHS06-004567_Tumor,NA_RCHS06-004567_Tumor,,,,,,,,,,,,,,,
KAM54-T-E,VALS05-014946-E,Dual_AD808 Duplex,ACTTGATA,,250,,Kaiser Acral Melanoma,54,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,VALS05-014946-E_Tumor,NA_VALS05-014946-E_Tumor,,,,,,,,,,,,,,,
KAM2-T,SCHS08-007754,Dual_AD809 Duplex,GATCAGGT,,250,,Kaiser Acral Melanoma,2,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,SCHS08-007754_Tumor,NA_SCHS08-007754_Tumor,,,,,,,,,,,,,,,
KAM5-T,SFOS12-018173,Dual_AD812 Duplex,CTTGTACG,,250,,Kaiser Acral Melanoma,5,Kapa3_BB79,BB79_SeqL,BB79_CL,Tumor,NimV3,SFOS12-018173_Tumor,NA_SFOS12-018173_Tumor,,,,,,,,,,,,,,,
KAM10-T,SROS00-001103,Dual_AD824 Duplex,CGGAATCG,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,10,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,SROS00-001103_Tumor,NA_SROS00-001103_Tumor,,,,,,,,,,,,,,,
KAM45-T-D,MTZS94-007340,Dual_AD826 Duplex,CTATACTT,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,45,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,MTZS94-007340_Tumor,NA_MTZS94-007340_Tumor,,,,,,,,,,,,,,,
KAM49-T,SFOS94-003116,Dual_AD827 Duplex,CTCAGAAT,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,49,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,SFOS94-003116_Tumor,NA_SFOS94-003116_Tumor,,,,,,,,,,,,,,,
KAM27-T,SACS93-027850,Dual_AD828 Duplex,CTGCTGTA,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,27,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,SACS93-027850_Tumor,NA_SACS93-027850_Tumor,,,,,,,,,,,,,,,
KAM68-T,SCLS91-006557,Dual_AD829 Duplex,CCTTAGGT,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,68,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,SCLS91-006557_Tumor,NA_SCLS91-006557_Tumor,,,,,,,,,,,,,,,
KAM9-T-H,OAKS90-012369,Dual_AD830 Duplex,CACCGGCA,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,9,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,OAKS90-012369_Tumor,NA_OAKS90-012369_Tumor,,,,,,,,,,,,,,,
KAM98-T-B,HAYS02-005731,Dual_AD832 Duplex,GATATACG,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,98,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,HAYS02-005731_Tumor,NA_HAYS02-005731_Tumor,,,,,,,,,,,,,,,
KAM67-T,SRFS97-002805,Dual_AD833 Duplex,GATGCTAC,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,67,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,SRFS97-002805_Tumor,NA_SRFS97-002805_Tumor,,,,,,,,,,,,,,,
KAM124-T-B,VALS03-019832,Dual_AD887 Duplex,GCCTTAGA,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,124,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,VALS03-019832_Tumor,NA_VALS03-019832_Tumor,,,,,,,,,,,,,,,
KAM58-T-GIV,SSCS03-014369,Dual_AD836 Duplex,GCTCCATA,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,58,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,SSCS03-014369_Tumor,NA_SSCS03-014369_Tumor,,,,,,,,,,,,,,,
KAM86-T,RCHS01-003684,Dual_AD837 Duplex,GGCACAGT,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,86,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,RCHS01-003684_Tumor,NA_RCHS01-003684_Tumor,,,,,,,,,,,,,,,
KAM111-T-A2,WCRS99-012800,Dual_AD838 Duplex,GGCCTGCA,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,111,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,WCRS99-012800_Tumor,NA_WCRS99-012800_Tumor,,,,,,,,,,,,,,,
KAM77-T,HAYS90-005154,Dual_AD840 Duplex,TAATCGCG,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,77,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,HAYS90-005154_Tumor,NA_HAYS90-005154_Tumor,,,,,,,,,,,,,,,
KAM69-T,SFOS00-016989,Dual_AD841 Duplex,TACAGCAC,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,69,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,SFOS00-016989_Tumor,NA_SFOS00-016989_Tumor,,,,,,,,,,,,,,,
KAM117-T-D,VALS03-007457,Dual_AD882 Duplex,GAAACCAC,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,117,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,VALS03-007457_Tumor,NA_VALS03-007457_Tumor,,,,,,,,,,,,,,,
KAM103-T,SFO93-005184,Dual_AD843 Duplex,TCATTCAT,Kaiser Acral Melanoma,250,,Kaiser Acral Melanoma,103,Kapa3_BB80,BB80_SeqL,BB80_CL,Tumor,NimV3,SFO93-005184_Tumor,NA_SFO93-005184_Tumor,,,,,,,,,,,,,,,
Long-TN30-Tumor,DHM50691-14MP5C,Dual_AD810 Duplex,TAGCTTCA,,250,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Tumor,NimV2mix3,DHM50691-14MP5C_Tumor,NA_DHM50691-14MP5C_Tumor,,,,,,,,,,,,,,,
Long-TN30-Normal,DHM50691-14MP3,Dual_AD504 Duplex,GGCTCTGA,,250,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Normal,NimV2mix3,DHM50691-14MP3_Normal,NA_DHM50691-14MP3_Normal,,,,,,,,,,,,,,,
Long-TN31-Tumor,RNS14P13907B1,Dual_AD856 Duplex,ACAAACCG,,250,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Tumor,NimV2mix3,RNS14P13907B1_Tumor,NA_RNS14P13907B1_Tumor,,,,,,,,,,,,,,,
Long-TN31-Normal,SP-10-197431A,Dual_AD857 Duplex,ACCGGCAC,,122.8,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Normal,NimV2mix3,SP-10-197431A_Normal,NA_SP-10-197431A_Normal,,,,,,,,,,,,,,,
Long-TN32-Tumor,DHM57444-14MP,Dual_AD858 Duplex,ACGATATT,,250,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Tumor,NimV2mix3,DHM57444-14MP_Tumor,NA_DHM57444-14MP_Tumor,,,,,,,,,,,,,,,
Long-TN32-Normal,SP-12-177322A,Dual_AD859 Duplex,ACTCTCGA,,250,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Normal,NimV2mix3,SP-12-177322A_Normal,NA_SP-12-177322A_Normal,,,,,,,,,,,,,,,
Long-TN33-Tumor,DHM94457-13SK,Dual_AD860 Duplex,ACTGATAT,,250,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Tumor,NimV2mix3,DHM94457-13SK_Tumor,NA_DHM94457-13SK_Tumor,,,,,,,,,,,,,,,
Long-TN33-Normal,DHM48742-12MPE,Dual_AD861 Duplex,AGAAGAGT,,250,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Normal,NimV2mix3,DHM48742-12MPE_Normal,NA_DHM48742-12MPE_Normal,,,,,,,,,,,,,,,
Long-TN34-Tumor,Laverty13-88354,Dual_AD862 Duplex,AGGCCGCA,,250,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Tumor,NimV2mix3,Laverty13-88354_Tumor,NA_Laverty13-88354_Tumor,,,,,,,,,,,,,,,
Long-TN34-Normal,ICPMR19684.13A11,Dual_AD863 Duplex,ATAATTGA,,250,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Normal,NimV2mix3,ICPMR19684.13A11_Normal,NA_ICPMR19684.13A11_Normal,,,,,,,,,,,,,,,
Long-TN35-Tumor,SP-13-15691B,Dual_AD864 Duplex,ATACGGCG,,250,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Tumor,NimV2mix3,SP-13-15691B_Tumor,NA_SP-13-15691B_Tumor,,,,,,,,,,,,,,,
Long-TN35-Normal,SP-13-15691D,Dual_AD865 Duplex,ATCCTAAC,,250,,Long Australian Wild Type Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Normal,NimV2mix3,SP-13-15691D_Normal,NA_SP-13-15691D_Normal,,,,,,,,,,,,,,,
UM29,57059699,Dual_AD868 Duplex,ATTCCTTT,,250,,Uveal Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Tumor,NimV2mix3,57059699_Tumor,NA_57059699_Tumor,,,,,,,,,,,,,,,
UM30,57269600,Dual_AD869 Duplex,CAAAAGGT,,250,,Uveal Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Tumor,NimV2mix3,57269600_Tumor,NA_57269600_Tumor,,,,,,,,,,,,,,,
UM31,57213442,Dual_AD870 Duplex,CAACTACA,,174.8,,Uveal Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Tumor,NimV2mix3,57213442_Tumor,NA_57213442_Tumor,,,,,,,,,,,,,,,
UM34,57346060,Dual_AD871 Duplex,CACGATGA,,250,,Uveal Melanoma,,Kapa3_BB81,BB81_SeqL,BB81_CL,Tumor,NimV2mix3,57346060_Tumor,NA_57346060_Tumor,,,,,,,,,,,,,,,
KAM19-T,SROS10-009251,AD501,TATAGCCT,,110,,Kaiser Acral Melanoma,19,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,SROS10-009251_Tumor,NA_SROS10-009251_Tumor,,,,,,,,,,,,,,,
KAM32-T,FRSS99-007026,AD503,CCTATCCT,,100,,Kaiser Acral Melanoma,32,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,FRSS99-007026_Tumor,NA_FRSS99-007026_Tumor,,,,,,,,,,,,,,,
KAM60-T-B,SCLS04-001045,AD505,AGGCGAAG,,84.8,,Kaiser Acral Melanoma,60,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,SCLS04-001045_Tumor,NA_SCLS04-001045_Tumor,,,,,,,,,,,,,,,
KAM74-T-G,OAKS96-014392-G,AD506,TAATCTTA,,108,,Kaiser Acral Melanoma,74,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,OAKS96-014392-G_Tumor,NA_OAKS96-014392-G_Tumor,,,,,,,,,,,,,,,
KAM109-T,OAKS96-022398,AD507,CAGGACGT,,80.4,,Kaiser Acral Melanoma,109,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,OAKS96-022398_Tumor,NA_OAKS96-022398_Tumor,,,,,,,,,,,,,,,
KAM112-T-B,OAK84-008979-B,AD508,GTACTGAC,,100.4,,Kaiser Acral Melanoma,112,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,OAK84-008979-B_Tumor,NA_OAK84-008979-B_Tumor,,,,,,,,,,,,,,,
KAM115-T-A1,ROSS09-022626-A1,AD703,CGCTCATT,,105.2,,Kaiser Acral Melanoma,115,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,ROSS09-022626-A1_Tumor,NA_ROSS09-022626-A1_Tumor,,,,,,,,,,,,,,,
KAM119-T,SCHS11-018842-A1,AD704,GAGATTCC,,101.6,,Kaiser Acral Melanoma,119,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,SCHS11-018842-A1_Tumor,NA_SCHS11-018842-A1_Tumor,,,,,,,,,,,,,,,
KAM46-T,SSCS03-004945,AD819,AGCGCTTA,,,,Kaiser Acral Melanoma,46,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,SSCS03-004945_Tumor,NA_SSCS03-004945_Tumor,,,,,,,,,,,,,,,
KAM47-T,WCRS02-022688,AD821,ACCCAGCA,,,,Kaiser Acral Melanoma,47,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,WCRS02-022688_Tumor,NA_WCRS02-022688_Tumor,,,,,,,,,,,,,,,
KAM100-T-II,SACS02-020334,AD822 ,CCGTCCCG,,,,Kaiser Acral Melanoma,100,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,SACS02-020334_Tumor,NA_SACS02-020334_Tumor,,,,,,,,,,,,,,,
KAM75,HAYS98-001046,AD825 ,CTAGCTAC,,,,Kaiser Acral Melanoma,75,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,HAYS98-001046_Tumor,NA_HAYS98-001046_Tumor,,,,,,,,,,,,,,,
KAM64-T,SACS88-019073,AD831 ,GACGGAGA,,,,Kaiser Acral Melanoma,64,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,SACS88-019073_Tumor,NA_SACS88-019073_Tumor,,,,,,,,,,,,,,,
KAM50-T,SACS87-010145,AD834 ,GTAGAGTT,,,,Kaiser Acral Melanoma,50,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,SACS87-010145_Tumor,NA_SACS87-010145_Tumor,,,,,,,,,,,,,,,
KAM39-T,STRS91-006237,AD820 ,ACATCTGT,,,,Kaiser Acral Melanoma,39,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,STRS91-006237_Tumor,NA_STRS91-006237_Tumor,,,,,,,,,,,,,,,
KAM22-T,SSCS92-009981,AD853 ,AAGCGAGT,,,,Kaiser Acral Melanoma,22,Kapa3_BB82,BB82_SeqL,BB82_CL,Tumor,NimV3,SSCS92-009981_Tumor,NA_SSCS92-009981_Tumor,,,,,,,,,,,,,,,
T015-Normal,14-59304A,AD816,ATGTCAGA,,44.325,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Normal,NimV3,14-59304A_Normal,NA_14-59304A_Normal,14-59304,A,COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES,173416,216.4,,"Sections show a compound proliferation of plump, oval to small round melanocytes, arrayed as a few small nests along the epidermal-dermal junction, and as nests, cords and strands that extend into the superficial reticular dermis and are distributed around adnexa.",11,,,,,,M,1409245
T015-Nevus,14-59304A,AD817,AGATAGTT,,102.15,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Nevus,NimV3,14-59304A_Nevus,NA_14-59304A_Nevus,14-59304,A,COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES,173416,216.4,,"Sections show a compound proliferation of plump, oval to small round melanocytes, arrayed as a few small nests along the epidermal-dermal junction, and as nests, cords and strands that extend into the superficial reticular dermis and are distributed around adnexa.",11,,,,,,M,1409245
T016-Normal,13-48020,AD818,AGCATCAT,,32.04,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Normal,NimV3,13-48020_Normal,NA_13-48020_Normal,13-48020,A,"MELANOMA, 0.75 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",273588,172.5,"Melanoma in situ is present < 2 millimeters from the edge of the specimen.  This is a non-ulcerated melanoma and no dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.  I have reviewed this case with Dr. McCalmont who concurs with the diagnosis.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent fibrotic dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",66,T1a,0.75,,Primary,,F,1289322
T016-Nevus,13-48020,AD866,ATCTATTT,,110.4,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Nevus,NimV3,13-48020_Nevus,NA_13-48020_Nevus,13-48020,A,"MELANOMA, 0.75 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",273588,172.5,"Melanoma in situ is present < 2 millimeters from the edge of the specimen.  This is a non-ulcerated melanoma and no dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.  I have reviewed this case with Dr. McCalmont who concurs with the diagnosis.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent fibrotic dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",66,T1a,0.75,,Primary,,F,1289322
T017-Normal,14-13499,AD819,AGCGCTTA,,31.59,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Normal,NimV3,14-13499_Normal,NA_14-13499_Normal,14-13499,A,"MELANOMA, 0.62 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",273588,172.5,"Melanoma in situ is present a fraction of a millimeter from the edge of the specimen.  I have examined additional sections and a Melan-A stain.  The immunostain highlights areas of increased confluence of junctional melanocytes as well as scattered melanocytes above the dermo-epidermal junction.  Within the fibrotic dermis a few nests of melanocytes are also present.  There is also a small population of bland dermal melanocytes that represent a melanocytic nevus.  This is a non-ulcerated melanoma and no dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  Some bridging of rete is noted.  There are a few clusters similar melanocytes in the subjacent fibrotic dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",84,T1a,0.62,,Primary,,F,1363420
T017-Nevus,14-13499,AD821,ACCCAGCA,,110.7,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Nevus,NimV3,14-13499_Nevus,NA_14-13499_Nevus,14-13499,A,"MELANOMA, 0.62 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",273588,172.5,"Melanoma in situ is present a fraction of a millimeter from the edge of the specimen.  I have examined additional sections and a Melan-A stain.  The immunostain highlights areas of increased confluence of junctional melanocytes as well as scattered melanocytes above the dermo-epidermal junction.  Within the fibrotic dermis a few nests of melanocytes are also present.  There is also a small population of bland dermal melanocytes that represent a melanocytic nevus.  This is a non-ulcerated melanoma and no dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.","Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  Some bridging of rete is noted.  There are a few clusters similar melanocytes in the subjacent fibrotic dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.",84,T1a,0.62,,Primary,,F,1363420
T020-Normal,13-64515B,AD822,CCGTCCCG,,66.15,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Normal,NimV3,13-64515B_Normal,NA_13-64515B_Normal,13-64515,B,"MELANOMA, 1.2 MILLIMETERS IN THICKNESS, EXTENDING TO WITHIN APPROXIMATELY 2 MILLIMETERS OF THE LATERAL INKED MARGINS",139522,172.5,"Part of this proliferation probably represents a melanocytic nevus, and thus the melanoma likely arose within a melanocytic nevus. Is there a history of a long-standing pigmented lesion at this site with recent change? Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a modest proliferation rate among the dermal melanocytes. A broad dermal scar is present within this specimen as well. The scar is in close proximity to an infundibular follicular cyst, and thus it is possible that the scar arose due to cyst rupture. However, it is also possible that the scar is due to a former procedure at this site. Is there a history of a former biopsy? Diagnostic features of note include:  Procedure: Excisional biopsy Tumor site: Right upper back Microscopic tumor type:  Superficial spreading Breslow thickness: 1.2 millimeters Ulceration: not present Margins, peripheral and deep: The melanoma is located within approximately 2 millimeters of the lateral margins and 5 millimeters of the deep margin Mitotic index: < 1/mm2 Microsatellitosis: not identified Vascular invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2aNxMx  Given the proximity of the melanoma to the lateral inked margins, further treatment at this site is warranted. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this assessment.","Sections show a compound melanocytic proliferation with a biphasic pattern.  One population is composed of a proliferation of melanocytes arranged in an asymmetrical and poorly circumscribed fashion both along the dermo-epidermal junction and within the dermis. Many of these melanocytes are spindled and heavily pigmented. Single melanocytes predominate over nests in some areas along the dermo-epidermal junction and melanocytes track down adnexa as single cells. There are nests, cords and strands of similar melanocytes in the underlying dermis, where the size of the melanocytes generally does not diminish with descent. There is also a population of darker-staining melanocytes that diminish in size with descent into the dermis. Both an infundibular follicular cyst and a broad dermal scar are apparent as well.",57,T2a,1.2, Superficial spreading,Primary,1,M,1292049
T020-Nevus,13-64515B,AD824,CGGAATCG,,16.875,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Nevus,NimV3,13-64515B_Nevus,NA_13-64515B_Nevus,13-64515,B,"MELANOMA, 1.2 MILLIMETERS IN THICKNESS, EXTENDING TO WITHIN APPROXIMATELY 2 MILLIMETERS OF THE LATERAL INKED MARGINS",139522,172.5,"Part of this proliferation probably represents a melanocytic nevus, and thus the melanoma likely arose within a melanocytic nevus. Is there a history of a long-standing pigmented lesion at this site with recent change? Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a modest proliferation rate among the dermal melanocytes. A broad dermal scar is present within this specimen as well. The scar is in close proximity to an infundibular follicular cyst, and thus it is possible that the scar arose due to cyst rupture. However, it is also possible that the scar is due to a former procedure at this site. Is there a history of a former biopsy? Diagnostic features of note include:  Procedure: Excisional biopsy Tumor site: Right upper back Microscopic tumor type:  Superficial spreading Breslow thickness: 1.2 millimeters Ulceration: not present Margins, peripheral and deep: The melanoma is located within approximately 2 millimeters of the lateral margins and 5 millimeters of the deep margin Mitotic index: < 1/mm2 Microsatellitosis: not identified Vascular invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2aNxMx  Given the proximity of the melanoma to the lateral inked margins, further treatment at this site is warranted. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this assessment.","Sections show a compound melanocytic proliferation with a biphasic pattern.  One population is composed of a proliferation of melanocytes arranged in an asymmetrical and poorly circumscribed fashion both along the dermo-epidermal junction and within the dermis. Many of these melanocytes are spindled and heavily pigmented. Single melanocytes predominate over nests in some areas along the dermo-epidermal junction and melanocytes track down adnexa as single cells. There are nests, cords and strands of similar melanocytes in the underlying dermis, where the size of the melanocytes generally does not diminish with descent. There is also a population of darker-staining melanocytes that diminish in size with descent into the dermis. Both an infundibular follicular cyst and a broad dermal scar are apparent as well.",57,T2a,1.2, Superficial spreading,Primary,1,M,1292049
T020-Melanoma,13-64515B,AD825,CTAGCTAC,,40.095,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Tumor,NimV3,13-64515B_Tumor,NA_13-64515B_Tumor,13-64515,B,"MELANOMA, 1.2 MILLIMETERS IN THICKNESS, EXTENDING TO WITHIN APPROXIMATELY 2 MILLIMETERS OF THE LATERAL INKED MARGINS",139522,172.5,"Part of this proliferation probably represents a melanocytic nevus, and thus the melanoma likely arose within a melanocytic nevus. Is there a history of a long-standing pigmented lesion at this site with recent change? Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a modest proliferation rate among the dermal melanocytes. A broad dermal scar is present within this specimen as well. The scar is in close proximity to an infundibular follicular cyst, and thus it is possible that the scar arose due to cyst rupture. However, it is also possible that the scar is due to a former procedure at this site. Is there a history of a former biopsy? Diagnostic features of note include:  Procedure: Excisional biopsy Tumor site: Right upper back Microscopic tumor type:  Superficial spreading Breslow thickness: 1.2 millimeters Ulceration: not present Margins, peripheral and deep: The melanoma is located within approximately 2 millimeters of the lateral margins and 5 millimeters of the deep margin Mitotic index: < 1/mm2 Microsatellitosis: not identified Vascular invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2aNxMx  Given the proximity of the melanoma to the lateral inked margins, further treatment at this site is warranted. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this assessment.","Sections show a compound melanocytic proliferation with a biphasic pattern.  One population is composed of a proliferation of melanocytes arranged in an asymmetrical and poorly circumscribed fashion both along the dermo-epidermal junction and within the dermis. Many of these melanocytes are spindled and heavily pigmented. Single melanocytes predominate over nests in some areas along the dermo-epidermal junction and melanocytes track down adnexa as single cells. There are nests, cords and strands of similar melanocytes in the underlying dermis, where the size of the melanocytes generally does not diminish with descent. There is also a population of darker-staining melanocytes that diminish in size with descent into the dermis. Both an infundibular follicular cyst and a broad dermal scar are apparent as well.",57,T2a,1.2, Superficial spreading,Primary,1,M,1292049
T021-Nevus,14-22939,AD826,CTATACTT,,37.62,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Nevus,NimV3,14-22939_Nevus,NA_14-22939_Nevus,14-22939,A,"MELANOMA, 0.7 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO THE EDGE AND BASE OF THE SPECIMEN",173601,172.6,"Diagnostic features of note include the following. Definitive assessment of prognostic features should be deferred to the excision specimen, although I suspect the thickest areas are sampled herein. Because mitotic figures are evident in number in the dermal component, this lesion is staged as T1b. Procedure: shave biopsy Microscopic tumor type: superficial spreading Breslow thickness: 0.7 mm Ulceration: none Margins, peripheral and deep: involved Mitotic index: 4/square mm Microsatellitosis: cannot assess Vascular invasion: not evident Perineural invasion: not evident Regression: not evident Pathologic Staging (pTNM): pT1b pNX","Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis and mitotic figures are readily identified.  The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus) which mature with descent.  There is an infiltrate of lymphocytes and melanophages.",62,T1b,0.7,superficial spreading,Primary,4,M,1372863
T021-Melanoma,14-22939,AD827,CTCAGAAT,,13.59,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Tumor,NimV3,14-22939_Tumor,NA_14-22939_Tumor,14-22939,A,"MELANOMA, 0.7 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO THE EDGE AND BASE OF THE SPECIMEN",173601,172.6,"Diagnostic features of note include the following. Definitive assessment of prognostic features should be deferred to the excision specimen, although I suspect the thickest areas are sampled herein. Because mitotic figures are evident in number in the dermal component, this lesion is staged as T1b. Procedure: shave biopsy Microscopic tumor type: superficial spreading Breslow thickness: 0.7 mm Ulceration: none Margins, peripheral and deep: involved Mitotic index: 4/square mm Microsatellitosis: cannot assess Vascular invasion: not evident Perineural invasion: not evident Regression: not evident Pathologic Staging (pTNM): pT1b pNX","Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis and mitotic figures are readily identified.  The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus) which mature with descent.  There is an infiltrate of lymphocytes and melanophages.",62,T1b,0.7,superficial spreading,Primary,4,M,1372863
T023-Normal,13-61146,AD828,CTGCTGTA,,23.895,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Normal,NimV3,13-61146_Normal,NA_13-61146_Normal,13-61146,A,"MELANOMA OF 0.45 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173649,172.6,"This biopsy demonstrates a thin invasive melanoma that has developed in conjunction with a small congenital melanocytic nevus. With respect to staging, this non-ulcerated melanoma does not have melanocytes in mitosis in its small invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Both the melanoma and the melanocytic nevus appear narrowly excised in the available sections.","Sections show a proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, surrounded by a lymphocytic infiltrate.  Laterally in the superficial dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords.",26,T1a,0.45,,Primary,,F,1303150
T023-Nevus,13-61146,AD829,CCTTAGGT,,105.25,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Nevus,NimV3,13-61146_Nevus,NA_13-61146_Nevus,13-61146,A,"MELANOMA OF 0.45 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173649,172.6,"This biopsy demonstrates a thin invasive melanoma that has developed in conjunction with a small congenital melanocytic nevus. With respect to staging, this non-ulcerated melanoma does not have melanocytes in mitosis in its small invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Both the melanoma and the melanocytic nevus appear narrowly excised in the available sections.","Sections show a proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, surrounded by a lymphocytic infiltrate.  Laterally in the superficial dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords.",26,T1a,0.45,,Primary,,F,1303150
T023-Melanoma,13-61146,AD830 ,CACCGGCA,,118.35,,,,Kapa3_BB83,BB83_SeqL,BB83_CL,Tumor,NimV3,13-61146_Tumor,NA_13-61146_Tumor,13-61146,A,"MELANOMA OF 0.45 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS",173649,172.6,"This biopsy demonstrates a thin invasive melanoma that has developed in conjunction with a small congenital melanocytic nevus. With respect to staging, this non-ulcerated melanoma does not have melanocytes in mitosis in its small invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Both the melanoma and the melanocytic nevus appear narrowly excised in the available sections.","Sections show a proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, surrounded by a lymphocytic infiltrate.  Laterally in the superficial dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords.",26,T1a,0.45,,Primary,,F,1303150
UM27,57001550,AD831,GACGGAGA,,15.525,,uveal melanoma,,Kapa3_BB83,BB83_SeqL,BB83_CL,Tumor,NimV3,57001550_Tumor,NA_57001550_Tumor,,,,,,,,,,,,,,,
UM28,57291680,AD834,GTAGAGTT,,17.1,,uveal melanoma,,Kapa3_BB83,BB83_SeqL,BB83_CL,Tumor,NimV3,57291680_Tumor,NA_57291680_Tumor,,,,,,,,,,,,,,,
736TP-FFPE-L3,London-L3,AD861 ,AGAAGAGT,,,,Soyer Microbiopsy Study,,Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,London-L3_Tumor,NA_London-L3_Tumor,,,,,,,,,,,,,,,
736TP-FFPE-L13,London-L13,AD862 ,AGGCCGCA,,,,Soyer Microbiopsy Study,,Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,London-L13_Tumor,NA_London-L13_Tumor,,,,,,,,,,,,,,,
736TP-MB-L3-L2,London-L3,AD863 ,ATAATTGA,,,,Soyer Microbiopsy Study,,Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,London-L3_Tumor,NA_London-L3_Tumor,,,,,,,,,,,,,,,
736TP-MB-L3-L4,London-L3,AD864 ,ATACGGCG,,,,Soyer Microbiopsy Study,,Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,London-L3_Tumor,NA_London-L3_Tumor,,,,,,,,,,,,,,,
736TP-MB-L3-P1,London-L3,AD865 ,ATCCTAAC,,,,Soyer Microbiopsy Study,,Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,London-L3_Tumor,NA_London-L3_Tumor,,,,,,,,,,,,,,,
736TP-MB-L3-P2,London-L3,AD868 ,ATTCCTTT,,,,Soyer Microbiopsy Study,,Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,London-L3_Tumor,NA_London-L3_Tumor,,,,,,,,,,,,,,,
736TP-MB-L13-L1,London-L13,AD869 ,CAAAAGGT,,,,Soyer Microbiopsy Study,,Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,London-L13_Tumor,NA_London-L13_Tumor,,,,,,,,,,,,,,,
736TP-MB-L13-P2,London-L13,AD870 ,CAACTACA,,,,Soyer Microbiopsy Study,,Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,London-L13_Tumor,NA_London-L13_Tumor,,,,,,,,,,,,,,,
UM33,UM33,AD871 ,CACGATGA,,,,Soyer Microbiopsy Study,,Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,UM33_Tumor,NA_UM33_Tumor,,,,,,,,,,,,,,,
UM35_A,UM35_A,AD872 ,CACTCACG,Uveal Melanoma,,,,"Chan, Phyllis",Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,UM35_A_Tumor,NA_UM35_A_Tumor,,,,,,,,,,,,,,,
UM39,UM39,AD873 ,CAGGCGAC,Uveal Melanoma,,,,"Perry, Arthur",Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,UM39_Tumor,NA_UM39_Tumor,,,,,,,,,,,,,,,
UM40,UM40,AD874 ,CATGGCTT,Uveal Melanoma,,,,"Presnell, Kathleen",Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,UM40_Tumor,NA_UM40_Tumor,,,,,,,,,,,,,,,
UM41,UM41,AD875 ,CATTTTAT,Uveal Melanoma,,,,"Combs, Aurielle",Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,UM41_Tumor,NA_UM41_Tumor,,,,,,,,,,,,,,,
UM36,UM36,AD847 ,TTCTCCGA,Uveal Melanoma,,,,"Grinnon, Margaret",Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,UM36_Tumor,NA_UM36_Tumor,,,,,,,,,,,,,,,
UM37,UM37,AD848 ,TGCCATCG,Uveal Melanoma,,,,"Griffin, Gale",Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,UM37_Tumor,NA_UM37_Tumor,,,,,,,,,,,,,,,
736TP-F-L13,London-L13,AD878 ,CCCATGCA,Uveal Melanoma,,,,"Dixon, Milena",Kapa3_BB84,BB84_SeqL,BB84_CL,Tumor,NimV3,London-L13_Tumor,NA_London-L13_Tumor,,,,,,,,,,,,,,,
UM41-A,57715138,,,16.5,742.5,,"Uveal Melanoma, left eye, s/p enucleation",,Kapa3_BB86,BB86_SeqL,BB86_CL,Tumor,NimV3,57715138_Tumor,NA_57715138_Tumor,,,,,,,,,,,,,,,
UM41-B,57715138,,,9.29,418.05,,"Uveal Melanoma, left eye  ",,Kapa3_BB86,BB86_SeqL,BB86_CL,Tumor,NimV3,57715138_Tumor,NA_57715138_Tumor,,,,,,,,,,,,,,,
UM42,332771,,,15.3,688.5,,"Uveal Melanoma (choroidal melanoma, right eye)",,Kapa3_BB86,BB86_SeqL,BB86_CL,Tumor,NimV3,332771_Tumor,NA_332771_Tumor,,,,,,,,,,,,,,,
UM43,57723220,,,0.062,2.79,,"Uveal Melanoma (choroidal melanoma, right eye)",,Kapa3_BB86,BB86_SeqL,BB86_CL,Tumor,NimV3,57723220_Tumor,NA_57723220_Tumor,,,,,,,,,,,,,,,
UM44,55875588,,,0.07,3.15,,Uveal Melanoma,,Kapa3_BB86,BB86_SeqL,BB86_CL,Tumor,NimV3,55875588_Tumor,NA_55875588_Tumor,,,,,,,,,,,,,,,
UM45,57714581,,,0.176,7.92,,"Uveal Melanoma (choroidal lesion, left eye)",,Kapa3_BB86,BB86_SeqL,BB86_CL,Tumor,NimV3,57714581_Tumor,NA_57714581_Tumor,,,,,,,,,,,,,,,
UM47-Tumor,UM47,,,,1.11,,Uveal Melanoma,,Kapa3_BB87,BB87_SeqL,BB87_CL,Tumor,NimV3,UM47_Tumor,NA_UM47_Tumor,,,,,,,,,,,,,,,
UM47-Normal,UM47,,,,59,,Serum to be used as Normal Control,,Kapa3_BB87,BB87_SeqL,BB87_CL,Normal,NimV3,UM47_Normal,NA_UM47_Normal,,,,,,,,,,,,,,,
Sample_KAM1-T,Sample_KAM1-T,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM1-T_Tumor,NA_Sample_KAM1-T_Tumor,,,,,,,,,,,,,,,
Sample_KAM106-T,Sample_KAM106-T,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM106-T_Tumor,NA_Sample_KAM106-T_Tumor,,,,,,,,,,,,,,,
Sample_KAM12-T,Sample_KAM12-T,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM12-T_Tumor,NA_Sample_KAM12-T_Tumor,,,,,,,,,,,,,,,
Sample_KAM121-T-B,Sample_KAM121-T-B,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM121-T-B_Tumor,NA_Sample_KAM121-T-B_Tumor,,,,,,,,,,,,,,,
Sample_KAM20-T,Sample_KAM20-T,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM20-T_Tumor,NA_Sample_KAM20-T_Tumor,,,,,,,,,,,,,,,
Sample_KAM3-T-A,Sample_KAM3-T-A,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM3-T-A_Tumor,NA_Sample_KAM3-T-A_Tumor,,,,,,,,,,,,,,,
Sample_KAM35-T,Sample_KAM35-T,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM35-T_Tumor,NA_Sample_KAM35-T_Tumor,,,,,,,,,,,,,,,
Sample_KAM38-T-B,Sample_KAM38-T-B,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM38-T-B_Tumor,NA_Sample_KAM38-T-B_Tumor,,,,,,,,,,,,,,,
Sample_KAM53-T,Sample_KAM53-T,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM53-T_Tumor,NA_Sample_KAM53-T_Tumor,,,,,,,,,,,,,,,
Sample_KAM61-T,Sample_KAM61-T,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM61-T_Tumor,NA_Sample_KAM61-T_Tumor,,,,,,,,,,,,,,,
Sample_KAM7-T,Sample_KAM7-T,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM7-T_Tumor,NA_Sample_KAM7-T_Tumor,,,,,,,,,,,,,,,
Sample_KAM78-T-III,Sample_KAM78-T-III,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM78-T-III_Tumor,NA_Sample_KAM78-T-III_Tumor,,,,,,,,,,,,,,,
Sample_KAM82-T-B8,Sample_KAM82-T-B8,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM82-T-B8_Tumor,NA_Sample_KAM82-T-B8_Tumor,,,,,,,,,,,,,,,
Sample_KAM84-T,Sample_KAM84-T,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM84-T_Tumor,NA_Sample_KAM84-T_Tumor,,,,,,,,,,,,,,,
Sample_KAM94-T,Sample_KAM94-T,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM94-T_Tumor,NA_Sample_KAM94-T_Tumor,,,,,,,,,,,,,,,
Sample_KAM96-T,Sample_KAM96-T,,,,,,,,Kapa3_BB88,BB88_SeqL,BB88_CL,Tumor,NimV3,Sample_KAM96-T_Tumor,NA_Sample_KAM96-T_Tumor,,,,,,,,,,,,,,,